Annexure-1 Patents Granted for Drugs (Products and Processes)

Home , Benzothiazole, Betahistine, Lafutidine, Levosulpiride, Mizolastine, Substituted benzofuran

ANNEXURE‐1‐ Patents Granted for Drugs/Medicines (Products and Processes) related to fields of Chemicals and Biotechnology during last 3 years and current year . Application_number Patent_date_Of_G TITLE_OF_INVENTION PATENT_NUMBER rant 1432/MUMNP/2010 01‐04‐2016 A METHOD OF ADAPTING THE PROCEDURE FOR EPICUTANEOUS 272455 DESENSITIZATION 1844/KOLNP/2008 01‐04‐2016 [4‐(6‐HALO‐7‐SUBSTITUTED ‐2,4‐DIOXO‐1,4‐DIHYDRO‐2H‐ 272457 QUINAZOLIN‐3‐YL)‐PHENYL]‐5‐CHLORO‐THIOPHEN‐2‐YL‐ SULFONYLUREAS AND FORMS AND METHODS RELATED THERETO 2284/CHE/2007 05‐04‐2016 STILBENE BASED COMPOUNDS AS HDAC INHIBITORS 272490 306/DELNP/2009 05‐04‐2016 "A COMPOSITION FOR ENHANCING EXECUTIVE COGNITIVE 272500 FUNCTION IN A HEALTHY HUMAN SUBJECT" 3512/KOLNP/2008 05‐04‐2016 BIFUNCTIONAL HISTONE DEACETYLASE INHIBITORS 272514 3451/DELNP/2006 07‐04‐2016 "VINFLUNINE PHARMACEUTICAL COMPOSITION AND PROCESS FOR 273980 PREPARING THE SAME." 2481/MUM/2008 10‐04‐2016 PREPARATION OF PHENYLACETIC ACID DERIVATIVE 276185 2019/MUM/2008 12‐04‐2016 STABLE ORAL ATORVASTATIN FORMULATION AND PROCESS OF ITS 272594 PREPARATION 4334/DELNP/2008 12‐04‐2016 “A LENTIVIRAL VECTOR‐BASED VACCINE” 272595 118/DELNP/2009 12‐04‐2016 “STABLE LAQUINIMOD PREPARATIONS” 272596 4129/KOLNP/2009 12‐04‐2016 RECONSTITUTED SURFACTANTS HAVING IMPROVED PROPERTIES 272602

2218/CHE/2007 13/04/2016 CARBON NANOSPHERE‐N‐(4‐CHLORO‐3‐TRIFLUOROMETHYL‐ 272637 PHENYL)‐2‐ETHOXY‐6‐PENTADECYLBENZAMIDE COMPOSITION AND A PROCESS THEREOF 1876/KOLNP/2010 13‐04‐2016 COMPOSITIONS AND METHODS FOR TREATING DISEASES OF THE 272623 NAIL 3140/CHENP/2006 13‐04‐2016 PHARMACEUTICAL COMPOSITIONS COMPRISING IBOPAMINE 272638 MALEATE AND PROCESS FOR PREPARING THE SAME 1106/MUM/2010 18‐04‐2016 CINAMIC COMPOUNDS AND DERIVATIVES THEREFROM FOR THE 272653 INHIBITION OF HISTONE DEACETYLASE 3893/KOLNP/2007 18‐04‐2016 A METHOD FOR PRODUCING AN EXTRACT OF GINKGO BILOBA 272655 HAVING A REDUCED CONTENT OF 4'‐O‐METHYL PYRIDOXINE AND BIFLAVONES 2754/DELNP/2009 18‐04‐2016 "A METHOD OF MAKING STANNSOPORFIN AND STANNSOPORFIN 272659 SO PRODUCED" 679/DELNP/2009 19‐04‐2016 "PHARMACEUTICAL COMPOSITIONS 457" 272674 266/MUM/2011 19‐04‐2016 LIPOPOLYMERIC NANOCAPSULES FOR DELIVERING HYDROPHOBIC 272675 DRUGS 131/MUM/2006 19‐04‐2016 NOVEL 11β‐HYDROXYANDROSTA‐4‐ENE‐3‐ONES 272676 52/MUMNP/2011 20‐04‐2016 “A NATURAL ALLICIN TABLET AND PREPARATION METHOD 272692 THEREOF” 478/DELNP/2011 22/04/2016 "THE USE OF WNT5‐A PEPTIDE DERIVATES FOR THE TREATMENT OF 272745 MELANOMA AND GASTRIC CANCER" 1352/MUM/2006 25‐04‐2016 ANTIMICROBIAL DERIVATIVES OF ANACARDIC ACID AND PROCESS 272748 FOR PREPARING THE SAME 358/MUMNP/2009 25‐04‐2016 “MODIFIED ERYTHROPOIETIN” 272749 2190/MUM/2011 26‐04‐2016 "A NANOCOCHLEATE ‐NANOSPHERE COMPLEX" 272767 212/MUM/2010 26‐04‐2016 COMPLEXED ANTIBODY‐SUBSTRATE NANO‐PARTICULATES FOR 272769 BINDING OF CHROMATIN FRAGMENTS 523/MUM/2007 26‐04‐2016 A METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION 272779 COMPRISING FLUCONAZOLE 146/MUM/2012 26‐04‐2016 TRANSNASAL MICROEMULSION OF AN ANTISPASTIC AGENT 272781 518/KOLNP/2009 27‐04‐2016 METHODS OF SYNTHESIS AND/OR PURIFICATION OF 272791 DIAMINOPHENOTHIAZINIUM COMPOUNDS 1664/KOLNP/2007 27‐04‐2016 AN OPHTHALMIC OIL‐IN‐WATER EMULSION 272797 1113/MUM/2008 27‐04‐2016 COMBINED MEASLES‐HUMAN PAPILLOMA VACCINE FOR 272803 THERAPEUTIC AND PROPHYLACTIC USE

Page 1 of 85 4028/DELNP/2009 27‐04‐2016 “PROCESS FOR MANUFACTURING OPHTHALMIC OIL‐IN‐WATER 272807 EMULSIONS” 2078/MUM/2007 28/04/2016 STABLE PHARMACEUTICAL COMPOSITIONS OF CALCITRIOL AND 272821 MINERAL SUPPLEMENTS 2728/KOLNP/2007 28‐04‐2016 A PROCESS FOR THE PRODUCTION OF A TABLET 272820 212/DELNP/2011 03‐05‐2016 "MULTIPHASE PERSONAL CARE COMPOSITION WITH ENHANCED 272918 DEPOSITION" 8751/DELNP/2007 04‐05‐2016 "A HOMOGENEOUS PHARMACEUTICAL COMPOSITION FOR 272946 TREATING INFLAMMATORY DISORDER" 3849/CHENP/2008 06‐05‐2016 A READY TO DRINK LIQUID FOR ALZHEIMER PATIENTS 272979 1992/DEL/2008 06‐05‐2016 "1,2,4,5‐TETRAHYDRO‐3H‐BENZAZEPINE COMPOUNDS, A PROCESS 272987 FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM" 2271/KOLNP/2009 09‐05‐2016 HETEROCYCLIC RECEPTOR AGONISTS FOR THE TREATMENT OF 272993 DIABETES AND METABOLIC DISORDERS 2707/DELNP/2007 11‐05‐2016 "COMBINATIONS OF NICOTINIC ACETYLCHOLINE ALPHA 7 273041 RECEPTOR AGONISTS" 1919/CHENP/2008 12‐05‐2016 PHYSICALLY AND CHEMICALLY STABLE, WATER‐SOLUBLE, 273059 AMPHIPHILIC POLYMER‐PDGF COMPLEX AND A METHOD THEREOF

4187/KOLNP/2008 16‐05‐2016 ANTIFUNGAL AGENTS 273093 7490/DELNP/2006 18‐05‐2016 "PHARMACEUTICAL COMPOSITIONS FOR DRUG DELIVERY" 273120 1702/MUM/2009 19‐05‐2016 WATER‐BASED ANTI‐LICE PHARMACEUTICAL COMPOSITIONS AND 273136 THE PROCESS FOR PREPARING THE SAME 1945/MUMNP/2007 23‐05‐2016 A COMPOSITION FREE FROM PRESERVING AGENT AND PARTICLES 273167

2067/KOLNP/2008 24‐05‐2016 AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS 273186 741/MUMNP/2008 25‐05‐2016 A COMPOSITION THAT COMPRISES DISACCHARIDE 273212 573/DELNP/2009 26/05/2016 "N‐TERMINAL DERIVATISATION OF PROTEINS WITH 273231 POLYSACCHARIDES" 2318/DELNP/2009 27‐05‐2016 "AN IpaD POLYPEPTIDE AND KIT THEREOF" 273263 4515/DELNP/2009 30/05/2016 POLYPEPTIDE FILMS AND METHODS 273297 7300/DELNP/2007 31‐05‐2016 "VACCINE" 273328 369/CHE/2010 31‐05‐2016 A THIN FILM DRUG DELIVERY SYSTEM AND A PROCESS FOR MAKING 273337 THE SAME 2501/DELNP/2010 31‐05‐2016 "HYDROXYAPATITE‐TARGETING MULTIARM POLYMERS AND 273340 CONJUGATES MADE THEREFROM" 1170/MUMNP/2010 03‐06‐2016 PERSONAL CARE COMPOSITION 273405 1707/KOLNP/2008 07‐06‐2016 METHOD FOR PREPARING A FAXTOR IX FORMULATION 273436 4563/DELNP/2009 08‐06‐2016 "A linear cyclodextrin containing polymer conjugate " 273456 2025/MUMNP/2010 09‐06‐2016 PROCESS FOR THE PREPARATION OF DONEPEZIL HYDROCHLORIDE 273476

477/MUMNP/2009 09‐06‐2016 COMPOSITION FOR PROMOTING ACTIVITY OF ANTI‐CANCER 273477 THERAPIES 2051/MUMNP/2008 12‐06‐2016 SKIN LIGHTENING AGENTS, COMPOSITIONS AND METHODS 277929 37/MUMNP/2010 14‐06‐2016 PIPERIDINE/PIPERAZINE DERIVATIVES 273531 5131/DELNP/2009 15‐06‐2016 "PHARMACEUTICAL COMPOSITION FOR TREATING INFLUENZA 273554 VIRUS INFECTION" 1994/CHE/2006 15‐06‐2016 AN IMPROVED PROCESS FOR PREPARING ROSUVASTATIN CALCIUM 273564

2266/DEL/2009 16‐06‐2016 "USE OF IVABRADINE AS DIAGNOSTIC AGENT IN THE METHOD OF 273579 CORONARY ANGIOGRAPHY BY MULTISLICE COMPUTED TOMOGRAPHY" 7760/DELNP/2009 17‐06‐2016 "Valproate, dicloroacetate and alkyl phosphate esters of honokiol 273597 and their use in the treating cancers" 690/MUM/2008 20‐06‐2016 FORMULTION CONTAINING ANTIARRHYTHMIC DRUG 273623 1780/KOLNP/2009 21‐06‐2016 DICLOFENAC GEL 273641 692/MUM/2008 21‐06‐2016 ENTERIC COATED COMPOSITION OF PANTOPRAZOLE 273642

Page 2 of 85 2714/MUMNP/2008 21‐06‐2016 A BIOADHESIVE CONTROLLED RELEASE MONOLITHIC TABLET FOR 273646 THE TREATMENT OF FEMALE GENITAL DISORDERS 68/DELNP/2008 22‐06‐2016 PROCESS FOR SYNTHESIZING A CETP INHIBITOR. 273675 1008/CHE/2005 24‐06‐2016 NEW IMPROVED GEL FORMULATION 273717 3327/CHENP/2008 24‐06‐2016 RECOMBINANT MONOVALENT ANTIBODIES AND METHODS FOR 273720 PRODUCTION THEREOF 1327/MUM/2005 27‐06‐2016 IMPROVED COMPOSITIONS FOR CANCER THERAPY 273763 3052/DELNP/2008 28‐06‐2016 "INTERLEUKIN‐13 ANTIBODY COMPOSITION" 273776 10732/DELNP/2008 29‐06‐2016 FIBER‐REINFORCED COMPOSITES AND METHOD FOR THE 273818 MANUFACTURE THEREOF 8968/DELNP/2007 29‐06‐2016 "LIPID CONSTRUCT FOR DELIVERY OF INSULIN TO A MAMMAL" 273815 1074/KOL/2008 30‐06‐2016 A METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION 273880 FOR TREATMENT OF PSORIASIS 4529/DELNP/2007 30‐06‐2016 "A METHOD FOR STABILIZING DONEPEZIL OR A PHARMACEUTICAL 273889 SALT THEREOF" 4148/CHENP/2008 01‐07‐2016 COMPOSITION, PROCESS FOR PREPARATION AND METHOD OF USE 273958

1810/DELNP/2008 04‐07‐2016 "An aqueous, stable, sterile argatroban composition" 273991 3739/CHENP/2009 10‐07‐2016 “AN HBV VACCINE AND A PROCESS OF PREPARING THE SAME” 276267 911/CHENP/2008 11‐07‐2016 PHOSPHONATED RIFAMYCINS 274081 4652/DELNP/2007 11‐07‐2016 'COMPOSITIONS COMPRISING ORNITHINE AND PHENYLACETATE OR 274090 PHENYLBUTYRATE FOR TREATING HEPATIC ENCEPHALOPATHY'

481/MUM/2010 11‐07‐2016 "AN IMPROVED PROCESS FOR THE PREPARATION OF HMG‐COA 274096 REDUCTASE INHIBITORS VIA CHIRAL DIOL SULFONES INTERMEDIATES" 265/KOLNP/2010 12‐07‐2016 PROCESS FOR THE PREPARATION OF CONTROLLED‐RELEASE SOLID 274107 FORMULATIONS CONTAINING OXCARBAZEPINE, AND FORMULATIONS OBTAINABLE BY SAID PROCESS 429/MUMNP/2010 12‐07‐2016 POLYPEPTIDE, MATRIX AND METHOD OF INDUCING EX VIVO TISSUE 274118 FORMATION 718/MUMNP/2010 12‐07‐2016 COMPLEX COMPRISING SOLUBLE FRAGMENT OF INFLUENZA VIRUS 274124 PB2 PROTEIN CAPABLE OF BINDING RNA‐CAP 3420/DELNP/2008 13‐07‐2016 METHOD OF INHIBITING THE PROLIFERATION AND MIGRATION OF 274146 HELICOBACTER PYLORI 1196/DEL/2010 14‐07‐2016 SALBUTAMOL PATCH AND A PROCESS OF PREPARATION THEREOF 274160

7665/DELNP/2009 14‐07‐2016 "BENEFIT AGENT CONTAINING DELIVERY PARTICLE" 274161 6760/DELNP/2007 14‐07‐2016 "PHARMACEUTICAL FORMS WITH IMPROVED PHARMACOKINETIC 274179 PROPERTIES" 4366/CHENP/2008 14‐07‐2016 PHARMACEUTICAL COMPOSITION AND A SOFT GELATIN CAPSULE 274184 FORMULATION COMPRISING A BI‐CYCLIC COMPOUND 1902/DELNP/2008 15‐07‐2016 "POLYSACCHARIDE VACCINE FOR STAPHYLOCOCCAL INFECTIONS" 274200

1295/KOLNP/2009 15‐07‐2016 METHODS OF SYNTHESIZING PHARMACEUTICAL SALTS OF A 274223 FACTOR XA INHIBITOR 1951/DELNP/2009 15‐07‐2016 "VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT" 274225 5462/DELNP/2007 15‐07‐2016 "ANTITUMOR AGENT" 274234 1610/MUMNP/2009 19‐07‐2016 A PROCESS OF PREPARING CRYSTALLINE POLYMORPHIC FORMS OF 274275 COUMPOUND I 140/MUM/2009 21‐07‐2016 CONTROLLED RELEASE CHRONOTHERAPEUTIC PHARMACEUTICAL 274321 COMPOSITION 255/CHE/2006 22‐07‐2016 AN IMPROVED PROCESS FOR THE PREPARATION OF DONEPEZIL 274375 HYDROCHLORIDE 1367/CHENP/2008 22‐07‐2016 COMPOSITIONS FOR STIMULATING NEUROGENESIS AND 274385 INHIBITING NEURONAL DEGENERATION 64/MUM/2010 22‐07‐2016 PROCESSES FOR THE PREPARATION OF ENTACAPONE POLYMORPHS 274386

6040/DELNP/2007 23‐07‐2016 "A GLYCERIN‐FREE DEXIBUPROPEN COMPOSITION AND A METHOD 274402 THEREOF"

Page 3 of 85 36/MUMNP/2010 25‐07‐2016 PIPERIDINE/PIPERAZINE DERIVATIVES 274409 1937/MUMNP/2008 25‐07‐2016 CRUSH‐RESISTANT OXYCODONE TABLETS INTENDED FOR 274418 PREVENTING ACCIDENTAL, MISUSE AND UNLAWFUL DIVERSION 2612/DEL/2013 25‐07‐2016 "A PROCESS FOR PREPARATION OF NON‐LIQUID CHEWABLE 274429 PARTICULATE MOUTH COOLANT" 2500/DEL/2013 25‐07‐2016 "A PROCESS FOR PREPARATION OF SLOW RELEASE CHEWABLE 274438 BREATH FRESHENER COMPOSITION" 2032/CHE/2007 26‐07‐2016 SKIN CARE / LIGHTENING AGENT BASED ON PROTOCATECHUIC ACID 274460 DERIVATIVES AND COMPOSITIONS THEREOF 1221/MUMNP/2009 27‐07‐2016 ANTIBACTERIAL QUINOLINE DERIVATIVES 274511 1068/MUMNP/2009 29‐07‐2016 ACYLAMINOPYRAZOLES AS FGFR INHIBITORS 274580 6016/DELNP/2009 29‐07‐2016 "A CONJUGATE OF INSULIN AND VITAMIN B12 FOR ORAL DELIVERY" 274582

2360/DELNP/2008 29‐07‐2016 "COMPOSITION BASED ON MINERAL CONCENTRATES DERIVED FOR 274602 PRECIOUS STONES" 635/DELNP/2008 29‐07‐2016 "SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS FOR 274605 HIGHLY WATER SOLUBLE DRUGS" 545/DEL/2009 30‐07‐2016 "ATTRACTANT COMPOSITION FOR BED BUGS 274635 1247/KOLNP/2009 02‐08‐2016 PROBIOTIC ORAL DOSAGE FORMS 274654 2193/KOLNP/2009 02‐08‐2016 A PROCESS FOR PREPARATION OF A SUSTAINED‐RELEASE 274669 COMPOSITION OF A MICROCAPSULE 322/KOLNP/2011 02‐08‐2016 PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, 274674 INFLAMMATORY AND INFECTIOUS DISEASES 6015/CHENP/2009 05‐08‐2016 PROCESS FOR MAKING GALANTAMINE 274735 2558/MUMNP/2010 05‐08‐2016 A POLYMERIC CONJUGATE , 274737 4853/DELNP/2009 08‐08‐2016 "VEGETARIAN MICROCAPSULES" 274755 1753/MUMNP/2010 08‐08‐2016 CATIONIC COPOLYMERS FORMULATED WITH PIGMENTED 274758 COSMETIC COMPOSITIONS EXHIBITING RADIANCE WITH SOFT FOCUS 2457/CHENP/2009 08‐08‐2016 CANINE LYME DISEASE VACCINE 274768 3297/CHENP/2006 09‐08‐2016 A SUBSTITUTED MORPHOLINE COMPOUND 274781 510/CHENP/2009 09‐08‐2016 POLYMERIZABLE DENTAL MATERIAL 274786 1756/MUM/2009 10‐08‐2016 AN AQUEOUS COMPOSITION SUITABLE FOR INTRANASAL DRUG 274812 DELIVERY 5149/DELNP/2010 11‐08‐2016 "METHOD FOR THE PRODUCTION OF PELLETS FOR AN ACTIVE 274840 SUBSTANCE AND PHARMACEUTICAL FORMULATION" 2443/MUMNP/2011 11‐08‐2016 PARTICULATE MATERIAL FOR CONTROLLED RELEASE OF ACTIVE 274843 INGREDIENTS 2360/CHE/2006 11‐08‐2016 XENO‐FREE AND FEEDER FREE CULTURE CONDITIONS FOR HUMAN 274858 EMBRYONIC STEM CELLS AND METHODS THEREOF 1266/CHENP/2010 11‐08‐2016 HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN NERVE GROWTH 274868 FACTOR 937/DELNP/2009 11‐08‐2016 "TRIAZINE DERIVATIVES AS SODIUM CHANNEL BLOCKERS AND 274872 ANTIFOLATES" 3588/DELNP/2011 11‐08‐2016 "NOVEL METHOD FOR PREPARING GRANULATES OF ACTIVE 274880 PRINCIPLES, AND GRANULATES OBTAINED THEREOF" 656/DEL/2009 11‐08‐2016 "MULTIPLE ACTION SUSTAINED RELEASE HYBRID CONJUGATE" 274883 2713/MUM/2009 16/08/2016 TOPICAL MEDICINAL FORMULATION 274950 2049/MUMNP/2010 16‐08‐2016 HIGH INTERNAL PHASE WATER‐IN‐OIL EMULSION COMPOSITION 274961

923/CHE/2006 16‐08‐2016 "3‐(HETEROCYCLYL)‐N‐(ARYLSULFONYL)INDOLE DERIVATIVES AS 274974 FUNCTIONAL 5‐HT6 LIGANDS" 942/MUM/2008 17‐08‐2016 A PROCESS OF PREPARING FREE FLOWING POLYACRYLIC ACID 274978 GRANULES 7313/CHENP/2010 17‐08‐2016 RECOMBINANT CHIMERIC ANTIGENS FOR DIAGNOSIS OF SCRUB 274995 TYPHUS

Page 4 of 85 3272/CHENP/2008 18‐08‐2016 A NUCLEAR RECEPTOR BINDING AGENT 3‐FLUORO‐N‐(4‐ 275013 FLUOROPHENYL)‐4‐HYDROXY‐N‐(4‐HYDROXYPHENYL)BENZAMIDE

4630/DELNP/2009 22‐08‐2016 "LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR 275058 MANUFACTURING THE SAME" 3305/CHE/2008 22‐08‐2016 CONTROLLED RELEASE FORMULATIONS OF ANTI‐TUBERCULAR 275061 DRUGS USING DIFFERENT BIODEGRADABLE NATURAL POLYMERS 423/KOLNP/2006 22‐08‐2016 RAPIDLY DISINTEGRATING TASTE‐MASKED TABLET 275079 2499/DEL/2013 22‐08‐2016 "A PROCESS FOR PREPARATION OF A DENTAL HEALTH 275091 COMPOSITION" 3311/DELNP/2007 24/08/2016 "TRANSDERMAL DELIVERY SYSTEMS FOR EXTENDED RELEASE OF 275134 SUFENTANIL" 799/KOLNP/2010 26‐08‐2016 PHARMACEUTICAL COMPOSITIONS CONTAINING DOPAMINE 275181 RECEPTOR LIGANDS AND METHODS OF TREATMENT USING DOPAMINE RECEPTOR LIGANDS 7988/DELNP/2006 26‐08‐2016 "PHOSPHOLIPID GEL COMPOSITIONS FOR DRUG DELIVERY AND 275182 METHODS OF TREATING CONDITIONS USING SAME" 3156/DELNP/2008 26‐08‐2016 TRIAZOLE DERIVATIVES AS INHIBITORS OF 11‐BETA‐ 275190 HYDROXYSTEROID DEHYDROGENASE‐1 3916/CHENP/2007 26‐08‐2016 CHEMICALLY DEFINED VACCINE STABILIZER 275195 7133/DELNP/2008 26‐08‐2016 "MICROSPHERES COMPRISING NANOCAPSULES CONTAINING A 275196 LIPOPHILIC DRUG" 1875/KOLNP/2010 29‐08‐2016 NANOEMULSIONS 275218 6172/DELNP/2008 29‐08‐2016 "MATERIAL" 275230 3451/KOLNP/2010 30‐08‐2016 PYRROLIDINE DERIVATIVES 275254 5249/DELNP/2009 30‐08‐2016 WOUND DRESSING WITH A BACTERIAL ADSORBING COMPOSITION 275256 AND MOISTURE HOLDING SYSTEM 2598/DEL/2008 30‐08‐2016 QUINAZOLINONE LINKED PYRROLO[2,1‐C][1,4]BENZODIAZEPINE 275269 HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF 41/MUMNP/2011 30‐08‐2016 LIQUID CLEANSING COMPOSITIONS COMPRISING MICROFIBROUS 275270 CELLULOSE SUSPENDING POLYMERS 2701/DEL/2011 31/08/2016 HERBAL LEECH REPELLANT SPRAY FORMULATION AND A PROCESS 275383 FOR PREPARATION THEREOF 2239/DELNP/2008 31‐08‐2016 "COMPOSITION COMPRISING AT LEAST ONE NAPHTHOIC ACID 275336 DERIVATIVE AND AT LEAST ONE COMPOUND OF POLYURETHANE POLYMER TYPE OR DERIVATIVES THEREOF, PREPARATION PROCESSES THEREFOR AND USES THEREOF" 2589/KOLNP/2009 31‐08‐2016 MAPK/ERK KINASE INHIBITORS 275359 4133/DELNP/2008 31‐08‐2016 "FUNCTIONAL INFLUENZA VIRUS LIKE PARTICLES (VLPS)" 275385 7579/DELNP/2008 05‐09‐2016 "Mono‐substituted furanyl‐ or thiopheneyl‐n‐oxysulfonamides 275455 compound of formula(Vx)” 6840/DELNP/2008 06‐09‐2016 "ANTI‐INFECTIVE SOLUTION COMPRISING A COMPOUND OF 275471 PYRIDO (3,2,1‐IJ)‐BENZOXADIAZINE TYPE" 2632/DELNP/2012 07‐09‐2016 "HEPARANASE ACTIVITY INHIBITOR" 275486 4048/CHENP/2008 08‐09‐2016 PHARMACEUTICAL COMPOSITIONS COMPRISING MIXTURES OF 274779 POLYMERS AND ACTIVE INGREDIENTS SPARINGLY SOLUBLE IN WATER 2763/MUM/2010 08‐09‐2016 "NOVEL CIPROFLOXACIN OTIC SOLUTIONS" 274795 2427/CHENP/2008 09‐09‐2016 FLUORESCENT NANOPARTICLES 275540 1479/MUM/2009 12‐09‐2016 A PROCESS FOR SYNTHESIS OF DIARYLPYRIMIDINE NON‐ 275560 NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR 2508/KOLNP/2006 12‐09‐2016 COMBINED MEDICAMENT COMPRISING A VECTOR OF AN ISOLATED 275575 POLYNUCLEOTIDE, ENCODING AN ENZYME THAT CONVERTS A PRODRUG INTO AN ACTIVE CYTOTOXIC COMPOUND

3914/DELNP/2011 13‐09‐2016 "PERFUME SYSTEMS" 275594 6986/DELNP/2006 14‐09‐2016 "A COATED TABLET COMPRISING A TABLET CORE" 275601 1855/MUMNP/2008 15‐09‐2016 DUAL PHASE ABRASIVE TOOTHPASTE COMPOSITION 275618

Page 5 of 85 690/KOL/2008 15‐09‐2016 A BASIS PARTICLE AND A METHOD FOR MANUFACTURING THE 275630 SAME. 696/DEL/2008 15‐09‐2016 A METHOD FOR THE PREPARATION OF FENTANYL 275640 6594/CHENP/2008 19‐09‐2016 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF 275692 PHENYEPHRINE 5300/CHENP/2008 20‐09‐2016 PHARMACEUTICAL FORMULATIONS COMPRISING CRYSTALLINE 275738 HYDROCHLORIDE MONOHYDRATE SALT OF SALT OF (5S,8S)‐ 8‐[{ (1R)‐1‐‐(3,5 ‐ BIS‐ (TRIFLUOROMETHY)PHENYL]‐ETHOXY}‐METHYL]‐8‐ PHENYL‐17‐DIAZA‐SPIRO[4 5]DECAN‐2‐ONE 381/MUM/2009 21‐09‐2016 PHARMACEUTICAL FORMULATIONS OF TELMISARTAN AND 275761 PROCESS FOR PREPARING THE SAME 485/DELNP/2011 22/09/2016 "USE OF OPIOID ANTAGONISTS FOR TREATING URINARY 275826 RETENTION" 1343/DELNP/2011 22‐09‐2016 "FILM PREPARATION CONTAINING LOPERAMIDE HYDROCHLORIDE" 275787

1118/DEL/2007 22‐09‐2016 "PHARMACEUTICAL COMPOSITIONS OF NEVIRAPINE AND 275805 STAVUDINE AND PROCESS OF PREPARATION THEREOF" 3789/DELNP/2008 23‐09‐2016 “EXTERNAL PREPARATION FOR SKIN CONTAINING A 275847 PHOSPHORYLATED SACCHARIDE" 4915/DELNP/2010 24‐09‐2016 "OPHTHALMIC COMPOSITIONS WITH AN AMPHOTERIC 275883 SURFACTANT AND HYALURONIC ACID" 5338/DELNP/2011 25‐09‐2016 “PHARMACEUTICAL COMPOSITION CONTAINING AN ANIONIC 275891 DRUG, AND A PRODUCTION METHOD THEREFOF” 3567/CHENP/2008 26‐09‐2016 THERMOREVERSIBLE OIL‐IN‐WATER EMULSION 275900 1313/DELNP/2006 27‐09‐2016 "NOVEL GLP‐1 DERIVATIVES" 275964 9973/DELNP/2007 27‐09‐2016 "A PHARMACEUTICAL COMPOSITION FOR TOPICAL 275970 ADMINISTRATION" 1936/MUM/2006 28‐09‐2016 NOVEL LYOPHILIZED AND STABILIZED FORMULATIONS OF PEG‐ 275974 INTERFERON ALPHA CONJUGATES 154/MUM/2010 28‐09‐2016 A METHOD OF SCREENING /IDENTIFYING AEGLE MARMELOS 275977 DERIVED AEGELINE ACETYLCHOLINESTERASE 1529/MUMNP/2009 28‐09‐2016 A COMPOSITION FOR TREATING XEROSTOMIA 275981 5338/CHENP/2007 28‐09‐2016 RESPONSIVE MRI CONTRAST AGENTS 276002 353/DELNP/2008 29‐09‐2016 "SUSTAINED RELEASE OF ANTIINFECTIVES" 276035 9943/DELNP/2008 29‐09‐2016 "PROCESS FOR THE SYNTHESIS OF (+) AND (‐)‐1‐(3,4‐ 276078 DICHLOROPHENYL)‐3‐AZABICYCLO[3.1.0]HEXANE" 4061/DELNP/2007 29‐09‐2016 "AQUEOUS OPHTHALMIC SUSPENSION OF CRYSTALLINE 276080 REBAMIPIDE" 7095/DELNP/2007 30‐09‐2016 "TOOTH WHITENER" 276116 754/DELNP/2008 30‐09‐2016 "PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF SSDNA 276133 VIRUSES" 2312/KOLNP/2007 05‐10‐2016 NANOPARTICLE COMPOSITION AND METHODS FOR SYNTHESIS 273005 THEREOF 559/MUMNP/2006 05‐10‐2016 MEDICAMENT ON THE BASIS OF HONEY, PREPARATION AND USE 276226 THEREOF 2496/MUMNP/2008 06‐10‐2016 A PHARMACEUTICAL BLOOD GAS NO CARRIER COMPOSITION 276234 167/MUM/2011 06‐10‐2016 A PROCESS FOR THE PREPARATION OF AMORPHOUS FORM OF 276243 VILAZODONE HYDROCHLORIDE 909/MUM/2008 07‐10‐2016 SMART DRUG DELIVERY SYSTEM 276264 3048/MUM/2009 07‐10‐2016 STABILIZED DONEPEZIL FORMULATIONS 276272 262/DELNP/2009 08‐10‐2016 ORAL LIQUID PHARMACEUTICAL COMPOSITION 274817 2639/DEL/2007 10‐10‐2016 AN IMPROVED PROCESS FOR PREPARATION OF TRANS‐3, 4‐ 276287 DIARYLCHROMAN 2587/MUMNP/2008 13‐10‐2016 STABLE PHARMACEUTICAL COMPOSITION CONTAINING DOCETAXEL 276298 AND A METHOD OF MANUFACTURING THE SAME 1597/MUMNP/2010 13‐10‐2016 PLATINUM COMPLEX COMPOUND AND UTILIZATION OF THE SAME 276300

1451/DELNP/2008 14‐10‐2016 "PYRROLOPYRIDINE DERIVATIVES AND USE OF SAME AS PPAR 276310 RECEPTOR MODULATORS" 3593/CHENP/2010 14‐10‐2016 NOVEL IMIDAZOLE‐SUBSTITUTED ARYLAMIDE COMPOUNDS 276322

Page 6 of 85 1652/MUM/2009 14‐10‐2016 A NOVEL HERBAL HYDRO‐GEL COMPOSITION FOR SKIN WOUNDS 276328

805/MUMNP/2011 17‐10‐2016 PHARMACEUTICAL COMPOSITION FOR PREVENTION AND 276357 TREATMENT OF DIABETES OR OBESITY COMPRISING A COMPOUND THAT INHIBITS ACTIVITY OF DIPEPTIDYL PEPTIDASE‐IV, AND OTHER ANTIDIABETIC OR ANTIOBESITY AGENTS AS ACTIVE INGREDIENTS

2343/KOLNP/2010 18‐10‐2016 DRUG DELIVERY SYSTEM FOR ADMINISTRATION OF A WATER 276371 SOLUBLE, CATIONIC AND AMPHIPHILIC PHARMACEUTICALLY ACTIVE SUBSTANCE 1130/MUM/2010 18‐10‐2016 NOVEL HYPOGLYCEMIC COMPOUNDS 276375 2472/KOLNP/2010 18‐10‐2016 COMPRESSED CHEWING GUM TABLET 276386 1188/KOL/2009 19‐10‐2016 AMINO ACID MOISTURISER 276395 968/KOL/2007 19‐10‐2016 PHARMACEUTICAL COMPOSITIONS OF RIFAXIMIN 276412 1590/MUMNP/2010 20‐10‐2016 “PHARMACEUTICAL COMPOSITION WITH GELLING PROPERTIES 276429 CONTAINING A TYROSINE DERIVATIVE” 993/CHENP/2009 21‐10‐2016 COSMETIC OR DERMATOLOGICAL PREPARATIONS COMPRISING N‐ 276465 ACETYLCYSTEINE 1599/MUMNP/2010 21‐10‐2016 A PHARMACEUTICAL COMPOSITION 276478 1415/KOLNP/2009 24‐10‐2016 3‐HYDROXY‐1,5‐DIHYDRO‐PYRROL‐2‐ONE DERIVATIVES AS 276495 INHIBITORS OF GLUTAMINYL CYCLASE FOR THE TREATMENT OF ULCER, CANCER AND OTHER DISEASES 3139/DELNP/2010 24‐10‐2016 "ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE 276502 THEREOF" 3101/DELNP/2004 25‐10‐2016 "ORODISPERSABLE PHARMACEUTICAL FORMULATION" 276555 497/CHENP/2009 26‐10‐2016 A COSMETIC METHOD FOR SUNSCREENING HUMAN AND ANIMAL 276583 HAIR AND SKIN 2527/KOLNP/2009 26‐10‐2016 MEDICALLY ACTIVE PLASTER 276603 2325/DELNP/2010 26‐10‐2016 "COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A 276618 POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT METHOD" 6631/DELNP/2010 26‐10‐2016 "HAIR CONDITIONING COMPOSITION" 276624 1190/KOL/2005 26‐10‐2016 A BIOCOMPATIBLE, NON‐BIODEGRADABLE, NON‐TOXIC POLYMER 276626 USEFUL FOR PHARMACEUTICAL PREPARATIONS 123/MUM/2012 27‐10‐2016 A METHOD FOR PREPARING NANOSTRUCTURED CALCIUM SILICATE 276632 AS DRUG DELIVERY AGENT. 4322/KOLNP/2009 28‐10‐2016 DI‐SUBSTITUTED AMIDES FOR ENHANCING GLUTAMATERGIC 276686 SYNAPTIC RESPONSES 58/DEL/2007 28‐10‐2016 AN INDUSTRIAL PROCESS FOR THE PREPARATION OF PURE 276691 ROPINIROLE 6352/DELNP/2009 28‐10‐2016 A Pharmaceutical Formulation Comprising δ‐aminolevulinic Acid 276697 And An Iron Compound 2042/DELNP/2008 31/10/2016 "ANTIFUNGAL COMPOSITION" 276783 3310/DELNP/2010 31‐10‐2016 "OLIGOMER‐TRICYCLIC CONJUGATES" 276777 1449/MUMNP/2010 02‐11‐2016 HYDROPHOBIC MODIFIED PRES‐DERIVED PEPTIDES OF HEPATITIS B 276854 VIRUS (HBV) AND THEIR USE AS HBV AND HDV ENTRY INHIBITORS

2579/DELNP/2011 02‐11‐2016 "CLEANSING FORMULATIONS COMPRISING NON‐CELLULOSIC 276869 POLYSACCHARIDES WITH MIXED CATIONIC SUBSTITUENTS" 5854/DELNP/2009 03‐11‐2016 " A STABLE DIGESTIVE ENZYME COMPOSITIONS HAVING COATED 276890 PARTICLES AND ITS USE THEREOF" 5492/CHENP/2009 04‐11‐2016 "EPILATORY COMPOSITIONS" 276905 812/MUMNP/2011 07‐11‐2016 METHOD FOR PREPARING EXTRACT FRACTION REINFORCED WITH 276936 GINSENOSIDES RG1 OR RB1 FROM GINSENG 907/CHE/2007 07‐11‐2016 A PROCESS FOR THE PREPARATION OF 6‐(5‐CHLOROPYRID‐2‐YL)‐5‐ 276937 (4‐METHYLPIPERAZIN‐1‐YL)‐CARBONYLOXY‐7‐0X0‐5,6‐ DIHYDROPYRROLO‐[3,4‐B]‐PYRAZINE AND IT’S ENETIOMERICALLY ENRICHED ISOMER 5704/CHENP/2008 07‐11‐2016 PEPTIDE COMPLEMENTARY TO ACETYLCHOLINE RECEPTOR AND 276941 COMPOSITIONS COMPRISING THEREOF

Page 7 of 85 5372/DELNP/2008 07‐11‐2016 SUBLIMABLE SUSTAINED RELEASE DELIVERY SYSTEM AND METHOD 276950 OF MAKING SAME 6054/CHENP/2009 07‐11‐2016 “A COMPOSITION AND PROCESS THEREOF” 276959 244/DEL/2003 08‐11‐2016 A CONTRACEPTIVE COMPOSITION 274841 7998/DELNP/2009 08‐11‐2016 "PHARMACEUTICAL SOLID PREPARATION COMPRISING 276983 BENZAZEPINES AND PRODUCTION METHOD THEREOF" 954/CHENP/2010 08‐11‐2016 METHOD FOR DETERMINING EROSIVE POTENTIAL IN SALIVA OF AN 277001 ORAL COMPOSITION AND THE COMPOSITION 8539/DELNP/2010 08‐11‐2016 CONTROLLED RELEASE CORTICOSTEROID COMPOSITIONS AND 277022 METHODS FOR THE TREATMENT OF OTIC DISORDERS 3244/DELNP/2010 08‐11‐2016 "USE OF OLIGOSACCHARIDES CONTAINING N‐ACETYLLACTOSAMINE 277031 FOR MATURATION OF IMMUNE RESPONSES IN NEONATES"

6/CHE/2004 09‐11‐2016 3‐(PYRROLIDIN‐3‐YL)INDOLES AS 5‐HT6 RECEPTORS MODULATORS 277044

2356/CHENP/2008 09‐11‐2016 PREPARATION FOR IONTOPHORESIS 277052 2034/KOLNP/2005 10‐11‐2016 A PHARMACEUTICAL COMPOSITION COMPRISING FACIALLY 277095 AMPHIPHILIC OLIGOMERS 689/KOL/2008 11‐11‐2016 ORALLY‐DISINTEGRATING TABLET AND MANUFACTURING METHOD 277135 THEREOF 532/CHENP/2009 11‐11‐2016 A CONCENTRATED ANTIBIOTIC FORMULATION AND A SOLUTION 277141 5515/DELNP/2009 11‐11‐2016 "STABILIZATION OF VITAMIN B12" 277148 2180/DELNP/2010 11‐11‐2016 "MIXED METAL COMPOUNDS FOR TREATMENT OF HYPERPHOS 277152 PHATAEMIA" 1433/MUMNP/2010 11‐11‐2016 IMMUNOTHERAPEUTIC METHOD FOR INCREASING GROUNDNUT 277159 TOLERANCE IN A SUBJECT 2877/KOLNP/2009 16‐11‐2016 COMPOUNDS FOR THE PREVENTION OF CARDIOVASCULAR 277244 DISEASES 1032/MUMNP/2012 17‐11‐2016 LIPID LAYER FORMING COMPOSITION FOR ADMINISTRATION ONTO 277299 A SURFACE OF A LIVING ORGANISM. 2012/MUM/2007 17‐11‐2016 TOPICAL FORMULATION CONTAINING HALOBETASOL 277300 5399/CHENP/2008 17‐11‐2016 PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE 277303 1016/MUMNP/2010 17‐11‐2016 “NEW THERAPEUTIC APPROACHES FOR TREATING CMT AND 277318 RELATED DISORDERS” 1175/CHENP/2006 18‐11‐2016 An Injectable Pharmaceutical Product 277357 242/DEL/2005 18‐11‐2016 "A PROCESS FOR THE INDUSTRIAL SYNTHESIS OF THE AGOMELATIN 277368 COMPOUND” 21/CHENP/2009 18‐11‐2016 METHOD FOR PRODUCING LIPASE, TRANSFORMED YARROWIA 277386 LIPOLYTICA CELL CAPABLE OF PRODUCING SAID LIPASE AND THEIR USES 3393/CHENP/2010 22‐11‐2016 COMPOSITIONS FOR ENHANCING THE IMMUNOGENICITY OF A 277451 VACCINE 2636/MUM/2011 22‐11‐2016 AN IMPROVED PROCESS FOR PREPARING FESOTERODINE AND ITS 277456 SALT 672/MUM/2011 22‐11‐2016 "CONJOINED LIPID BASED MULTI COMPARTMENT NANOVESICLES 277461 FOR DRUG DELIVERY". 2061/MUM/2007 22‐11‐2016 NOVEL OPHTHALMIC COMPOSITIONS 277467 7035/DELNP/2010 23‐11‐2016 "ORAL COMPOSITIONS COMPRISING SHELLAC WAX AND BLEACHED 277496 SHELLAC FOR USE IN STOMATOLOGY AND DENTAL CARE"

8257/DELNP/2009 23‐11‐2016 "FORMULATION CONTAINING HYDROCARBONS" 277527 1152/KOL/2007 24‐11‐2016 PROCESS FOR THE PREPARATION OFCOMPOSITION CONSISTING OF 277561 AMORPHOUS FORM OF CARVEDILOL DIHYDROGENPHOSPHATE 1999/DEL/2010 24‐11‐2016 A NOVEL FORMULATION TO TRANSDERMALLY DELIVER 277571 ANTIHYPERTENSIVE AGENT WITH PERMEABILITY ENHANCER 125/MUM/2012 24‐11‐2016 "A TRIAZOLE LINKED PICOLYLIMINE CONJUGATE OF CALIX[6]ARENE" 277575

1869/CHE/2006 25‐11‐2016 A PROCESS FOR THE PREPARATION OF CANDESARTAN 277607

Page 8 of 85 2872/MUM/2011 28‐11‐2016 A COMPOUND FOR SKIN AND A METHOD OF MAKING THE SAME 277635

7692/DELNP/2009 28‐11‐2016 “MATRIX‐TYPE TRANSDERMAL DRUG DELIVERY SYSTEM AND 277659 PREPARATION METHOD THEREOF” 4410/DELNP/2009 28‐11‐2016 "A METHOD FOR MAKING AN IMMUNOGENIC CONJUGATE" 277665 3064/KOLNP/2009 28‐11‐2016 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS 277693

3197/KOLNP/2007 29/11/2016 SUBLINGUAL COATED TABLET 277767 272/MUM/2007 29‐11‐2016 A HERBAL COMPOSITION FOR THE PREVENTION AND TREATMENT 277700 OF ENDOPARASITES OR TAPEWORMINFESTATION IN ANIMALS,

10441/DELNP/2008 29‐11‐2016 "COMPOSITIONS OF GLYCOPYRRONIUM SALT FOR INHALATION" 277715

6594/DELNP/2008 29‐11‐2016 “A METHOD FOR IMPROVING THE PHARMACEUTIC PROPERTIES OF 277719 MICROPARTICLES COMPRISING DIKETOPIPERAZINE AND AN ACTIVE AGENT” 413/MUM/2012 30/11/2016 "A GREENER PROCESS FOR THE PREPARATION OF SULFONAMIDE 277772 CHALCONE DERIVATIVES 6355/CHENP/2008 30/11/2016 SPRAYABLE GEL‐TYPE SKIN/MUCOSA‐ADHESIVE PREPARATION AND 277801 ADMINISTRATION SYSTEM USING THE PREPARATION 1379/MUMNP/2012 30‐11‐2016 CIRCULATION OF COMPONENTS DURING MICROFLUIDIZATION 277780 AND/OR HOMOGENIZATION EMULSIONS 7066/DELNP/2007 30‐11‐2016 HUMANIZED L243 ANTIBODIES 277789 1736/CHENP/2009 01‐12‐2016 PERSONAL CARE COMPOSITIONS HAVING DERIVATIZED 277838 QUATERNIZED CELLULOSE ETHERS 8563/DELNP/2010 01‐12‐2016 “STABILIZED TRANSDERMAL DRUG DELIVERY SYSTEM” 277846 2578/MUM/2008 02‐12‐2016 PHARMACEUTICAL FORMULATION 277866 3599/DELNP/2011 02‐12‐2016 "Granulate of gamma‐ hydroxybutyric acid and process of 277875 preparation thereof" 1899/MUMNP/2010 02‐12‐2016 “1,5‐DIPHENYL‐PYRROLIDIN‐2‐ONE COMPOUNDS AS CB‐1 277883 LIGANDS” 6776/DELNP/2009 02‐12‐2016 TRIAZOLE DERIVATIVES WHICH ARE SMO ANTAGONISTS 277884 2014/MUM/2007 05‐12‐2016 AN IMPROVED PROCESS FOR PREPARATION OF PHOSPHATE 277891 BINDING POLYMER 1666/MUMNP/2008 06‐12‐2016 MEDICATED PATCH 277922 1890/CHE/2007 07‐12‐2016 PROCESS FOR THE PREPARATION OF CARBAPENEM ANTIBIOTIC 277942 2411/MUM/2008 07‐12‐2016 ELECTROCHEMICAL COMPOSITION AND ASSOCIATED TECHNOLOGY 277969

1523/MUM/2007 07‐12‐2016 A PROCESS OF LYOPHILIZATION OF A FORMULATION COMPRISING 277981 HIB‐PRT‐TT CONJUGATE 350/MUM/2009 07‐12‐2016 CANCER CELL BINDING RECOMBINANT LECTIN WITH ANTITUMOR 277986 ACTIVITY AND METHOD OF PREPARATION 5452/DELNP/2010 07‐12‐2016 LIQUID FORMULATION OF FSH 277994 4516/KOLNP/2009 08‐12‐2016 METHODS FOR PRODUCING ARIPIPRAZOLE SUSPENSION AND 274907 FREEZE‐DRIED FORMULATION 1431/MUMNP/2010 08‐12‐2016 METHOD AND COMPOSITIONS FOR CUTANEOUS IMMUNISATION 278014

730/KOLNP/2010 09‐12‐2016 PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS 275564 INHIBITORS OF SGLT 9174/DELNP/2007 09‐12‐2016 "PHARMACEUTICAL COMPOSITIONS COMPRISING OF ARSENOUS 278046 ACID, ITS SODIUM SALT AND ITS DERIVATIVES INTENDED FOR THE TREATMENT OF UROGENITAL CANCER AND ITS METASTASIS"

4144/KOLNP/2009 09‐12‐2016 PROCESS FOR OBTAINING STEROIDAL PHOSPHATE COMPOUNDS 278053

3737/DELNP/2009 09‐12‐2016 "Injection solution for treating arthritic disorders" 278054 2587/MUMNP/2010 09‐12‐2016 EXTERNAL PREPARATION FOR SKIN 278058 875/CHENP/2009 09‐12‐2016 PHARMACEUTICAL COMPOSITION WITH CONTROLLED ACTIVE 278062 INGREDIENT DELIVERY FOR ACTIVE INGREDIENTS WITH GOOD SOLUBILITY IN WATER

Page 9 of 85 8211/DELNP/2007 09‐12‐2016 "A DIABODY MOLECULE COMPRISING A FIRST POLYPEPTIDE CHAIN 278072 AND A SECOND POLYPEPTIDE CHAIN" 7696/DELNP/2008 14‐12‐2016 "POLYPEPTIDE USEFUL IN VACCINE PREPARATION FOR LUNG 278095 CANCER" 2005/KOLNP/2010 14‐12‐2016 A METHOD FOR FORMULATING 6‐(5‐FLUORO‐ 2‐(3,4,5‐ 278101 TRIMETHOXYPHENYLAMINO)PYRIMIDIN‐4‐YLAMINO)‐2,2‐ DIMETHYL‐3‐OXO‐2H‐PYRIDO[3,2‐ B][L,4]OXAZIN‐4(3H)‐YL)METHYL PHOSPHATE DISODIUM SALT INTO A FORMULATION FOR TABLET COMPRESSION 2694/MUMNP/2010 14‐12‐2016 SUNSCREEN COMPOSITE PARTICLES IN COSMETIC COMPOSITIONS 278105

2777/DELNP/2009 14‐12‐2016 "A METHOD FOR MAKING A SLOW RELEASE ESTRADIOL 278115 FORMULATION" 608/DEL/2008 14‐12‐2016 C2‐FLUORO SUBSTITUTED PIPERAZINE LINKED PYRROLO[2,1‐ 278139 C)[1,4]BENZODIAZEPINE DIMERS AND A PROCESS FOR THE PREPARATION THEREOF 1377/CHE/2009 15‐12‐2016 ORAL LIQUID COMPOSITIONS OF RESVERATROL OR ITS 278152 PHARMACEUTICALLY ACCEPTABLE SALT 6933/DELNP/2007 16‐12‐2016 "ENDOPARASITICIDAL COMPOSITIONS" 278191 1245/CHE/2006 16‐12‐2016 IMPROVED PROCESS FOR THE PREPARATION OF CEFORANIDE IN 278213 PURE FORM 59/CHENP/2009 16‐12‐2016 BROAD SPECTRUM AND SKIN FRIENDLY DISINFECTING 278216 COMPOSITION 340/KOLNP/2010 19‐12‐2016 A SKIN DRESSING WITH NITRITE SALT 278238 4230/DELNP/2008 19‐12‐2016 "TRANSDERMAL THERAPEUTIC SYSTEM" 278261 4342/KOLNP/2007 19‐12‐2016 ORAL DELIVERY DEVICES FOR COLONIC RELEASE OF ADSORBENTS 278272

4527/CHENP/2010 20/12/2016 HIGH CONCENTRATION ANTIBODY‐CONTAINING LIQUID 278326 FORMULATION 6556/DELNP/2008 20‐12‐2016 "COMPOSITIONS AND METHODS FOR THE TREATMENT AND 278276 PREVENTION OF DISEASE" 6640/CHENP/2008 20‐12‐2016 OXOPYRIDINE COMPOUDS AS P38 MAP KINASE INHIBITORS 278314 3650/CHENP/2007 20‐12‐2016 A COMBINATION OF A CYTOTOXIC COMPOUND AND PYRAZOLE 278316 COMPOUNDS 5058/DELNP/2009 21‐12‐2016 "INHIBITORS OF AKT ACTIVITY" 278395 3413/DELNP/2011 21‐12‐2016 "ORAL CARE COMPOSITIONS COMPRISING SPHERICAL FUSED 278351 SILICA" 9296/DELNP/2007 22‐12‐2016 "A COMPOUND OF FORMULA IV" 278409 2437/KOLNP/2011 23/12/2016 PREPARATION METHOD OF POLYMERIC MICELLES COMPOSITION 278479 CONTAINING A POORLY WATER‐SOLUBLE DRUG 6094/DELNP/2005 23‐12‐2016 "RESOLUTION OF ALPHA‐(PHENOXY) PHENYLACETIC ACID 278459 DERIVATIVES" 6085/DELNP/2010 23‐12‐2016 "OXADIAZOANTHRACENE COMPOUNDS FOR THE TREATMENT OF 278473 DIABETES" 7373/DELNP/2010 26‐12‐2016 "TETRAZOLE COMPOUNDS FOR REDUCING URIC ACID" 278529 3716/DELNP/2008 26‐12‐2016 "An EGFRvIII peptide and temzolomide" 278538 8255/DELNP/2009 26‐12‐2016 HYDROCARBON MIXTURES AND USE THEREOF 278571 8909/DELNP/2010 26‐12‐2016 “COMBINATION OF PILOCARPIN AND METHIMAZOL FOR TREATING 278573 CHARCOT‐MARIETOOTH DISEASE AND RELATED DISORDERS”

1317/DEL/2008 26‐12‐2016 IMPROVED PROCESS FOR PRODUCING S‐OMEPRAZOLE 278588 MAGNESIUM IN AMORPHOUS FORM 2904/DELNP/2004 27‐12‐2016 Process for the Preparation of a Composition comprising IL‐18 278617 Inhibitor 7799/DELNP/2009 27‐12‐2016 "VACCINE PEPTIDE COMBINATIONS AGAINST CAT ALLERGY" 278624 1367/CHE/2011 27‐12‐2016 IMMUNOGENIC COMPOSITION FOR LYMPHATIC FILARIAL VACCINE 278637

4364/DELNP/2009 28/12/2016 “AN INSULINOTROPIC COMPLEX USING AN IMMUNOGLOBULIN 278654 FRAGMENT”

Page 10 of 85 6678/DELNP/2007 28‐12‐2016 "PHARMACEUTICALLY ACTIVE PHOSPHATE BINDERS, THEIR 278666 MANUFACTURE, COMPOSITIONS CONTAINING THEM AND THEIR USE" 2605/KOLNP/2008 28‐12‐2016 FGF‐RECEPTOR AGONIST DIMERIC COMPOUNDS 278672 4714/DELNP/2007 28‐12‐2016 "A LIQUID PHARMACEUTICAL FORMULATION" 278673 8331/DELNP/2007 28‐12‐2016 "PRODUCTION OF GLUCOSAMINE FROM PLANT SPECIES" 278680 8304/DELNP/2008 28‐12‐2016 "A COMPOSITION COMPRISING AN AQUEOUS LUBRICANT BASE" 278692

7700/DELNP/2007 28‐12‐2016 "ANTI ‐ INFLAMMATORY FORMULATION" 278700 1246/CHE/2006 29‐12‐2016 IMPROVED PROCESS FOR THE PREPARATION OF CEFEPIME 278712 INTERMEDIATE 7813/DELNP/2007 29‐12‐2016 NOVEL VACCINE FORMULATIONS 278719 2938/KOLNP/2011 29‐12‐2016 A PROCESS FOR THE PREPARATION OF A POLYMER CONJUGATE OF 278723 AN INDOLOCARBAZOLE COMPOUND 5312/DELNP/2010 29‐12‐2016 RESUSCITATION FLUID 278740 3174/DELNP/2010 29‐12‐2016 "COMPOSITIONS AND DEVICES" 278745 678/DEL/2007 30‐12‐2016 A VACCINE COMPOSITION COMPRISING POLYMERIC 278769 NANOPARTICLES AND MICROPARTICLES FOR INDUCING TH1 AND TH2 RESPONSE 3646/DELNP/2010 30‐12‐2016 "A POWERFUL VACCINE COMPOSITION COMPRISING A 278784 LIPOPEPTIDE AND POLY I:C AS AN ADJUVANT" 6146/DELNP/2006 31‐12‐2016 "INDAZOLES, BENZOTHIAZOLES ,BENZOISOTHIAZOLES, 278844 BENZISOXAZOLES, AND PREPARATION AND USES THEREOF" 1945/MUMNP/2011 04‐01‐2017 "METHOD FOR PREPARING ACYCLOVIR 2/3 HYDRATE" 278935 947/DEL/2007 05‐01‐2017 "PROCESS FOR STABILISING THIPHENE DERIVATIVES" 278947 783/DELNP/2009 05‐01‐2017 "A METHOD FOR MAKING SOLID DISPERSIONS OF MIDOSTAURIN" 278972

261/KOLNP/2010 05‐01‐2017 NEW ANTIMICROBIAL COMPOUNDS, THEIR SYNTHESIS AND THEIR 278976 USE FOR TREATMENT OF MAMMALIAN INFECTIONS 2721/MUMNP/2010 06‐01‐2017 TOPICAL GEL COMPOSITION FOR THE TREATMENT OF ACTINIC 278979 KERATOSIS 1406/MUM/2009 06‐01‐2017 COSMETIC OR PHARMACEUTICAL PREPARATION FOR THE SKIN 278986 1529/CHE/2008 06‐01‐2017 IMPROVED PROCESS FOR THE PREPARATION OF HIGH PURITY 278989 SUNITINIB AND ITS PHARMACEUTICALLY ACCEPTABLE SALT 3730/CHENP/2011 06‐01‐2017 A METHOD OF PREPARING AN ISOLATED MULTIPOTENT 278992 GLOMERULAR MESENCHYMAL STEM CELLS 4716/DELNP/2009 06‐01‐2017 "AGGLOMERATED HYDROXYETHYLCELLULOSE COMPOSITION" 278993 3752/KOLNP/2009 06‐01‐2017 NOVEL COMPOUNDS FOR TREATING MENTAL DISORDERS, AND 279002 PREPARATION AND USES THEREOF 4638/DELNP/2010 06‐01‐2017 “METHOD OF PRODUCING JAPANESE ENCEPHALITIS VACCINE 279004 STABLY STORABLE OVER LONG TIME AND USE OF THE VACCINE” 2490/DELNP/2004 09‐01‐2017 "COUPLING LOW MOLECULAR SUBSTANCES TO A MODIFIED 279011 POLYSACCHARIDE" 6442/DELNP/2010 09‐01‐2017 "PROCESSES OF MAKING ORAL COMPOSITIONS CONTAINING GEL 279013 NETWORKS" 10382/DELNP/2008 09‐01‐2017 “LOW DOSE SUBLINGUAL TABLETS OF OPIOID ANALGESICS AND 279019 PREPARATION PROCESS” 4840/DELNP/2009 09‐01‐2017 "SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS" 279024 7881/DELNP/2006 09‐01‐2017 "PRE‐FORMULATIONS FOR IN‐SITU GENERATION OF CONTROLLED 279042 RELESE LIPID FORMULATIONS" 2698/MUMNP/2010 10‐01‐2017 COSMETIC SUNSCREEN COMPOSITE PARTICULES 279071 1514/MUM/2006 10‐01‐2017 PELLETS OF HERBAL EXTRACTS AND PROCESS FOR PREPARING THE 279073 SAME 38/KOLNP/2007 11‐01‐2017 IMMUNOSTIMULATORY OLIGONUCLEOTIDE MULTIMERS 279102 2571/KOLNP/2008 12‐01‐2017 AN IMMUNOGENIC COMPOSITION FOR INFANTS COMPRISING A 279133 MULTIVALENT STREPTOCOCCUS PNEUMONIAE VACCINE 5845/DELNP/2006 12‐01‐2017 TOOTH‐WHITENING COMPOSITIONS COMPRISING SILICONE 279150 POLYMER AND METHODS THEREFOR"

Page 11 of 85 1757/DELNP/2009 12‐01‐2017 "METHODS FOR DELIVERING VOLATILE ANESTHETICS FOR 279149 REGIONAL ANESTHESIA AND/OR PAIN RELIEF" 4593/DELNP/2009 12‐01‐2017 "METHOD FOR TREATING OR PREVENTING SYSTEMIC 279161 INFLAMMATION" 4182/KOLNP/2010 13/01/2017 FUSED BICYCLIC PYRIMIDINE COMPOUNDS AS AURORA KINASE 279196 INHIBITORS 5114/DELNP/2008 13‐01‐2017 "FORMULATION" 279178 1861/MUM/2010 16‐01‐2017 TELMISARTAN AND HYDROCHLOROTHIAZIDE COMPOSITION 279229 1680/CHE/2005 17‐01‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF SODIUM SALT 279294 OF CEPHALOSPORIN ANTIBIOTIC 2612/CHE/2010 17‐01‐2017 PROCESS FOR THE PREPARATION OF 5‐BENZYLOXY‐2‐ (4‐ 279266 BENZYLOXYPHENYL) ‐3‐ METHYL‐1H‐INDOLE 2204/MUM/2011 17‐01‐2017 "PREPARATION OF SUBSTITUTED 1H‐IMIDAZO[4,5‐C] QUINOLINE" 279270

273/MUM/2007 18‐01‐2017 A HERBAL THERAPEUTIC PRODUCT FOR THE PREVENTION AND 279313 TREATMENT OF RETENTION OFPLACENTA IN CATTLE AND BUFFALOES 2864/CHE/2007 18‐01‐2017 IMPROVED PROCESS FOR THE PREPARATION OF (2E)‐2‐CYANO‐3‐ 279316 (3,4‐DIHYDROXY‐5‐NITROPHENYL)‐N,N‐DIETHYL‐2‐PROPENAMIDE POLYMORPHIC FORM A 4711/DELNP/2009 18‐01‐2017 "PHARMACEUTICAL COMPOSITION" 279322 526/CHE/2008 18‐01‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF APREPITANT 279324

5094/DELNP/2008 18‐01‐2017 "NUCLEOTIDE AND OLIGONUCLEOTIDE PRODRUGS" 279329 5458/DELNP/2006 18‐01‐2017 "STEROID‐CONTAINING SUSTAINED RELEASE INTRAOCULAR 279332 IMPLANTS AND RELATED METHODS" 719/DEL/2009 19‐01‐2017 NOVEL SYNERGISTIC COMBINATION OF FERULA ASAFOETIDA WITH 279380 DEHYDRATED DIALDOL PRODUCT AS POTENT ANTIFUNGAL AGENT

8360/DELNP/2008 19‐01‐2017 "CONTROLLED RELEASE DELIVERY DEVICE COMPRISING AN 279389 ORGANOSOL COAT" 1025/DEL/2006 19‐01‐2017 "A compound of 4‐(1‐Adamantyl)‐2‐substitutedquinolone 279395 derivatives as new structural class of anti‐tuberculosis agents"

2366/MUMNP/2011 19‐01‐2017 ADJUVANT COMPOSITIONS COMPRISING A NON‐IONIC 279396 ISOTONICITY AGENT 681/KOL/2008 19‐01‐2017 COSMETIC HAIR COMPOSITIONS COMPRISING FUNCTIONALIZED 279401 METAL OXIDE LAYERED PIGMENTS 386/DELNP/2010 20‐01‐2017 "PHARMACEUTICAL COMPOSITIONS" 279429 18/DEL/2006 23‐01‐2017 "NANOPARTICULATE FORMULATION FOR ORAL DELIVERY OF 279439 COENZYME Q10" 2847/DELNP/2010 23‐01‐2017 "ORAL CARE REGIMEN" 279451 2575/KOLNP/2010 23‐01‐2017 A METHOD FOR PREPARING PARTICLES OF CYCLOSPORINE A 279458 8115/DELNP/2010 23‐01‐2017 "ADMINISTRABLE COMPOSITIONS" 279459 906/CHE/2005 24‐01‐2017 "COMPOSITIONS OF ANTI VIRAL COMPOUND" 279483 1865/MUMNP/2012 24‐01‐2017 “METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION 279488 9388/DELNP/2008 24‐01‐2017 "AN IN VITRO METHOD OF STIMULATING T CELLS" 279489 4642/DELNP/2009 24‐01‐2017 POLYMERIC CARRIERS OF THERAPEUTIC AGENTS AND 279497 RECOGNITION MOIETIES FOR ANTIBODY‐BASED TARGETING OF DISEASE SITES 1050/CHE/2006 24‐01‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE 279496

4548/DELNP/2007 24‐01‐2017 "ORAL TREATMENT COMPOSITIONS CONTAINING AN ANTI‐ 279523 ADHESION AGENT, ANTIBACTERIAL AGENT AND INCOMPATIBLE COMPOUND" 313/DEL/2006 25‐01‐2017 A PHARAMACEUTICAL FORMULATION CONTAINING QUERCETIN 279549 FOT THE TREATMENT OF DIABETIC NEPHROPATHY 7819/DELNP/2009 25‐01‐2017 "A COMPOUND OF FORMULA (I)" 279540 1854/CHENP/2008 25‐01‐2017 (R)‐6‐METHYLOXAALKYL EXEMESTANE COMPOUNDS AND RELATED 279563 METHOD OF USE

Page 12 of 85 3329/MUM/2010 27‐01‐2017 LIPIDIC NANOPARTICLES BASED COMPOSITION AND METHOD OF 279598 FORMULATION AND USE THEREOF 6204/DELNP/2009 27‐01‐2017 "TRICYCLIC NITROGEN CONTAINING COMPOUNDS AS 279599 ANTIBACTERIAL AGENTS" 3076/CHENP/2008 27‐01‐2017 Pharmaceutical Composition comprising hemicalcium salt of (E)‐7‐ 279608 [4‐(4‐fluorophenyl)‐6‐isopropyl‐2‐ [methyl(methylsulfonyl)amino]pyrimidin‐5‐yl]‐(3R,5S)‐3,5‐ dihydroxyhept‐6‐enoic acid 5003/DELNP/2008 27‐01‐2017 "SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE 279610 AND TWO OR MORE POLYLACTIDE‐CO‐GLYCOLIDE POLYMERS"

2216/CHE/2007 27‐01‐2017 ORAL MEDICAMENT CONTAINING ANTHELMINTICS 279642 973/CHE/2010 27‐01‐2017 A LOW PH SKIN CARE COSMETIC COMPOSITION 279643 8937/DELNP/2008 27‐01‐2017 STABILIZED COMPOSITIONS CONTAINING ALKALINE LABILE DRUGS 279672

4256/KOLNP/2008 28‐01‐2017 THIONINIUM COMPOUNDS. 279680 1329/DELNP/2004 28‐01‐2017 "DRUG DELIVERY SYSTEM FOR CONSCIOUS SEDATION" 279679 4227/DELNP/2012 28‐01‐2017 "POLYMERIC BIGUANIDE PRESERVATION OF PRECIPITATED 279681 CALCIUM CARBONATE" 7478/DELNP/2009 30‐01‐2017 SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF 279699 MICROPARTICLES 4933/DELNP/2008 30‐01‐2017 "A METHOD FOR THE PREPARATION OF A GRANULATED CALCIUM‐ 279721 CONTAINING COMPOUND" 8324/DELNP/2010 30‐01‐2017 NOVEL ADJUVANT COMPOSITIONS 279724 2449/MUMNP/2012 30‐01‐2017 POLYSACCHARIDE CONJUGATION WITH DETOXIFIED E. COLI HEAT 279735 LABILE ENTEROTOXIN (LT) USED AS VACCINE 4569/DELNP/2006 30‐01‐2017 "A METHOD OF PRODUCING A DELIVERY SYSTEM SAID DELIVERY 279737 SYSTEM AND A COMPOSITION THEREOF" 832/DELNP/2010 30‐01‐2017 A Method For Preparing A CONJUGATE VACCINE 279748 1186/MUMNP/2010 30‐01‐2017 SKIN EXTERNAL PREPARATIONS 279759 2460/DEL/2005 30‐01‐2017 "NOVEL 1‐[(4‐DIPHENYLMETYL)‐PIPERAZIN‐1‐YL]‐3‐ 279758 ARYLOXYPROPAN‐2‐OL 475/DELNP/2009 30‐01‐2017 A METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGEN 279764 10555/DELNP/2008 30‐01‐2017 "PROLYL HYDROXYLASE INHIBITORS" 279762 1368/MUMNP/2011 31‐01‐2017 MODIFIED GIARDIA PROTOZOAN PARASITE AND VACCINE 279795 COMPRISING THE SAME 7894/DELNP/2007 31‐01‐2017 COSMETIC COMPOSITIONS CONTAINING ESTERS BASED ON 2‐ 279831 PROPYLHEPTANOL 1468/DEL/2012 31‐01‐2017 "A PROCESS FOR PREVENTING AN CURING DIABETES BY ULTRA 279880 VIOLET RADIATION" 329/CHENP/2009 02‐02‐2017 PHARMACEUTICALLY ACCEPTABLE SOLUBILIZING COMPOSITION 279913 AND PHARMACEUTICAL DOSAGE FORM CONTAINING SAME 1252/CHE/2007 06‐02‐2017 ENTERIC COATED GRANULE AND METHOD FOR PREPARING THE 279955 SAME 327/CHENP/2009 06‐02‐2017 SKIN EXTERNAL PREPARATION 279959 2606/DELNP/2009 06‐02‐2017 "GALENICAL FORM FOR THE ADMINISTRATION OF ACTIVE 279984 INGREDIENTS BY TRANSMUCOUS MEANS" 7833/DELNP/2010 06‐02‐2017 "ORAL COMPOSITIONS AND USES THEREOF" 280001 2002/MUM/2011 07‐02‐2017 "PHARMACEUTICAL COMBINATION" 280009 5471/DELNP/2010 08‐02‐2017 "VOLATILE ANESTHETIC COMPOSITIONS COMPRISING EXTRACTIVE 286008 SOLVENTS FOR REGIONAL ANESTHESIA AND/OR PAIN RELIEF"

5787/DELNP/2012 08‐02‐2017 A PHARMACEUTICAL COMPOSITION COMPRISING 3 BETA HYDROXY 280053 5 ALPHA PREGNAN 20 ONE WITH IMPROVED STORAGE AND SOLUBILITY PROPERTIES 2064/DELNP/2010 10‐02‐2017 "PERSONAL CARE COMPOSITIONS COMPRISING UNDECYL 280115 SULFATES" 3676/DELNP/2010 10‐02‐2017 "IMPROVED TAXANE DELIVERY SYSTEM" 280122 263/CHENP/2009 10‐02‐2017 FCYRIIB‐SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF 280132

Page 13 of 85 1510/MUM/2008 10‐02‐2017 FOSAPREPITANT AND PROCESSES FOR THE PREPARATION THEREOF 280136

2498/DELNP/2011 13‐02‐2017 2‐ACYLAMINOPROPOANOL‐TYPE GLUCOSYLCERAMIDE SYNTHASE 280166 INHIBITORS 8570/DELNP/2009 13‐02‐2017 "HYDROLYSABLE POLYMERIC FMOC‐LINKERS" 280172 946/MUMNP/2010 13‐02‐2017 RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING 280184 ANTIGENS FOR COLON AND PANCREATIC CANCERS

1856/MUMNP/2009 13‐02‐2017 ASPARTATE OF 1‐CYCLOPROPYL‐6‐FLUORO‐7‐(8‐METHOXYIMINO‐ 280193 2,6‐DIAZA‐ SPIRO[3.4]OCT‐6‐YL)‐4‐OXO‐1,4‐DIHYDRO‐ [1,8]NAPHTHYRIDINE‐3‐CARBOXYLIC ACID, METHOD FOR PREPARING THE SAME, AND ANTIMICROBIAL PHARMACEUTICAL COMPOSITION COMPRISING THE SAME 3953/DELNP/2011 14‐02‐2017 "METHOD FOR PREPARING PERSONAL CARE COMPOSITION 280241 COMPRISING SURFACTANT AND HIGH MELTING POINT FATTY COMPOUND" 2305/DELNP/2008 15/02/2017 "QUINOLINES AND THEIR THERAPEUTIC USE" 280286 3490/CHENP/2010 15/02/2017 AQUEOUS SHEAR‐THINNING PERSONAL CARE COMPOSITION 280272 3695/CHENP/2008 15‐02‐2017 BIOLOGICALLY ACTIVE COMPOSITION COMPRISING 280251 ETHYLCELLULOSE 2743/DELNP/2009 15‐02‐2017 "HAEMAGGLUTININ H5 PROTEIN OF INFLUENZA VIRUS " 280257 2770/MUM/2010 15‐02‐2017 DISINFECTANT AND METHOD FOR ITS PREPARATION AND USE 280259 1265/KOL/2009 16‐02‐2017 AN AQUEOUS TRANSPARENT SOLUTION FOR USE IN PERSONAL 280310 CARE FORMULATIONS 861/CHENP/2008 16‐02‐2017 N‐(ARYLAMINO)‐SULFONAMIDE INHIBITORS OF MEK 280313 4007/KOLNP/2009 16‐02‐2017 A PROCESS FOR PREPARING 2‐(5‐(4‐(2‐ 280315 MORPHOLINOETHOXY)PHENYL)PYRIDIN‐2‐YL)‐N‐ BENZYLACETAMIDE 8184/DELNP/2009 17‐02‐2017 "PEPTIDE SLOW‐RELEASE FORMULATIONS" 280334 2492/CHE/2009 17‐02‐2017 "PROCESS FOR THE PREPARATION OF LAMIVUDINE" 280339 2477/KOLNP/2008 17‐02‐2017 ETHANOL‐PRECIPITATED PHASEOLUS VULGARIS EXTRACTS, THEIR 280375 USE AND FORMULATIONS 2643/DEL/2009 20‐02‐2017 "Recombinant Domain III envelope protein useful for detecting 280386 Japanese Encephalitis Virus" 3414/DELNP/2011 20‐02‐2017 "ORAL CARE COMPOSITIONS WITH IMPROVED AESTHETICS AND 280390 FUSED SILICA" 5540/DELNP/2009 20‐02‐2017 "A COMPOUND" 280402 990/CHENP/2010 20‐02‐2017 NEW COMPOSITIONS BASED ON POLYSACCHARIDES GRAFTED BY 280405 POLYAMINE OR POLYSULPHURISED COMPOUNDS 10770/DELNP/2008 20‐02‐2017 "HIGH FLUORIDE ION ORAL CARE COMPOSITION AND METHOD FOR 280440 MAINTAINING ANTICARIES ACTIVITY" 5047/DELNP/2010 21/02/2017 STABLE ELSAMITRUCIN SALT FORMULATIONS 280504 3690/CHENP/2008 21/02/2017 POLYMER FORMULATIONS OF CETP INHIBITORS 280475 1068/CHENP/2009 21‐02‐2017 ANTI‐MICROBIAL PHOTODYNAMIC THERAPY 280444 164/KOLNP/2011 21‐02‐2017 QUINOXALINEDIONE DERIVATIVES 280467 3266/DELNP/2011 21‐02‐2017 "ORAL CARE COMPOSITIONS" 280513 5738/DELNP/2010 22/02/2017 "TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN 280570 (PGRN)" 267/CHENP/2009 22‐02‐2017 A LIQUID PHARMACEUTICAL FORMULATION AND A PROCESSFOR 280534 THE PREPARATION THEREOF 733/MUMNP/2010 22‐02‐2017 HAIR CARE COMPOSITION. 280545 8151/DELNP/2011 22‐02‐2017 "ORAL COMPOSITIONS CONTAINING POLYGUANIDINIUM 280569 COMPOUNDS AND METHODS OF MANUFACTURE AND USE THEREOF" 7848/DELNP/2007 22‐02‐2017 "SUBSTITUTED OXAZOLE DERIVATIVES AND THEIR USE AS TYROSINE 280571 KINASE INHIBITORS" 5239/DELNP/2005 23/02/2017 "PHOSPHONATE COMPOUND" 280586

Page 14 of 85 5522/DELNP/2008 23‐02‐2017 "SUBSTITUTED 4‐AMINO‐PYRROLOTRIAZINE DERIVATIVES USEFUL 280620 FOR TREATING HYPER‐PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS" 5068/DELNP/2008 23‐02‐2017 HYDROPHOBIC CORE CARRIER COMPOSITIONS FOR DELIVERY OF 280639 THERAPEUTIC AGENTS, METHODS OF MAKING AND USING THE SAME 2190/DEL/2004 27‐02‐2017 "NITRO‐GROUP BASED TOPICAL FORMULATION FOR TREATMENT 280668 OF ACUTE PPRIPHERAL MICROVASCULAR DISEASES"

3441/DELNP/2006 27‐02‐2017 "POLYCYCLIC COMPOUNDS SUITABLE FOR USE IN TREATMENT OF 280675 RESPIRATORY SUNCYTIAL VIRUS 1665/MUM/2009 27‐02‐2017 A PROCESS FOR PREPARATION OF A LOTION FOR TREATMENT OF 280682 CORN 2301/DEL/2006 27‐02‐2017 A PHARMACEUTICAL AEROSOL FORMULATION AND A METHOD FOR 280711 PREPARATION THEREOF 1654/DELNP/2007 27‐02‐2017 "ANTIDIABETIC ORAL INSULIN‐BIGU ANIDE COMBINATION." 280713 5186/DELNP/2011 27‐02‐2017 PHARMACEUTICAL COMPOSITION COMPRISING ALEGLITAZAR 280728 2076/MUMNP/2010 28‐02‐2017 “TRANSDERMALLY ABSORBABLE PREPARATION” 280762 665/DELNP/2010 28‐02‐2017 "RADIOPHARMACEUTICAL COMPOSITION" 280769 1166/DELNP/2010 28‐02‐2017 "NON‐AQUEOUS COMPOSITIONS" 280794 2158/DEL/2009 28‐02‐2017 PH SENSITIVE CONTROLLED RELEASE MICROCAPSULES AND A 280828 PROCESS OF PREPARATION OF THE SAME 884/DEL/2007 28‐02‐2017 "PROBES AND PRIMERS FOR IDENTIFICATION OF MYCOBACTERIAL 280840 PROTEIN USEFUL AS POTENTIAL DRUG TARGETS"

7906/DELNP/2008 28‐02‐2017 BIORESORBABLE CONTROLLED‐RELEASE COMPOSITION 280862 7492/DELNP/2010 01‐03‐2017 "PHARMACEUTICAL COMPOSITIONS COMPRISING BRIVARACETAM" 280886

2003/MUM/2007 01‐03‐2017 PROCESS FOR PREPARATION OF (S) (N‐[[3‐[3‐FLUORO‐4‐(4‐ 280889 MORPHOLINYL)PHENYL]‐2‐OXO‐5‐ OXAZOLIDINYL] METHYL]ACETAMIDE 117/MUMNP/2011 01‐03‐2017 PROCESS FOR PREPARING MICROPARTICLES 280892 8803/DELNP/2011 02‐03‐2017 "A SOLID DOSE COMPOSITION" 280923 1415/DEL/2010 02‐03‐2017 "HERBAL OIL COMPOSITION IN CONTROLLING BLOOD SUGAR 280929 WITHOUT RISK OF HYPOGLYCEMEA" 564/DELNP/2011 02‐03‐2017 “TRIAZOLO [4, 5‐D] PYRAMIDINE DERIVATIVES AND THEIR USE AS 280942 PURINE RECEPTOR ANTAGONISTS” 410/DELNP/2010 03‐03‐2017 VIROSOMES COMPRISING HEMAGGLUTININ DERIVED FROM AN 280973 INFLUENZA VIRUS PRODUCED IN A CELL LINE, COMPOSITIONS, METHODS OF MANUFACTURING, USE THEREOF 2677/MUM/2011 03‐03‐2017 "MULTIPARTICULATE CONTROLLED POROSITY OSMOTIC SYSTEM" 280989

4890/DELNP/2008 03‐03‐2017 "SALT OF POTASSIUM ATP CHANNEL OPENER " 280967 401/MUM/2008 03‐03‐2017 PROCESS FOR THE PREPARATION OF 4‐AMINO‐N‐[1‐(1‐CYCLOHEX‐3‐ 280974 ENYLMETHYL)‐4‐PIPERIDYL]‐2‐ETHOXY‐5‐NITRO‐BENZAMIDE AND SALTS THEREOF 7750/DELNP/2008 03‐03‐2017 "8‐AZABICYCLO[3.2.1] OCTANE COMPOUNDS AS MU OPIOID 280975 RECEPTOR ANTAGONISTS" 2222/DELNP/2010 06‐03‐2017 “CRYSTALLINE FORMS OF TRYPTOPHAN HYDROXYLASE INHIBITOR 281019 AND PHARMCEUTICALLY ACCEPTABLE SALTS THEREOF ”

3208/KOLNP/2007 06‐03‐2017 APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF 281057 COMPLEMENT‐RELATED DISORDERS 45/DEL/2009 06‐03‐2017 SYNTHESIS OF HEXADECYL CIS‐9 TETRADECENOATE AND 281062 HEXADECYL CIS‐10‐TETRADECENOATE AND THEIR EVALUATION FOR ANTI ARTHRITIS PROPERTIES IN RATS 203/CHENP/2010 07‐03‐2017 FUSED HETEROARYL PYRIDYL AND PHENYL 284869 BENZENESULFONAMIDES AS CCR2 MODULATORS FOR THE TREATMENT OF INFLAMMATION 8359/DELNP/2008 07‐03‐2017 "DRUG DELIVERY COMPOSITION" 281085

Page 15 of 85 4982/DELNP/2010 07‐03‐2017 CONDENSED AMINODIHYDROTHIAZINE DERIVATIVE 281114 5143/DELNP/2010 07‐03‐2017 "PHARMACEUTICAL COMPOSITIONS CONTAINING AT LEAST ONE 281118 PROTEINACEOUS ACTIVE INGREDIENT PROTECTED AGAINST DIGESTIVE ENZYMES" 3622/DELNP/2010 08‐03‐2017 "A SHAMPOO COMPOSITION AND METHOD OF PREPARATION 281133 THEREOF" 1051/DELNP/2007 08‐03‐2017 "CERAMIDE DERIVATIVES AS MODULATORS OF IMMUNITY AND 281138 AUTOIMMUNITY" 1257/CHE/2007 08‐03‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF GALANTAMINE 281143 HYDROBROMIDE 571/DELNP/2009 08‐03‐2017 "A COMPOSITION COMPRISING A POPULATION OF 281171 POLYSACCHARIDE DERIVATIVES" 9159/DELNP/2008 09‐03‐2017 “STEREOSELECTIVE REDUCTION OF A MORPHINONE” 281211 3580/CHENP/2010 09‐03‐2017 A COMPOSITION COMPRISING OF VITAMIN E DERIVATIVE AND 281224 ANNEXIN V 201647026752 09‐03‐2017 BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS 281230 5487/DELNP/2011 09‐03‐2017 PAIN TREATMENT 281233 2694/MUM/2009 10‐03‐2017 TOPICAL MEDICINAL FORMULATION FOR FUNGAL INFECTION OF 288008 NAILS

1214/MUMNP/2011 10‐03‐2017 “METHOD FOR PREPARING MICROSPHERES AND MICROSPHERES 281237 PRODUCED THEREBY” 4157/CHENP/2009 10‐03‐2017 INDAZOLE DERIVATIVES AS KINASE INHIBITORS AND PROCESS FOR 281246 PREPARING THE SAME 1651/CHE/2007 10‐03‐2017 A PROCESS FOR PREPARATION OF A NOVEL COMPOUND 281259 DIHYDROXY GYMNEMIC TRIACETATE FROM GYMNEMA SYLVESTRE R.BR.LEAVES WITH ANTIDIABETIC ACTIVITY 2001/MUMNP/2010 10‐03‐2017 “PHARMACEUTICAL COMPOSITION 271” 281260 2697/CHENP/2010 14/03/2017 COVALENTLY BOUND GLYCOLIPIDS 281294 1802/DEL/2008 14‐03‐2017 "MIXTURES WHICH CAN BE ISOLATED FROM EUGENIA JAMBOLANA 281291 LAMARCK SEEDS, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS" 4481/CHENP/2008 14‐03‐2017 AN IMIDAZOQUINOLINE AND A PHARMACEUTICAL COMPOSITION 281301 COMPRISING IMIDAZOQUINOLINE DERIVATIVE 9145/DELNP/2010 15‐03‐2017 FULVIC ACID AND ANTIBIOTIC COMBINATION 281318 5294/KOLNP/2008 15‐03‐2017 REDUCED COENZYME Q10‐CONTAINING COMPOSITION AND 281348 METHOD FOR PRODUCING THE SAME 2879/DELNP/2012 15‐03‐2017 "CARRAGEENAN‐CONTAINING AQUEOUS ANTIMICROBIAL 281352 COMPOSITIONS" 1176/CHE/2008 15‐03‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF CEFOZOPRAN 281355

1150/DELNP/2004 15‐03‐2017 "PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING 281356 OXY GROUP BEARING AROMATIC ALDEHYDES" 2487/DELNP/2008 16‐03‐2017 "COMPOSITION WITH SUSTAINED RELEASE OF THE ACTIVE 281384 INGREDIENT, PROCESS FOR THE PREPATATION THEROF AND USE THEREOF" 437/MUM/2010 17/03/2017 "STABILIZED FLUCONAZOLE POLYMORPH III FORMULATION" 281430 4303/KOLNP/2010 17‐03‐2017 BENZOFURANE, BENZOTHIOPHENE, BENZOTHIAZOL DERIVATIVES 281414 AS FXR MODULATORS 1507/KOLNP/2010 17‐03‐2017 ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE‐CHAINS 281417 1466/DELNP/2008 17‐03‐2017 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INNER 281434 EAR DISORDERS 1902/MUM/2008 20‐03‐2017 AN IMPROVED PROCESS FOR REPARING TELMISARTAN AND 281469 INTERMEDIATES THEREOF 1202/CHE/2006 20‐03‐2017 A SYNERGISTIC ANTI‐TUMOR COMPOSITION 281500 1375/DELNP/2011 20‐03‐2017 “PHARMACEUTICAL COMPOSITIONS AND METHODS FOR 281502 STABILIZING THE SAME” 114/DEL/2006 20‐03‐2017 STABLE PHARMACEUTICAL COMPOSITION OF AN ACID LABILE 281512 COMPOUND AND PROCESS FOR PREPARING THEREOF

Page 16 of 85 1866/KOLNP/2010 21‐03‐2017 4‐PYRAZOLYL‐N‐ARYLPYRIMIDIN‐2‐AMINES AND 4‐PYRAZOLYL‐N‐ 281540 HETEROARYLPYRIMIDIN‐2‐AMINES AS JANUS KINASE INHIBITORS

3337/CHENP/2006 22‐03‐2017 A CONJUGATE COMPRISING AN ENTRY INHIBITOR COVALENTLY 281609 ATTACHED TO A WATER SOLUBLE POLYMER 6279/CHENP/2008 22‐03‐2017 PYRIDONE SULFONAMIDES AND PYRIDONE SULFAMIDES AS MEK 281617 INHIBITORS 5058/KOLNP/2010 22‐03‐2017 SERIES OF SKIN‐WHITENING (LIGHTENING) COMPOUNDS 281625 9605/DELNP/2007 22‐03‐2017 AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF 281647 5326/DELNP/2010 22‐03‐2017 "BITHERAPY AND TRITHERAPY USED FOR TREATING AN HIV‐ 281664 POSITIVE PATIENT" 1575/DELNP/2004 22‐03‐2017 "PERORAL ACTIVE AGENT SUSPENSION" 281669 1608/DELNP/2010 22‐03‐2017 "PHARMACEUTICAL COMPOSITIONS" 281676 5857/DELNP/2009 22‐03‐2017 "PHARMACEUTICAL COMPOSITION" 281679 264/KOLNP/2010 23/03/2017 QUATERNARY OPIOID CARBOXAMIDES 281686 4097/DELNP/2010 24‐03‐2017 "ANTI‐VEGF ANTIBODY COMPOSITIONS AND METHODS" 281735 1281/CHE/2007 24‐03‐2017 IMPROVED PROCESS FOR THE PREPARATION OF RABEPRAZOLE 281737 1135/DELNP/2011 24‐03‐2017 “PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTENSION 281788 AND METABILIC SYNDROME AND USE THEREOF” 1337/DEL/2007 24‐03‐2017 "COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A 281790 POLYCONDENSATE, METHOD OF COSMETIC TREATMENT USING SAID COMPOSITION, SAID POLYCONDENSATE AND METHOD AND PREPARATION" 2904/CHENP/2008 27/03/2017 PHARMACEUTICAL COMBINATION,PROCESS AND KIT THEREOF 281831 1486/CHE/2009 27‐03‐2017 PROCESS FOR PREPARING METADOXINE 281820 7586/DELNP/2009 27‐03‐2017 "A METHOD OF PREPARING A HYDRAZIDE" 281842 6839/DELNP/2007 27‐03‐2017 COMPOSITION OF INHIBITION OF CATHEPSIN K 281853 3682/KOLNP/2008 28/03/2017 METHODS FOR PREPARING COMPLEX MULTIVALENT 281882 IMMUNOGENIC CONJUGATES 584/KOLNP/2010 28/03/2017 SOLID PREPARATION COMPRISING ALOGLIPTIN AND METFORMIN 281903 HYDROCHLORIDE 2450/DEL/2008 28/03/2017 A HOMEOPATHIC PREPARATION FOR RELEASE OF STUCK PLACENTA 281902 DURING DELIVERY OF BABIES IN ANIMALS 695/KOLNP/2011 28‐03‐2017 PERSONAL CARE PRODUCTS 281866 7641/CHENP/2010 28‐03‐2017 HYBRID PROTEIN COMPRISING SHIGA TOXIN PROTEINS, CHOLERA 281867 TOXIN PROTEINS OR ESCHERICHIA COLI HEAT‐LABILE TOXIN PROTEINS 5693/CHENP/2008 28‐03‐2017 ANTIBACTERIAL AGENTS 281872 790/DELNP/2010 28‐03‐2017 "NOVEL CONJUGATED PROTEINS AND PEPTIDES" 281873 54/DELNP/2010 28‐03‐2017 "ENCHANCEMENT OF THE EFFICACY OF THERAPEUTIC PROTEINS" 281893

2513/CHENP/2009 28‐03‐2017 “AN INTRA‐MAMMARY TEAT SEALANT FORMULATION” 281895 5265/DELNP/2009 28‐03‐2017 A pharmaceutical composition for the treatment or prevention of 281899 Endometriosis 1534/CHE/2010 28‐03‐2017 A NOVEL SYNERGISTIC PHARMACEUTICAL COMPOSITION FOR 281900 TOPICAL APPLICATIONS 8923/DELNP/2008 28‐03‐2017 "SOLID ORAL COMPOSITIONS BASED ON S‐ADENOSYL METHIONINE 281920 AND/OR NADH AND PROCESS FOR OBTAINING THEM"

2123/MUMNP/2011 29/03/2017 COMPOSITION COMPRISING CLIMBAZOLE FUNGICIDE AND ZINC 281943 GLUCONATE 768/DEL/2010 29‐03‐2017 α‐YOHIMBINE AND ITS DERIVATIVES AS ANTIPSYCHOTIC AGENTS 281936 AND PROCESS OF THEIR PREPARATIONS 9908/DELNP/2008 29‐03‐2017 "RECOMBINANT OR TRANSGENIC FACTOR VII COMPOSITION, EACH 281970 FACTOR VII MOLECULE HAVING TWO N‐GLYCOSYLATION SITES WITH DEFINED GLYCAN UNITS" 805/KOLNP/2010 29‐03‐2017 INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY 281974 2984/MUM/2009 29‐03‐2017 A NOVEL PHARMACEUTICAL FLOATING DOSAGE FORM 281980

Page 17 of 85 650/CHE/2008 29‐03‐2017 A MONOCLONAL ANTIBODY AND A METHOD THEREOF 281985 1552/MUM/2010 29‐03‐2017 CALCIUM CITRATE MALATE SUSPENSION 281997 300/DELNP/2007 29‐03‐2017 "A SOLUTION OF LEVODOPA" 282012 3543/KOLNP/2009 29‐03‐2017 PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF 282013 2613/KOLNP/2011 30/03/2017 COATING MATERIAL FOR SOLID MEDICINE AND SOLID MEDICINE 282120 FORMED WITH SAME 2453/DEL/2008 30/03/2017 A HOMEOPATHIC COMPOSITION FOR PREVENTION OF 282049 MISCARRIAGE IN ANIMALS 1471/MUM/2007 30‐03‐2017 PROCESS OF LYOPHILIZATION OF FORMULATION CONTAINING 282033 MANNITOL 7528/CHENP/2009 30‐03‐2017 VESICLE USEFUL FOR EXTERNAL PREPARATION FOR SKIN, AND 282040 EXTERNAL PREPARATION FOR SKIN COMPRISING THE VESICLE 1930/MUM/2009 30‐03‐2017 NOVEL COMPLEX FOR TREATMENT AND/OR PROPHYLAXIS OF 282069 PARASITIC INFECTIONS 4279/DELNP/2006 30‐03‐2017 "A LIPOPHILE COMPLEXES" 282118 2190/DELNP/2009 31/03/2017 “GRANULATE CONTAINING A PHARMACEUTICALLY ACTIVE 282283 SUBSTANCE AND METHOD FOR ITS MANUFACTURE” 8783/CHENP/2011 31‐03‐2017 A PHARMACEUTICAL COMPOSITION COMPRISING CENTHAQUIN 282155

602/DEL/2008 31‐03‐2017 NOVEL PHENANATHRYLPHENOL LINKED PYRROLO [2,1,‐C][1,4] 282164 BENZODIAZEPINE HYBRIDS AS POTENTIAL ANTITUMOUR AGENTS AND PROCESS FOR THE PREPARATION THEREOF 622/KOLNP/2006 31‐03‐2017 AN OIL IN WATER FOAMABLE EMULSION 282189 4632/CHENP/2009 31‐03‐2017 DERMAL FILM‐FORMING LIQUID FORMULATIONS FOR DRUG 282235 RELEASE TO SKIN 5203/DELNP/2011 31‐03‐2017 "HYLAURONIC ACID CONTAINING COMPOSITIONS FOR TREATMENT 282264 OF WOUNDS, SCARS, POST‐SURGICAL ADHESION FORMATION"

4851/DELNP/2007 31‐03‐2017 "ORAL CARE COMPOSITIONS CONTAINING FLAVONOIDS AND 282271 FLAVANS" 1848/MUM/2011 04‐04‐2017 "ANTI‐THROMBOTIC COMPOUNDS" 282322 7603/CHENP/2010 04‐04‐2017 PHARMACEUTICAL COMPOSITION COMPRISING RECOMBINANT 282323 HUMAN GROWTH HORMONE PEGYLATED PRODRUG CONJUGATE

1017/CHE/2010 05‐04‐2017 PHARMACEUTICAL COMPOSITION COMPRISING TAMARIND SEED 282337 POLYOSE FOR MODIFIED RELEASE OF DRUG 2996/MUM/2010 05‐04‐2017 "PHARMACEUTICAL COMPOSITION OF SERRATIOPEPTIDASE" 282344 5465/DELNP/2008 06‐04‐2017 "A PROCESS FOR MAKING A POLYCABOXYLIC ACID COMPOSITION " 282384

3338/DELNP/2009 06‐04‐2017 "PROCESS FOR PREPARING A WATER‐IN‐OIL EMULSION 282374 COMPRISING AN IMMUNOSTIMULATORY COMPLEX" 2281/MUM/2010 06‐04‐2017 PROCESS FOR THE PREPARATION OF 2‐ARYL THIAZOLE DERIVATIVE 282377

1916/CHENP/2009 07‐04‐2017 FORMULATIONS COMPRISING CYCLIC COMPOUNDS 282398 7469/DELNP/2009 07‐04‐2017 "IMPROVED DEPOT FORMULAITONS" 282406 235/DEL/2005 12‐04‐2017 A PROCESS FOR PREPARATION OF A TOPICAL FORMULATION FOR 282466 PREVENTION AND MANAGEMENT OF PERIPHERAL VASCULAR DISEASES 2656/MUM/2011 12‐04‐2017 "A PROCESS FOR THE PREPARATION OF POLYHERBAL 282473 FORMULATION EFFECTIVE TO TREAT KIDNEY STONES" 3256/MUM/2010 12‐04‐2017 "BIOTRANSFORMATION OF BIOLOGICALLY ACTIVE COMPOUNDS 282486 FROM MEDICINAL PLANTS" 4329/DELNP/2008 12‐04‐2017 "CAMPTOTHECIN DERIVATIVES AS CHEMORADIOSENSITIZING 282487 AGENTS" 2347/MUMNP/2010 13‐04‐2017 “PHENYL AND BENZODIOXINYL SUBSTITUTED INDAZOLES 282502 DERIVATIVES” 1720/CHE/2008 13‐04‐2017 CONTROLLED RELEASE DRUG FORMULATION OF POORLY SOLUBLE 282506 DRUG WITH CONSTANT DRUG RELEASE RATE 1772/MUM/2011 17‐04‐2017 AN APPARATUS AND PROCESS TO DETERMINE THE DURATION OF 282543 BIOADHESION IN VITRO

Page 18 of 85 2940/CHENP/2009 18/04/2017 A DRUG SOLUTION CONTAINING PACK WITH A REDUCED 282569 DISSOLVED OXYGEN CONTENT 3954/DELNP/2011 19‐04‐2017 "PERSONAL CARE COMPOSITION IN THE FORM OF AN ARTICLE 282606 HAVING A HYDROPHOBIC SURFACE‐RESIDENT COATING" 1471/MUMNP/2009 19‐04‐2017 “FLUORESCENT EMULSIONS FOR OPTICAL IMAGING” 282607 2550/KOLNP/2010 20‐04‐2017 CHEMICAL MOLECULES THAT INHIBIT THE SLICING MECHANISM 282628 FOR TREATING DISEASES RESULTING FROM SPLICING ANOMALIES

9345/DELNP/2010 20‐04‐2017 "SYNERGISTIC PRESERVATIVE BLENDS" 282631 5788/DELNP/2011 20‐04‐2017 "PROCESSES FOR COATING A CARRIER WITH MICROPARTICLES" 282639 1967/KOLNP/2005 20‐04‐2017 3‐ALKYLIDENEHYDRAZINO SUBSTITUTED HETEROARYL 282646 COMPOUNDS AS THROMBOPOIETIN RECEPTOR ACTIVATORS 4249/CHENP/2008 21‐04‐2017 FLUORIDE COMPOSITION AND METHODS FOR DENTAL 282664 MINERALIZATION 4173/DELNP/2008 21‐04‐2017 "SEGMENTED PHARMACEUTICAL DOSAGE FORMS" 282668 2547/CHE/2007 24‐04‐2017 AN IMPROVED PROCESS FOR THE PURIFICATION OF CEFTIOFUR 282686 HYDROCHLORIDE 451/CHENP/2011 24‐04‐2017 STABILIZATION OF BODY‐CARE AND HOUSEHOLD PRODUCTS 282688 7217/DELNP/2009 24‐04‐2017 "DRUG COMBINATION OF BETA 2 AGONIST AND A PROGESTIN FOR 282691 THE TREATMENT OF MUSCLE LOSS" 2930/CHE/2007 24‐04‐2017 PROCESS FOR PRODUCING 2‐[1‐METHYL‐5‐(4‐METHYLBENZOYL)‐ 282712 PYRROL‐2‐YL ACETIC ACID OR SALT THEREOF 6161/DELNP/2009 24‐04‐2017 "A BALLISTIC RESISTANT FIBROUS COMPOSITE" 282714 4597/KOLNP/2010 25‐04‐2017 THIENOPYRIDONE DERIVATIVES AS AMP‐ACTIVATED PROTEIN 282754 KINASE(AMPK) ACTIVATORS 1753/KOLNP/2010 25‐04‐2017 A METHOD OF FORMING A SOLID PHARMACEUTICAL DOSAGE 282759 FORM WITH VISIBLE MICRO‐AND NANO STRUCTURED SURFACES

10316/DELNP/2008 26‐04‐2017 "DHA ESTERS AND USE THEREOF IN TREATMENT AND PREVENTION 282802 OF CARDIOVASCULAR DISEASE" 4325/CHENP/2007 26‐04‐2017 A COMPOSITION FOR IMMUNIZATION AGAINST MYCOBACTERIUM 282828 INFECTIONS 1838/MUMNP/2010 26‐04‐2017 PYRIMIDINE‐2‐AMINE COMPOUNDS AND THEIR USE AS INHIBITORS 282831 OF JAK KINASES 3371/DELNP/2010 27‐04‐2017 CORTICOSTEROID COMPOSITIONS 282871 74/DEL/2007 27‐04‐2017 "A NOVEL ANTIMICROBIAL POLYHERBAL COMPOSITION" 282906 3076/DELNP/2010 28/04/2017 “NOVEL HISTONE DEACETYLASE INHIBITORS" 282938 3269/DELNP/2009 28‐04‐2017 LAYERED PHARMACEUTICAL FORMULATIONS COMPRISING AN 282966 INTERMEDIATE RAPIDLY DISSOLVING LAYER 886/MUMNP/2012 28‐04‐2017 A PROCESS FOR PREPARING MICROCAPSULES HAVING A CORE 282972 ENCAPSULATED WITHIN A METALOXIDE SHELL, 1847/MUMNP/2010 28‐04‐2017 NOVEL METHOD FOR THE PRODUCTION OF SULPHONYLPYRROLES 282991 AS HDAC INHIBITORS 1596/KOLNP/2010 28‐04‐2017 STABILIZED PEDIATRIC SUSPENSION OF CARISBAMATE 282992 2553/MUM/2010 02‐05‐2017 PHARMACEUTICAL COMPOSITIONS OF CURCUMIN 283059 2446/MUM/2007 03‐05‐2017 A ONCE A DAY, STABLE PHARMACEUTICAL COMPOSITION FOR 283075 ORAL ADMINISTRATION 10790/DELNP/2008 03‐05‐2017 "Aqueous liquid formulation for inhalation comprising a sulfoalkyl 283080 ether beta‐cyclodextrin and corticosteroid" 1074/KOLNP/2010 03‐05‐2017 AN IMPLANTABLE MEDICAL DEVICE 283083 3839/DELNP/2011 04‐05‐2017 "Pharmaceutical Compositions for treating and/or preventing Inner 283101 Ear Conditions" 2732/DELNP/2010 05‐05‐2017 "DIALYSIS SOLUTIONS CONTAINING PYROPHOSPHATES" 283152 9406/DELNP/2008 05‐05‐2017 "PYRROLOPYRIMIDINE COMPOUNDS AND THEIR USES" 283133 2038/MUM/2008 05‐05‐2017 A COMPOSITION FOR MAKING JALJEERA AND A PROCESS THEREOF 283145

3180/DELNP/2010 05‐05‐2017 "PREVENTION AND TREATMENT OF SECONDARY INFECTIONS 283154 FOLLOWING VIRAL INFECTION" 287/MUM/2009 06‐05‐2017 PHARMACEUTICAL COMPOSITION FOR ATHEROSCLEROSIS 283909

Page 19 of 85 10056/DELNP/2008 08‐05‐2017 "AN ANTI‐NR10/IL‐31RA ANTIBODY AND USE THEREOF" 283171 1768/MUMNP/2011 08‐05‐2017 DISPERSION OF PHYTOSTEROLS 283174 8326/DELNP/2009 08‐05‐2017 "STERILE, INJECTABLE AQUEOUS FORMULATION" 283175 608/DEL/2011 08‐05‐2017 SKIN TREATING COMPOSITION AND APPLICATIONS THEREOF 283187 3683/KOLNP/2010 09‐05‐2017 QUINOXALINONE DERIVATIVES AS INSULIN SECRETION 283208 STIMULATORS 191/MUMNP/2010 09‐05‐2017 “PHENYLACETIC ACID COMPOUND” 283225 2286/MUM/2012 11‐05‐2017 "PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF LEG 283236 CRAMPS." 1651/DELNP/2009 11‐05‐2017 "SOLID CITRATE AND TARTRATE SALTS OF DPP‐IV INHIBITORS" 283269 6565/DELNP/2009 11‐05‐2017 IMMUNOGENIC COMPOSITIONS COMPRISING MYCOBACTERIUM 283276 TUBERCULOSIS POLYPEPTIDES AND FUSIONS THEREOF

3600/CHENP/2009 15/05/2017 LIPASE VARIANTS FOR PHARMACEUTICAL USE 283306 2726/KOLNP/2011 16‐05‐2017 COATED SOLID PREPARATION 283336 1743/KOLNP/2008 17‐05‐2017 ANTINEOPLASTIC COMBINATIONS WITH MTOR INHIBITOR, 283351 HERCEPTIN, AND/OR HKI‐272 2557/CHENP/2009 17‐05‐2017 TES7 AND ANTIBODIES THAT BIND THERETO 283355 7960/DELNP/2006 17‐05‐2017 "PHTHALAZINE DERIVATIVES AS PARP INHIBITORS" 283357 3018/MUM/2009 17‐05‐2017 A PROCESS FOR PREPARATION OF MULTIPARTICULATE MODIFIED 283367 RELEASE PHARMACEUTICAL COMPOSITIONS 794/CHE/2009 18‐05‐2017 PROCESS FOR THE PREPARATION OF DESMOPRESSIN 283381 281/KOLNP/2011 19‐05‐2017 3‐(3‐PYRIMIDIN‐2‐YL‐BENZYL)‐1,2,4‐TRIAZOLO (4,3‐B)PYRIDAZINE 283405 DERIVATIVES AS MET KINASE INHIBITORS 2939/DELNP/2006 19‐05‐2017 "LIQUID PHARMACEUTICAL COMPOSITION FOR THE PROLONGED 283425 RELEASE OF INTERFERON (S)" 6031/DELNP/2006 19‐05‐2017 "CARBOLINE COMPOUNDS AND COMPOSITION" 283435 335/DELNP/2007 19‐05‐2017 "USE OF COMPOUNDS CONTAINING THIOL GROUPS AS AN EFFLUX 283436 PUMP INHIBITOR" 4464/DELNP/2008 19‐05‐2017 "GANAXOLONE FORMULATIONS AND METHODS FOR MAKING AND 283439 USE THEREOF" 4785/DELNP/2008 22‐05‐2017 "ONCOGENIC RAS‐SPECIFIC CYTOTOXIC COMPOUND AND 283463 METHODS OF USE THEREOF" 2469/KOLNP/2010 22/05/2017 COMPRESSED CHEWING GUM TABLET 283446 6592/DELNP/2007 22‐05‐2017 "LAYERED NANOPARTICLES" 283462 3516/MUM/2010 23‐05‐2017 PHARMACEUTICAL COMPOSITIONS OF TENECTEPLASE 283474 1490/DELNP/2010 23‐05‐2017 "METHODS OF PREPARING 4‐PHENYL‐6‐(2,2,2‐TRIFLUORO‐1‐ 283482 PHENYLETHOXY)PYRIMIDINE‐BASED COMPOUNDS" 2829/MUM/2009 25‐05‐2017 A PROCESS FOR THE PREPARATION OF RIFAMPICIN PELLETS OR 283558 RIFAMPICIN GASTRORETENTIVE PELLETS 6425/DELNP/2009 25‐05‐2017 "USE OF OLIGOMERS OF LACTIC ACID IN THE TREATMENT OF 283564 GYNAECOLOGICAL DISORDERS" 9025/DELNP/2008 26‐05‐2017 "ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF 283620 PROSTATE CANCER AND ANDROGEN RECEPTOR‐ASSOCIATED DISEASE" 6657/DELNP/2010 26‐05‐2017 "ORALLY‐DISINTEGRATING SOLID PREPARATION" 283651 4760/DELNP/2012 29/05/2017 “PACLITAXEL/ STEROIDAL COMPLEX” 283662 2020/DELNP/2010 29/05/2017 "FOAMABLE FLUORIDE ORAL CARE COMPOSITION" 283660 2741/DELNP/2009 29‐05‐2017 “LIQUID CHALCOGENIDE COMPOSITIONS AND METHODS OF 283663 MANUFACTURING AND USING THE SAME” 1345/DEL/2008 29‐05‐2017 "COSMETIC COMPOSITION FOR APPLICATION TO THE SKIN" 283665 173/DELNP/2010 30‐05‐2017 "SUBSTITUTED 6‐ANILINOPURINE DERIVATIVES AS INHIBITORS OF 283713 CYTOKININ OXIDASE/DEHYDROGENASE AND PREPARATIONS CONTAINING THESE DERIVATIVES" 2989/KOLNP/2010 30‐05‐2017 PARENTERAL FORMULATIONS FOR THE ADMINISTRATION OF 283740 DOPAMINE 672/DEL/2010 31‐05‐2017 A BIOMIMETIC PROCESS FOR THE SYNTHESIS OF AQUEOUS 283789 FERROFLUIDS FOR BIOMEDICAL APPLICATIONS

Page 20 of 85 4406/CHENP/2010 01‐06‐2017 A PROCESS FOR PRODUCING GAMMA MANGOSTIN 283874 3953/KOLNP/2009 02‐06‐2017 MODULATORS OF CFTR 283881 506/DEL/2010 02‐06‐2017 “A NOVEL SALMONELLA TYPHI PROTEIN AS SUBUNIT VACCINE” 283894 7205/DELNP/2007 03‐06‐2017 METHOD FOR OPTIMIZING FLUORIDE UPTAKE OF TEETH BY 281045 APPLYING A LIQUID DENTIFRICE COMPOSITION 1396/MUMNP/2009 05‐06‐2017 SKIN LIGHTENING COMPOSITION FOR HYPERPIGMENTED SKIN 283918 5622/DELNP/2012 06‐06‐2017 STABILIZATION OF ZINC OXIDE FILM IN ORAL COMPOSITIONS 283952 3137/DELNP/2010 06‐06‐2017 "ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE 283970 THEREOF" 2497/MUM/2010 06‐06‐2017 PEARLESCENT LIQUID COSMETIC COMPOSITION 283982 3642/CHENP/2009 06‐06‐2017 STABILIZATION OF UV‐SENSITIVE ACTIVE INGREDIENTS 283993 5909/CHENP/2009 07‐06‐2017 DEPILATORY COMPOSITION 283998 9607/DELNP/2011 07‐06‐2017 "SODIUM IBUPROFEN TABLETS AND METHODS OF 284003 MANUFACTURING PHARMACEUTICAL COMPOSITIONS INCLUDING SODIUM IBUPROFEN" 455/KOL/2010 07‐06‐2017 PROCESS FOR PREPARING A COMPOSITION EFFECTIVE AGAINST 284007 GASTRO‐INTESTINAL DISORDERS 2676/CHENP/2009 07‐06‐2017 “DUAL ACTION, INHALED FORMULATIONS PROVIDING BOTH AN 284045 IMMEDIATE AND SUSTAINED RELEASE PROFILE” 2448/DEL/2008 08‐06‐2017 A HOMEOPATHIC PREPARATION FOR CONDITIONING OF BARREN 284077 LAND/SALINE LAND 2889/DELNP/2008 08‐06‐2017 “IMPROVED TESTOSTERONE GEL AND METHOD OF USE” 284078 254/DEL/2007 08‐06‐2017 "NOVEL IMMUNOTHERAPEUTIC METHOD FOR TREATMENT OF 284087 CANCER" 1925/KOLNP/2010 09‐06‐2017 PHARMACEUTICAL COMPOSITIONS WITH A MECHANISM OF MULTI‐ 284094 TARGET RECEPTOR RETROACTION FOR TREATING DEPRESSION

3132/CHENP/2009 09‐06‐2017 LIQUID ANTI‐RABIES ANTIBODY FORMULATIONS 284108 1726/CHENP/2009 09‐06‐2017 THERAPEUTIC COMPOSITIONS COMPRISING A SPECIFIC 284113 ENDOTHELIN RECEPTOR ANTAGONIST AND A PDE5 INHIBITOR 9480/DELNP/2008 09‐06‐2017 "DIMPLED ADHERING TROCHE FOR USE ON TEETH OR 284115 ORTHODONTIC BRACES" 828/MUMNP/2011 09‐06‐2017 ANTIPERSPIRANT COMPOSITIONS 284126 829/MUMNP/2011 09‐06‐2017 ANTIPERSPIRANT COMPOSITIONS 284127 433/DEL/2009 11‐06‐2017 "A METHOD FOR PRODUCING CALCUIM CARBONATE 289249 NANOPARTICIES USING RECOMBINANT CARBONIC ANHYDRASE FROM AZOSPIRILLUM BRASILENSE". 603/DEL/2008 12‐06‐2017 NOVEL BENZIMIDAZOLE LINKED PYRROLO[2, 1‐C] BENZODIAZEPINE 284153 HYBRIDS AS POTENTIAL ANTITUMOUR AGENTS AND PROCESS FOR THE PREPARATION THEREOF 539/MUMNP/2011 12‐06‐2017 UNIVERSAL SENSORY STRUCTURANT 284155 5168/DELNP/2009 12‐06‐2017 "SOLID BETALAIN COMPOSITIONS AND METHODS" 284159 5540/DELNP/2008 12‐06‐2017 PERSONAL CARE COMPOSITIONS CONTAINING CATIONICALLY 284163 MODIFIED STARCH AND AN ANIONIC SURFACTANT SYSTEM 785/DEL/2008 13‐06‐2017 ISOXAZOLINE LINKED PYRROLO[2,1‐C][1,4]BENZODIAZEPINE 284169 HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND THE PROCESS FOR PREPARATION THEREOF 2136/MUM/2010 13‐06‐2017 "PROCESS FOR PREPARATION OF N‐BENZYL‐2‐ 284175 ACETAMIDOPROPIONAMIDE DERIVATIVE" 6945/DELNP/2006 13‐06‐2017 "A COATED TABLET COMPOSTION" 284186 6008/DELNP/2006 13‐06‐2017 "A HOMOGENEOUS PHARMACEUTICAL COMPOSITION SUITABLE 284190 FOR THE TREATMENT OF RHINITIS" 4357/DELNP/2005 14‐06‐2017 "P38 INHIBITORS AND METHODS OF USE THEREOF" 284209 889/MUMNP/2010 14‐06‐2017 HERBAL COMPOSITIONS AND METHODS FOR TREATING HEPATIC 284222 DISORDERS 2180/CHENP/2007 14‐06‐2017 VACCINES AGAINST JAPANESE ENCEPHALITIS VIRUS AND WEST NILE 284237 VIRUS 2750/DELNP/2007 15/06/2017 "QUINUCLIDINE DERIVATIVES AND THEIR USE AS MUSCARINIC M3 284278 RECEPTOR ANTAGONISTS"

Page 21 of 85 2918/DELNP/2007 15‐06‐2017 "OPTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES" 284277

737/KOLNP/2008 16‐06‐2017 BETA‐LACTAMYL PHENYLALANINE, CYSTEINE, AND SERINE 284299 VASOPRESSIN ANTAGONISTS 2146/MUMNP/2009 19‐06‐2017 DPP‐IV INHIBITOR INCLUDING BETA‐AMINO GROUP, PREPARATION 284333 METHOD THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR PREVENTING AND TREATING A DIABETES OR AN OBESITY 858/DELNP/2009 19‐06‐2017 "A COMPOUND OF FORMULA (I)" 284343 4850/CHENP/2009 19‐06‐2017 PELLETS COMPRISING AN ACTIVE SUBSTANCE MATRIX RESISTANT 284351 TO GASTRIC JUICE 171/MUM/2012 19‐06‐2017 ANTI‐RHD MONOCLONAL ANTIBODIES 284359 2258/MUMNP/2011 20/06/2017 “METHOD FOR PREPARING ENCAPSULATED LIVER CELL 284386 COMPOSITION” 2137/DELNP/2009 20‐06‐2017 "CONTROLLED RELEASE COMPLEX COMPOSITION COMPRISING 284361 ANGIOTENSIN‐II‐RECEPTOR BLOCKERS AND HMG‐COA REDUCTASE INHIBITORS" 546/DELNP/2007 20‐06‐2017 A POLYSACCHARIDE COMPOSITION OF GANODERMA 284383 4062/DELNP/2010 20‐06‐2017 "ORAL CARE PRODUCT AND METHODS OF USE AND MANUFACTURE 284384 THEREOF" 1573/DEL/2004 20‐06‐2017 "A NOVEL FUNGAL STRAIN OF CANDIDA TROPICALIS" 284387 2170/DELNP/2010 20‐06‐2017 "TOPICAL COMPOSITION" 284399 2575/DEL/2007 21‐06‐2017 "PROCESS FOR THE PURIFICATION OF SINGLE POLYPEPTIDE CHAIN 284404 PROTEINS" 1760/MUM/2010 21‐06‐2017 "A METHOD FOR PREPARATION OF HIGHLY PURE ASIATICOSIDE 284406 COMPOSITION FROM CENTELLA ASIATICA 306/KOLNP/2011 21‐06‐2017 DIRECTLY COMPRESSIBLE AND RAPIDLY DISINTEGRATING TABLET 284411 MATRIX 1084/MUM/2006 21‐06‐2017 A COMPOSITION FOR THE TREATMENT OF ASTHMA 284421 143/DEL/2010 21‐06‐2017 PROCESS FOR THE PREPARATION OF A GRANULAR ORAL 284433 COMPOSITION 6003/DELNP/2012 22‐06‐2017 PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND 284447 ROSUVASTATIN 6561/CHENP/2008 22‐06‐2017 PHARMACEUTICAL FORMULATIONS FOR THE PROLONGED RELEASE 284492 OF ACTIVE PRINCIPLE(S), AND PROCESS FOR PRODUCING THE SAME

4966/CHENP/2008 23‐06‐2017 PHARMACEUTICAL COMPOSITION COMPRISING OSELTAMIVIR 284534 PHOSPHATE 3494/DELNP/2009 23‐06‐2017 "A CHEMICALLY MODIFIED PROTEINACEOUS CONSTRUCT" 284500 133/MUM/2008 23‐06‐2017 A METHOD FOR PREPARATION OF LIPOSOMES 284531 716/CHENP/2007 23‐06‐2017 MULTIPARTICULATES 284537 2445/DEL/2008 27/06/2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF ANIMALS 284568 SUFFERING FROM PRIMARY STAGES OF MAMMARY GLAND DISORDERS" 2456/DEL/2008 27‐06‐2017 A HOMEOPATHIC PREPARATION FOR EASY MILKING OF ANIMALS 284570

5099/DELNP/2009 27‐06‐2017 “A NOVEL PHARMACEUTICAL COMPOSITION” 284577 8114/DELNP/2007 27‐06‐2017 COMPOSITIONS AND METHODS FOR TREATMENT OF EYE 284595 DISORDERS 4452/CHENP/2009 27‐06‐2017 "POLY(ADP‐RIBOSE)POLYMERASE INHIBITORY COMPOUND" 284604 2721/CHENP/2010 28‐06‐2017 A NEW NUTRACEUTICAL COMPOSITION FROM GARCINIA 284654 MANGOSTANA 154/MUMNP/2010 28‐06‐2017 CYCLIC AMINE SUBSTITUTED PYRIMIDINEDIAMINES AS PKC 284671 INHIBITORS 2451/DEL/2008 28‐06‐2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF ANIMALS 284673 SUFFERING FROM INTESTINAL PARASITES WORMS INFECTION AND ASSOCIATED CONSTIPATION, STOMACH BLOATING ETC 1596/CHENP/2010 28‐06‐2017 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL 284682 COMPOSITION FOR NON‐OPIOIDS WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL

Page 22 of 85 2454/DEL/2008 29‐06‐2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF ANIMALS 284699 SUFFERING FROM MAMMARY GLAND DISORDERS 5203/CHENP/2010 29‐06‐2017 PROTOPANAXADIOL‐TYPE GINSENOSIDE COMPOSITIONS 284703 194/CHENP/2008 29‐06‐2017 BREATH FRESHENING AND ORAL CLEANSING PRODUCT 284713 COMPRISING A MAGNOLIA BARK EXTRACT AND SURFACTANT 3871/CHENP/2008 29‐06‐2017 COMPOSITIONS FOR VAGINAL USE 284744 2791/DEL/2008 29‐06‐2017 SYNERGISTIC ANTIFUNGAL COMPOSITION OF DEHYDRATED 284748 DIALDOL PRODUCT AND NATURAL PRODUCT 3615/KOLNP/2010 29‐06‐2017 HCV PROTEASE INHIBITORS 284752 2876/CHENP/2008 29‐06‐2017 TARGETING VECTOR‐PHOSPHOLIPID CONJUGATES 284761 4507/KOLNP/2008 30‐06‐2017 SITE‐SPECIFIC INTESTINAL DELIVERY OF ADSORBENTS, ALONE OR IN 284798 COMBINATION WITH DEGRADING MOLECULES 10627/DELNP/2008 30‐06‐2017 COMPOSITONS AND METHODS FOR TREATING PARASITIC 284805 INFECTIONS 957/MUM/2004 30‐06‐2017 Novel tri –polymer combination based controlled release 284820 composition 3867/CHENP/2008 30‐06‐2017 PHARMACEUTICAL COMPOSITION FOR APPLICATION TO NAIL 284828 4254/KOLNP/2010 30‐06‐2017 QUINAZOLINE DERIVATIVES 284850 258/MUM/2007 03‐07‐2017 HERBAL COMPOSITIONS FOR PREVENTION AND TREATMENT OF 284870 MAREK'S DISEASE AND IMMUNITY ENHANCEMENT IN POULTRY 1314/DELNP/2007 03‐07‐2017 "A DELAYED RELEASE PHARMACEUTICAL FORMULATION 284890 COMPRISING KATP CHANNEL OPENERS" 697/DELNP/2007 05‐07‐2017 "STABILISED PROSTAGLANDIN COMPOSITION" 284922 2359/DEL/2010 05‐07‐2017 ANTI‐INFLAMMATORY AND ANTI‐ANGIOGENIC PEPTIDES AND 284923 THEIR USES 5585/CHENP/2007 06‐07‐2017 IL‐31 MONOCLONAL ANTIBODIES AND METHODS OF USE 284946 6762/CHENP/2009 06‐07‐2017 PHARMACEUTICAL FORMULATIONS CONTAINING LIPOTIC ACID 284941 DERIVATIVES 4860/DELNP/2007 06‐07‐2017 "ORAL COMPOSITIONS CONTAINING OXIDIZED CAMELLIA" 284943 2080/CHE/2011 07‐07‐2017 PROCESS FOR PREPARATION OF A PLANT BASED ANTIVIRAL 284965 COMPOSITION FOR THE TREATMENT OF HIV AND HIV RELATED ACQUIRED IMMUNO DEFICIENCY SYNDROME 316/CHE/2010 07‐07‐2017 PROCESS FOR THE PURIFICATION OF DEFERASIROX 284974 8293/DELNP/2008 07‐07‐2017 LOW MOLECULAR WEIGHT AMPHOLYTIC POLYMERS FOR 284975 PERSONAL CARE APPLICATIONS 5578/DELNP/2008 07‐07‐2017 USE OF TYPE II PNEUMOCYTES IN THE TREATMENT OF PULMONARY 284983 DISEASES ASSOCIATED WITH PULMONARY FIBROSIS

235/MUM/2011 09‐07‐2017 A method for making an extract of an overground part of 287179 Hedychium coronarium Koenig 4188/DELNP/2007 10‐07‐2017 "A METHOD FOR PREPARING AN EXTRACT OF PIPER LAETISIPICUM 285022 C.DC." 305/DELNP/2007 11‐07‐2017 "CYCLIC PROGESTIN REGIMENS AND KITS" 289320 2540/DEL/2008 11‐07‐2017 CINNAMIDO‐PYRROLO[2,1‐C][1,4]BENZODIAZEPINES AS POTENTIAL 285045 ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF 3870/CHENP/2008 11‐07‐2017 HEMOSTATIC MATERIAL 285055 3512/CHENP/2009 11‐07‐2017 PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION 285072

1785/CHE/2009 11‐07‐2017 "STABLE PHARMACEUTICAL COMPOSITIONS" 285082 2626/DELNP/2010 12‐07‐2017 "PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT 285102 AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES" 7338/DELNP/2006 12‐07‐2017 "OXIDATIVE DEGRADATION PRODUCTS OF ATORVASTATIN 285134 CALCIUM". 8103/CHENP/2011 13‐07‐2017 ANTIMYCOTIC PHARMACEUTICAL COMPOSITION 285139 2168/MUMNP/2011 14‐07‐2017 SWOLLEN SILICONE COMPOSITION AND PROCESS OF PRODUCING 285191 SAME

Page 23 of 85 4633/CHENP/2009 14‐07‐2017 COMPOSITION COMPRISING WATER SOLUBLE CHITOSAN AMINO‐ 285207 POLYSACCHARIDE 6490/DELNP/2010 14‐07‐2017 'PHARMACEUTICAL COMPOSITION COMPRISING RACETAM AND 285234 CARNITINE AND PROCESS FOR ITS PREPARATION' 3869/DELNP/2010 17‐07‐2017 MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULFONAMIDES AS 285245 INHIBITORS OF HCV REPLICATION 2196/DELNP/2008 17‐07‐2017 "SACHET FORMULATION FOR AMINE POLYMERS" 285250 7342/DELNP/2008 17‐07‐2017 "NANOPARTICLES FOR IMMUNOTHERAPY" 285284 2121/DEL/2009 18/07/2017 "IMIDAZOTHIAZOLE‐CHALCONE HYBRIDS AS POTENTIAL 285355 ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF" 1711/DEL/2007 18‐07‐2017 AN IMPROVED PROCESS FOR THE ISOLATION OF 2,5‐DIHYDROXY‐1, 285296 4‐BENZOQUINONE DERIVATIVES LIKE EMBELIN FROM NATURAL RESOURCES 1074/MUM/2012 18‐07‐2017 "PHARMACEUTICAL COMPOSITION CONTAINING ACRYLATE TYPE 285298 AQUEOUS BASED PRESSURE SENSITIVE ADHESIVE FOR TRANSDERMAL DRUG DELIVERY" 9017/DELNP/2008 18‐07‐2017 "METHODS TO ADMINISTER SOLID DOSAGE FORMS OF ETHINYL 285319 ESTRADIOL AND PRODRUGS THEREOF WITH IMPROVED BIOAVAILABILITY" 6795/DELNP/2009 18‐07‐2017 COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON 285322 PROPYLHEPTANOL 2456/DEL/2007 18‐07‐2017 5‐[TRIMETHOXY PHENYL]‐1‐THIOMTHYL‐N‐ARYLAMINO‐PENTA‐1,4‐ 285336 DIEN‐3‐ONES 755/DEL/2007 18‐07‐2017 "COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A 285339 POLYCONDENSATE, COSMETIC TREATMENT PROCESS USING THE SAID COMPOSITION, THE SAID POLYCONDENSATE, AND PREPARATION PROCESS THEREFOR" 1182/DEL/2006 18‐07‐2017 "A PROCESS FOR THE PREPARATION OF ATAXANE DERIVATIVE" 285341 3136/KOLNP/2009 18‐07‐2017 A TRANSDERMAL DELIVERY DEVICE AND METHOD OF 285344 PREPARATION THEREOF 1814/CHENP/2010 19‐07‐2017 PHARMACEUTICAL COMPOSITION 285374 1203/MUMNP/2012 19‐07‐2017 HYDROPHILIC FILTRATION DURING MANUFACTURE OF VACCINE 285375 ADJUVANTS 3740/CHENP/2010 19‐07‐2017 PREPARATION OF CATIONIC TERPOLYMERS AND PERSONAL CARE 285399 COMPOSITIONS 645/DEL/2008 19‐07‐2017 "A PROCESS FOR SYNTHESIS OF POLYMERIC MICRO/ 285405 NANOPARTICLES FOR DRUG (BIOACTIVE AGENT) DELIVERY APPLICATIONS" 635/DELNP/2011 19‐07‐2017 CONTROLLED RELEASE ANTIMICROBIAL COMPOSITIONS AND 285410 METHODS FOR THE TREATMENT OF OTIC DISORDERS 956/CHENP/2010 20‐07‐2017 ANTIFUNGAL COMPOSITION 285431 876/DEL/2008 21‐07‐2017 "HERBAL COMPOSITION FOR CHIN AND NECK FIRMING" 285462 679/DEL/2008 21‐07‐2017 "HERBAL COMPOSITION FOR HIPS,THIGHS AND ARMS FIRMING" 285463

1357/CHENP/2010 21‐07‐2017 BUFFER SOLUTIONS HAVING SELECTIVE BACTERICIDAL ACTIVITY 285468 AGAINST GRAM NEGATIVE BACTERIA AND METHODS OF USING SAME 3157/DELNP/2007 21‐07‐2017 "SOPHORAE SUBPROSTRATAE RADIX EXTRACT FOR PREVENTION 285504 AND TREATMENT OF RESPIRATORY DISEASES" 8256/DELNP/2009 22‐07‐2017 HYDROCARBON MIXTURES AND USE THEREOF 285507 2695/MUMNP/2010 24/07/2017 SUNSCREEN COMPOSITE PARTICLES DISPERSED IN WATER‐IN‐OIL 285510 COSMETIC COMPOSITIONS 2697/MUMNP/2010 24/07/2017 SUNSCREEN FORMULA VANISHING CREAM 285511 1920/DELNP/2010 24‐07‐2017 "PROCESS FOR THE MANUFACTURE OF A PHARMACEUTICAL 285514 PRODUCT" 2311/DEL/2006 24‐07‐2017 UREA BASED INCLUSION COMPLEXES OF ISOTRETINOIN ,ENALAPRIL 285521 MALEATE AND AMILORIDE HYDROCHLORIDE AND PROCESSES THEREOF 2340/MUMNP/2011 24‐07‐2017 COMPOSITION 285536

Page 24 of 85 131/DELNP/2008 24‐07‐2017 POLYUNSATURATED FATTY ACIDS FOR TREATMENT OF DEMENTIA 285544 AND PRE‐DEMENTIA‐RELATED CONDITIONS 6304/DELNP/2006 24‐07‐2017 "COMPOUNDS AND COMPOSITIONS AS CATHEPSIN INHIBITORS" 285553

7561/DELNP/2009 24‐07‐2017 "A PHARMACEUTICAL FORMULATION" 285557 9244/DELNP/2007 25‐07‐2017 "A SOLID PHARMACEUTICAL COMPOSITION WITH A FIRST 285617 FRACTION OF A DISPERSION MEDIUM AND A SECOND FRACTION OF A MATRIX, THE LATTER BEING AT LEAST PARTIALLY FIRST EXPOSED TO GASTROINTESTINAL FLUIDS" 4032/DELNP/2011 26/07/2017 "METHOD FOR PREPARING PERSONAL CARE COMPOSITION 285641 COMPRISING SURFACTANT AND HIGH MELTING POINT FATTY COMPOUND" 3348/MUM/2012 26‐07‐2017 "A PROCESS FOR PREPARATION OF INTRAVENOUS COMPOSITION" 285627

5229/DELNP/2008 26‐07‐2017 ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEM 285633 891/DEL/2006 26‐07‐2017 SYNTHESIS OF NOVEL PYRROLO [1'',2'':1,6]‐, AND MORPHOLINO 285645 [1'',2'':1,6]TETRAHYDROPYRIDO[2,3‐B]‐QUINOLINE

1114/DEL/2009 26‐07‐2017 A NOVEL ANTI‐DIABETIC FUROSTANOLIC‐SAPONIN‐RICH (FSR) 285647 FRACTION FROM FENUGREEK SEEDS 4181/DELNP/2012 27‐07‐2017 "ANTI‐EROSION TOOTHPASTE COMPOSITION" 285713 223/KOLNP/2010 27‐07‐2017 (2S,3R)‐N‐(2‐((3‐PYRIDINYL)METHYL)‐1‐AZABICYCLO[2,2,2]OCT‐3‐ 285735 YL)BENZOFURAN‐2‐CARBOXAMIDE, NOVEL SALT FORMS 2466/CHENP/2011 28/07/2017 4,5,6,7‐TETRAHYDROIMIDAZO[4,5‐C]PYRIDINE COMPOUNDS 285810 2452/DEL/2008 28/07/2017 A HOMEOPATHIC PREPARATION FOR TREATMENT OF MOUTH 285773 ULCERS AND FOOT ULCERS IN ANIMALS 8668/DELNP/2010 28‐07‐2017 "CAPSULE PHARMACEUTICAL DOSAGE FORM COMPRISING A 285760 SUSPENSION FORMULATION OF AN INDOLINONE DERIVATIVE" 1391/MUM/2007 28‐07‐2017 A SYNERGISTIC ANTIBIOTIC FORMULATION 285771 3236/KOLNP/2009 28‐07‐2017 4‐NAPHTHYLOXY SUBSTITUTED QUINOLINE OR QUINAZOLINE 285781 DERIVATIVES 1136/MUMNP/2011 28‐07‐2017 HAIR CARE COMPOSITION COMPRISING A DENDRITIC 285785 MACROMOLECULE 1184/MUM/2009 28‐07‐2017 VACCINE COMPOSITION CONTAINING NOVEL ADJUVANTS 285791 5364/CHENP/2010 28‐07‐2017 METHOD FOR PRODUCTION OF ORALLY RAPIDLY DISINTEGRATING 285816 TABLET COMPRISING IMIDAFENACIN AS ACTIVE INGREDIENT

1726/DEL/2012 28‐07‐2017 "NEW CO‐CRYSTALS OF AGOMELATINE, A PROCESS FOR THEIR 285822 PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM" 213/MUMNP/2011 31/07/2017 LIQUID PERSONAL CLEANSING COMPOSITION 285880 4166/CHENP/2010 31‐07‐2017 COATED PHARMACEUTICAL OR NUTRACEUTICAL PREPARATION 285888 WITH ENHANCED PULSED ACTIVE SUBSTANCE RELEASE 732/KOLNP/2012 31‐07‐2017 FILM COATING AGENT FOR SOLID PREPARATION, AND SOLID 285860 PREPARATION USING SAME 3600/CHENP/2010 31‐07‐2017 A SOLID COMPRESSED CONTROLLED RELEASE FORMULATION 285887 611/DEL/2009 31‐07‐2017 PLANT EXTRACT FOR TREATING ANXIETY DISORDERS 285895 2100/KOLNP/2010 31‐07‐2017 ANALOGUES AND DERIVATIVES OF MYCOPHENOLIC ACID 285931 625/KOLNP/2010 31‐07‐2017 METHOD FOR PREPARING AN INHALABLE DRY‐POWDER 285933 MEDICAMENT 5052/DELNP/2009 02‐08‐2017 "SP35 ANTIBODIES AND USES THEREOF" 286022 925/CHENP/2009 03‐08‐2017 TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE 286045 1099/KOLNP/2010 03‐08‐2017 GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES 286052 3288/CHENP/2009 03‐08‐2017 A SYSTEM FOR DETERMINING A DISTRIBUTION OF RADIOACTIVE 286057 AGENTS IN A SUBJECT 1193/KOLNP/2011 03‐08‐2017 A STABLE TOPICAL CREAM COMPOSITION 286059 514/KOLNP/2009 07‐08‐2017 PEPTIDES HAVING PHARMACOLOGICAL ACTIVITY FOR TREATING 286107 DISORDERS ASSOCIATED WITH ALTERED CELL MIGRATION, SUCH AS CANCER

Page 25 of 85 7974/DELNP/2010 07‐08‐2017 "TRANSNASAL ANTICONVULSIVE PHARMACEUTICAL COMPOSITION 286116 COMPRISING POORLY SOLUBLE ANTICONVULSANT"

949/KOLNP/2010 08‐08‐2017 PSMA BINDING LIGAND‐LINKER CONJUGATES AND METHODS FOR 286122 USING 3068/MUM/2010 08‐08‐2017 PHARMACEUTICAL COMPOSITION OF TAXOIDS 286125 1204/MUM/2009 09‐08‐2017 A MEDICINAL COMPOSITION FOR CURING DIABETES TYPE II 286209 3404/CHENP/2010 10‐08‐2017 AGENT FOR TREATING ULCER 286222 6300/CHENP/2010 10‐08‐2017 NOVEL 1‐BENZYL‐3‐HYDROXYMETHYLINDAZOLE DERIVATIVES 286226 6866/CHENP/2009 10‐08‐2017 NEW METHOD FOR PREPARING ISOFAGOMINE AND ITS 286227 DERIVATIVES 6826/DELNP/2008 10‐08‐2017 "COMPOSITIONS AND METHODS FOR INDUCING BONE GROWTH 286234 AND INHIBITING BONE LOSS" 8431/DELNP/2008 10‐08‐2017 "MULTI‐LAYER MEDICAL PATCH WITH IMPERMEABLE CENTER" 286247 878/CHENP/2009 11‐08‐2017 A PHARMACEUTICAL LIPOSOMAL FORMULATION FOR 286260 PHOTODYNAMIC THERAPHY 3200/DELNP/2009 11‐08‐2017 "HPV ANTIGEN FUSION PROTEIN VACCINE COMPOSITIONS AND 286292 USES THEREOF" 8081/DELNP/2007 11‐08‐2017 "MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE‐PROTEIN 286321 CONJUGATE COMPOSITION" 795/CHE/2009 14‐08‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF ROTIGOTIN 286338 AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS 7685/DELNP/2008 14‐08‐2017 "A PHARMACEUTICAL COMBINATION FOR CHEMOSENSIBILIZATION 286342 " 3015/DELNP/2007 16/08/2017 "ALIPHATIC AMINE POLYMER SALTS FOR TABLETING" 286357 2510/CHE/2010 16/08/2017 THE COMPRESSION COATED TABLET COMPOSITION FOR 286353 CHRONOTHERAPY OF HYPERTENSION 191/MUM/2008 16‐08‐2017 AN IMPROVED PROCESS FOR THE PREPARATION OF 2‐BUTYL‐4‐ 286363 CHLORO‐1‐[[(2'(1H‐TETRAZOLE‐5‐YL)[1,1 BIPHENYL]‐4‐YL]METHYL]‐ 1H‐IMIDAZOLE‐5‐METHANOL 4453/DELNP/2010 17‐08‐2017 "METHOD FOR PREPARING NANOPARTICLES BASED ON 286387 FUNCTIONAL AMPHIPHILIC MOLECULES OR MACROMOLECULES, AND THE USE THEREOF" 662/DEL/2008 18‐08‐2017 HERBAL COMPOSITON OF WAIST & TUMMY TRIMMING / FIRMING 286399

4860/DELNP/2008 18‐08‐2017 “A DEPIGMENTING COMPOSITION ” 286408 5609/DELNP/2010 18‐08‐2017 "COMPOSITIONS AND METHODS FOR INFLUENCING RECOVERY 286425 FROM STRENUOUS PHYSICAL ACTIVITY" 631/CHE/2006 18‐08‐2017 PROCESS FOR ISOLATION OF BERGENIN FROM CAESALPINIA 286441 DIGYNA ROTTLER 151/MUM/2007 21‐08‐2017 NOVEL COMPOSITION OF PAPAIN AS DESLOUGHING SKIN CARE 286455 AGENTS AND METHOD THEREOF 4987/CHENP/2010 21‐08‐2017 SKIN WHITENING AGENT AND EXTERNAL PREPARATION FOR THE 286495 SKIN 3606/DELNP/2007 21‐08‐2017 "NONAQUEOUS PREPARATION FOR PERCUTANEOUS ABSORPTION 286497 CONTAINING NONSTEROIDAL ANTI INFLAMMATORY ANALGESIC"

1279/MUMNP/2011 22‐08‐2017 "EMULSIFIED COSMETIC COMPOSITION" 286512 4510/KOLNP/2010 22‐08‐2017 BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS 286515 4912/DELNP/2010 22‐08‐2017 "USE OF POLYELECTROLYTE COMPLEXES IN ANTIPERSPIRANT 286531 TECHNOLOGY" 831/DELNP/2009 23‐08‐2017 "VITAMIN D COMPOSITIONS AND METHOD OF ADMINSTRATION TO 286544 A HUMAN BEING" 1962/KOLNP/2009 24‐08‐2017 IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS KINASE 286624 INHIBITORS 126/DEL/2010 24‐08‐2017 A PROCESS FOR THE PREPARATION OF COLLAGENOUS FILM FOR 286626 OPTHALMIC APPLICATIONS 3774/DELNP/2010 25‐08‐2017 "A COMPOSITION SUITABLE FOR ENHANCING CONGNITIVE 286637 FUNCTIONS IN AN ANIMAL"

Page 26 of 85 6461/DELNP/2010 25‐08‐2017 "KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATING OR 286644 PREVENTING OCULAR PAIN" 3183/DELNP/2010 25‐08‐2017 “PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF ASTHMA, 286652 COPD, ALLERGIC RHINITIS, ALLERGIC CONJUNCTIVITIS, ATOPIC DERMATITIS, CANCER, HEPATITIS B, HEPATITIS C, HIV, HPV, BACTERIAL INFECTIONS AND DERMATOSIS” 6294/DELNP/2007 28‐08‐2017 "PHARMACEUTICAL LIPID COMPOSITIONS" 286691 6547/CHENP/2009 28‐08‐2017 "CRYSTAL MODIFICATIONS OF TRANSMISSION DYES" 286698 235/DEL/2011 28‐08‐2017 PROCESS FOR PREPARATION OF MONOISOAMYL 286702 DIMERCAPTOSUCCINIC ACID AND APPLICATIONS THEREOF. 252/DEL/2007 28‐08‐2017 "IMMUNOTHERAPEUTIC COMPOSITION" 286707 453/CHENP/2010 28‐08‐2017 MICROPARTICLES COMPRISING PCL AND USES 286712 3410/CHENP/2008 28‐08‐2017 BOTULINUM NANOEMULSIONS 286725 7476/DELNP/2010 28‐08‐2017 IMPROVEMENTS TO SOLUTION AND METHOD FOR CLEANING 286737 TOOTH ENAMEL 2419/KOLNP/2009 29/08/2017 SMALL VOLUME ORAL TRANSMUCOSAL DOSAGE FORMS 286766 CONTAINING SUFENTANIL FOR TREATMENT OF PAIN 4918/DELNP/2008 29/08/2017 COSMETIC OR DERMATOLOGICAL COMPOSITIONS COMPRISING 286753 MODIFIED TITANIUM DIOXIDE PARTICLES 749/DELNP/2011 29‐08‐2017 "THERAPEUTIC AND PROPHYLACTIC FORMULATION FOR ORAL 286787 CARE" 2912/CHENP/2010 29‐08‐2017 “A COMPOSITION COMPRISING INSULINOTROPIC PEPTIDE 286798 CONJUGATE” 941/KOLNP/2009 29‐08‐2017 SELECTIVELY TARGETED ANTIMICROBIAL PEPTIDES AND THE USE 286802 THEREOF 1259/DEL/2007 29‐08‐2017 "A NOVEL DENGUE ENVELOPE DOMAIN III‐BASED TETRAVALENT 286804 PROTEIN VACCINE" 3786/KOLNP/2010 29‐08‐2017 SOLID ORAL FORM WITH DUAL RELEASE PROFILE, CONTAINING 286808 MULTIPARTICULATES 4185/DELNP/2012 30‐08‐2017 "DISSOLVABLE FILMS CONTAINING HIGH CONCENTRATIONS OF 286811 NONIONIC SURFACTANTS SUCH AS POLYSORBATES TO ENHANCE HIGH SOLID LOADINGS" 86/DEL/2007 30‐08‐2017 "ROSAGLITAZONE LOADED BRAIN PERMEABLE NANOPARTICLES 286815 AND METHOD OF PREPARATION" 87/DEL/2007 30‐08‐2017 "STATIN LOADED BRAIN PERMEABLE NANOPARTICLES AND 286818 METHOD OF PREPARATION" 5810/DELNP/2005 30‐08‐2017 "PROCESS FOR OBTANING TRITERPENES FROM PLANT AND/OR 286840 THEIR COMPONENTS." 6520/DELNP/2006 30‐08‐2017 "LIPIDS, LIPID COMPLEXES AND USE THEREOF" 286846 1865/CHE/2009 30‐08‐2017 "AN IMPROVED PROCESS FOR PREPARATION OF ROSUVASTATIN 286863 CALCIUM" 4723/DELNP/2008 30‐08‐2017 "COMBINATION VACCINE COMPRISING AN ATTENUATED BOVINE 286866 VIRAL DIARRHEA VIRUS" 1300/KOL/2009 31‐08‐2017 STABLE EGUALENE SODIUM SOLID PREPARATION 286893 106/KOL/2012 31‐08‐2017 AN IMPROVED SKIN BRIGHTENING COMPLEX 286902 2778/CHENP/2010 31‐08‐2017 “A COMPLEX OF NUCLEIC ACID AND CATIONIC NANOPARTICLES 286924 AND METHOD OF PREPARATION THEREOF” 3462/DELNP/2008 31‐08‐2017 "SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS AND 286927 METHODS OF PREPARATION THEREOF" 1874/MUMNP/2009 31‐08‐2017 BENZIMIDAZOLE CANNABINOID AGONISTS 286930 1811/CHENP/2010 31‐08‐2017 ANTIFUNGAL PHARMACEUTICAL COMPOSITION 286955 5708/DELNP/2009 31‐08‐2017 "BACTERIAL EXTRACT FOR DIGESTIVE OR URINARY TRACT 286966 DISORDERS AND PROCESS FOR ITS PREPARATION" 8845/DELNP/2008 31‐08‐2017 "PROCESS FOR PREPARING SPRAY DRIED FORMULATIONS OF TMC 286996 125" 2961/DELNP/2010 01‐09‐2017 " A Formulation in the form of a lozenge comprising an 287015 endothermic cooling agent and one or more active ingredients"

3862/DELNP/2010 01‐09‐2017 "THERAPEUTIC AGENT FOR PRURITUS" 287016 1340/DELNP/2010 01‐09‐2017 "A METHOD OF PREPARING THE VACCINE COMPOSITION" 287022

Page 27 of 85 5804/DELNP/2006 04‐09‐2017 "A‐3‐OR 4‐MONOSUBSTITUTED PHENOL OR THIOPHENOL 287044 DERIVATIVES COMPOUND OF THE FORMULA (1) " 618/DEL/2008 04‐09‐2017 STYRENE MALEIC ANHYDRIDE BASED FORMULATION FOR MALE 287045 CONTRACEPTION AND PROSTATE CANCER 1369/MUM/2008 04‐09‐2017 STABILIZED PREPARATION OF ERYTHROPOIETIN AND PROCESS OF 287065 FORMULATION 3674/KOLNP/2010 05‐09‐2017 STABILIZED OLEOSOME PREPARATIONS AND METHODS OF MAKING 287089 THEM 2971/KOLNP/2008 05‐09‐2017 VACCINES AND IMMUNOTHERAPEUTICS USING CODON OPTIMIZED 287092 IL‐15 AND METHODS FOR USING THE SAME 1008/KOLNP/2009 05‐09‐2017 LONG LASTING DRUG FORMULATIONS 287099 2763/KOLNP/2010 05‐09‐2017 MICROPARTICLE AND PHARMACEUTICAL COMPOSITION THEREOF 287102

7838/DELNP/2007 05‐09‐2017 A CONTROLLED RELEASE COMPOSITION FOR TREATING PROSTATE 287112 RELATED DISEASES 2481/CHE/2007 06‐09‐2017 A PROCESS FOR PREPARATION OF TETRAHYDROCARBAZOLONE 287156 DERIVATIVES 1148/CHE/2008 07‐09‐2017 A PROCESS FOR THE PREPARATION OF VALPROIC ACID 287182 7808/DELNP/2010 07‐09‐2017 "SOLID PHARMACEUTICAL FORMULATION WITH DELAYED RELEASE" 287216

2929/CHE/2007 08‐09‐2017 PROCESS FOR PRODUCING 5‐FLUORO‐1‐(2R, 5S)‐[2‐ 287250 (HYDROXYMETHYL)‐1,3‐OXATHIOLAN‐5‐Y1]CYTOSINE 6539/DELNP/2009 11‐09‐2017 "PYRAZOLO [3,4‐B] PYRIDINE DERIVATIVES AS 287282 PHOSPHODIESTERASE INHIBITORS" 14/KOLNP/2007 12‐09‐2017 "DIMENSIONAL ANALYSIS OF SACCHARIDE CONJUGATES WITH 287314 GPC & SECMALS" 747/DELNP/2011 13‐09‐2017 "COMPOSITIONS FOR TREATING ROSACEA COMPRISING CHITOSAN 287342 AND A DICARBOXYLIC ACID" 4018/DELNP/2005 13‐09‐2017 "COMBINATIONS FOR THE TREATMENT OF DISEASES INVOLVING 287343 CELL PROLIFERATION, MIGRATION OR APOPTOSIS OF MYELOMA CELLS, OR ANGIOGENESIS" 2722/CHE/2009 14‐09‐2017 Process for preparation and purification of pegylated interferon 287389

105/MUM/2011 14‐09‐2017 SELF ASSEMBLED NANOSTRUCTURED SALIVA SUBSTITUTES. 287402 575/CHENP/2009 14‐09‐2017 "NANOLIPOSOME COMPRISING LIPOSOME MEMBRANE 287406 CONTAINING ESTERIFIED LECITHIN" 1921/KOLNP/2005 15‐09‐2017 A PROTECTED ANTINEOPLASTIC AGENT 287427 4043/DELNP/2009 18/09/2017 "GALENICAL FORM FOR THE ADMINISTRATION OF PARACETAMOL 287452 BY TRANSMUCOUS MEANS" 364/DELNP/2011 18/09/2017 A SINGLE PHASE PHARMACEUTICAL COMPOSITION OF A 5‐HT1 287444 INHIBITOR AND AN NSAID 1807/MUM/2008 18‐09‐2017 PROLONGED RELEASE FORMULATION OF AMISULPRIDE 287456 961/MUMNP/2011 18‐09‐2017 “PHARMACEUTICAL COMPOSITIONS WITH ATTENUATED RELEASE 287462 OF PHENOLIC OPIOIDS” 6451/DELNP/2009 18‐09‐2017 "A PHARMACEUTICAL COMPOSITION" 287478 288/CHENP/2009 19/09/2017 PHARMACEUTICAL COMPOSITIONS 287504 2710/CHENP/2011 19‐09‐2017 MIXTURES OF ALKYLSULFOCUCCINATES AND THEIR USE 287497 3003/CHE/2007 19‐09‐2017 A PROCESS FOR PREPARATION OF E‐ISOMER OF 1‐4‐ 287509 (METHYLPHENYL)‐1‐(2‐PYRIDYL)‐3‐PYRROLIDINO PROP‐1‐ENE AND ACID ADDITION SALTS THEREOF 3155/DELNP/2011 19‐09‐2017 "PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING 287520 SENSATION" 6453/CHENP/2008 19‐09‐2017 PATCH AND USES THEREOF 287529 3540/DELNP/2011 20‐09‐2017 "NICOTINE IMMUNONANOTHERAPEUTICS" 287537 3541/DELNP/2011 20‐09‐2017 "TARGETING OF ANTIGEN PRESENTING CELLS WITH 287539 IMMUNONANOTHERAPEUTICS" 627/MUMNP/2011 21‐09‐2017 NEW CONTROLLED RELEASE ACTIVE AGENT CARRIER 287590 176/MUMNP/2011 21‐09‐2017 A process for preparing a compound of formula I 287592

Page 28 of 85 5401/DELNP/2011 21‐09‐2017 "OINTMENT FOR THE TOPICAL TREATMENT OF HAEMORRHOIDS" 287598

8104/CHENP/2011 22‐09‐2017 ANTIMYCOTIC PHARMACEUTICAL COMPOSITION 287640 1321/DELNP/2008 22‐09‐2017 “CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION” 287659 4349/DELNP/2012 22‐09‐2017 "A composition comprising as active ingredients one or more 287669 antimicrobial agents and one or more chalcone compounds" 5400/CHENP/2012 22‐09‐2017 PROCESS FOR THE PREPARATION OF GADOBENATE DIMEGLUMINE 287677 COMPLEX IN A SOLID FORM 1426/DELNP/2006 22‐09‐2017 BICYCLIC [3.1.0] DERIVATIVES AS GLYCINE TRANSPORTER 287678 INHIBITORS 2432/KOLNP/2009 25/09/2017 NEUROMUSCULAR BLOCKING AGENTS 287758 1943/CHENP/2011 25‐09‐2017 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL 287692 COMPOSITION FOR NON‐OPIOIDS WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL 4893/CHENP/2010 25‐09‐2017 DEPILATORY COMPOSITION COMPRISING HYDROPHOBIC 287702 PARTICLES, PROCESS FOR PREPARATION AND METHOD OF USE 4731/DELNP/2011 25‐09‐2017 "ADHESIVE MATERIAL CONTAINING 5‐METHYL‐1‐PHENYL‐2‐(1H)‐ 287717 PYRIDONE" 6202/DELNP/2010 25‐09‐2017 "COMBINED USE OF CHOLESTANOL DERIVATIVE" 287752 3910/DELNP/2008 26/09/2017 "USE OF PYRROLOQUINOLINE COMPOUNDS TO KILL CLINICALLY 287814 LATENT MICROORGANISMS" 938/KOL/2007 26‐09‐2017 PROCESS FOR PREPARING HYDROXYCARBOXAMIDES 287797 7595/CHENP/2010 27‐09‐2017 PHARMACEUTICAL FORMULATION CONTAINING PALMITOYL 287852 ETHANOLAMIDE AND STEAROYL ETHANOLAMIDE 3748/KOLNP/2009 27‐09‐2017 A COMPOSITION COMPRISING BACTERIALLY‐DERIVED MINICELLS 287864

6394/CHENP/2009 28‐09‐2017 “ATTENUATED VIRUSES USEFUL FOR VACCINES” 287882 7526/DELNP/2010 28‐09‐2017 "A METHOD FOR INDUCING CD14 POSITIVE MONOCYTES TO 287896 DIFFERENTIATE INTO DENDRITIC CELL‐LIKE CELLS." 2749/DEL/2006 29‐09‐2017 "PROCESS FOR THE PREPARATION OF THIAZOLIDINE DERIVATIVES" 287961

161/DELNP/2011 29‐09‐2017 A process for the conjugation of a peptide or protein containing a 287966 thiol or amino group to a polymer" 6638/DELNP/2009 29‐09‐2017 "A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF 287986 MACULAR DEGENERATION" 2326/MUMNP/2011 02‐10‐2017 A STABILIZER FOR PREPARING FREEZE‐DRIED VACCINE WITHOUT 280148 GELATIN AND THE PREPARATION METHOD OF FREEZE‐DRIED VACCINE 5744/DELNP/2010 04‐10‐2017 "PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR 288038 PREVENTION OF OSTEOARTICULAR DISEASES" 5710/DELNP/2011 05‐10‐2017 "HIGH DOSAGE DORAMECTIN FORMULATION" 288086 541/KOLNP/2009 08‐10‐2017 1H‐IMIDAZO[4.5‐B] PYRAZIN‐2‐OLS, AND COMPOSITIONS THEREOF 286254

2816/KOLNP/2009 09‐10‐2017 A Medicament System Comprising a Solvating System and A 288165 Polymeric Film‐ Forming Medical Sealant 7087/DELNP/2008 09‐10‐2017 "PHARMACEUTICAL AGENT COMPRISING A BENZAMIDE 288172 DERIVATIVES AS ACTIVE INGREDIENT" 1852/KOLNP/2005 10‐10‐2017 FORMULATIONS AND METHODS FOR TREATING RHINOSINUSITIS 288227

6398/CHENP/2010 10‐10‐2017 “PHENOXYPYRIDINYLAMIDE DERIVATIVES AND THEIR USE IN THE 288235 TREATMENT OF PDE4 MEDIATED DISEASE STATES” 1715/MUMNP/2011 10‐10‐2017 ANTIPERSPIRANT COMPOSITIONS 288246 576/MUMNP/2011 11‐10‐2017 “DISPERSION OF SOFT POLYMER PARTICLES, COSMETIC 288262 COMPOSITION COMPRISING IT AND COSMETIC TREATMENT METHOD” 1178/MUM/2008 11‐10‐2017 A PROCESS FOR MANUFACTURING TOPICAL COMPOSITION 288263 1742/DEL/2009 12‐10‐2017 "A CONTROLLED RELEASE PHARMACEUTICAL FORMULATION" 288303 175/DEL/2010 12‐10‐2017 SYNTHETIC PHOSPHODIESTERASE 4 (PDE‐4) INHIBITOR WITH 288310 ANTIASTHMATIC ACTIVITY

Page 29 of 85 753/DELNP/2009 12‐10‐2017 "A COMPOUND OF FORMULA (I)" 288320 4684/DELNP/2010 12‐10‐2017 CYTOSTATIC COMPOSITION 288329 9394/DELNP/2008 13‐10‐2017 “A FORMULATION WHICH STABILIZES A POLYSACCHARIDE‐PROTEIN 288364 CONJUGATE” 2557/MUMNP/2010 13‐10‐2017 NOVEL CONJUGATES OF POLYMERS HAVING A THERAPEUTICALLY 288386 ACTIVE AGENT AND AN ANGIOGENESIS TARGETING MOIETY ATTACHED THERETO AND USES THEREOF IN THE TREATMENT OF ANGIOGENESIS RELATED DISEASES 1572/DELNP/2012 13‐10‐2017 IMPROVED PHARMACOKINETICS OF S‐ADENOSYLMETHIONINE 288387 FORMULATIONS 6382/CHENP/2011 16‐10‐2017 “ANTI‐RHESUS D MONOCLONAL ANTIBODY” 288399 360/CHE/2010 16‐10‐2017 PROCESS FOR THE PREPARATION OF METOPIMAZINE 288433 1714/DEL/2007 17‐10‐2017 "NOVEL EXTENDED RELEASE COMPOSITIONS COMPRISING 288448 MYCOPHENOLATE SODIUM AND PROCESSES THEREOF" 3448/KOLNP/2007 17‐10‐2017 A MULTIVALENT INFLUENZA IMMUNOGENIC COMPOSITION 288463 1882/DEL/2008 17‐10‐2017 "A METHOD OF PREPARING NEW ANTI CANCER HERBAL MEDICINE 288464 AND PRODUCT THERE OF" 746/CHE/2008 18‐10‐2017 HETEROCYCLIC COMPOUNDS AS ADENOSINE RECEPTOR 288516 ANTAGONISTS 6187/CHENP/2010 23‐10‐2017 SELF‐DESTRUCTING TRANSDERMAL THERAPEUTIC SYSTEM HAVING 288566 IMPROVED FUNCTIONALITY AND EFFICACY 3576/DELNP/2008 23‐10‐2017 "PHARMACEUTICAL COMPOSITION" 288580 4309/DELNP/2009 23‐10‐2017 "OPHTHALMIC AND OTIC COMPOSITIONS OF FACIALLY 288585 AMPHIPHILIC POLYMERS AND OLIGOMERS AND USES THEROF" 4478/KOLNP/2010 24/10/2017 PYRROLOPYRIDINES AS KINASE INHIBITORS 288627 8597/DELNP/2011 24‐10‐2017 POWDERED SOLID COSMETIC AND MANUFACTURING METHOD 288609 THEREFOR 3256/DELNP/2009 24‐10‐2017 "METHOD FOR PREPARING A POLYMER CONJUGATE" 288618 9708/DELNP/2008 24‐10‐2017 "VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL 288621 ADMINISTRATON" 9686/DELNP/2008 24‐10‐2017 "MATERNAL SUPPLEMENT" 288645 2473/CHENP/2011 25/10/2017 WATER INSOLUBLE POLYMER: STARCH‐BASED FILM COATINGS FOR 288711 COLON TARGETING 5339/CHENP/2009 25‐10‐2017 METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE 288663 RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE 2185/DELNP/2005 25‐10‐2017 "PHARMACEUTICAL COMPOSITIONS COMPRISING A BASIC 288678 RESPECTIVELY ACIDIC DRUG COMPOUND, A SURFACTANT AND A PHYSIOLOGICALLY TOLERABLE WATER‐SOLUBLE ACID RESPECTIVELY BASE" 7828/DELNP/2008 25‐10‐2017 "B CELL‐BASED VACCINE LOADED WITH THE LIGAND OF NATURAL 288718 KILLER T CELL AND ANTIGEN" 7719/CHENP/2010 25‐10‐2017 PRODRUGS AND DRUG‐MACROMOLECULE CONJUGATES HAVING 288725 CONTROLLED DRUG RELEASE RATES 7134/DELNP/2009 26‐10‐2017 COSMETIC COMPOSITIONS COMPRISING ESTERS BASED ON 2‐ 288747 PROPYLHEPTANOIC ACID 840/DELNP/2010 26‐10‐2017 "METHOD OF MAKING AN ISETHIONATE SALT" 288752 569/CHENP/2009 26‐10‐2017 A SYNTHETIC BIFUNCTIONAL NON‐ANTIBODY COMPOUND. 288770 9900/DELNP/2008 26‐10‐2017 "FUNGICIDAL AZOCYCLIC AMIDES" 288780 567/DELNP/2010 27‐10‐2017 THE USE OF MONOMYCOLYL GLYCEROL (MMG) AS AN ADJUVANT 288789

131/KOLNP/2009 27‐10‐2017 VACCINES FOR MALARIA 288805 8101/DELNP/2010 27‐10‐2017 "AGENT FOR THE TREATMENT AND/OR PROPHYLAXIS OF AN 288814 AUTOIMMUNE DISEASE AND FOR THE FORMATION OF REGULATORY T CELLS" 1152/CHENP/2011 27‐10‐2017 MODIFIED BOVINE G‐CSF POLYPEPTIDES AND THEIR USES 288818 3682/KOLNP/2010 27‐10‐2017 PYRIDOPYRAZINONES DERIVATIVES INSULIN SECRETION 288842 STIMULATORS, METHODS FOR OBTAINING THEM AND USE THEREOF FOR THE TREATMENT OF DIABETES

Page 30 of 85 7080/DELNP/2011 27‐10‐2017 "ANALOGUES OF NEUROPEPTIDE Y HAVING A 4‐HYDROXYPROLINE 288844 SUBSTITUTION AT POSITION 34" 3148/KOLNP/2009 30/10/2017 "FORMULATIONS CONTAINING CYNARA SCOLYMUS AND 288913 PHASEOLUS VULGARIS EXTRACTS FOR REDUCING OBESITY" 2836/KOLNP/2011 30/10/2017 COMPOSITION COMPRISING EGG WHITE‐CHALCANTHITE FOR 288953 PREVENTING OR TREATING CANCER 1272/DELNP/2007 30‐10‐2017 "NUCLEOSIDE PHOSPHONATE CONJUGATES AS ANTI HIV AGENTS" 288882

1470/CHE/2007 30‐10‐2017 IMPROVED PROCESS FOR THE PREPARATION OF ZOLIPIDEM AND 288884 PREPARATION OF ITS NOVEL INTERMEDIATE 3735/DELNP/2011 30‐10‐2017 “PROCESS FOR PREPARING CHLORINS" 288917 7646/DELNP/2010 30‐10‐2017 "CONJUGATES OF A CHOLINESTERASE MOIETY AND A POLYMER" 288940 1294/KOLNP/2011 30‐10‐2017 NOVEL PROSTAGLANDIN I2 DERIVATIVE 288950 525/DEL/2006 31‐10‐2017 SYNTHESIS AND ANTIBACTERIAL ACTIVITIY OF NOVEL 288968 ERYTHROMYCIN DERIVATIVES 9228/DELNP/2008 31‐10‐2017 "USE OF MULTIVALENT SYNTHETIC LIGANDS OF SURFACE 288994 NUCLEOLIN FOR TREATING CANCER OR INFLAMMATION" 967/CHENP/2011 31‐10‐2017 HAIR CONDITIONING COMPOSITION 289007 2345/DELNP/2013 01‐11‐2017 HOMO AND HETERO POLYAMINO ACID DERIVATIVES OF 289108 FULLERENE ,METHOD FOR PRODUCING AND PHARMACEUTICAL COMPOSITIONS THEREOF 3940/KOLNP/2010 02‐11‐2017 OXYMETHYLENE ARYL COMPOUNDS AND USES THEREOF 289112 4070/DELNP/2010 02‐11‐2017 METHOD FOR ENHANCING STABILITY OF PURIFIED LYSOSOMAL 289121 ENZYME AND PHARMACEUTICAL COMPOSITION COMPRISING PURIFIED LYSOSOMAL ENZYME AND ACTIVE SITE‐SPECIFIC CHAPERONE 3783/DELNP/2010 02‐11‐2017 Process for reducing tendency of a Glycopyrronium salt to 289126 aggregate and/or agglomerate during storage 1655/MUMNP/2010 03‐11‐2017 An orally ingestible composition as BLOOD LIPID LOWERING 289197 AGENTS 1216/MUM/2007 03‐11‐2017 NOVEL TETRAHYDROPYRIMIDINE COMPOUNDS AS ANTICANCER 289198 AGENTS AND MICROWAVE ASSISTED PROCESS FOR THEIR PREPARATION 2324/MUM/2011 03‐11‐2017 "A METHOD AND APPARATUS FOR SYNTHESIZING VESICLES BY 289207 INTERDIFFUSION OF STATIONARY PHASES" 241/MUM/2008 05‐11‐2017 NOVEL PHENOTHIAZINE DERIVATIVES AS NOOTROPIC AGENTS 283259 8288/CHENP/2010 06‐11‐2017 NOVEL PHENYLIMIDAZOLE DERIVATIVES AS PDE10A ENZYME 289257 INHIBITORS 2059/MUMNP/2007 07‐11‐2017 A PHARMACEUTICAL PREPARATION COMPRISING IN SEPARATE 289282 VIALS,A LYOPHILIZED EPOTHILONE ANALOG 4946/KOLNP/2010 08‐11‐2017 NUTRITIVE COMPOSITION COMPRISING DEXTROSE AND AMINO 289344 ACIDS 6350/DELNP/2011 08‐11‐2017 "SOLID PHARMACEUTICAL COMPOSITION COMPRISING 289348 AMLODIPINE AND LOSARTAN WITH IMPROVED STABILITY" 5937/DELNP/2009 08‐11‐2017 "TREATMENT OF INFLAMMATION AND/OR ENDOTOXIC SHOCK" 289373 1164/DEL/2002 08‐11‐2017 "A TASTE MASKING PHARMACEUTICAL COMPOSITION" 289381 1313/CHENP/2010 09‐11‐2017 Pharmaceutical composition comprising N‐(5‐TERT‐BUTYL‐ 289420 ISOXAZOL‐3‐ YL)‐N''‐{4‐[7‐(2‐MORPHOLIN‐4‐YL‐ ETHOXY)IMIDAZO[2,1‐ B][1,3]BENZOTHIAZOL‐2‐YL]PHENYL}UREA

6562/DELNP/2006 09‐11‐2017 "1‐AZA‐BICYCLO[3,3.1]NONANES" 289430 1211/DELNP/2007 09‐11‐2017 "NUCLEOSIDE PHOSPHONATE CONJUGATES AS ANTI HIV AGENTS" 289434

536/CHENP/2011 10‐11‐2017 ACTIVE TARGETING POLYMER MICELLE ENCAPSULATING DRUG AND 289446 PHARMACEUTICAL COMPOSITION 7802/DELNP/2008 10‐11‐2017 "DIETARY SUPPLEMENTS CONTAINING PROBIOTICS" 289460 8638/DELNP/2010 10‐11‐2017 "PHARMACEUTICAL COMBINATION" 289463 574/MUMNP/2012 10‐11‐2017 "A METHOD OF MANUFACTURING A PURIFIED NEWCASTLE DISEASE 289477 VIRUS CLONE" 8132/DELNP/2010 10‐11‐2017 "SULFOALKYL ETHER CYCLODEXTRIN COMPOSITIONS" 289487

Page 31 of 85 2980/CHENP/2012 10‐11‐2017 ANTIMICROBIAL AND VULNERARY ACTION PHARMACEUTICAL 289494 COMPOSITION FOR EXTERNAL APPLICATION AND ITS PRODUCTION PROCESS 1358/MUMNP/2011 13‐11‐2017 ODOR CONTROLLED PERSONAL CARE COMPOSITIONS CONTAINING 289505 HYDROXYPROPYL TRIALKYLAMMONIUM SALTS 1551/DELNP/2009 13‐11‐2017 "COMPOUNDS AND METHODS FOR 18F LABELED AGENTS" 289509 10058/DELNP/2008 13‐11‐2017 "PHARMACEUTICAL COMPOSITION COMPRISING NICOTINE" 289515 7849/DELNP/2009 13‐11‐2017 "A METHOD FOR MODIFYING POLYPHENOL CONTAINING PLANT 289522 MATERIALS AND MEDICAL USES OF MODIFIED POLYPHENOL PLANT CONTAINING MATERIALS" 6302/CHENP/2010 13‐11‐2017 NOVEL 1‐BENZYL‐3‐HYDROXYMETHYLINDAZOLE DERIVATIVES AND 289525 USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP‐1, CX3CR1 AND P40 2350/DELNP/2011 13‐11‐2017 ALCOHOL‐RESISTANT SUSTAINED‐RELEASE ORAL PHARMACEUTICAL 289526 FORM BASED ON MICROGRANULES 1118/KOL/2011 14‐11‐2017 A PHARMACEUTICAL COMPOSITIONS FOR DEHYDRATING 289545 ATROPHYING AND ELIMINATING PATHOLOGICAL TISSUES 7513/DELNP/2009 14‐11‐2017 "QUINOLINE DERIVATIVES AS P13 KINASE INHIBITORS" 289553 866/MUMNP/2010 14‐11‐2017 ANTIPERSPIRANT COMPOSITION AND PRODUCT 289557 384/DEL/2009 14‐11‐2017 "POLYMERIC NANOMATRIX ASSOCIATED DELIVERY OF 289560 KAEMPFEROL IN RATS TO IMPROVE ITS OSTEOGENIC ACTION" 3478/DEL/2012 14‐11‐2017 “NEW PROCESS FOR THE SYNTHESIS OF IVABRADINE AND 289578 ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID” 4645/CHENP/2011 15‐11‐2017 METHOD FOR PRODUCING A MOLECULAR PROBE FOR IMAGING OF 289586 PANCREATIC ISLET 1166/MUMNP/2011 15‐11‐2017 ORAL COMPOSITION 289610 5619/DELNP/2012 16‐11‐2017 3‐(3‐AMINOPIPERIDIN‐1‐YL)‐5‐OXO‐1, 2,4‐TRIAZINE DERIVATES AS 289659 DIPEPTIDYL PEPTIDASE IV(DPP‐IV) INHIBITORS 1929/CHENP/2006 16‐11‐2017 ANTI‐GLYPICAN 3 ANTIBODY 289667 3103/KOLNP/2008 16‐11‐2017 HUMAN ANTI‐IL‐23 ANTIBODIES, COMPOSITIONS, METHODS AND 289670 USES 1989/DELNP/2010 17‐11‐2017 THERMO‐KINETIC MIXING FOR PHARMACEUTICAL APPLICATIONS 289679

7957/DELNP/2006 17‐11‐2017 "NANOPARTICLES OF A DERIVATIVE OF 2;,2'‐DIFLUORO‐2'‐ 289693 DEOXYCYTIDINE AND PROCESS FOR PREPARING THE SAME" 3051/DELNP/2007 17‐11‐2017 "COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE 289697 INHIBITORS" 4761/DELNP/2012 17‐11‐2017 “SUBMICRO EMULSION OF PACLITAXEL USING STEROID COMPLEX 289710 AS INTERMEDIATE CARRIER” 2646/MUMNP/2010 20/11/2017 COMPOSITIONS FOR LIGHTENING SKIN COLOR. 289738 2464/DELNP/2009 20‐11‐2017 "CONTROLLED RELEASE COMPOSITIONS" 289714 2124/KOLNP/2011 20‐11‐2017 MICROCAPSULES AND USES THEREOF 289725 2735/CHE/2010 21/11/2017 PROCESS FOR PREPARATION OF A HEXANE EXTRACT OF AEGLE 289767 MARMELOS FRUIT 684/MUMNP/2010 21‐11‐2017 INHIBITORS OF THE INTERACTION BETWEEN MDM2 AND P53 289768 6367/DELNP/2006 21‐11‐2017 "HIV INTEGRASE INHIBITORS" 289772 458/DEL/2009 21‐11‐2017 "NOVEL SUBSTITUTED SPIRO [INDOLINE‐HETEROCYCLE]‐ 289774 CARBOXYLIC ACID DERIVATIVES AS ANTIDIABETIC AND METABOLIC DISORDER TRATING AGENTS" 2074/DEL/2004 21‐11‐2017 "ANTIMALARIAL COMPOUND FROM GOMPHOSTEMA NIVEUM" 289775 151/DELNP/2011 21‐11‐2017 "DRUG LOADED POLYMERIC NANOPARTICLES AND METHODS OF 289790 MAKING AND USING SAME" 1416/DEL/2003 21‐11‐2017 "A METHOD FOR THE PREPARATION OF A GEL OF PLASMA RICH IN 289802 GROWTH FACTORS(P.R.G.F.)" 134/DELNP/2009 21‐11‐2017 BICYCLIC HETEROARYL INHIBITORS OF PDE4 289804 9104/DELNP/2008 22‐11‐2017 "PYRAZOLO [3, 4‐D] PYRIMIDINE DERIVATIVES USEFUL TO TREAT 289809 RESPIRATORY DISORDERS"

Page 32 of 85 8571/CHENP/2010 22‐11‐2017 METHOD FOR USING INACTIVATED JAPANESE ENCEPHALITIS VIRUS 289819 PARTICLES AS ADJUVANT 1181/MUM/2009 22‐11‐2017 COMBINED MEASLES‐MALARIA VACCINE 289823 1949/MUM/2012 22‐11‐2017 ANTI‐RHD MONOCLONAL ANTIBODIES 289825 3390/CHENP/2013 22‐11‐2017 PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR 289826 ANTAGONISTS 5861/DELNP/2009 22‐11‐2017 "STIMULATION OF AN IMMUNE RESPONSE BY CATIONIC LIPIDS" 289829 544/MUMNP/2011 22‐11‐2017 "HYDROXYBUTYRATE ESTER AND MEDICAL USE THEREOF" 289830 2319/DELNP/2009 22‐11‐2017 "A body fluid purifying arrangement" 289835 3600/CHENP/2011 23‐11‐2017 METHOD OF MAKING SUSTAINED RELEASE MICROPARTICLES 289846 543/MUMNP/2012 23‐11‐2017 "ANTIBACTERIAL COMPOSITION COMPRISING BACTERIOPHAGE FOR 289856 PREVENTION OR TREATMENT OF INFECTIOUS DISEASES BY ONE OR MORE SALMONELLA STRAINS" 4547/DELNP/2010 23‐11‐2017 "PHARMACEUTICAL COMPOSITION FOR PREVENTING AND 289861 TREATING DIABETIC NEPHROPATHY AND THE PREPARATION METHOD THEREOF" 2599/DELNP/2009 23‐11‐2017 "An immunogenic composition comprising an inactivated form of 289868 HPGGT" 3788/CHE/2010 24‐11‐2017 PHARMACEUTICAL COMPOSITIONS COMPRISING STARCH 289893 PHOSPHATE 3564/KOLNP/2008 24‐11‐2017 STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND 289902 METHODS OF ANALYZING THEM 1950/KOLNP/2012 24‐11‐2017 METHODS OF SYNTHESIZING AND ISOLATING N‐(BROMOACETYL)‐ 289908 3,3‐DINITROAZETIDINE AND A COMPOSITION INCLUDING THE SAME 2362/KOLNP/2010 27‐11‐2017 PERSONAL CARE AND COSMETIC COMPOSITION CONTAINING 289957 TETRAPEPTIDES WITH THE MOTIFS GX1 X2G, PX1X2P, OR PX1X2K

5237/DELNP/2010 27‐11‐2017 "METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF 289970 INSULIN" 1913/CHE/2011 28‐11‐2017 A PROCESS FOR PREPARATION OF NEVIRAPINE 290005 1770/MUM/2015 28‐11‐2017 A FREEZE DRIED PHARMACEUTICAL FORMULATION OF RIFABUTIN 290030 AND PROCESS FOR PREPARATION THEREOF 3858/MUM/2015 28‐11‐2017 PROCESS FOR PREPARATION OF PARENTERAL FORMULATION OF 290034 MICAFUNGIN SODIUM 1244/DEL/2010 28‐11‐2017 ANTI TUBERCULAR AGENTS 290036 1603/CHENP/2010 28‐11‐2017 A PHARMACEUTICAL COMPOSITION COMPRISING IRL‐1620 290038 3037/CHENP/2011 29/11/2017 “Antisense Oligonucleotides for Skipping of Exon 45” 290067 2239/DELNP/2004 29‐11‐2017 "A COSMETIC COMPOSITION FOR REDUCING SUBCUTANEOUS 290064 EXCESS FAT" 2438/CHENP/2008 29‐11‐2017 A COMPOUND COMPRISING AN AUTOANTIGENIC PEPTIDE AND A 290071 CARRIER WITH A MHC BINDING MOTIF 3090/KOLNP/2010 29‐11‐2017 AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING 290094 BORATE‐ POLYOL COMPLEXES 3865/CHENP/2011 29‐11‐2017 A METHOD FOR OBTAINING NALMEFENE HYDROCHLORIDE 290098 DIHYDRATE 528/DEL/2006 30/11/2017 "ISOLATION AND SYNTHESIS OF NOVEL FURANO‐AND 290171 PYRANOFLAVONOIDS AS ANTIDIABETIC AGENTS" 2929/DELNP/2010 30‐11‐2017 "METHOD OF DELIVERING AN ANTI‐CANCER AGENT TO A CELL" 290111 4633/KOLNP/2010 30‐11‐2017 Method for preparing a hypoallergen for immunotherapy 290115 522/DEL/2006 30‐11‐2017 A PHARMACEUTICAL COMPOSITION FOR THE 290121 PREVENTION/TREATMENT OF BONE DISORDERS AND A PROCESS FOR THE PREPARATION THEREOF 7553/CHENP/2010 30‐11‐2017 MODULATORS OF DOPAMINE NEUROTRANSMISSION 290133 37/CHE/2010 30‐11‐2017 PROCESS FOR THE PURIFICATION OF LUMEFANTRINE 290142 3228/KOLNP/2009 30‐11‐2017 RECOMBINANT CHIMERIC PROTEIN OF NEUTROPHIL INHIBITORY 290162 FACTOR AND HIRUGEN AND PHARMACEUTICAL COMPOSITION THEREOF 10564/DELNP/2008 04‐12‐2017 "Oral Adhering Disc For Dry Mouth" 290237

Page 33 of 85 1252/MUMNP/2011 05‐12‐2017 ANTIPERSPIRANT COMPOSITIONS AND PRODUCTS 290295 5793/CHENP/2010 05‐12‐2017 PHARMACEUTICAL COMPOSITION FOR PREVENTING DYSBIOSIS 290302 ASSOCIATED WITH ENTERNAL ADMINISTRATION OF ANTIBIOTICS

5799/CHENP/2011 05‐12‐2017 TOPICAL COMPOSITION 290313 3558/KOLNP/2009 06‐12‐2017 BINDING LIGAND LINKED DRUG DELIVERY CONJUGATES OF 284161 TUBULYSINS 3486/DELNP/2009 06‐12‐2017 PERSONAL CARE COMPOSITION COMPRISING AMINOSILICONE AND 284151 NATURALLY DERIVED CATIONIC POLYMERS 2887/KOLNP/2008 06‐12‐2017 COMPOSITION FOR INHIBITING ADVERSE IMMUNE RESPONSE IN 290333 HISTOCOMPATIBILITY‐MISMATACHED 127/DEL/2010 06‐12‐2017 A NEW SERIES OF ARTEMISININ DERIVATIVES WITH 290351 POTENTANTICANCER ACTIVITIES 2487/MUMNP/2011 07‐12‐2017 "A METHOD FOR PRODUCING A COMPOSITION COMPRISING 290367 METAXALONE" 392/DEL/2011 07‐12‐2017 2‐PHENYL BENZOTHLAZOLE LINKED IMIDAZOLE COMPOUNDS AS 290369 POTENTIAL ANTICANCER AGENTS 2488/MUMNP/2011 07‐12‐2017 "A METHOD FOR PRODUCING A COMPOSITION COMPRISING 290371 MELOXICAM" 2490/MUMNP/2011 07‐12‐2017 "A COMPOSITION COMPRISING PARTICLES OF DICLOFENAC ACID" 290373

3852/CHENP/2012 07‐12‐2017 BODY CARE PRODUCT COMPRISING BENZOTROPOLONE 290374 COMPOUNDS 349/CHE/2009 07‐12‐2017 A PROCESS FOR COVALENTLY BONDING A DRUG TO THE SURFACE 290382 OF CHEMICALLY EXFOLIATED GRAPHITE OXIDE (CEGO) WITHOUT SPACER FOR THE TREATMENT OF CANCER 2450/MUM/2011 07‐12‐2017 "COMPOSITIONS FOR EXTENDED PERIODS OF SKIN 290384 MOISTURIZATION" 3932/CHENP/2011 07‐12‐2017 BENZYLIDENE COMPOUNDS COMPRISING PHOSPHONO‐GROUPS 290390

385/KOLNP/2009 07‐12‐2017 INHIBITORS OF PLASMA KALLIKREIN 290393 208/DEL/2009 08‐12‐2017 "COLLOIDAL COMPOSITION OF GRISEOFULVIN" 290424 4000/CHENP/2010 08‐12‐2017 LIQUID ANTISEPTIC COMPOSITIONS CONTAINING IODINE AND A 290430 SUGAR AND/OR SUGAR ALCOHOL 6823/CHENP/2011 08‐12‐2017 COMPOSITIONS,SYNTHESIS AND METHODS OF UTILIZING 290431 ARYLPIPERAZINE DERIVATIVES 932/KOLNP/2008 08‐12‐2017 MULTIPLE VACCINATION INCLUDING SEROGROUP C 290435 MENINGOCOCCUS 2077/DELNP/2011 10‐12‐2017 "BIOPOLYMER CONJUGATES COMPRISING AN INTERLEUKIN‐11 288349 ANALOG" 6377/DELNP/2008 11‐12‐2017 "STABLIZED PHARMACEUTICAL COMPOSITION" 290455 3516/KOLNP/2010 11‐12‐2017 BUTENAFINE HYDROCHLORIDE‐CONTAINING AQUEOUS PATCH 290456 7944/CHENP/2010 11‐12‐2017 3‐AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL 290468 COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR 34/DELNP/2008 12‐12‐2017 ORALLY DISINTEGRATING POWDER COMPRISING CILOSTAZOL AND 290528 MANNITOL 1177/MUMNP/2010 12‐12‐2017 TOPICAL COMPOSITION COMPRISING COLORING ANTIOXIDANTS 290491

1036/CHENP/2010 12‐12‐2017 IMMUNOGENIC COMPOSITION COMPOSED OF AN ISOLATED 290519 CARBOHYDRATE POLYMER AGAINST CAMPYLOBACTER JEJUNI 2615/DELNP/2008 12‐12‐2017 "AUTOMATED RADIOLABELLING METHOD" 290523 2651/DELNP/2004 13/12/2017 "AMINO‐SUBSTITUTED (E)‐2, 6‐DIALKOXYSTYRYL4‐SUBSTITUTED 290561 BENZYLSULFONES FOR TREATING PROLIFERATIVE DISORDERS" 7876/DELNP/2006 13‐12‐2017 "ALPHA, BETA‐UNSATURATED SULFONES, SULFOXIDES, 290535 SULFONIMIDES, SULFINIMIDES, ACYLSULFONAMIDES AND ACYLSULFINAMIDES AND THERAPEUTIC USES THEREOF" 1105/KOL/2010 13‐12‐2017 COMPOSITIONS COMPRISING AN NFKB‐INHIBITOR AND A 290558 TROPOELASTIN PROMOTER

Page 34 of 85 83/DEL/2010 13‐12‐2017 "A PROCESS FOR THE PREPARATION OF NANOSILVER 290584 NANOHYDROGEL BASED ANTIMICROBIAL AGENT" 3050/DEL/2010 14‐12‐2017 “PHARMACEUTICAL COMPOSITION IN FORM OF AQUEOUS SYRUP 290589 COMPRISING LEVOCETIRIZINE DIHYDROCHLORIDE AND MONTELUKAST SODIUM ” 5735/CHENP/2012 14‐12‐2017 MACROMOLECULE FOR DELIVERING PROTEIN, POLYPEPTIDE OR 290608 PEPTIDE DRUGS AND A PRODUCTION METHOD FOR THE SAME, AND A SLOW RELEASE COMPOSITION FOR PROTEIN, POLYPEPTIDE OR PEPTIDE DRUGS AND A PRODUCTION METHOD FOR THE SAME

1121/CHE/2009 14‐12‐2017 PROCESS FOR THE PREPARATION OF LANTHANUM CARBONATE 290621 DIHYDRATE 2384/CHENP/2011 14‐12‐2017 GRANULATES, PROCESS FOR PREPARING THEM AND 290635 PHARMACEUTICAL PRODUCTS CONTAINING THEM 5013/CHENP/2010 14‐12‐2017 DOXORUBICIN ADJUVANTS TO REDUCE CARDIOTOXICITY 290641 2182/DELNP/2009 15/12/2017 "SUSTAINED RELEASE DEVICE AND METHOD FOR OCULAR DELIVERY 290692 OF ADRENERGIC AGENTS" 9859/CHENP/2011 15‐12‐2017 BENZYLIDENE MALONATES 290678 3515/CHENP/2011 18‐12‐2017 3‐PHENYL‐3‐METHOXY‐PYRROLIDINE DERIVATIVES USEFUL AS 290754 MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION 208/KOLNP/2008 18‐12‐2017 MELANOCORTIN RECEPTOR LIGANDS 290770 4039/KOLNP/2009 19/12/2017 A MELANOCORTIN‐4 SELECTIVE RECEPTOR AGONIST COMPOUND 290823

7211/DELNP/2009 19/12/2017 "NUCLEIC ACID MICROPARTICLES FOR PULMONARY DELIVERY" 290813 9774/CHENP/2011 19‐12‐2017 “DRUG DELIVERY SYSTEM COMPRISING POLYOXAZOLINE AND A 290788 BIOACTIVE AGENT” 2527/MUM/2007 20/12/2017 NANODISPERSION 290850 2204/CHENP/2011 20‐12‐2017 CHELATING AMPHIPHILIC POLYMERS 290834 85/DELNP/2011 20‐12‐2017 "HIGH CONTENT SODIUM IBUPROFEN GRANULES, THEIR 290843 PREPARATION AND THEIR USE IN PREPARING NON‐EFFERVESCENT SOLID DOSAGE FORMS" 642/KOLNP/2011 20‐12‐2017 SILICON DIOXIDE NANOPARTICLES AND THE USE TEREOF FOR 290859 VACCINATION 5522/CHENP/2011 20‐12‐2017 COSMETIC COMPOSITION AND HAIR WASH 290862 3098/CHENP/2012 21‐12‐2017 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS 290946 5123/DELNP/2011 21‐12‐2017 NOVEL COMPOSITION COMPRISING ANAGRELIDE PARTICLES FOR 290954 THE TREATMENT OF ESSENTIAL THROMBOCYTHEMIA 2838/CHE/2009 22‐12‐2017 "BICYCLIC COMPOUNDS AS ALPHA4 BETA2 NICOTINIC 290964 ACETYLCHOLINE RECEPTOR LIGANDS" 872/CHENP/2010 22‐12‐2017 PHARMACEUTICAL COMPOSITION COMPRISING 11‐DEOXY‐ 290970 PROSTAGLANDIN COMPOUND AND METHOD FOR STABILIZING THE COMPOUND 1830/KOLNP/2010 22‐12‐2017 A METHOD FOR PRODUCING ADAPALENE GELS 291017 6577/DELNP/2013 26‐12‐2017 EFFERVESCENT GAMMA HYDROXYBUTYRIC ACID GRANULES 291051 3223/CHENP/2011 27‐12‐2017 “BENZIMIDAZOLE DERIVATIVES FOR MODULATING THE GABAA 291082 RECEPTOR COMPLEX“ 7448/CHENP/2010 27‐12‐2017 BENZIMIDAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS 291092

8145/DELNP/2011 27‐12‐2017 "A STABLE IRON OLIGOSACCHARIDE COMPOUND" 291100 3579/CHENP/2010 27‐12‐2017 FLUORESCENT MARKER FOR CELL DEATH IN THE EYE 291113 4243/KOLNP/2011 28‐12‐2017 SYNTHESIS OF 1‐AMINO‐1,;5‐CYCLOHEXANE MESYLATE 291134 9506/DELNP/2008 28‐12‐2017 "DPP IV INHIBITOR FORMULATIONS" 291136 8454/CHENP/2011 28‐12‐2017 A MICROSPHERE CONTAINING A POORLY SOLUBLE DRUG AND 291164 METHOD OF PREPARING THE SAME 1874/DELNP/2010 29‐12‐2017 RNA VACCINES 291203 2559/MUM/2009 29‐12‐2017 AN IMPROVED PROCESS FOR PREPARATION OF TAXANE 291223 DERIVATIVES

Page 35 of 85 5835/CHENP/2011 29‐12‐2017 “ANIONIC OIL‐IN‐WATER EMULSIONS CONTAINING 291232 PROSTAGLANDINS AND USES THEREOF” 802/DEL/2008 29‐12‐2017 "TUNGSTEN NANOPARTICLE AND ITS TARGETING TO THE LIVER" 291242 1971/DELNP/2010 29‐12‐2017 "LH LIQUID FORMULATIONS" 291255 758/DEL/2013 01‐01‐2018 NEW PROCESS FOR THE SYNTHESIS OF IVABRADINE AND ADDITION 291264 SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID

5252/CHENP/2011 01‐01‐2018 AN S NS INHIBITOR COMPRISING NOVEL BICYCLIC HETEROCYCLIC 291268 COMPOUND 4857/KOLNP/2010 02‐01‐2018 CONJUGATED VI SACCHARIDES 291300 2150/DEL/2004 02‐01‐2018 "PROCESS OF MAKING STABLE NEEM MELIACIN(S) CONCENTRATES 291334 AND PRODUCTS WITH CONTROLLED ACTIVE INGREDIENT RELEASE"

1336/KOL/2011 03‐01‐2018 SKIN CARE COMPOSITION CONTAINING ACTIVES IN HIGH 291360 INTERFACIAL PHASE EMULSIFICATION SYSTEM 6038/DELNP/2009 04‐01‐2018 "AN IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION 291392 CONTAINING DAPAGLIFLOZIN PROPYLENE GLYCOL HYDRATE " 2491/MUMNP/2011 04‐01‐2018 "A COMPOSITION COMPRISING PARTICLES OF INDOMETHACIN" 291396

2476/MUM/2008 04‐01‐2018 STABLE PHARMACEUTICAL COMPOSITION OF OLOPATADINE 291399 6571/DELNP/2007 04‐01‐2018 "PROCESS FOR THE PRODUCTION OF CALCIUM COMPOSITIONS IN A 291411 CONTINUOUS FLUID BED" 7343/DELNP/2009 05‐01‐2018 "CONJUGATED BIOLOGICAL MOLECULES AND THEIR PREPARATION" 291424

9912/DELNP/2008 05‐01‐2018 "PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND 291426 LOSARTAN" 1311/MUM/2009 05‐01‐2018 SUSTAINED RELEASE DOSAGE FORM OF GLICLAZIDE 291443 953/DEL/2007 05‐01‐2018 NOVEL 4β‐AMINO PODOPHYLLOTOXIN CONGENERS AS POTENTIAL 291453 ANTICANCER AGENTS AND A PROCESS FOR THE PREPARATION THEREOF 1928/MUM/2011 05‐01‐2018 "PROCESS FOR PREPARATION OF SEVELAMER HYDROCHLORIDE 291454 AND FORMULATION THEREOF" 1114/MUMNP/2010 08‐01‐2018 “CYCLIC, CYSTEIN‐FREE PROTEIN” 291474 2657/CHE/2011 08‐01‐2018 NEW BARBITURATES OF NITRO AROMATIC COMPOUNDS AS ANTI 291497 CONVULSANTS, HYPNOTIC AGENTS, DYES AND FLUORESCENT MOLECULES 1978/MUMNP/2009 09‐01‐2018 “IMIDAZOQUINOLINES WITH IMMUNO‐MODULATING PROPERTIES” 291520

8254/DELNP/2009 09‐01‐2018 HYDROCARBON MIXTURE COMPRISING LINEAR C11 AND LINEAR 291535 C13 HYDROCARBONS 8544/DELNP/2009 09‐01‐2018 A process for producing an extract from Neobeguea spp. root tissue 291545

1677/MUMNP/2011 09‐01‐2018 ANTISEPTIC COMPOSITIONS COMPRISING SILVER IONS AND 291549 MENTHOL AND USES THEREOF 5909/DELNP/2009 09‐01‐2018 “NOVEL VIII FACTORS FOR THE TREATMENT OF HEMOPHILIA A ” 291559 1315/CHENP/2011 10‐01‐2018 “PHARMACEUTICAL COMPOSITIONS AND METHODS FOR 291582 PRODUCING LOW IMPURITY CONCENTRATIONS OF THE SAME” 5996/CHENP/2008 10‐01‐2018 A BIODEGRADABLE IMPLANT CONSISTING OF A CORE AND 291595 HYDROPHOBIC POLYMER COATING 2195/DELNP/2010 10‐01‐2018 "AN ORALLY BIOAVAILABLE COMPOSITION & METHOD OF 291611 PREPARATION THEREOF" 5253/CHENP/2010 11‐01‐2018 FENTANYL‐CONTAINING PATCH FOR EXTERNAL USE 291620 8425/DELNP/2008 11‐01‐2018 "OPHTHALMIC COMPOSITIONS COMPRISING POVIDONE‐IODINE" 291629

11284/DELNP/2012 11‐01‐2018 2 PYRIDYL SUBSTITUTED IMIDAZOLES AS THERAPEUTIC ALK5 291635 AND/OR ALK4 INHIBITORS 7173/DELNP/2010 11‐01‐2018 "OLIGOMER‐ARYLOXY‐SUBSTITUTED PROPANAMINE CONJUGATES" 291651

426/MUM/2009 12‐01‐2018 COMPOSITION FOR THE TREATMENT OF HAIR LOSS AND BALDNESS 291673

Page 36 of 85 8454/DELNP/2010 12‐01‐2018 "COMPOSITION COMPRISING A COMPLEXED (M) RNA AND A 291696 NAKED MRNA FOR PROVIDING OR ENHANCING AN IMMUNOSTIMULATORY RESPONSE IN A MAMMAL AND USES THEREOF" 2846/DELNP/2010 15‐01‐2018 "CONSTRUCTS CONTAINING MULTIPLE EXPRESSION CASSETTES FOR 291707 CANCER THERAPY" 584/MUM/2007 15‐01‐2018 NOVEL PHARMACEUTICALLY ACTIVE COMPOUNDS USEFUL AS 291708 ANTIVIRAL AGENTS AND PROCESS OF PREPARATION THEREOF 2984/CHE/2012 15‐01‐2018 POLYMORPHIC FORM OF BORTEZOMIB AND PROCESS FOR 291709 PREPARATION THEIR OF 1396/CHENP/2008 15‐01‐2018 “BALSALAZIDE FORMULATIONS AND MANUFACTURE AND USE 291731 THEREOF” 1595/CHENP/2010 16‐01‐2018 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL OPIOID 291755 COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL 2657/DELNP/2012 16‐01‐2018 "DENTIFRICE COMPRSING STANNOUS FLUORIDE PLUS ZINC CITRATE 291756 AND LOW LEVELS OF WATER" 7189/CHENP/2010 17‐01‐2018 ACTIVATOR FOR PEROXISOME PROLIFERATOR‐ACTIVATED 291801 RECEPTOR 6343/CHENP/2009 17‐01‐2018 "INHIBITORS OF BRUTON'S TYROSINE KINASE" 291810 1834/MUM/2009 17‐01‐2018 NOVEL SILICONE PRESSURE SENSITIVE ADHESIVE COMPOSITION 291817 FOR TRANSDERMAL DRUG DELIVERY 2008/DELNP/2009 17‐01‐2018 EFFICIENT SYNTHESIS OF CHELATORS FOR NUCLEAR IMAGING AND 291824 RADIOTHERAPY: COMPOSITIONS AND APPLICATIONS 6400/DELNP/2009 18‐01‐2018 "A PHARMACEUTICAL COMPOSITION COMPRISING AN 291836 OLIGOGULURONATE OR OLIGOGALACTURONATE AND A MACROMOLECULAR DRUG” 4526/DELNP/2010 18‐01‐2018 COMPOSITIONS COMPRISING NICOTINIC AGONISTS AND METHODS 291847 OF USING SAME 501/DELNP/2010 19/01/2018 "PHARMACEUTICAL PREPARATIONS CONTAINING HIGHLY VOLATILE 291883 SILICONES" 7962/DELNP/2010 19‐01‐2018 "PREPARATION OF INTERMEDIATES USEFUL IN THE SYNTHEIS OF 2'‐ 291891 CYANO‐2'‐DEOXY‐N4‐PALMI‐TOYL‐1‐BETA‐D‐ ARABINOFURANOSYLCYTOSINE" 858/KOL/2007 19‐01‐2018 BIOACTIVE COMPOUND(S) FROM MARINE GASTROPOD MOLLUSC 291906 (TELESCOPIUM TELESCOPIUM) AS POTENTIAL ANTICANCER/ ANTIPROLIFERATIVE AGENTS 2995/MUM/2009 22‐01‐2018 PROCESS FOR THE PREPARATION OF NIMORAZOLE 291929 3686/DELNP/2011 22‐01‐2018 "IMPROVED DISSOLUTION STABILITY OF CALCIUM CARBONATE 291937 TABLETS" 3027/DELNP/2010 22‐01‐2018 A PHARMACEUTICAL COMPOUND FOR TREATING POLYCYSTIC 291938 KIDNEY DISEASES WITH CARAMIDE DERIVATIVES AND METHOD THEREOF 196/KOLNP/2011 22‐01‐2018 PRODRUGS OF CABOTEGRAVIR 291942 1363/DELNP/2010 22‐01‐2018 IMMUNOGENIC COMPOSITIONS AND METHODS 291956 2632/MUM/2009 22‐01‐2018 COMPOSITION FOR RELEIVING STRESS 291959 408/KOLNP/2010 23/01/2018 DOUBLE FUSION YERSINIA PESTIS ANTIGENS, VACCINE 292028 COMPOSITIONS, AND RELATED METHODS 209/KOL/2012 23‐01‐2018 LIQUID FILM FORMING POLYMERIC COMPOSITE MATERIALS THAT 291983 CAN SERVE AS DELIVERY VEHICLES FOR ACTIVE INGREDIENTS USED IN DERMATOLOGICAL,COSMETICS AND FOOD FORMULATIONS/PRODUCTS 6845/CHENP/2010 23‐01‐2018 PARTIAL PEPTIDE OF SURVIVIN PRESENTED ON MHC CLASS II 292013 MOLECULE 234/MUM/2009 23‐01‐2018 PROCESS FOR THE SYNTHESIS OF CLEISTANTHIN 292014 8912/DELNP/2010 23‐01‐2018 "LIQUID COMPOSITION OF CISPLATIN COORDINATION 292019 COMPOUND" 9187/DELNP/2011 23‐01‐2018 "DENTIFRICE COMPOSITION" 292020

Page 37 of 85 1280/KOLNP/2011 23‐01‐2018 A COMPOSITION COMPRISING RIBOFLAVIN PHOSPHATE AND 292030 ENHANCERS SELECTED FROM BIOENHANCERS AND PHOTOENHANCERS

122/KOLNP/2012 23‐01‐2018 A DOUBLE‐ STRANDED RNA COMPOUND. 292031 8975/DELNP/2007 23‐01‐2018 "BACTERIAL CELLULOSE‐CONTAINING FORMULATIONS AND 292039 METHOD OF PRODUCING EFFECTIVE BACTERIAL CELLULOSE‐ CONTAINING FORMULATIONS" 2343/MUMNP/2011 24‐01‐2018 COMPOSITION 292100 5174/DELNP/2010 25/01/2018 "MICROVESICLES" 292114 2898/DELNP/2011 25/01/2018 A PROCESS FOR MANUFACTURING RESERVOIR MICROCAPSULES 292133 3429/DELNP/2011 25/01/2018 PLANT EXTRACTION METHOD AND COMPOSITIONS 292151 1030/DELNP/2008 25‐01‐2018 "DEFECTIVE RIBOSOMAL PRODUCTS IN BLEBS (DRIBBLES) AND 292118 METHODS OF USE TO STIMULATE AN IMMUNE RESPONSE" 4915/CHENP/2011 25‐01‐2018 STABLE CONSTITUTIVELY HIGH EXPRESSION VECTOR FOR 292126 PREPARING HPV VACCINE AND RECOMBINANT LACTIC ACID BACTERIA TRANSFORMED THEREBY 7531/DELNP/2010 25‐01‐2018 HER2/NEU‐SPECIFIC ANTIBODIES AND METHODS OF USING SAME 292128

3672/DELNP/2011 25‐01‐2018 PROLONGED RELEASE COMPOSITIONS COMPRISING 292131 BRIVARACETAM AND SELETRACETUM 991/CHENP/2011 25‐01‐2018 ENCAPSULATION OF LIPOPHILIC OR AMPHIPHILIC THERAPEUTIC 292135 AGENTS IN NANO‐EMULSIONS 7435/CHENP/2009 25‐01‐2018 ANTIBODIES TO HPD‐1 292137 8136/DELNP/2010 25‐01‐2018 CANNABINOIDS IN COMBINATION WITH NON‐CANNABINOID 292146 CHEMOTHERAPEUTIC AGENTS (E.G.SERM OF ALKYLATING AGENTS)

4225/DELNP/2009 25‐01‐2018 "OXYGEN SUPPLY FOR CELL TRANSPLANT AND VASCULARIZATION" 292157

470/CHENP/2011 29/01/2018 PHARMACEUTICAL COMPOSITIONS COMPRISING TRICYCLIC 292218 CARBOXAMIDES 3559/DELNP/2011 29‐01‐2018 “INCLUSION COMPLEXES OF PINOCEMBRIN WITH CYCLODEXTRIN 292191 OR ITS DERIVATIVES” 520/DELNP/2011 30/01/2018 "PHARMACEUTICAL COMPOSITIONS" 292310 960/KOL/2009 30‐01‐2018 FORMULATION FOR PREVENTION AND TREATMENT OF BACTERIAL 292257 INFECTIONS AND PROCESS FOR PREPARATION THEREOF

2959/DELNP/2012 30‐01‐2018 IMINOTHIADIAZINE DIOXIDE COMPOUNDS AS BACE INHIBITORS, 292259 COMPOSITIONS, AND THEIR USE 1897/CHE/2010 30‐01‐2018 IMPROVED PROCESS FOR THE PREPARATION OF SEVELAMER AND 292268 ITS PHARMACEUTICALLY ACCEPTABLE SALTS 1652/CHE/2007 30‐01‐2018 A PROCESS FOR PREPARATION OF A NOVEL COMPOUND 292282 GYMNEMIC DIACETATE FROM GYMNEMA SYLVESTRE R.BR. LEAVES WITH ANTIDIABETIC ACTIVITY 8215/CHENP/2010 30‐01‐2018 PEPTIDE MANUFACTURING PROCESS 292289 807/DEL/2010 30‐01‐2018 PROCESS FOR PRODUCING 4‐AMINOPYRIDINES 292313 9682/DELNP/2013 30‐01‐2018 CLEAR HAIR CARE COMPOSITION COMPRISING BASE OIL AND 292320 HYDROPHILIC COMPONENT 2834/CHENP/2012 30‐01‐2018 "TOPICAL FORMULATIONS COMPRISING A STEROID" 292323 7336/DELNP/2010 30‐01‐2018 “CHEWING GUM COMPOSITIONS COMPRISING CANNABINOIDS” 292329

4151/DELNP/2011 30‐01‐2018 IMMUNOSTIMULATORY OLIGONUCLEOTIDES 292330 2611/KOLNP/2012 30‐01‐2018 "A COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT AND 292337 METHOD OF PREPARING THE SAME" 1223/KOLNP/2010 30‐01‐2018 FLUID COSMETIC COMPOSITION COMPRISING A MONOALCOHOL 292339

6524/CHENP/2010 31‐01‐2018 AMYLOID BETA PEPTIDES RESISTANT TOWARDSFIBRILLOGENESIS 292362 AND OLIGOMERS THEREOF 569/DEL/2007 31‐01‐2018 UTERINE STIMULATION STICKS. 292377

Page 38 of 85 1827/MUM/2006 31‐01‐2018 A PROCESS FOR THE PREPARATION OF A HERBAL FORMULATION 292390 FOR THE CONTROL O F APHID, WHITE FLY AND HELIOTHIS

7014/DELNP/2010 31‐01‐2018 A pharmaceutical composition for producing a desired change in a 292401 target structure 1345/KOLNP/2010 31‐01‐2018 AN IMMUNOGENIC FORMULATION THAT CONFERS PROTECTION 292436 AGAINST THE INFECTION BY A RESPIRATORY SYNCTIAL VIRUS (RSV).

6335/DELNP/2012 31‐01‐2018 “THIENO [2, 3‐B] PYRIDINEDIONE ACTIVATORS OF AMPK AND 292442 THERAPEUTIC USES THEREOF” 2073/MUM/2008 01‐02‐2018 PHARMACEUTICAL COMPOSITION COMPRISING COENZYME Q10 291287

3279/DELNP/2006 01‐02‐2018 "A COMPOSITION FOR TRANSDERMAL DELIVERY" 292450 4533/DELNP/2010 01‐02‐2018 "COUNTER‐PRESSURE FILTRATION OF PROTEINS" 292468 3566/DEL/2011 02‐02‐2018 "STABILIZED MICROBICIDAL COMPOSITION" 292490 1030/KOLNP/2011 02‐02‐2018 INHALABLE PARTICLES COMPRISING TIOTROPIUM 292499 2422/CHENP/2011 02‐02‐2018 2‐ARYL‐PROPIONIC ACIDS AND DERIVATIVES AND 292514 PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 34/KOL/2010 04‐02‐2018 NOVEL BASE FOR EFFECTIVE TRANSDERMAL DELIVERIES OF ACTIVES 295383

59/CHENP/2011 05‐02‐2018 STABILIZER AND VACCINE COMPOSITION COMPRISING ONE OR 296466 MORE LIVE ATTENUATED FLAVIVIRUSES 7323/DELNP/2012 05‐02‐2018 ORAL CARE COMPOSITION 292541 7800/DELNP/2009 05‐02‐2018 "SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE 292550 COMPOUNDS" 2959/MUM/2010 05‐02‐2018 "A NOVEL HOLLOW MULTIPARTICULATE EXCIPIENT FOR DRUG 292575 DELIVERY" 3885/DELNP/2012 06‐02‐2018 RHODACYANINE DERIVATIVE AND PHARMACEUTICAL 292588 COMPOSITION FOR TREATING LEISHMANIASIS 11315/DELNP/2012 06‐02‐2018 METHODS OF DELIVERING A HEALTH CARE ACTIVE BY 292589 ADMINISTERING PERSONAL HEALTH CARE ARTICLES COMPRISING A FILAMENT 2878/MUM/2011 06‐02‐2018 "A TOPICAL COMPOSITION FOR TREATMENT OF WOUNDS" 292591 2492/KOLNP/2012 06‐02‐2018 NOVEL COMPOSITION 292606 3870/CHENP/2011 07‐02‐2018 SUBSTITUTED TETRAHYDROPYRAN SPIRO PYRROLIDINONE AND 298401 PIPERIDINONE 2695/MUM/2011 07‐02‐2018 "NANOPARTICLE BASED COSMETIC COMPOSITION" 292636 3959/DELNP/2011 07‐02‐2018 THIENOTRIAZOLODIAZEPINE DERIVATIVES ACTIVE ON APO A 292639 280/CHENP/2011 07‐02‐2018 PROCESS FOR THE PREPARATION OF SPIROKETAL DERIVATIVES 292641 1908/MUM/2012 07‐02‐2018 "A NOVEL PROCESS FOR THE FOUR STEP PROTECTING GROUP FREE 292674 SYNTHESIS OF (+)‐HAGEN'S GLAND LACTONES" 1622/KOLNP/2011 07‐02‐2018 LIPIDATED IMIDAZOQUINOLINE DERIVATIVES 292680 10666/DELNP/2012 08‐02‐2018 CLEAR LEAVE ON HAIR CARE COMPOSITION COMPRISING 292697 AMINOSILICONE AND ITS SOLVENT 1345/DELNP/2010 08‐02‐2018 SCREENING METHODS USING G‐PROTEIN COUPLED RECEPTORS 292709 AND RELATED COMPOSITIONS 1950/DEL/2010 09‐02‐2018 CARBONATE FREE LAYERED DOUBLE HYDROXIDES AND A PROCESS 292752 FOR THE PREPARATION THEREOF

7502/CHENP/2009 09‐02‐2018 HOMOGENEOUS VACCINE COMPOSITION FOR THE TUMOR 292772 TREATMENT AND ITS OBTAINING METHOD 3019/DELNP/2011 11‐02‐2018 ANTIGENS THAT ELICIT IMMUNE RESPONSE AGAINST FLAVIVIRUS 302865 AND METHODS OF USING SAME 2663/MUM/2010 11‐02‐2018 "A METHOD FOR PREPARING AN ANTI VIRAL AGENT" 302868 2699/MUMNP/2010 12‐02‐2018 NIACINAMIDE CONTAINING COSMETIC COMPOSITIONS WITH 292818 IMPROVED SKINFEEL PROPERTIES 7420/DELNP/2010 12‐02‐2018 "NICOTINE LOZENGE COMPOSITIONS" 292827 7205/DELNP/2011 13‐02‐2018 TREATMENT OF CANCER WITH IMMUNOSTIMULATORY HIV TAT 292852 DERIVATIVE POLYPEPTIDES

Page 39 of 85 841/CHE/2009 13‐02‐2018 “HERBAL EXFOLIATING COMPOSITION COMPRISING PHASEOLUS 292860 MUNGO AND CYPHOMANDRA BETACEAE" 2656/CHENP/2010 15‐02‐2018 ULTRAVIOLET ABSORBER WATER‐DISPERSED COMPOSITION 292961 7410/DELNP/2009 16‐02‐2018 "USE OF 4‐PYRROLIDIN‐1‐YL)QUINOLINE COMPOUNDS TO KILL 292987 CLINICALLY LATENT MICROORGANISMS" 1143/CHENP/2010 19‐02‐2018 HUMANIZED CXCR5 ANTIBODIES, DERIVATIVES THEREOF 293032 3774/KOLNP/2009 20‐02‐2018 “A TRUNCATED L1 PROTEIN OF HUMAN PAPILLOMAVIRUS TYPE 16” 293074

3392/DELNP/2011 20‐02‐2018 IMPROVED ANTI‐CD19 ANTIBODIES 293079 2383/MUMNP/2009 21‐02‐2018 “NOVEL COMPOUNDS 951: A BIPHENYLOXYPROPANOIC ACID AS 293122 CRTH2 MODULATOR AND INTERMEDIATES” 1498/MUM/2010 21‐02‐2018 "PROCESS TO MANUFACTURE MEDICINAL PREPARATION 293129 INTERALIA CONTAINING AND LUMEFANTRINE IN SOFT GELATIN CAPSULE" 472/DELNP/2010 21‐02‐2018 "LEISHMANIA STEROL 24‐C‐METHYLTRANSFERASE COMPOSITIONS 293168 FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF LEISHMANIASIS" 5408/DELNP/2012 22/02/2018 ORAL CARE FORMULATIONS FOR MALODOR CONTROL 293200 1645/MUM/2008 22‐02‐2018 A PROCESS OF LYOPHILIZING HIGH FILL VOLUME FORMULATIONS 293201 CONTAINING MANNITOL 1278/MUM/2008 22‐02‐2018 CONTROLLED RELEASE ORAL PHARMACEUTICAL 293219 PREPARATION OF CEFIXIME TRIHYDRATE WITH PROBENECID 3303/DELNP/2013 22‐02‐2018 ORAL COMPOSITIONS CONTAINING MICROAGGREGATES 293244 1430/DEL/2011 22‐02‐2018 "A SOFT‐GEL CAPSULE FORMULATION FOR NUTRACEUTICAL VALUE 293255 FROM SEABUCKTHORN" 67/CHENP/2012 23/02/2018 METALLIC NANOPARTICLES, PREPARATION AND USES THEREOF 293287 8468/CHENP/2011 23‐02‐2018 “Pharmaceutical Compositions comprising Controlled release 293282 floatingmicroparticles” 8981/DELNP/2010 23‐02‐2018 "USE OF CELL‐PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL 293291 TRANSDUCTION PATHWAY FOR THE TREATMENT OF CHRONIC OR NON‐CHRONIC INFLAMMATORY DIGESTIVE DISEASES"

7265/DELNP/2010 23‐02‐2018 "DRY TRANSGLUTAMINASE COMPOSITION" 293310 7340/DELNP/2010 23‐02‐2018 VITAMIN E DERIVATIVES AND THEIR USES 293317 3498/CHENP/2010 23‐02‐2018 QUARTERNIZATION OF THE ADDITIVE AMINO ALKYLMETHACRYLATE 293335 COPOLYMER E FOR IMPROVING PERMEABILITY AND SOLUBILITY OF PHARMACEUTICALS 4843/CHENP/2011 26/02/2018 PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS 293406 (THIOSEMICARBAZONES) 2937/CHENP/2011 26‐02‐2018 CARBAZOLE COMPOUNDS AND THERAPEUTIC USES OF THE 293340 COMPOUND 4256/KOLNP/2009 26‐02‐2018 A PROCESS FOR THE PREPARATION OF NOVEL PIPERAZINE SALTS AS 293352 D3/D2 ANTAGONISTS 9974/DELNP/2008 26‐02‐2018 "A PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR 293368 ADMINISTRATION COMPRISING E‐TMC278 BASE" 2703/DEL/2011 26‐02‐2018 "PHARMACEUTICAL COMPOSITIONS OF ARTEMISININ DERIVATIVE 293399 AND PROCESS OF PREPARATION THEREOF" 183/DEL/2010 26‐02‐2018 AN ANTITUBERCULAR FORMULATION OF 4‐ALKOXY PHENYL 293425 CYCLOPROPYL ALKANOLS 425/DELNP/2013 26‐02‐2018 NEW FORMULATIONS OF 14 ‐ EPI ‐ANALOGUES OF VITAMIN D 293434 617/KOLNP/2010 26‐02‐2018 ISOTHIAZOLOPYRIDINONES USEFUL FOR THE TREATMENT OF 293436 (INTER ALIA) CYSTIC FIBROSIS 9045/DELNP/2011 27‐02‐2018 CHEMOSENSORY RECEPTOR LIGAND‐BASED THERAPIES 293443 5402/DELNP/2010 27‐02‐2018 "CONJUGATED FACTOR VIII MOLECULES" 293445 2741/DELNP/2011 27‐02‐2018 "COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS" 293447 4334/DELNP/2012 27‐02‐2018 “ENDODONTIC SEALING COMPOSITION” 293466 5574/DELNP/2011 27‐02‐2018 “PHARMACEUTICAL FORMULATION OF NANONISED FENOFIBRATE” 293509

Page 40 of 85 6093/DELNP/2010 27‐02‐2018 "MODIFIED RELEASE COMPOSITION COMPRISING DOXOFYLLINE" 293512

1903/DEL/2013 27‐02‐2018 PROCESS FOR THE ENZYMATIC SYNTHESIS OF (7S)‐1‐(3,4‐ 293519 DIMENTHOXYBICYCLO[4.2.0]ICTA‐,3,5‐TRIEN‐7‐YL) N‐METHYL METHANAMINE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND SALTS THEREOF 6626/DELNP/2010 27‐02‐2018 MIMOTOPES OF ALPHA‐SYNUCLEIN FOR THE TREATMENT OF 293522 NEURODEGENERATIVE DISORDERS 2401/CHENP/2012 27‐02‐2018 PERSONAL CARE COMPOSITIONS WITH ETHYLENE ACRYLIC ACID 293541 COPOLYMER AQUEOUS DISPERSIONS 232/CHENP/2010 28/02/2018 MOLECULES FOR TARGETING COMPOUNDS TO VARIOUS SELECTED 293576 ORGANS OR TISSUES 4211/CHENP/2008 28/02/2018 MICROPARTICULATE PHARMACEUTICAL FORMS RESISTANT TO 293628 IMMEDIATERELEASE OF THE ACTIVE PRINCIPLE IN THE PRESENCE OF ALCOHOL 5294/DELNP/2013 28‐02‐2018 CONTINUOUS ARYCYCLIC COMPOUND 293557 4387/CHENP/2012 28‐02‐2018 AQUEOUS PATCHES CONTAINING DICLOFENAC SODIUM 293558 2307/CHE/2009 28‐02‐2018 "IMPROVED PROCESS FOR THE PREPARATION OF ZILEUTON" 293566 2697/DEL/2010 28‐02‐2018 SUBSTITUTED 4‐ACRYLAMIDOPODOPHYLLOTOXIN CONGENERS AS 293591 ANTITUMOUR ANTIBIOTICS AND PROCESS FOR THE PREPARATION THEREOF 32/MUM/2013 28‐02‐2018 "INTRANASAL MICRO‐EMULSION OF AN ANTI‐MALARIAL DRUG, 293596 ARTEMETHER" 2718/MUMNP/2012 28‐02‐2018 HYDROXY ACID COMPOUND OF SUBSTITUTED PHENOL 293601 PREPARATION METHOD AND MEDICAL USE THEREOF 1294/DELNP/2013 28‐02‐2018 PROCESS FOR THE PRODUCTION OF L CARNITINE TARTRATE 293603 2131/MUM/2011 28‐02‐2018 A PHARMACEUTICAL COMPOSITION OF CINNARIZINE 293609 5157/CHENP/2009 28‐02‐2018 "TREATING STROKE AND OTHER DISEASES WITHOUT INHIBITING N‐ 293614 TYPE CALCIUM CHANNELS" 1149/MUM/2010 01‐03‐2018 "CALCIUM CONTAINING ORAL COMPOSITIONS" 293675 2471/DELNP/2011 02‐03‐2018 "3,3'4,4'‐TETRAHYDROXY‐2,2'‐BIPYRIDINE‐N, N'‐DIOXIDES FOR THE 293753 TREATMENT OF RENAL CELL CARCINOMA" 3537/CHENP/2010 02‐03‐2018 SUNSCREEN COMPOSITIONS COMPRISING COLOUR PIGMENTS 293757 514/MUMNP/2011 04‐03‐2018 “PHARMACEUTICAL FORMULATION 514” 295417 1258/KOL/2009 05‐03‐2018 A NOVEL FORMULATION FOR TREATING FUNGAL INFECTION 293776 7838/DELNP/2013 06‐03‐2018 COMPOSITION COMPRISING PERLITE AND A POLYMER BEARING A 293830 CARBOSILOXANE DENDRIMER BASED UNIT 6557/CHENP/2012 06‐03‐2018 4' ‐ AZIDO‐NUCLEOSIDES AS ANTI‐HCV COMPOUNDS 293832 6566/DELNP/2010 06‐03‐2018 “A Cytokine‐antibody DNL (Dock and Lock) Complex” 293871 4710/CHENP/2009 06‐03‐2018 "MICROCAPSULES COMPRISING ENCAPSULATED FRAGRANCES" 293873 6318/DELNP/2010 06‐03‐2018 "AN AQUEOUS SUSPENSION CONTAINING SURFACE‐ MODIFIED 293894 PARTICLE OF A THERAPEUTIC AGENT COATED WITH OPSONIN " 8442/CHENP/2011 06‐03‐2018 TRANSDERMAL PREPARATION 293895 4364/KOLNP/2009 07‐03‐2018 VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR 293947 POLYSACCHARIDE CONJUGATES 4655/DELNP/2007 07‐03‐2018 "A PHARMACEUTICAL COMPOSITION FOR INHIBITING GROWTH OF 293956 CANCER CELLS" 4363/KOLNP/2009 07‐03‐2018 VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR 293958 POLYSACCHARIDE CONJUGATES 5194/DELNP/2010 07‐03‐2018 “PHARMACEUTICAL COMPOSITION INCLUDING BETA‐ 293974 ADRENORECEPTOR ANTAGONISTS 2576/DELNP/2012 08‐03‐2018 "OXALIPLATIN NANOPARTICLES AND METHOD FOR PREPARING 293981 SAME" 3937/KOLNP/2011 08‐03‐2018 INTRAVENOUS FORMULATION WITH WATER‐SOLUBLE COCRYSTALS 293988 OF ACETYLSALICYLIC ACID AND THEANINE 3538/MUM/2010 09‐03‐2018 CURCUMIN MONOSULPHATE, ITS SALTS, PROCESS FOR SYNTHESIS 294015 THEREOF AND TREATMENT OF CANCER

Page 41 of 85 2511/DEL/2008 09‐03‐2018 SUBSTITUTED BENZFUROCHROMENES AND RELATED COMPOUNDS 294021 FOR THE PREVENTION AND TREATMENT OF BONE RELATED DISORDERS 9644/DELNP/2011 09‐03‐2018 DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED ISOMER 294023 CONTENTS 1473/DELNP/2011 09‐03‐2018 "MULTI‐ARM POLYMERIC ALKANOATE CONJUGATES" 294034 6843/DELNP/2012 09‐03‐2018 ANDROGEN RECEPTOR MODULATORS AND USES THEREOF 294038 2152/DELNP/2011 09‐03‐2018 ISOLATION AND IDENTIFICATION OF GLYCOSAMINOGLYCANS 294040 2138/CHE/2007 09‐03‐2018 SKIN CARE AGENT AND COMPOSITIONS THEREOF 294050 6664/CHENP/2011 09‐03‐2018 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION WITH 294064 RESISTANCE AGAINST THE INFLUENCE OF ETHANOL EMPLOYING A COATING COMPRISING NEUTRAL VINYL POLYMERS AND EXCIPIENTS

4018/DELNP/2011 09‐03‐2018 “CONCENTRATED LIQUID DIET” 294076 2937/MUM/2009 09‐03‐2018 AN IMPROVED PROCESS FOR THE PREPARATION OF PERINDOPRIL 294106 AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

4574/DELNP/2011 12‐03‐2018 "DYE SOLUTION" 294109 4428/DELNP/2008 12‐03‐2018 "OLANEXIDINE GLUCONATE" 294133 6877/DELNP/2010 12‐03‐2018 "METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 294146 PLASMA LEVELS" 6090/DELNP/2010 12‐03‐2018 "STABILIZED ANGIOPOIETIN‐2 ANTIBODIES AND USES THEREOF" 294150 8427/CHENP/2011 13‐03‐2018 “METHOD FOR STORING AN IMMUNOGENIC COMPOSITION 294183 AVAILABLE UNTIL NEEDED FOR ADMINISTRATION TO AN ANIMAL”

6968/DELNP/2011 13‐03‐2018 RILUZOLE AQUEOUS SUSPENSIONS 294188 8949/DELNP/2010 13‐03‐2018 "USE OF CELL‐PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL 294191 TRANSDUCTION PATHWAY FOR THE TREATMENT OF VARIOUS DISEASES" 1341/CHENP/2011 13‐03‐2018 LYOPHILIZED FORMULATIONS OF ENGINEERED ANTI‐IL‐23P19 294196 ANTIBODIES 562/KOL/2009 13‐03‐2018 NOVEL INTERMEDIATES IN THE PREPARATION OF 1,4‐DIPHENYL 294217 AZETIDINONE 528/MUM/2009 13‐03‐2018 LIPID BASED PHARMACEUTICAL PREPARATIONS FOR ORAL AND 294226 TOPICAL APPLICATION; THEIR COMPOSITIONS, METHODS AND USES THEREOF 1423/KOLNP/2010 13‐03‐2018 ANTIBODIES SPECIFIC FOR THE PROTOFIBRIL FORM OF BETA‐ 294232 AMYLOID PROTEIN 124/DEL/2010 14‐03‐2018 NOVEL PORPHYRIN DERIVATIVES FOR PHOTODYNAMIC THERAPY 294263 (PDT): A PROCESS FOR THE PREPARATION THEREOF AND THEIR USE AS PDT AGENTS AND FLUORESCENCE PROBES FOR BIOLOGICAL APPLICATIONS 9005/DELNP/2012 14‐03‐2018 HIGH SHEAR APPLICATION IN DRUG DELIVERY 294264 2340/DELNP/2009 14‐03‐2018 "A STABLE COMPOSITION COMPRISING A BONE ANABOLIC 294317 PROTEIN, NAMELY A PTHRP ANALOGUE, AND USES THEREOF" 6300/CHENP/2011 15‐03‐2018 PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL 294328 COMPOSITION COMPRISING EZETIMIBE 4017/DELNP/2013 15‐03‐2018 ORAL AND PERSONAL CARE COMPOSITIONS COMPRISING ZINC 294333 CONTAINING FILMS 182/DEL/2010 15‐03‐2018 NOVEL DISPIRO CYCLOALKANONES USEFUL AS INHIBITORS OF NAD+‐ 294354 DEPENDENT DNA LIGASE AND ANTITUBERCULAR AGENTS 10929/DELNP/2012 16‐03‐2018 POLYMERIC SYSTEM FOR DELIVERING A PRESERVATIVE‐FREE 294408 PROSTAGLANDIN‐BASED NONVISCOUS SOLUTION 420/DEL/2012 16‐03‐2018 PROCESS FOR PREPARATION OF FORMULATION OF NANOCOPPER 294416 TO COMBAT BACTERIAL BLIGHT POMEGRANATE, RICE AND BEAN

8185/CHENP/2010 16‐03‐2018 ORODISPERSIBLE MANNITOL 294448 2064/CHE/2010 16‐03‐2018 A PROCESS TO PREPARE ANTIOXIDANT AND ANTIINFLAMMATORY 294451 CONCENTRATES FROM BROWN AND RED SEAWEEDS AND A PRODUCT THEREOF

Page 42 of 85 6488/DELNP/2012 16‐03‐2018 AN ANTIMICROBIAL SOLUTION 294460 2435/CHENP/2012 20‐03‐2018 (Z)‐2‐CYANO‐3‐HYDROXY‐BUT‐2‐ENOIC ACID‐(4'‐ 294535 TRIFLUORMETHYLPHENYL)‐AMIDE TABLET FORMULATIONS WITH IMPROVED STABILITY 452/DELNP/2010 20‐03‐2018 "METHODS AND COMPOSITIONS FOR TREATING DISORDERS" 294564 3146/DEL/2012 20‐03‐2018 AN ORAL LIQUID FORMULATION AS CYANIDE ANTIDOTE 294602 5002/DELNP/2013 21‐03‐2018 FILMS AND COMPOSITIONS COMPRISING THE SAME 294639 9438/DELNP/2011 21‐03‐2018 "COMPOSITIONS AND METHODS FOR DRUG DELIVERY" 294657 2990/MUM/2011 21‐03‐2018 A QUINALDINE DERIVATIVE AND ITS PREPARATION 294671 7207/DELNP/2011 21‐03‐2018 "CARRIER COMPRISING A VITAMIN E DERIVATIVE" 294679 1580/DEL/2011 21‐03‐2018 "SUBSTITUTED 4‐ ARYLTHIAZOL‐2‐HYDRAZONES FOR THE 294724 TREATMENT OF TUBERCULOSIS" 3428/DELNP/2010 22/03/2018 METHODS FOR DESIGNING AND PREPARING VACCINES 294760 COMPRISING DIRECTED SEQUENCE POLYMER COMPOSITIONS VIA THE DIRECTED EXPANSION OF EPITOPES 1859/DELNP/2012 22‐03‐2018 "NOVEL PHARMACEUTICAL FORMULATION AGAINST DRUG 294725 MISUSE" 2601/MUM/2009 22‐03‐2018 A NOVEL MULTIPARTICULATE CONTROLLED POROSITY OSMOTIC 294752 PUMP OF OXYBUTYNIN HYDROCHLORIDE 2091/MUMNP/2010 22‐03‐2018 "AN ANTIVIRAL COMPOSITION" 294778 8361/DELNP/2009 22‐03‐2018 "SUBSTITUTED IMIDAZOHETEROCYCLES" 294786 307/CHENP/2011 23/03/2018 CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME 294790

2792/DEL/2008 23‐03‐2018 OSMOTIC CONTROLLED RELEASE ORAL FORMULATION OF 294829 LYCOPENE WITH ENHANCED SOLUBILITY 2154/DELNP/2014 23‐03‐2018 PERSONAL CARE COMPOSITIONS AND METHODS OF MAKING SAME 294845

3489/DELNP/2012 23‐03‐2018 MICROCRYSTALLINE CELLULOSE AND CALCIUM PHOSPHATE 294846 COMPOSITIONS USEFUL AS PHARMACEUTICAL EXCIPIENTS 3643/DELNP/2012 26‐03‐2018 ENDOGLIN ANTIBODIES 294860 1404/KOLNP/2010 26‐03‐2018 "A CHIMERIC CONSTRUCT" 294874 1700/CHE/2012 26‐03‐2018 A PROCESS FOR PREPARATION OF IRON SUCROSE COMPLEX 294877 6552/CHENP/2009 26‐03‐2018 "SOLID DOSAGE FORMS COMPRISING AN ENTERIC COATING WITH 294881 ACCELERATED DRUG RELEASE" 6328/CHENP/2009 26‐03‐2018 "COMBINATION OF BLYS INHIBITION AND/OR APRIL INHIBITION 294883 AND IMMUNOSUPPRESSANTS FOR TREATMENT OF AUTOIMMUNE DISEASE" 676/CHENP/2012 26‐03‐2018 COMPOSITION FOR TREATMENT OF TUBERCULOSIS 294897 1622/MUMNP/2010 26‐03‐2018 “COMPOUNDS” 294899 6207/DELNP/2013 26‐03‐2018 LONG LASTING CONTROLLED RELEASE LIPOSOME COMPOSITION 294934 AND METHOD FOR PRODUCING SAME 2148/KOLNP/2011 26‐03‐2018 STABLE TABLET CONTAINING 4,5‐EPOXYMORPHINAN DERIVATIVE 294936

2304/DELNP/2013 27/03/2018 HYDRATED N FULLERENE AMINO ACIDS METHOD FOR PRODUCING 294981 THE LATTER AND PHARMACEUTICAL COMPOSITIONS ON THE BASIS THEREOF 9957/CHENP/2011 27‐03‐2018 “COSMETIC COMPOSITION COMPRISING ENCAPSULATED SILICONE 295008 COMPOUNDS” 3769/DELNP/2007 27/03/2018 "A pharmaceutical composition" 295009 7208/CHENP/2010 27‐03‐2018 METHOD OF FORMING NON‐IMMUNOGENIC HYDROPHOBIC 294979 PROTEIN NANOPARTICLES AND USES THEREFOR 4920/DELNP/2005 27‐03‐2018 "FREEZE‐DRIED PREPARATION CONTAINING METHYLCOBALAMIN 295018 AND PROCESS FOR PRODUCING SAME" 1424/DELNP/2010 27‐03‐2018 "METHOD FOR PRODUCING VIRAL VACCINES" 295041 4935/DELNP/2012 28/03/2018 "INVERSE EMULSIONS COMPRISING AN ALKOXYLATED ESTER OIL" 295106

3746/DEL/2012 28/03/2018 DEVELOPMENT OF POLYMERIC FORMULATIONS OF BIOACTIVE 295150 MOLECULES AND METHOD OF PREPARATION THEREOF

Page 43 of 85 4189/KOLNP/2010 28/03/2018 THIENOPYRIDONE DERIVATIVES AS AMP‐ACTIVATED PROTEIN 295269 KINASE (AMPK) ACTIVATORS 1219/DELNP/2011 28‐03‐2018 DOCK‐AND‐LOCK (DNL) VACCINES FOR MULTIPLE MYELOMA 295098 THERAPY 4941/DELNP/2012 28‐03‐2018 CARNITINE GRANULATE AND METHODS FOR ITS PRODUCTION 295113 3061/DELNP/2011 28‐03‐2018 "PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK" 295116 10165/DELNP/2007 28‐03‐2018 " COMPOSITION FOR INCREASING THE CYTOTOXIC ACTIVITY OF 295146 EXHAUSTED T CELLS" 734/KOL/2012 28‐03‐2018 HERBAL COMPOSITION AND MEDICAMENT THEREOF FOR 295175 TREATING EPILEPSY 2640/DELNP/2011 28‐03‐2018 "CHEWABLE GELLED EMULSIONS" 295188 733/CHENP/2007 28‐03‐2018 TRANSDERMAL DRUG DELIVERY DEVICE WITH TRANSLUCENT 295241 PROTECTIVE FILM 1374/MUM/2012 28‐03‐2018 "A PHARMACEUTICAL COMPOSITION FOR CONTROLLING NAUSEA 295259 AND VOMITING" 2299/KOLNP/2010 28‐03‐2018 METHODS AND DEVICES FOR MINIMALLY‐INVASIVE EXTRAOCULAR 295266 DELIVERY OF RADIATION TO THE POSTERIOR PORTION OF THE EYE

2378/MUM/2009 30/03/2018 AN EFFICIENT PROCESS FOR SYNTHESIS OF DEXMETHYLPHENIDATE 295308

3307/DELNP/2011 30‐03‐2018 "LEPTIN COMPOSITIONS AND METHODS FOR TREATING 295300 PROGRESSIVE COGNITIVE FUNCTION DISORDERS RESULTING FROM ACCUMULATION OF NEUROFIBRILLARY TANGLES AND AMLYOID BETA" 4601/KOLNP/2010 30‐03‐2018 NIP THIAZOLE DERIVATIVES AS INHIBITORS OF 11‐BETA‐ 295304 HYDROXYSTEROID DEHYDROGENASE‐1 1742/MUMNP/2011 30‐03‐2018 PROCESS FOR THE PREPARATION OF PYRAZOLE DERIVATIVES. 295315 8913/DELNP/2010 31‐03‐2018 NON‐HORMONAL STEROID MODULATORS OF NF‐KB FOR 295321 TREATMENT OF DISEASE 107/KOL/2012 31‐03‐2018 SKIN CARE FORMULATIONS COMPRISING HERBAL COMPONENTS 295331

2524/DELNP/2011 31‐03‐2018 FAT EMULSION FOR ARTIFICIALLY FEEDING SERIOUSLY ILL 295337 INTENSIVE CARE PATIENTS 4103/KOLNP/2011 31‐03‐2018 ORALLY DISINTEGRATING COATED TABLET 295349 953/MUMNP/2013 31‐03‐2018 IMPROVED PHARMACEUTICAL STARTER PELLETS 295350 244/KOL/2012 02‐04‐2018 NANOMATERIAL BASED COSMETIC PRODUCTS 295357 22/CHENP/2011 02‐04‐2018 ALPHA HELIX MIMETICS AND METHODS RELATING THERETO 295395 2979/DELNP/2009 04‐04‐2018 "A PERSONAL CARE COMPOSITION COMPRISING GLYOXAL 295462 CROSSLINKED CATIONIC GUAR" 5098/DELNP/2011 04‐04‐2018 A PHARMACEUTICAL COMPOSITION AND A PROCESS FOR 295477 PREPARING THE SAME 9474/DELNP/2012 04‐04‐2018 LIQUID FORMULATIONS OF RUPATADINE FUMARATE 295488 2856/KOLNP/2006 05‐04‐2018 A COMPOSITION COMPRISING BOTULINUM TOXINS AND KIT FOR 295534 ADMINISTERING THE SAME THEREOF 1145/CHENP/2010 06‐04‐2018 AMINO‐ACID‐CONTAINING MEDICINAL GRANULAR PREPARATION 295572 HIGHLY EASY TO TAKE 1103/MUMNP/2011 06‐04‐2018 PA method for producing an active ingredient‐containing 295576 polyurethane patch 2874/MUM/2012 07‐04‐2018 CAPSULE FOR ENCAPSULATING A TABLET 298520 5708/CHENP/2011 09‐04‐2018 “COMPLEX AND PRODUCTION PROCESS” 300720 4783/DELNP/2011 09‐04‐2018 RECOMBINANT AVIAN INFLUENZA VACCINE AND USES THEREOF 300704 1728/MUM/2010 09‐04‐2018 STABLE LIQUID PHARMACEUTICAL COMPOSITIONS OF RANITIDINE 295604

8388/CHENP/2011 10‐04‐2018 FENTANYL‐CONTAINING ADHESIVE PREPARATION FOR EXTERNAL 295642 USE 6197/DELNP/2013 10‐04‐2018 ORAL COMPLEX COMPOSITION COMPRISING OMEGA 3 FATTY ACID 295652 ESTER AND HMG COA REDUCTASE INHIBITOR 1843/DEL/2010 11‐04‐2018 NOVEL COUMARIN‐CHALCONE HYBRIDS AS ANTICANCER AGENTS 295689

Page 44 of 85 4109/CHE/2011 12‐04‐2018 PROCESS OF PREPARATION OF TETRACYCLINE LOADED O ‐ 303963 CARBOXYMETHYL CHITOSAN NANOPARTICLES 3328/DELNP/2011 12‐04‐2018 "HIV‐1 INTEGRASE DERIVED STIMULATORY PEPTIDES INTERFERING 295729 WITH INTEGRASE‐REV PROTEIN BINDING" 4168/KOLNP/2009 13/04/2018 “OPTIMIZED TACI‐FC FUSION PROTEIN” 295755 6935/DELNP/2010 13‐04‐2018 "ANTIGEN‐AND‐DRUG VEHICLE COMPRISING SYNTHETIC PEPTIDE, 295762 AND MUCOSAL VACCINE USING THE SAME" 1511/KOLNP/2011 16‐04‐2018 POLYSACCHARIDES COMPRISING CARBOXYL FUNCTIONAL GROUPS 295816 SUBSTITUTED BY A HYDROPHOBIC ALCOHOL DERIVATIVE

3867/CHE/2010 17‐04‐2018 SALTS OF 3‐CYCLOPROPYLMETHOXY ‐4‐ 295824 DIFLUOROMETHOXYBENZOIC ACID AND ITS USE 4748/DELNP/2013 17‐04‐2018 ORAL CARE COMPOSITIONS 295833 9927/DELNP/2012 17‐04‐2018 VACCINES COMPRISING CHOLESTEROL AND CPG AS SOLE 295853 ADJUVANT ‐ CARRIER MOLECULES 7389/DELNP/2013 17‐04‐2018 PROCESS FOR THE PRODUCTION OF A PEMETREXED SALT 295856 381/MUMNP/2012 17‐04‐2018 "EXTERNAL PREPARATION" 295859 4987/CHE/2012 18/04/2018 PROCESS FOR THE PREPARATION OF ALCAFTADINE 295901 1531/DELNP/2011 19‐04‐2018 “PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS” 295904

1965/KOLNP/2011 19‐04‐2018 THIOCHROMENE DERIVATIVES AS HIP HYDROXYLASE INHIBITORS 295924

5604/DELNP/2012 20‐04‐2018 INTERMEDIATES AND SURFACTANTS USEFUL IN HOUSEHOLD 295939 CLEANING AND PERSONAL CARE COMPOSITIONS AND METHODS OF MAKING THE SAME 795/KOLNP/2011 23‐04‐2018 "A METHOD FOR PREPARING MULTILAYERED BLOOD PRODUCT" 295992 2859/CHE/2009 23‐04‐2018 “FORMULATIONS OF ANTIBODY” 295994 1703/KOLNP/2010 23‐04‐2018 "MULTITYPE HPV PEPTIDE COMPOSITIONS FOR TREATMENT OR 295995 PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION" 545/KOLNP/2011 23‐04‐2018 PHOSPHATE BINDING MATERIALS AND THEIR USES 295998 9825/CHENP/2011 23‐04‐2018 ESTER MIXTURES AND COMPOSITIONS COMPRISING SUCH ESTER 296003 MIXTURES 3080/KOLNP/2013 24/04/2018 NOVEL PIPERIDINYL MONOCARBOXYLIC ACIDS AS S1P1 RECEPTOR 296041 AGONISTS 3544/DELNP/2011 24/04/2018 "ADJUVANT INCORPORATION IN IMMUNONANOTHERAPEUTICS" 296027

900/DEL/2006 24‐04‐2018 "A PROCESS FOR THE PREPARATION OF POTENTIAL ANTIULCER 296011 COMPOUNDS FROM GINGER (ZINGIBER OFFCINALE) RHIZOME " 7507/CHENP/2012 24‐04‐2018 ANTI LEISHMANIAL COMPOUND AND ANTI LEISHMANIAL DRUG 296047 9746/CHENP/2012 24‐04‐2018 “GLUCAGON‐LIKE PEPTIDE‐1 ANALOGUE AND USE THEREOF” 296089 4791/DELNP/2013 25‐04‐2018 METAL SALT COMPOSITIONS 296112 5099/DELNP/2011 25‐04‐2018 "A DISINTEGRATING TABLET" 296125 5447/CHENP/2010 25‐04‐2018 PROCESS FOR STABILIZING AN ADJUVANT CONTAINING VACCINE 296126 COMPOSITION 10775/DELNP/2012 25‐04‐2018 PHARMACEUTICAL FORMULATION IN THE FORM OF BILAYERED 296129 TABLETS COMPRISING HMG COA REDUCTASE INHIBITOR AND IRBESARTAN 170/KOL/2014 25‐04‐2018 AN AQUEOUS ALCOHOL FREE WATERLESS CLEANSING SYSTEM FOR 296133 COSMETICS AND DERMATOLOGICAL APPLICATION 2375/KOLNP/2011 25‐04‐2018 SILICA‐BASED ANTIBACTERIAL AND ANTIFUNGAL 296136 NANOFORMULATION 5461/CHENP/2009 26/04/2018 "ANTIBODIES AGAINST ERBB3" 296147 358/MUMNP/2012 26/04/2018 DELIVERY SYSTEM 296231 1801/MUMNP/2013 26‐04‐2018 PHARMACEUTICAL COMPOSITION FOR TREATING HEPATIC DISEASE 296164

2116/MUMNP/2014 26‐04‐2018 SOLID COMPOSITION COMPRISING SALT OF AMINOCARBOXYLIC 296173 ACID

Page 45 of 85 4895/KOLNP/2011 26‐04‐2018 IMPROVED RECONSTITUTED SURFACTANT COMPOSITION 296183 CONTAINING ANALOGS OF SURFACTANT PROTEIN B (SP‐B) AND SURFACTANT PROTEIN C (SP‐C) 829/MUM/2011 26‐04‐2018 A PHARMACEUTICAL COMPOSITION COMPRISING FIBRATE AND 296191 FOLIC ACID 10869/DELNP/2012 27‐04‐2018 “ANTIPSYCHOTIC INJECTABLE DEPOT COMPOSITION” 296238 5363/DELNP/2010 27‐04‐2018 "PHARMACEUTICAL COMPOSITION OR COMBINATION DRUG" 296259 4712/DELNP/2006 27‐04‐2018 A COMPOUND OF FORMULA (II) 296299 3000/MUM/2009 28‐04‐2018 A PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE 296354 PERINDOPRIL 779/KOL/2009 01‐05‐2018 A METHOD FOR PREPARING A WATER DISPERSIBLE GLYCERYL 296360 MONOOLEATE (GMO) MAGNETIC NANOPARTICLE (MNP) FORMULATION AND USE OF THE SAME 10893/DELNP/2012 01‐05‐2018 “SYNERGISTIC HERBICIDAL COMPOSITIONS CONTAINING 296377 PROPYZAMIDE AND AMINOPYRALID” 2653/MUMNP/2012 01‐05‐2018 ARYL AND HETEROARYL‐QUINOLIN COMPOUND 296393 1960/DEL/2011 02‐05‐2018 PHARMACEUTICAL COMPOSITIONS FOR ENHANCING ANTICANCER 296411 EFFICACY OF TAMOXIFEN” 3455/CHE/2011 02‐05‐2018 "A METAL DOPED PROTEIN–SORAFENIB NANOMEDICINE 296417 FORMULATIONFOR CANCER TREATMENT" 1038/KOL/2009 02‐05‐2018 "HERBAL COMPOSITION FOR USE IN A HYDRO GENERATOR FAN" 296425

4993/KOLNP/2007 02‐05‐2018 A METHOD OF MAKING AN IMMUNOGENIC COMPOSITION 296428 252/KOL/2011 02‐05‐2018 ORAL CARE COMPOSITIONS 296431 1838/DELNP/2012 02‐05‐2018 "SPLA2 HYDROLYSABLE LIPOSOMES WITH IMPROVED STORAGE 296446 STABILITY" 2793/CHENP/2009 02‐05‐2018 “CHIMERICAL PEPTIDIC MOLECULES WITH ANTIVIRAL PROPERTIES 296464 AGAINST THE VIRUSES OF THE FLAVIVIRIDAE FAMILY”

2071/CHE/2007 03‐05‐2018 PROCESS FOR THE PREPARATION OF LAMIVUDINE FORM I 293798 2039/MUM/2010 03‐05‐2018 A HERBAL COMPOSITION (FC) FOR THE TREATMENT OF CERVICAL 293782 CANCER 1846/DELNP/2014 03‐05‐2018 METHOD FOR PURIFICATION OF CLEAVED PRO INSULIN 296509 3889/CHE/2011 03‐05‐2018 CATIONIC ANTIBACTERIAL COMPOSITION 296510 236/CHENP/2010 04‐05‐2018 INTRADERMAL INFLUENZA VACCINE 296525 731/DELNP/2013 04‐05‐2018 An oral prolonged release pharmaceutical composition comprising 296540 oxycodone and naloxone 2412/MUM/2011 07‐05‐2018 1,6‐DIAZABICYCLO[3,2,1]OCTAN‐7‐ONE DERIVATIVES 298526 2780/DELNP/2013 07‐05‐2018 TRANSDERMAL ABSORPTION PREPARATION 298570 768/DELNP/2006 07‐05‐2018 "SYNTHETIC PEPTIDE VACCINES FOR FOOT‐AND‐MOUTH DISEASE" 296573

4056/DELNP/2008 07‐05‐2018 FORMULATION FOR ORAL ADMINISTRATION FOR THE TREATMENT 296580 OF TYPE 2 DIABETES 949/KOLNP/2011 08‐05‐2018 PROCESSES FOR THE PREPARATION OF SGLT2 INHIBITORS 296612 9363/CHENP/2011 09‐05‐2018 FACTOR VII COMPOSITION 296635 1075/MUMNP/2012 09‐05‐2018 SUNSCREEN COMPOSITION 296641 1943/DEL/2010 09‐05‐2018 "SCAR PRIMERS AND A KIT FOR THE AUTHENTICATION OF UNANI 296647 DRUG MULETHI (GLYCERRHIZA GLABRA) AND ITS ADULTERANT ABRUS PRECATORIOUS". 435/KOL/2012 10‐05‐2018 SKIN CARE COMPOSITION COMPRISING EXTRACTS OF 301895 APHANAMIXIS ROHITUKA 354/KOLNP/2008 14‐05‐2018 "COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING 296736 ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES" 3933/DELNP/2013 14‐05‐2018 NOVEL PYRIDYL BENZOXAZINE DERIVATIVES PHARMACEUTICAL 296762 COMPOSITION COMPRISING THE SAME AND USE THEREOF 1334/MUM/2012 14‐05‐2018 READY TO BE INFUSED GEMCITABINE SOLUTION 296771 3840/DEL/2012 15‐05‐2018 “NEW PROCESS FOR THE SYNTHESIS OF IV ABRADINE AND 296775 ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID”

Page 46 of 85 1358/CHENP/2012 15‐05‐2018 A COMPOSITION COMPRISING AN AFUCOSYLATED ANTI‐CD20 296780 ANTIBODY AND BENDAMUSTINE 4924/DELNP/2011 15‐05‐2018 "COMPOSITIONS COMPRISING PROBIOTIC AND PREBIOTIC 296785 COMPONENTS AND MINERAL SALTS, WITH LACTOFERRIN" 3118/KOLNP/2009 15‐05‐2018 ACTIVIN ‐ACTRIIA ANTAGONISTS AND USES FOR PROMOTING BONE 296794 GROWTH IN CANCER PATIENTS 4929/CHENP/2010 15‐05‐2018 NON‐POLYMERIC COMPOSITIONS FOR CONTROLLED DRUG 296799 DELIVERY 2793/CHENP/2013 15‐05‐2018 A PHARMACEUTICAL COMPOSITION 296804 6775/CHENP/2011 15‐05‐2018 PAEDIATRIC SOLUTIONS COMPRISING A BETA‐BLOCKER 296807 7277/CHENP/2010 15‐05‐2018 3‐PHENYLPYRAZOLO[5,1‐b]THIAZOLE COMPOUND 296814 3600/CHENP/2012 15‐05‐2018 FORMULATIONS COMPRISING TRIPTAN COMPOUNDS 296816 1328/DEL/2010 16‐05‐2018 "A RECOMBINANT HAEMAGGLUTININ DOMAIN‐CONTAINING 296824 PROTEIN FOR THE DETECTION AND DIAGNOSIS OF GLANDERS AND METHOD OF PREPARATION THEREOF" 4826/KOLNP/2007 16‐05‐2018 MULTIVALENT IMMUNOGENIC COMPOSITION CONTAINING 296830 BACTERIAL CAPSULAR CONJUGATE VACCINES CONJUGATED USING DIFFERENT PROCESSES 319/MUMNP/2013 16‐05‐2018 CLEAR LIQUID COMPOSITION COMPRISING ALKANOYL GLYCINATE, 296850 AMPHOTERIC SURFACTANT, ALKYL SULFATE AND SPECIFIC ASSOCIATIVE ACRYLATE POLYMERS 1268/MUMNP/2012 17‐05‐2018 “OXYNTOMODULIN PEPTIDE ANALOGUE” 296856 8910/DELNP/2012 17‐05‐2018 PRODUCTION OF ATORVASTATIN LOW IN ETHER IMPURITIES 296865 230/KOL/2011 18‐05‐2018 A PROCESS FOR EXTRACTION OF PURE SILICA FROM LOW GRADE 296906 COAL AND OTHER LOW GRADE SILICIOUS MINERAL 524/DELNP/2011 21/05/2018 "COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING 296918 COMPLEMENT PROTEIN C5" 2211/DELNP/2009 21‐05‐2018 "LIPID CONTAINING FORMULATIONS" 296912 6966/DELNP/2012 21‐05‐2018 ANTAGONIST ANTI IL 7 RECEPTOR ANTIBODIES AND METHODS 296934 2612/MUM/2009 22/05/2018 "STABILIZERS FOR VACCINE COMPOSITIONS" 296960 2580/DELNP/2013 22/05/2018 PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN 296974 PROCESSES FOR THEIR OBTAINMENT AND METHOD OF TREATING INTESTINAL DISEASE 684/MUM/2010 22‐05‐2018 "STABILIZED PROLONGED RELEASE PHARMACEUTICAL 296983 COMPOSITION COMPRISING ATYPICAL ANTIPSYCHOTIC" 4608/CHENP/2011 22‐05‐2018 “PHARMACEUTICAL DOSAGES DELIVERY SYSTEM” 296988 4598/DELNP/2012 23/05/2018 PHARMACEUTICAL COMPOSITION 297012 3670/DEL/2012 23‐05‐2018 CHITOSAN MICROPARTICLES FOR MUCOSAL DRUG DELIVERY 297023 216/KOL/2013 24‐05‐2018 ANTI‐HAIR LOSS FORMULATION 297049 01124/DELNP/2003 25‐05‐2018 "SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE COMPOUND" 297089

537/MUMNP/2011 25‐05‐2018 SENSORY MODIFIER 297098 3870/KOLNP/2009 25‐05‐2018 COMPOSITIONS AND METHODS FOR PROPHYLAXIS AND 297102 TREATMENT OF ADDICTIONS 2179/DEL/2010 25‐05‐2018 BENZOTHIAZOLE COMPOUNDS AND PROCESS FOR THE 297106 PREPARATION THEREOF 2272/DEL/2009 25‐05‐2018 “A PROCESS FOR PREPARATION OF HERBAL APHRODISIAC HARD 297117 BOILED CANDY FORMULATION” 2340/CHE/2007 25‐05‐2018 AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL 297120 COMPOSITION AND A PROCESS THEREOF 3203/CHE/2011 28‐05‐2018 HETEROARYL COMPOUNDS AS 5‐HT4 RECEPTOR LIGANDS 297139 1216/DELNP/2012 28‐05‐2018 "CRYSTALLIZATION METHOD AND BIOAVAILABILITY" 297148 905/MUMNP/2012 28‐05‐2018 TRANSDERMALLY ABSORBABLE DONEPEZIL‐CONTAINING 297158 PREPARATION 655/MUM/2010 28‐05‐2018 "AN EFFICIENT PROCESS FOR SYNTHESIS OF FLUORO‐SUBSTITUTED 297176 ARYL CARBONYL PIPERIDINYL COMPOUNDS" 3704/CHENP/2011 29/05/2018 CYTOTOXIC T CELL EPITOPE PEPTIDE FOR SARS CORONAVIRUS, AND 297193 USE THEREOF

Page 47 of 85 4286/CHENP/2012 29‐05‐2018 A PROCESS FOR CONVERTING A SOLID (METH) ACRYLATE 297199 COPOLYMER INTO A DISPERSED FORM BY MEANS OF A DISPERSING AGENT 370/KOLNP/2012 29‐05‐2018 ε‐POLYLYSINE CONJUGATES AND THE USE THEREOF 297215 8373/DELNP/2011 30‐05‐2018 COMPRESSIBLE AND FREE‐FLOW CO‐AGGLOMERATES OF 297219 MANNITOL AND GRANULAR STARCH 1437/CHENP/2011 30‐05‐2018 COPOLYMERS USEFUL AS RHEOLOGY MODIFIERS AND HOME AND 297223 PERSONAL CARE COMPOSITIONS 2043/MUMNP/2013 30‐05‐2018 NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS 297239 8870/DELNP/2012 30‐05‐2018 COMPOSITION FOR AMELIORATING HYPOALBUMINEMIA 297249 CONTAINING A BRANCHED‐CHAIN AMINO ACID 2765/MUM/2009 30‐05‐2018 "Oripavine to 4,5a‐epoxy‐3,14‐dihydroxynormorphinan‐7‐ene‐6‐ 297260 one" 6664/CHENP/2012 31‐05‐2018 PHARMACEUTICAL COMPOSITION AND PREPARATION FOR ORAL 297289 ADMINISTRATION 8568/CHENP/2010 31‐05‐2018 PHARMACEUTICAL DOSAGE FORM COMPRISING POLYMERIC 297310 CARRIER COMPOSITION 1963/KOLNP/2011 31‐05‐2018 PYRAZINOPYRAZINES AND DERIVATIVES AS KINASE INHIBITORS 297333 797/DEL/2012 01‐06‐2018 "A PROCESS FOR SYNTHESIS OF CHIRAL 3‐SUBSTITUTED 297355 TETRAHYDROQUINOLINE DERIVATIVES " 2089/KOLNP/2011 03‐06‐2018 TGR5 MODULATORS AND METHODS OF USE THEREOF 293851 2153/CHENP/2011 04‐06‐2018 SILVER ION DELIVERY PLATFORM 297382 433/KOL/2011 04‐06‐2018 A METHOD OF PREPARATION OF COMPOSITION 297386 10072/CHENP/2012 04‐06‐2018 IMPROVEMENTS IN OR RELATING TO DEPILATORY COMPOSITIONS 297388

10903/DELNP/2012 05‐06‐2018 NOVEL SPIROHETEROCYCLIC COMPOUNDS AS MGLU5 297395 ANTAGONISTS 2125/MUM/2011 05‐06‐2018 PHARMACEUTICAL COMPOSITIONS COMPRISING SULBACTAM AND 297397 BETA‐LACTAMASE INHIBITOR 6793/CHENP/2010 06‐06‐2018 IMPROVED FORMULATIONS FOR POORLY PERMEABLE ACTIVE 297423 PHARMACEUTICAL INGREDIENTS 6869/CHE/2015 06‐06‐2018 TOPICAL COMPOSITIONS FOR THE TREATMENT OF ACNE 297442 2440/CHENP/2012 06‐06‐2018 PROCESS FOR THE SYNTHESIS OF 4,5,6,7‐TETRACHLORO‐3',6'‐ 297453 DIHYDROXY‐2',4',5',7'‐TETRAIODO‐3H‐SPIRO[ISOBENZOFURAN‐1,9'‐ XANTHEN]‐3‐ONE (ROSE BENGAL) AND RELATED XANTHENES

4394/DELNP/2012 06‐06‐2018 "A METHOD OF LYOPHILIZING A COMPOSITION COMPRISING 297470 ANTITHROMBIN III (AT III)" 3819/DELNP/2006 08‐06‐2018 ANTIVIRAL AGENTS 299722 4924/KOLNP/2011 08‐06‐2018 “TRIPTOLIDE PRODRUGS” 297525 217/MUMNP/2013 09‐06‐2018 SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED DIAMINES 300773

9461/CHENP/2013 11‐06‐2018 2 ‐ (2, 4, 5 ‐ SUBSTITUTED ‐ANILINO) PYRIMIDINE DERIVATIVES AS 297581 EGFRMODULATORS USEFUL FOR TREATING CANCER 8079/CHENP/2012 11‐06‐2018 PROCESSES FOR THE SYNTHESIS OF DIARYLTHIOHYDANTOIN AND 297583 DIARYLHYDANTOIN COMPOUNDS 5102/CHENP/2013 12‐06‐2018 "MICROPARTICLES CONTAINING PHYSIOLOGICALLY ACTIVE 304098 PEPTIDE, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME" 4697/DELNP/2011 12‐06‐2018 PHARMACEUTICAL FORMULATIONS COMPRISING VORICONAZOLE 297589 AND PROCESSES FOR PREPARATION THEREOF 161/MUM/2010 12‐06‐2018 "SUSTAINED RELEASE DOSAGE FORM OF QUETIAPINE" 297608 2674/CHENP/2014 13/06/2018 FOAM‐FORMING AEROSOL PRODUCT 297633 158/MUMNP/2012 13‐06‐2018 4‐(benzimidazol‐2‐ylamino)benzamide derivatives and salts or 297616 solvates thereof and a method of synthesizing a pharmaceutical compound 7544/DELNP/2010 13‐06‐2018 "STIMULATION OF AN IMMUNE RESPONSE BY ENANTIOMERS OF 297624 CATIONIC LIPIDS"

Page 48 of 85 2623/MUMNP/2012 14/06/2018 LEVOCARRIMYCIN PHARMACEUTICAL COMPOSITIONS 297672 PREPARATION METHODS AND USES THEREOF 464/MUM/2010 14‐06‐2018 A PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL 297641 COMPOSITION OF KILLED CELLS WITH SUBSTANTIALLY RETAINED IMMUNOGENICITY

6040/DELNP/2011 14‐06‐2018 TRANSDERMAL DELIVERY OF DICLOFENAC, CARBAMAZEPINE AND 297658 BENZYDAMINE 10805/CHENP/2012 14‐06‐2018 COSMETICS COMPRISING COSMETIC COMPOSITION‐IMPREGNATED 297667 URETHANE FOAM 3694/DELNP/2009 15‐06‐2018 “IMIDAZO[1,2‐B]PYRIDAZINE AND PYRAZOLO[1,5‐A]PYRIMIDINE 297681 DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS”

1718/MUMNP/2012 15‐06‐2018 SUSTAINED RELEASE NUCLEIC ACID MATRIX COMPOSITIONS 297683 2061/CHE/2008 18‐06‐2018 OSMOTIC CONTROLLED RELEASE DOSAGE FORM OF METFORMIN 297753

2350/KOLNP/2011 19/06/2018 AQUEOUS COMPOSITION CONTAINING FOLLICLE‐STIMULATING 297793 HORMONE 5713/DELNP/2009 19‐06‐2018 "BACTERIAL EXTRACT FOR RESPIRATORY DISORDERS AND PROCESS 297775 FOR ITS PREPARATION" 11220/DELNP/2012 19‐06‐2018 “A Solid Composition Comprising dimethyl (2S,2’S)‐1,1’‐((2S,2’S)‐ 297792 2,2’‐(4,4’‐((2S,5S)‐1‐(4‐tertbutylphenyl)pyrrolidine‐2,5‐diyl)bis(4,1‐ phenylene))bis(azanediyl)bis(oxomethylene)bis(pyrrolidine‐2,1‐ diyl))bis(3‐methyl‐1‐oxobutane‐2,1‐diyl)dicarbamate

6995/DELNP/2008 19‐06‐2018 "A PHARMACEUTICAL COMPOSITION" 297811 394/DELNP/2011 19‐06‐2018 STRUCTURAL VARIANTS OF ANTIBODIES FOR IMPROVED 297817 THERAPEUTIC CHARACTERISTICS 20/DEL/2009 19‐06‐2018 A TOPICAL FORMULATION 297820 8331/DELNP/2009 19‐06‐2018 "INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE DELIVERY OF 297833 MACROMOLECULES AND WATER‐SOLUBLE DRUGS" 1149/MUMNP/2012 20‐06‐2018 SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES 297847

800/MUM/2014 20‐06‐2018 "MICROEMULSIONS OF LIPIDATED GLYCINES AND PHENOXY 297869 ETHANOL FOR PRESERVATION OF PERSONAL CARE PRODUCTS 2189/CHE/2013 20‐06‐2018 PROCESS FOR THE PREPARATION OF LINAGLIPTIN VIA NOVEL 297872 INTERMEDIATES 757/CHE/2011 20‐06‐2018 PROCESS FOR PREPARING POLYMORPH OF CURCUMIN 297877 551/MUMNP/2012 21‐06‐2018 SEAMLESS ALGINATE CAPSULES AND METHOD OF PRODUCTION 297918 THEREOF 4072/DELNP/2013 22/06/2018 A PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT 297979 OF NON INFECTIOUS DISEASES 6027/CHENP/2012 22‐06‐2018 FUSED HETEROAROMATIC PYRROLIDINONES AS SYK INHIBITORS 297952

7663/DELNP/2012 22‐06‐2018 ORAL CARE COMPOSITION 297976 3968/CHENP/2011 25‐06‐2018 "ANTI‐PD‐L1 ANTIBODIES AND THEIR USE TO ENHANCE T‐CELL 297982 FUNCTION" 1299/CHENP/2012 25‐06‐2018 “SKIN EXTERNAL‐PREPARATION COMPOSITION” 297987 1465/DELNP/2011 25‐06‐2018 CARDIOPLEGIC PREPARATION 298000 1649/CHE/2009 25‐06‐2018 A COMPOSITION USEFUL AS ROTAVIRUS VACCINE AND A METHOD 298017 THEREFOR 2947/DELNP/2011 25‐06‐2018 "NUTRITIONAL COMPOSITION TO PROMOTE HEALTHY 298024 DEVELOPMENT AND GROWTH" 759/CHENP/2012 25‐06‐2018 A COMPOSITION COMPRISING A THERAPEUTICALLY EFFECTIVE 298037 AMOUNT OF O‐CARBAMOYL‐(D)‐PHENYLALANINOL COMPOUND 1076/MUMNP/2012 26‐06‐2018 SUNSCREEN COMPOSITION WITH FATTY ACID ALKANOLAMIDES 298064 5300/CHE/2013 26‐06‐2018 FORMULATIONS FOR DISSOLUTION OF PETROLEUM SLUDGE OR 298066 WAXES AND METHOD FOR EVALUATION THEREOF

Page 49 of 85 6673/CHENP/2013 26‐06‐2018 NOVEL POLYSACCHARIDE DERIVATIVES, DOSAGE FORMS AND A 298075 PROCESS FORPREPARING A DOSAGE FORM 6800/CHENP/2009 26‐06‐2018 A PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND 298083 ITS PROCESS FOR PREPARATION 1180/DELNP/2013 26‐06‐2018 METHOD FOR PRODUCING PHENYL SUBSTITUTED HETEROCYCLIC 298092 DERIVATIVE BY MEANS OF COUPLING METHOD USING A PALLADIUM COMPOUND 9853/CHENP/2011 27‐06‐2018 ESTER MIXTURES AND COMPOSITIONS COMPRISING SUCH ESTER 298113 MIXTURES 1180/DEL/2007 27‐06‐2018 ANTI‐LEISHMANIAL ACTIVITY OF PARAMOMYCIN IN CATIONIC 298145 LIPOSOMAL FORMULATION 213/DEL/2011 27‐06‐2018 PROCESS FOR THE PREPARATION OF TALC BASED FORMULATION 298158 FOR LDPE‐DEGRADING BACTERIAL CONSORTIA 2309/MUM/2010 28/06/2018 A PHARMACEUTICAL COMPOSITION COMPRISING OFLOXACIN AND 298212 CEFUROXIME 2951/MUM/2010 28‐06‐2018 A PHOTOSTABLE SUNSCREEN COMPOSITION 298208 4940/DELNP/2012 28‐06‐2018 PROLYL HYDROXYLASE INHIBITORS 298216 6017/CHENP/2011 28‐06‐2018 A SOLID DISPERSION 298234 1066/MUMNP/2013 28‐06‐2018 COMPOSITIONS COMPRISING FATTY ACYL ISETHIONATE 298249 SURFACTANT PRODUCT ALKANOYL COMPOUNDS AND TRIGLYCERIDES WITH LOW LEVEL OF HYDROGENATION 2689/MUM/2009 29/06/2018 EXTENDED RELEASE VENLAFAXINE HCI PELLETS 298260 1559/DELNP/2012 29‐06‐2018 NOVEL PHARMACEUTICAL COMPOSITION COMPRISING A 298252 MACROLIDE IMMUNOSUPPRESSANT DRUG 148/MUM/2011 29‐06‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF NEPAFENAC" 298253

217/CHE/2005 29‐06‐2018 A process for production of a by‐product dimethyl sulphoxide 298268

7275/CHENP/2009 29‐06‐2018 HUMANIZED ANTIBODIES TO AMYLOID BETA 298269 123/DELNP/2013 29‐06‐2018 COMPOSITION FOR NUCLEIC ACID DELIVERY, CARRIER 298271 COMPOSITION, PHARMACEUTICAL COMPOSITION USING THE COMPOSITION FOR NUCLEIC ACID DELIVERY OR THE CARRIER COMPOSITION AND METHOD FOR DELIVERING NUCLEIC ACID 8513/CHENP/2010 29‐06‐2018 ORAL COMPOSITIONS CONTAINING ENHANCED ANTIBACTERIAL 298278 COMBINATIONS OF ANTIOXIDANTS AND EXTRACTS OF MAGNOLIA

1065/DELNP/2012 29‐06‐2018 "PARTICULATE COMPOSITION AND PHARMACEUTICAL 298297 COMPOSITION CONTAINING THE SAME" 8185/CHENP/2012 29‐06‐2018 IMPROVED STABLE AQUEOUS FORMULATION OF (E)‐4‐ 298302 CARBOXYSTYRYL‐4‐CHLOROBENZYL SULFONE 3071/KOLNP/2011 29‐06‐2018 C5AR ANTAGONISTS 298319 7776/DELNP/2013 29‐06‐2018 TABLET TYPE COMPOSITION FOR ORAL ADMINISTRATION AND 298323 METHOD FOR PRODUCING SAME 1715/MUM/2010 29‐06‐2018 MICROSPHERES AND PHOTOPROTECTIVE PERSONAL CARE 298352 COMPOSITION COMPRISING SAME 2580/KOLNP/2008 02‐07‐2018 ORGAN PRESERVATION AND/OR PERFUSION 292660 6567/DELNP/2015 02‐07‐2018 METHOD FOR PREPARING HAIR CARE COMPOSITIONS COMPRISING 298390 A STEP OF ADDING PERFUMES AND/OR SILICONES BEFORE ANTIDANDRUFF AGENTS 31/MUM/2013 02‐07‐2018 "SYNTHESIS AND CHARACTERIZATION OF NOVEL DI‐AZO CROSS‐ 298408 LINKED POLYMER FOR COLON SPECIFIC DELIVERY" 5066/DELNP/2012 02‐07‐2018 "BETA‐CARBOLINES FOR USE IN THE TREATMENT OF HEARING LOSS 298416 AND VERTIGO" 2028/CHENP/2013 03‐07‐2018 COMPOSITION CONTAINING TETRACYCLIC COMPOUND 298424 2049/DEL/2008 03‐07‐2018 "A PROCESS OF PREPARATION OF OINTMENT BASE" 298425 1827/DEL/2008 03‐07‐2018 CURCUMIN NANOPARTICLES AND METHODS OF PRODUCING THE 298432 SAME 221/KOL/2012 03‐07‐2018 MICROEMULSION COMPOSITION FOR COSMETICS AND 298450 DERMATOLOGICAL APPLICATION 1441/CHE/2011 03‐07‐2018 NOVEL PROCESS FOR THE PREPARATION OF ETRAVIRINE 298456

Page 50 of 85 39/KOLNP/2011 03‐07‐2018 A PROCESS FOR PREPARING A CRYSTALLINE MODIFICATION OF (R)‐ 298457 DOPC 1849/KOLNP/2007 03‐07‐2018 CELL‐PENETRATING CHIMERIC POLYPEPTIDE AND 298459 PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 1500/DELNP/2013 04‐07‐2018 5a‐ANDROSTANE‐3ß,5,6ß‐TRIOL INJECTION AND PREPARATION 298479 METHOD THEREFOR 1228/CHENP/2011 04‐07‐2018 “PHARMACEUTICAL COMPOSITION FOR TREATING HYPERTENSION 298487 AND METABOLIC SYNDROME AND USE THEREOF”

2220/MUM/2009 04‐07‐2018 AN ANTIMICROBIAL COMPOSITION 298498 837/DEL/2009 05‐07‐2018 "SEA BUCKTHORN (HIPPOPHAE RHAMNOLDES L.)EXTRACT 298527 ENCAPSULATED IN PVA CRYOGELS FOR TREATMENT OF BURN WOUNDS" 8315/DELNP/2011 05‐07‐2018 "PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL 298546 DERIVATIVES AND METHODS OF MAKING THE SAME"

4999/CHENP/2010 06‐07‐2018 A PROCESS FOR PRODUCTION OF NANOPARTICLE CARRIERS FOR 297476 DRUG DELIVERY 2743/MUMNP/2011 06‐07‐2018 ORAL CARE COMPOSITIONS COMPRISING A POLYMERIC DYE 298582 938/KOLNP/2011 06‐07‐2018 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND 298597 PREVENTION OF CANCERS 9828/DELNP/2011 06‐07‐2018 Cosmetic depigmenting composition 298611 4355/KOLNP/2009 08‐07‐2018 “LINEAR EXPRESSION CONSTRUCTS FOR PRODUCTION OF 299784 INFLUENZA VIRUS PARTICLES” 365/DELNP/2013 09‐07‐2018 QUINAZOLINE COMPOUNDS 298627 7728/DELNP/2012 09‐07‐2018 DENTURE ADHESIVE COMPOSITIONS 298671 1882/MUMNP/2014 10‐07‐2018 "HETEROBICYCLIC COMPOUNDS AS BETA‐LACTAMASE INHIBITORS" 298697

8065/DELNP/2011 11‐07‐2018 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER 298742 1068/KOLNP/2011 11‐07‐2018 1‐PHENYLPYRROLE COMPOUNDS 298734 2397/CHENP/2011 11‐07‐2018 BISPECIFIC ANTI‐VEGF/ANTI‐ANG‐2 ANTIBODIES 298751 1719/KOLNP/2012 11‐07‐2018 PROCESS FOR THE PREPARATION OF O‐DESMETHYL‐VENLAFAXINE 298754 AND SALTS THEREOF 1521/KOLNP/2012 11‐07‐2018 PREPARATION OF A POWDERY PHARMACEUTICAL COMPOSITION 298756 BY MEANS OF AN EXTRUDER 562/CHENP/2014 12‐07‐2018 INHIBITORS OF INFLUENZA VIRUSES REPLICATION 304215 8194/DELNP/2012 12‐07‐2018 METHOD FOR PRESERVING ALUM ADJUVANTS AND ALUM 298773 ADJUVANTED VACCINES 2195/KOLNP/2009 12‐07‐2018 NOVEL PROSTATE KALLIKREIN ALLERGEN 298789 2516/MUMNP/2011 12‐07‐2018 SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET 298804 ABSORBER 433/DELNP/2010 13‐07‐2018 "AMIDE COMPOUNDS" 298834 3759/CHENP/2010 16/07/2018 AN ANTI‐CD20 HUMAN MONOCLONAL ANTIBODY FORMULATION 298856

8158/DELNP/2010 16‐07‐2018 "ANTIOXIDANT INFLAMMATION MODULATORS: OLEANOLIC ACID 298853 DERIVATIVES WITH AMINO AND OTHER MODIFICATIONS AT C‐17"

436/KOL/2011 16‐07‐2018 “A METHOD FOR THE PREPARATION OF HERBAL MEDICAMENT FOR 298858 TREATMENT OF NERVE DISORDERS AND VARIOUS FORMS OF NEURONAL INJURIES” 201641027672 16‐07‐2018 QUORUM SENSING BASED POLYMER FOR STIMULATION OF 298859 BIOFILMS AND RELATED PHENOTYPES, AND PROCESS THEREOF 2149/MUMNP/2011 16‐07‐2018 “A PROCESS FOR THE PREPARATION OF A TREHALULOSE‐ 298865 CONTAINING COMPOSITION” 2193/MUMNP/2013 16‐07‐2018 BICYCLO (3.1.0) HEXANE 2,6 DICARBOXYLIC ACID DERIVATIVES AS 298866 MGLU2 RECEPTOR AGONIST 2053/DEL/2013 16‐07‐2018 AN ARTHROPOD REPELLENT NANOGEL FORMULATION. 298872 2188/CHE/2013 17‐07‐2018 A MICROBICIDAL COMPOSITE MATERIAL 298904

Page 51 of 85 3293/KOLNP/2011 18/07/2018 PYRIDAZINONE COMPOUNDS AND THEIR PHARMACEUTICALLY 298943 USABLE SALTS 3085/DELNP/2012 18‐07‐2018 “SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE 298938 USES THEREOF”. 4577/CHENP/2010 18‐07‐2018 A SLOW‐RELEASE FORMULATION BASED ON AN ASSOCIATION OF 298924 GLYCOGEN AND ALGINATE 265/DELNP/2012 18‐07‐2018 "SOLUTIONS COMPRISING POLYETHYLENE GLYCOL AND 298926 ELECTROLYTES" 5677/DELNP/2011 18‐07‐2018 "PHOSPHOINOSITIDE 3‐KINASE INHIBITORS WITH A ZINC BINDING 298946 MOIETY" 2585/DELNP/2011 19‐07‐2018 "IRON SOURCE PRODUCT IN THE FORM OF CAPSULES AND PROCESS 298965 FOR THEIR PREPARATION" 1620/MUM/2006 19‐07‐2018 A PROCESS FOR THE PREPARATION OF AN HERBAL SKIN OINTMENT 298977

2798/MUM/2011 19‐07‐2018 BIOACTIVE COMPOSITION FOR THE PROPHYLAXIS AND TREATMENT 298988 OF MALARIA, METHOD OF MANUFACTURING AND USING THE SAME. 914/DEL/2008 19‐07‐2018 “A SUPRAMOLECULAR INSULIN ASSEMBLY USEFUL AS PROTEIN 298991 THERAPEUTICS FOR THE TREATMENT OF METABOLIC DISORDERS AND A PROCESS FOR THE PREPARATION” 926/DEL/2011 20‐07‐2018 "IMPROVED PROCESS FOR THE PREPARATION OF IMATINIB AND ITS 299009 MESYLATE SALT" 8341/CHENP/2010 20‐07‐2018 MONOCLONAL ANTIBODIES HAVING HOMOSUBTYPE CROSS‐ 299017 NEUTRALIZATION PROPERTIES AGAINST INFLUENZA A VIRUSES SUBTYPE H1 8821/DELNP/2010 20‐07‐2018 “EXTRACT OF COPTIDIS RHIZOMA AND USE THEREOF IN TREATING 299057 RESPIRATORY DISEASE” 10866/CHENP/2012 20‐07‐2018 A PROCESS FOR ETRA VIRINE INTERMEDIATE AND POLYMORPHS OF 299062 ETRAVIRINE 2096/DELNP/2014 23‐07‐2018 SELF ASSEMBLED NANO STRUCTURE PARTICLE AND METHOD FOR 299068 PREPARING 1536/DEL/2008 23‐07‐2018 FORMULATIONS AND METHODS THEREOF FOR MAKING 299076 RADIOLABELED DRY POWDER INHALATION PREPARATION CONTAINING MICRONIZED SALBUTAMOL OR SALBUTAMOL SULPHATE 1411/MUMNP/2014 23‐07‐2018 IMPROVED INJECTIONS 299079 5514/DELNP/2005 23‐07‐2018 "STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS." 299085 1391/CHENP/2012 23‐07‐2018 PLASMODIUM FALCIPARUM HLA CLASS I RESTRICTED T‐CELL 299101 EPITOPES 2466/MUMNP/2010 24/07/2018 NALMEFENE PRODRUGS 299165 267/MUMNP/2011 24/07/2018 “Novel Pleuromutilin compounds” 299126 2012/MUM/2013 24‐07‐2018 "PALLADIUM CATALYZED SYNTHESIS OF BENZOFURANS AND 299110 COUMARINS USING PHENOL OR SUBSTITUTED PHENOLS" 1153/DEL/2009 24‐07‐2018 NOVEL TOPICAL MICROEMULSION FORMULATIONS FOR THE 299151 TREATMENT OF RHEUMETIC DISORDERS AND RELATED INFECTIONS" 1960/KOLNP/2010 24‐07‐2018 COMPOSITIONS AND METHODS OF ENHANCING IMMUNE 299158 RESPONSES TO EIMERIA 2359/MUM/2008 24‐07‐2018 A POLYMORPHIC FORM OF NICORANDIL AND PROCESS FOR THE 299167 PREPARATION THEREOF 1391/DEL/2013 25‐07‐2018 NEW PROCESS FOR THE PREPARATION OF AN ANTICONVULSANT 299217 AGENT PREGABALIN 9012/DELNP/2012 25‐07‐2018 EMULSION COMPOSITION 299223 8361/DELNP/2010 26‐07‐2018 "METHODS AND COMPOSITIONS FOR MAKING ANTIBODIES AND 299247 ANTIBODY DERIVATIVES WITH REDUCED CORE FUCOSYLATION"

580/CHENP/2011 26‐07‐2018 MICRONEEDLE DEVICE AND METHOD FOR ENHANCING THE 299249 EFFICACY OF JAPANESE ENCEPHALITIS VIRUS ANTIGEN WITH THE MICRONEEDLE DEVICE 1618/CHENP/2010 26‐07‐2018 DENTAL CEMENT SYSTEM 299251

Page 52 of 85 323/MUMNP/2010 26‐07‐2018 “ALKYLSULFONYL‐SUBSTITUTED THIAZOLIDE COMPOUNDS” 299275 219/MUMNP/2013 26‐07‐2018 ORAL CARE COMPOSITIONS 299277 6297/CHENP/2013 26‐07‐2018 COMPOUNDS AND METHODS FOR KINASE MODULATION AND 299291 INDICATIONS THEREFOR 1611/MUMNP/2012 26‐07‐2018 "OIL‐IN‐WATER TYPE EMULSION SUNSCREEN COSMETIC 299301 COMPOSITION" 2480/CHENP/2010 27/07/2018 HIGH CONCENTRATION CHITOSAN‐NUCLEIC ACID POLYPLEX 299354 COMPOSITIONS 2876/DELNP/2014 27/07/2018 COSMETIC CLEANSING COMPOSITION 299345 1905/CHENP/2009 27‐07‐2018 FULLY HUMAN HIGH YIELD PRODUCTION SYSTEM FOR IMPROVED 299326 ANTIBODIES AND PROTEINS 692/DELNP/2009 27‐07‐2018 "TAMPER RESISTANT ORAL PHARMACEUTICAL DOSAGE FORMS 299334 COMPRISING AN OPIOID ANALGESIS" 166/MUMNP/2013 27‐07‐2018 SUBSTITUTED PYRIDINE COMPOUND 299335 9828/DELNP/2013 27‐07‐2018 LOW WATER METAL ION DENTIFRICE 299339 1510/DELNP/2013 27‐07‐2018 METHOD FOR PREPARING MICROSPHERES AND MICROSPHERES 299351 PRODUCED THEREBY 5733/CHENP/2013 30/07/2018 OPTICALLY ACTIVE DIAZABICYCLOOCTANE DERIVATIVE AND 299416 METHOD FOR MANUFACTURING SAME 6346/CHENP/2011 30‐07‐2018 AMPHOLYTIC TER‐POLYMERS FOR USE IN PERSONAL CARE 299398 COMPOSITIONS 1682/MUMNP/2012 30‐07‐2018 DEGRADABLE REMOVABLE IMPLANT FOR THE SUSTAINED RELEASE 299418 OF AN ACTIVE COMPOUND 1029/MUM/2009 30‐07‐2018 A MEDICINAL ANTIBACTERIAL AND STEROIDS CREAM 299419 INCORPORATING A BIO POLYMERAND A PROCESS TO MAKE IT 861/DEL/2009 30‐07‐2018 PROCESS FOR PRODUCING GALANTAMINE AND SALTS THEREOF 299431 453/KOL/2012 30‐07‐2018 "A DEVICE FOR TREATMENT OF GLAUCOMA". 299450 2351/KOLNP/2009 30‐07‐2018 HUMAN ANTIBODIES THAT BIND CD22 AND USES THEREOF 299460 10237/CHENP/2012 30‐07‐2018 NITROGEN‐CONTAINING HETEROCYCLIC COMPOUND HAVING 299461 INHIBITORY EFFECT ON PRODUCTION OF KYNURENINE 257/MUM/2011 31/07/2018 A COMPOUND FOR THE TREATMENT OF LIPODYSTROPHY 299505 99/CHENP/2011 31‐07‐2018 SULFUR‐CONTAINING HETEROCYCLIC DERIVATIVE HAVING BETA 299474 SECRETASE INHIBITORY ACTIVITY 1140/DELNP/2008 31‐07‐2018 ANTI‐ALPHA V BETA 6 ANTIBODIES AND USES THEREOF 299479 80/CHENP/2013 31‐07‐2018 TETRAHYDROCARBOLINE DERIVATIVE 299491 1438/MUM/2012 31‐07‐2018 HIGH DOSE, LOW VOLUME INJECTABLE PREPARATION OF 299503 DICLOFENAC 1512/KOLNP/2013 31‐07‐2018 IMIDAZOLE DERIVATIVES AS PDE10A ENZYME INHIBITORS 299518 781/KOLNP/2010 31‐07‐2018 PROTEIN‐POLYMER CONJUGATES 299529 5968/CHENP/2012 31‐07‐2018 BUFALIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS 299539 THEREOF 6426/DELNP/2012 31‐07‐2018 ANTICOAGULANT ANTIDOTES 299553 1074/KOLNP/2013 31‐07‐2018 PHARMACEUTICAL TOPICAL COMPOSITION OF MUPIROCIN 299558 1025/DEL/2010 31‐07‐2018 “FRACTIONATION OF ADHATODA VASICA LEAVES” 299559 1813/KOLNP/2010 31‐07‐2018 CANCER VACCINE COMPOSITION 299564 989/CHENP/2011 31‐07‐2018 NANOCRYSTAL NANO‐EMULSION 299583 2375/MUM/2009 01‐08‐2018 "PHARMACEUTICAL COMPOSITIONS" 291470 1759/CHENP/2011 01‐08‐2018 "A SUBSTITUTED PYRROLINDINE‐2‐CARBOXAMIDE COMPOUND OF 299612 THE FORMULA I” 2799/CHENP/2010 01‐08‐2018 Multi‐layer co‐extrusion film generating and releasing Sulfur dioxide 299614

7996/DELNP/2014 01‐08‐2018 PYRAZOLE COMPOUNDS AS SGLT1 INHIBITORS 299618 3555/DELNP/2013 01‐08‐2018 A dual phase mouth wash 299619 3333/DEL/2015 02‐08‐2018 AN INTEGRATED PACKING, RECONSTITUTION AND DELIVERY DEVICE 299645 FOR ORAL VACCINES AND DRUGS CONTAINING MULTIPLE COMPONENTS 1645/KOLNP/2013 03‐08‐2018 PYRAZOLE COMPOUNDS 299680

Page 53 of 85 1449/DEL/2008 03‐08‐2018 "A METHOD OF PREPARATION OF A PHARMACEUTICAL 299697 COMPOSITION OF VACCINE AGAINST RABIES, WHICH COMPRISES OF DNA VACCINE BASED ON GLYCOPROTEIN GENE OF RABIES VIRUS CONJUGATED TO LAMP‐1SIGNAL SEQUENCE AT THE C‐TERMINUS AND AN ADJUVANT " 2256/MUMNP/2012 05‐08‐2018 PERSONAL WASH CLEANSER WITH MILD SURFACTANT SYSTEMS 296615 COMPRISING DEFINED ALKANOYL COMPOUNDS AND DEFINED FATTY ACYL ISETHIONATE SURFACTANT PRODUCT AND OPTIONAL SKIN OR HAIR BENEFIT AGENT 4529/DELNP/2010 06‐08‐2018 "NOVEL VACCINES AGAINST MULTIPLE SUBTYPES OF DENGUE 297542 VIRUS" 670/MUMNP/2013 06‐08‐2018 COMPOUNDS FOR INHIBITING CHK1 299723 2808/CHE/2010 06‐08‐2018 FUSED TRICYCLIC COMPOUNDS AS ADENOSINE RECEPTOR 299726 ANTAGONIST 1783/DELNP/2003 06‐08‐2018 "A pharmaceutical composition of polymethoxyflavone compound " 299738

993/CHE/2005 07‐08‐2018 "A PROCESS FOR THE PREPARATION OF ALMOTRIPTAN" 299757 246/KOL/2008 07‐08‐2018 A NOVEL PROCESS FOR THE PREPARATION OF ZOPICLONE 299774 44/MUMNP/2011 07‐08‐2018 “TRIAZOLE DERIVATIVE OR SALT THEREOF” 299780 782/DELNP/2009 07‐08‐2018 "A solid pharmaceutical comprising human growth hormone (hGH) 299781 and N‐(5‐chlorosalicyloyl)‐8‐aminocaprylic acid (5‐CNAC)"

6730/CHENP/2009 08‐08‐2018 "PHARMACEUTICAL COMPOSITION COMPRISING PHENYLALANINE 299803 AMMONIA‐LYASE VARIANT" 6065/DELNP/2013 08‐08‐2018 COMMERCIAL SCALE PROCESS FOR PRODUCTION OF PRRSV 299810 147/KOLNP/2011 09‐08‐2018 AN APPARATUS FOR TREATING CHRONIC WOUNDS WITH AN 299831 EXTRACELLULAR POLYMERIC SUBSTANCE SOLVATING SYSTEM 2339/CHE/2013 10‐08‐2018 AN IMPROVED PROCESS FOR PREPARATION OF DABIGATRAN 301964 ETEXILATE AND PHARMCEUTICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF 3290/KOLNP/2011 10‐08‐2018 PYRIDAZINONE DERIVATIVES 299859 3899/DELNP/2013 10‐08‐2018 METHOD FOR CHEMICALLY MODIFYING THE INTERNAL REGION OF 299864 A HAIR SHAFT 36/KOL/2013 10‐08‐2018 AN ANTI‐HAIR LOSS/HAIR GROWTH FORMULATION 299871 1350/MUM/2010 13‐08‐2018 An oral dosage for the treatment of viral diseases 299902 1082/MUMNP/2010 13‐08‐2018 TAPENTADOL COMPOSITIONS 299912 8140/DELNP/2010 13‐08‐2018 "PERFLUORCARBON NANOEMULSIONS WITH ENDOCYTOSIS 299928 ENHANCING SURFACE FOR GENE‐TRANSFER" 7209/DELNP/2012 14‐08‐2018 TOOTH WHITENING COMPOSITION 299977 10399/CHENP/2012 14‐08‐2018 A PROCESS OF CONVERSION OF ANY FORM OF IMATINIB MESYLATE 299984 TO IMATINIB MESYLATE FORM α 2488/DEL/2007 16/08/2018 "CONTROLLED PH‐DEPENDENT RELEASE PHARMACEUTICAL 299996 COMPOSITION FOR TREATING METALLIC POISONING" 2602/DEL/2008 16/08/2018 ISOXAZOLE/ISOXAZOLINE/COMBRETASTATIN LINKED 300026 DIHYDROQUINAZOLINONE HYBRIDS AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF 6630/DELNP/2008 16‐08‐2018 "A COMPOSITION FOR THE DYEING WITH LIGHTENING EFFECT OF 300001 KERATIN SUBSTANCES" 5446/DELNP/2010 17‐08‐2018 "ADHESIVE PATCH" 300033 5647/CHENP/2011 17‐08‐2018 NOVEL AMINOPYRAZINE DERIVATIVE AND 300040 COMPOSITIONSCOMPRISING AMINOPYRAZINE DERIVATIVE AS ACTIVEINGREDIENT 6564/DELNP/2008 17‐08‐2018 IMMUNOGENIC SUBSTANCES COMPRISING A POLYINOSINIC ACID‐ 300041 POLYCYTIDILIC ACID BASED ADJUVANT 685/KOLNP/2010 17‐08‐2018 METHOD FOR PREPARING A HYPERICUM EXTRACT IN NEEM OIL 300048 AND A SUBSTANCE SO OBTAINED 9828/DELNP/2012 17‐08‐2018 “NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ?2 ADRENERGIC 300052 AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES.”

Page 54 of 85 1733/DEL/2013 17‐08‐2018 CURCUMIN CONJUGATED GD NANOPARTICLES FOR IMAGING AND 300053 THERAPY. 524/KOL/2003 17‐08‐2018 STABILISATION OF PROTEIN IN AQUEOUS SUSPENSION 300055 1606/CHENP/2011 20‐08‐2018 "A CHIMERIC ANTIBODY CAPABLE OF BINDING VHZ" 300086 843/MUMNP/2014 20‐08‐2018 NEW COATED CONTROLLED RELEASE ACTIVE AGENT CARRIERS 300094 636/MUMNP/2012 20‐08‐2018 "WATER‐IN‐OIL‐TYPE SKIN CARE COMPOSITION" 300096 4525/DELNP/2008 21‐08‐2018 "NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE" 300117

8674/DELNP/2007 23‐08‐2018 "PTERIDINES USEFUL AS HCV INHIBITORS AND METHODS FOR THE 300181 PREPARATION THEREOF" 6850/DELNP/2011 23‐08‐2018 "LIPOSOME COMPOSITION" 300213 4892/CHENP/2014 24‐08‐2018 WHITENING COSMETIC 300257 10292/CHENP/2013 24‐08‐2018 METHOD FOR MANUFACTURING PYRAZOLE DERIVATIVE 300270 905/DELNP/2009 24‐08‐2018 "CASEIN COMPLEXES" 300280 2778/MUMNP/2012 27‐08‐2018 NON AQUEOUS ORAL CARE COMPOSITIONS 300285 9376/CHENP/2011 27‐08‐2018 PHARMACEUTICALLY ACCEPTABLE LIQUID COMPOSITIONS OF 300294 CARBIDOPA 2079/MUM/2007 27‐08‐2018 HERBAL COMPOSITION FOR REDUCING ADD/ADHD AND METHOD 300305 THEREOF 2582/DEL/2012 27‐08‐2018 "NOVEL ANTI‐PROLIFERATIVE COMPLEX AND A METHOD FOR 300324 PREPARATION THEREOF" 3029/CHENP/2014 28/08/2018 GRANULES COMPRISING AN ACTIVE SUBSTANCE 300380 990/CHE/2005 28‐08‐2018 A NOVEL PHARMACEUTICAL COMPOSITION 300350 9502/DELNP/2012 28‐08‐2018 “The Direct compression process 300378 4087/CHENP/2011 28‐08‐2018 ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2 300388 4754/CHENP/2013 28‐08‐2018 COMPOSITION OF MESALAMINE IN TREATING AND PREVENTING 300390 INFLAMMATION RELATED DISORDER 1427/KOLNP/2011 28‐08‐2018 COMBINATION GAS VACCINES AND THERAPEUTICS 300392 201741000424 28‐08‐2018 ORAL DISPERSIBLE FILM COMPOSITION 300396 1908/CHENP/2013 28‐08‐2018 PYRAZOLOQUINOLINE COMPOUND 300398 10925/CHENP/2012 28‐08‐2018 OPTICALLY ACTIVE DIBENZYLAMINE DERIVATIVE AND METHOD 300407 FOR PREPARING THEREOF 2622/MUMNP/2014 29‐08‐2018 NOVEL COMPOUND HAVING ABILITY TO INHIBIT 11?‐HSD1 ENZYME 300444 OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND METHOD FOR PRODUCING SAME 616/CHENP/2011 29‐08‐2018 “ANTI ‐ P2X7 PEPTIDES AND EPITOPES” 300457 709/KOLNP/2010 30/08/2018 PHARMACEUTICAL COMPOSITIONS FOR ADMINISTERING 300506 THERAPEUTIC CELLSTO THE ANIMAL CENTRAL NERVOUS SYSTEM 9922/CHENP/2012 30‐08‐2018 FLAVONOID DIMERS AND THEIR USE 300485 3736/DEL/2013 30‐08‐2018 ORAL CARE COMPOSITIONS WITH REDUCED SURFACE STAINING 300512 1034/KOLNP/2011 30‐08‐2018 RABIES VIRUS‐BASED RECOMBINANT IMMUNOCONTRACEPTIVE 300529 COMPOSITIONS AND METHODS OF USE 8121/DELNP/2010 30‐08‐2018 CYTOTOXIC IMMUNOGLOBULIN 300536 3597/DELNP/2006 31‐08‐2018 "SURFACE PROTECTION OF EXPOSED BIOLOGICAL TISSUES" 300567 201727019575 31‐08‐2018 AN INJECTABLE PREPARATION OF DICLOFENAC SALTS WITH 300571 HYDROXYPROPYL‐BETA CYCLODEXTRIN AND POLYSORBATE 80 4060/KOLNP/2012 31‐08‐2018 COATING AGENT FOR PHARMACEUTICAL SOLID PREPARATION, 300625 PHARMACEUTICAL FILM FORMULATION, AND COATED PHARMACEUTICAL SOLID PREPARATION 1128/CHENP/2014 31‐08‐2018 AQUEOUS COMPOSITIONS COMPRISING ARBEKACIN 300629 924/DEL/2006 31‐08‐2018 NOVEL INTEGRIN BINDING RGD‐HIPOPEPTIDES WITH GENE 300638 TRANSFER ACTIVITIES 5631/DELNP/2009 01‐09‐2018 "OLIGOMER‐PROTEASE INHIBITOR CONJUGATES" 291566 2444/DEL/2008 03‐09‐2018 A HOMEOPATHIC PREPARATION FOR INCREASING IMMUNITY OF 294035 ANIMALS DURING PREGNANCY AND DURING POST PREGNANCY PERIOD 2646/MUMNP/2011 04‐09‐2018 "IMPROVED LIPID FORMULATION" 300692

Page 55 of 85 1305/MUM/2011 04‐09‐2018 HERBAL BISCUITS AND METHODS OF PREPARATION THEREOF. 300698 1213/MUMNP/2010 05‐09‐2018 A pharmaceutical composition 300732 4617/DELNP/2009 05‐09‐2018 "A GUANIDINE COMPOUND FOR IMAGING CARDIAC INNERVATION" 300756

1080/MUMNP/2013 05‐09‐2018 ORAL CARE COMPOSITIONS COMPRISING PEARLESCENT PIGMENTS 300764

109/MUMNP/2012 06‐09‐2018 ANTIVIRAL COMPOUNDS, AN AGGREGATE COMPRISING PLURALITY 300794 OF THE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME 3026/MUM/2013 06‐09‐2018 A WOUND DRESSING CAPABLE OF IN‐SITU NOX RELEASE AND A 300809 PROCESS FOR MANUFACTURING THE SAME 220/KOL/2012 07‐09‐2018 SKIN CARE COMPOSITION FOR ANTI‐AGING AND SKIN LIGHTENING 300830

3417/MUM/2010 07‐09‐2018 A PHARMACEUTICAL COMPOSITION OF NIOSOMAL GEL FOR THE 300843 TOPICAL DELIVERY OF LORNOXICAM 1577/MUMNP/2014 07‐09‐2018 CYCLOALKANE DERIVATIVE 300845 358/MUM/2009 10‐09‐2018 A PROCESS TO MANUFACTURE A NOVEL CREAM 300880 147/DEL/2009 10‐09‐2018 A PROCESS OF PREPARATION OF A TOPICAL DERMAL PATCH 300882 9322/DELNP/2012 10‐09‐2018 A Method For Manufacturing An Oral Prolonged Release 300888 Pharmaceutical Composition 4741/KOLNP/2010 11‐09‐2018 ANTI‐AGING OR ANTIOXIDANT COMPOSITION 300921 1262/KOLNP/2009 11‐09‐2018 "A COMPOSITION FOR IMPROVING IMMUNE FUNCTION" 300928 808/MUMNP/2014 12‐09‐2018 A PERSONAL CLEANING COMPOSITION 300954 2767/KOLNP/2011 12‐09‐2018 NOVEL AMINO C‐XYLOSIDE COMPOUNDS, AND COSMETIC USE 300959 1319/MUM/2011 12‐09‐2018 "AN AMORPHOUS ILOPERIDONE AND PROCESSES FOR PREPARING 300969 SAME" 413/MUMNP/2012 12‐09‐2018 Composition for decreasing pigmentation 300981 1312/DEL/2008 12‐09‐2018 "COMPOSITIONS COMPRISING EUPHORBIA PROSTRATA AND 300984 PROCESS OF PREPARATION THEREOF" 10157/DELNP/2008 13‐09‐2018 "A PROCESS FOR OBTAINING AN ISOLATED STABLE JUGLONE 300995 EXTRACT OF WALNUTS" 5391/DELNP/2006 13‐09‐2018 "A MONOCLONAL HUMANIZED ANTI‐CS1 Luc63 ANTIBODY OR AN 301005 ANTI‐CS1 Luc63 ANTIGEN BINDING FRAGMENT" 6565/DELNP/2015 14‐09‐2018 METHOD FOR PREPARING HAIR CARE COMPOSITIONS COMPRISING 301025 A STEP OF CONTROLLING TEMPERATURE TO ADD ANTIDANDRUFF AGENTS 4185/KOLNP/2008 14‐09‐2018 METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP‐2 301040 DEPENDENT COMPLEMENT ACTIVATION 2073/DEL/2004 14‐09‐2018 "BIOACTIVE WATER FRACTION FROM GOMPHOSTEMA NIVEUM" 301042

107/MUMNP/2013 14‐09‐2018 FOAM ENHANCEMENT OF FATTY ACYL GLYCINATE SURFACTANTS 301058 23/MUM/2013 14‐09‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF 301060 BESIFLOXACIN" 3148/DELNP/2011 17/09/2018 "FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING 301111 MOLECULES" 4763/CHENP/2011 17/09/2018 COMPOSITIONS FOR DRUG ADMINISTRATION 301093 913/CHENP/2012 17‐09‐2018 A PHARMACEUTICAL COMPOSITION FOR AN IONTOPHORESIS 301083 840/MUMNP/2011 17‐09‐2018 A COMPOSITION FOR BUCCAL ABSORPTION OF NICOTINE FOR THE 301086 PURPOSE OF SMOKING CESSATION 1738/DELNP/2008 19‐09‐2018 "NOVEL 1 ARYL‐3‐AZABICYCLO[3.1.0]HEXANES:PREPARATION AND 301169 USE TO TREAT NEUROPSYCHIATRIC DISORDERS" 2816/DELNP/2009 19‐09‐2018 "NOVEL ALBUMIN‐FREE FACTOR VIII FORMULATIONS" 301183 3482/DEL/2005 19‐09‐2018 MOUTH DISSOLVING PHARMACEUTICAL COMPOSITION AND 301189 PROCESS FOR PREPARING THE SAME 5747/DELNP/2006 19‐09‐2018 "NUCLEOSIDE DERIVATIVES OF FORMULA I & II AND COMPOSITION 301190 THEREOF" 3369/MUM/2011 19‐09‐2018 "A MEDICINAL FORMULATION FOR USE IN PROTECTION FROM 301192 GAMMA IRRADIATION"

Page 56 of 85 1524/MUM/2011 19‐09‐2018 AN IMPROVED PROCESS FOR PREPARING LOSARTAN POTASSIUM 301193

1945/CHENP/2009 19‐09‐2018 KINASE INHIBITORS USEFUL FOR THE TREATMENT OF 301194 MYLEOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES 3797/CHE/2012 20‐09‐2018 "DENDRIMERS, CONJUGATES AND METHODS THEREOF" 301223 1453/MUM/2008 21‐09‐2018 PHARMACEUTICAL COMPOSITION OF INSULIN ANALOGS 301247 635/MUM/2008 21‐09‐2018 ANTIMICROBIALLY ACTIVE BIARYL OXAZOLIDINONE COMPOUNDS 301248

3942/MUM/2014 24‐09‐2018 PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN 301257 5375/CHENP/2011 24‐09‐2018 OLIGOMER PHENOTHIAZINE CONJUGATES 301274 1196/DELNP/2010 24‐09‐2018 "LENTIVIRAL GENE TRANSFER VECTORS AND THEIR MEDICINAL 301284 APPLICATIONS" 9053/DELNP/2014 25‐09‐2018 METHOD FOR PRODUCING SEPIAPTERIN AND 301318 TETRAHYDROLACTOYLPTERIN 10332/DELNP/2013 25‐09‐2018 ORAL CARE COMPOSITIONS 301323 1018/CHE/2013 25‐09‐2018 AN IMPROVED PROCESS FOR THE SYNTHESIS OF MELPHALAN AND 301329 THE HYDROCHLORIDE SALT 2774/MUM/2010 25‐09‐2018 PROCALCITONIN FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS 301334 AND GUIDANCE OF ANTIBIOTIC TREATMENT IN PATIENTS WITH ACUTE STROKE OR TRANSIENT ISCHEMIC ATTACK

7265/DELNP/2012 25‐09‐2018 “PDE10 INHIBITOR COMPOUNDS” 301341 816/CHENP/2013 25‐09‐2018 COSMETIC PREPARATIONS 301344 9403/DELNP/2013 25‐09‐2018 NOVEL AMINO PYRROLINE DERIVATIVES AND USE THEREOF IN THE 301358 PREVENTION AND/OR TREATMENT OF METABOLIC SYNDROME

9831/CHENP/2012 25‐09‐2018 TOPICAL PHARMACEUTICAL COMPOSITIONS 301360 290/DELNP/2012 25‐09‐2018 "IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS 301361 ANTIGENS" 3421/MUM/2010 25‐09‐2018 A PROCESS OF PREPARATION OF EZETIMIBE NANOSUSPENSION 301372 4342/CHENP/2013 26/09/2018 "8‐[5‐(1‐hydroxy‐1‐methylethyl)pyridin‐3‐yl]‐l‐[(2S)‐2‐ 301425 methoxypropyl]‐3‐methyl‐1,3‐dihydro‐2H‐imidazo[4,5‐c]quinolin‐2‐ one or a pharmaceutically acceptable salt thereof”

1861/MUMNP/2013 26‐09‐2018 NOVEL PHENYLPYRIDINE DERIVATIVE AND DRUG CONTAINING 301396 SAME 4043/DEL/2012 26‐09‐2018 FIBER WADDING FOR FILLING BONE DEFECTS 301410 201641011015 26‐09‐2018 APREMILAST PHARMACEUTICAL COMPOSITIONS 301416 9296/CHENP/2011 26‐09‐2018 “DOSAGE FORM” 301419 568/KOLNP/2011 26‐09‐2018 IMIDAZOLIDINE DERIVATIVES AS INHIBITORS OF GLUTAMINYL 301430 CYCLASE 1399/CHE/2011 26‐09‐2018 AN IMPROVED PROCESS FOR THE PREPARATION OF 301470 CURCUMINOIDS 2541/MUMNP/2012 26‐09‐2018 “NOVEL CONJUGATES OF CC‐1065 ANALOGS AND BIFUNCTIONAL 301476 LINKERS” 1695/KOLNP/2013 26‐09‐2018 TOPICAL COMPOSITIONS FOR PRESERVING OR RESTORING THE 301478 INTEGRITY OF MUCOSAE 1483/KOLNP/2009 27‐09‐2018 LIVE BACTERIAL VACCINES FOR VIRAL INFECTION PROPHYLAXIS OR 301571 TREATMENT 7116/DELNP/2011 27‐09‐2018 "THERAPEUTIC USES OF MASTIC GUM FRACTIONS" 301575 2814/CHENP/2011 28/09/2018 “A PHARMACEUTICAL COMPOSITION USING GONADOTROPIN ‐ 301683 RELEASING HORMONE (GNRH) COMBINED VARIANTS AS IMMUNOGEN” 4908/CHENP/2010 28/09/2018 ANTIBODIES DIRECTED TO ANGIOPOIETIN‐1 AND ANGIOPOIETIN‐2 301634 AND USE THEREOF 641/MUM/2012 28‐09‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF 301613 DIHYDROPYRIMIDIN‐2‐ONES"

Page 57 of 85 3528/DELNP/2013 28‐09‐2018 COSMETIC COMPOSITION HAIR COSMETIC AND HAIR TREATMENT 301672 COSMETIC 1697/MUM/2014 28‐09‐2018 "LOW VISCOUS, SULFATE‐FREE COLD‐DISPERSIBLE PEARLESCENT 301693 CONCENTRATE" 3154/CHENP/2013 29‐09‐2018 POLYMERIZABLE DENTAL MATERIAL COMPRISING REACTIVE PASTE 301700 FORMERS HARDENED DENTAL MATERIAL AND USE THEREOF

424/DELNP/2013 01‐10‐2018 FORMULATIONS OF 14 ‐ EPI ‐ANALOGUES OF VITAMIN D 291572 2664/MUMNP/2012 01‐10‐2018 “PURINONE DERIVATIVE” 301734 929/KOLNP/2013 03‐10‐2018 COMPOSITION FOR ACTIVE PRINCIPLES DELIVERY BY IMPLANT 301814 DEVICES 4528/CHENP/2011 04‐10‐2018 AVIAN INFLUENZA VACINE 295639 9901/CHENP/2012 04‐10‐2018 NOVEL AMIDE DERIVATIVE AND USE THEREOF AS MEDICINE 301821 2818/CHENP/2012 04‐10‐2018 OLIGOMER‐CALCIMIMETIC CONJUGATES AND RELATED 301830 COMPOUNDS 7255/CHENP/2015 04‐10‐2018 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DIABETES 301837 AND PRE‐DIABETES 1192/MUMNP/2013 04‐10‐2018 NOVEL PURINYLPYRIDINYLAMINO‐2,4‐DIFLUOROPHENYL 301856 SULFONAMIDE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION WITH INHIBITORY ACTIVITY AGAINST RAF KINASE, CONTAINING SAME AS ACTIVE INGREDIENT

2879/MUMNP/2012 04‐10‐2018 HAIR CARE COMPOSITION 301864 3619/KOLNP/2012 04‐10‐2018 FORMULATION COMPRISING NICOTINE AND A CATION EXCHANGE 301869 RESIN 201721031262 05‐10‐2018 SCAFFOLD GRAFT AND METHOD OF MANUFACTURING THEREOF 301880

1372/MUMNP/2009 05‐10‐2018 5,6‐SUBSTITUTED PYRIMIDINES 301894 5541/DELNP/2011 05‐10‐2018 "BETA‐AMINO ESTER COMPOUNDS AND USES THEREOF" 301904 285/KOLNP/2013 05‐10‐2018 DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE 301910 INHIBITOR 7467/CHENP/2009 05‐10‐2018 PRESERVATIVE FREE COMPOSITION COMPRISING 4‐ 301919 HYDROXYBENZALDEHYDE AND ANISIC ACID 1593/KOL/2007 05‐10‐2018 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF 301923 PREGABALIN 3313/CHENP/2013 07‐10‐2018 3‐SUBSTITUTED‐6‐(PYRIDINYLMETHOXY)‐PYRROLOPYRIDINE 298700 COMPOUNDS 4150/KOLNP/2009 08‐10‐2018 “GLP‐1 Fc FUSION PROTEIN FORMULATION” 301942 6974/CHENP/2013 08‐10‐2018 FORMULATION COMPRISING PHENYLAMINOPYRIMIDINE 301950 DERIVATIVE AS ACTIVE AGENT 538/CHENP/2013 08‐10‐2018 A METHOD OF CONTROLLING THE RELEASE OF AN ACTIVE 301953 INGREDIENT FROM A DOSAGE FORM 1694/CHENP/2013 08‐10‐2018 P2X4 RECEPTOR ANTAGONIST 301958 5745/CHENP/2014 08‐10‐2018 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF 301965 7801/CHENP/2010 08‐10‐2018 ANTI‐INFLAMMATORY AGENTS 301968 30/MUM/2013 09‐10‐2018 A topical formulation in the form of cream for use in burn wound 301987

338/MUMNP/2012 09‐10‐2018 A PEPTIDE FOR TREATING AND PREVENTING DEGENERATIVE DISC 302003 AND AFFECTING INHIBITION OF TGF‐B1 988/KOL/2013 09‐10‐2018 TRANSPARENT PERSONAL CARE AND COSMETIC PRODUCTS WITH 302035 INORGANIC ACTIVE INGREDIENTS IN MICRONIZED/COLLOIDAL FORM 6338/DELNP/2013 09‐10‐2018 FILMCOATED SOLID DOSAGE FORMS COMPRISING HONEY IN THE 302036 COATING 1396/KOLNP/2013 10‐10‐2018 FELBINAC‐CONTAINING EXTERNAL PATCH 302061 899/CHE/2011 10‐10‐2018 PROCESS FOR PREPARATION OF LENALIDOMIDE POLYMORPH 302068 2642/CHE/2013 10‐10‐2018 SUBSTITUTED 4‐HYDRAZINOTHIAZOLES AND PROCESSES FOR THEIR 302079 PREPARATION

Page 58 of 85 5261/DELNP/2012 10‐10‐2018 "ORAL CARE COMPOSITIONS" 302100 1937/DEL/2006 10‐10‐2018 A PROCESS FOR PREPARATION OF ANTIDIARRHOEAL FRACTION 302104 FROM XYLOCARPUS AND A PHARMACEUTICAL COMPOSITION THEREFROM 2648/DEL/2006 10‐10‐2018 "HERBAL FORMULATION FOR WOUND HEALING" 302105 816/KOL/2011 11‐10‐2018 a,a‐DIALKYL‐BENZYL ALCOHOL AND RELATED DERIVATIVES FOR 302120 SKIN‐LIGHTENING, ANTI‐AGEING AND ANTI‐BACTERIAL COMPOSITIONS 2408/MUM/2008 11‐10‐2018 SOFT GELATIN PASTILLES 302122 694/DELNP/2013 11‐10‐2018 4‐ALKYLRESORCINOL DERIVATIVE AND EXTERNAL PREPARATION 302136 FOR SKIN CONTAINING SAME 2884/CHENP/2011 12‐10‐2018 HIGH AFFINITY HUMAN ANTIBODIES TO HUMAN IL‐4 RECEPTOR 302148 779/KOLNP/2012 12‐10‐2018 PRESSURIZED METERED DOSE INHALER COMPRISING FORMOTEROL 302151 AND BECLOMETASONE DIPROPIONATE 5013/CHENP/2011 12‐10‐2018 NOVEL EICOSANOID DERIVATIVES 302152 10411/CHENP/2012 12‐10‐2018 NOVEL PHARMACEUTICAL COMPOUNDS 302155 2352/CHENP/2014 12‐10‐2018 NOVEL COMPOUNDS AS HIF‐ 1a INHIBITORS AND 302181 MANUFACTURING PROCESS THEREOF 5040/CHENP/2012 15‐10‐2018 ANTIBODY BINDING TO HUMAN CSF‐IR 302196 2266/MUM/2010 15‐10‐2018 A NOVEL PROCESS FOR PREPARATION OF BOSENTAN 302213 3708/DELNP/2006 15‐10‐2018 "A FORMULATION COMPRISING A CORTICOSTEROID, A SULFOALKYL 302216 ETHER‐BETA‐CYCLODEXTRIN (SAE‐B‐CD), AND AN AQUEOUS LIQUID" 537/DEL/2008 15‐10‐2018 CHALCONE LINKED PYRROLO [2,1‐C][1,4] BENZODIAZEPINE HYBRIDS 302219 AS POTENTIAL ANTICANCER AGENTS AND PROCESS FOR THE PREPARATION THEREOF 181/CHENP/2011 16‐10‐2018 PATCHES AND METHODS FOR THE TRANSDERMAL DELIVERY OF A 302235 THERAPEUTICALLY EFFECTIVE AMOUNT OF IRON 3817/DELNP/2013 16‐10‐2018 DENTIFRICE COMPOSITIONS CONTAINING CALCIUM SILICATE AND A 302241 BASIC AMINO ACID 1554/DELNP/2009 16‐10‐2018 “PROTEIN MATRIX VACCINES AND METHODS OF MAKING THEM” 302247

3759/DEL/2012 22/10/2018 ORAL GEL FOR SENSITIVITY AND TOOTH PAIN 302297 2867/DEL/2011 22‐10‐2018 "AN IMPROVED PROCESS OF CONVERSION OF LANTADENE A AND B 302295 TO REDUCED LANTADENE A AND B" 2483/MUMNP/2011 22‐10‐2018 "PRODUCTION OF ENCAPSULATED NANOPARTICLES AT HIGH 302300 VOLUME FRACTIONS" 6152/CHENP/2014 22‐10‐2018 Gambogenic acid derivative and method of preparing the same 302327

2994/MUM/2010 23‐10‐2018 USE OF MUCILAGE ISOLATED FROM SEEDS OF OCIMUM BASILICUM 302343 AS PHARMACEUTICAL EXCIPIENT 734/KOL/2011 23‐10‐2018 METHODS OF PREPARING NON‐ALCOHOL BIOACTIVE ESSENTIAL OIL 302345 MOUTH RINSE 7797/DELNP/2014 24‐10‐2018 METHOD FOR PRODUCING DISINTEGRATING PARTICULATE 302372 COMPOSITION COMPRISING ACID TYPE CARBOXYMETHYLCELLULOSE DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID TYPE CARBOXYMETHYLCELLULOSE AND ORALLY DISINTEGRATING TABLET INCLUDING DISINTEGRATING PARTICULATE COMPOSITION COMPRISING ACID TYPE CARBOXYMETHYLCELLULOSE 960/MUM/2009 24‐10‐2018 A NOVEL CREAM AND A PROCESS TO MANUFACTURE THE SAME 302376 7/MUMNP/2015 24‐10‐2018 TOOTH WHITENING ORAL CARE COMPOSITION 302377 1044/DELNP/2011 24‐10‐2018 ALPHA‐GALACTOSYL CERAMIDE ANALOGS AND THEIR USE AS 302381 IMMUNOTHERAPIES, ADJUVANTS, AND INTIVIRAL, ANTIBACTERIAL, AND ANTICANCER AGENTS 1539/CHENP/2013 25‐10‐2018 P2X4 RECEPTOR ANTAGONIST 302407 4040/CHENP/2012 25‐10‐2018 “COPPER SALTS OF ION EXCHANGE MATERIALS FOR USE IN THE 302410 TREATMENT AND PREVENTION OF INFECTIONS”

Page 59 of 85 5127/CHE/2012 26/10/2018 AMINO ACID COMPOSITIONS FOR THE TREATMENT OF DIABETIC 302481 RETINOPATHY 4691/CHENP/2011 26/10/2018 IN VITRO METHOD FOR INDUCING AN ANTIGENPRESENTINGCELL 302477 (APC) WITH CTL INDUCIBILIT 4793/CHENP/2012 26‐10‐2018 “METHOD FOR REMOVING CYTOKINES FROM BLOOD WITH 302453 SURFACE IMMOBILIZED POLYSACCHARIDES” 2551/DELNP/2012 26‐10‐2018 NOVEL PHENOL DERIVATIVE 302459 8116/CHENP/2012 26‐10‐2018 PHARMACEUTICAL OR NEUTRACEUTICAL FORMULATION 302483 3636/CHENP/2013 26‐10‐2018 "POLYPEPTIDES DERIVED FROMIL‐2 HAVING AGONIST ACTIVITY,FOR 302486 THE THERAPY OF CANCER AND CHRONIC INFECTIONS"

4160/DELNP/2009 26‐10‐2018 "P38 INHIBITORS AND METHODS OF USE THEREOF" 302490 1969/DEL/2009 29‐10‐2018 "COSMETIC COMPOSITION CONTAINING A DIBENZOYLMETHANE 302530 DERIVATIVE AND A DITHIOLANE COMPOUND; PROCESS FOR PHOTOSTABILIZING THE DIBENZOYLMETHANE DERIVATIVE"

2017/KOLNP/2011 29‐10‐2018 ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES 302541 RECOGNIZING SPECIFICALLY CD38 AND CYTARABINE 4145/CHENP/2012 30‐10‐2018 PHARMACEUTICAL COMPOSITION COMPRISING A GLP‐1 AGONIST 302570 AND METHIONINE 9618/DELNP/2012 30‐10‐2018 “INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC 302601 APPLICATIONS” 236/MUM/2010 30‐10‐2018 "AN IMPROVED PROCESS FOR THE PREPARATION OF REBOXETINE 302604 AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF"

10257/CHENP/2013 30‐10‐2018 PYRANO [3,2‐D] [1,3] THIAZOLE AS GLYCOSIDASE INHIBITORS 302619 2473/CHENP/2013 31/10/2018 PROCESS FOR PRODUCING DRUG BLOCK COPOLYMER COMPOSITE 302757 AND PHARMACEUTICAl PREPARATION CONTAINING SAME

1043/DELNP/2012 31‐10‐2018 ANTI‐RSV IMMUNOGENS AND METHODS OF IMMUNIZATION 302655 4962/CHE/2012 31‐10‐2018 A PROCESS FOR THE ISOLATION AND PURIFICATION OF LYCOPENE 302668 FROM RHODOSPIRILLUM SULFUREXIGENS JA143T AND RHODOSPIRILLUM ORYZAE JA318T AND UTILIZATION THEREOF

1035/MUMNP/2015 31‐10‐2018 HAIR CARE COMPOSITION 302685 8285/CHENP/2014 31‐10‐2018 NITROGEN‐CONTAINING HETEROCYCLIC COMPOUND OR 302696 SALTTHEREOF 348/CHENP/2011 31‐10‐2018 IMMUNOGENIC COMPOSITION FOR TREATING INFLUENZA 302699 1019/MUM/2009 31‐10‐2018 A Medicinal Antifungal And Steroid Cream incorporating a 302761 biopolymer And A Process To Make The Same 436/DELNP/2011 01‐11‐2018 "TRANSDERMAL PATCH CONTAINING FENTANYL OR SALT THEREOF" 291645

2723/MUM/2015 01‐11‐2018 PROCESS FOR PREPARATION OF CLEAR INJECTABLE SOLUTION OF 302794 MIDAZOLAM AND PENTAZOCINE AND INJECTABLE SOLUTION THEREOF 2065/CHE/2010 01‐11‐2018 A PROCESS TO CONCENTRATE ANTI‐INFLAMMATORY PRINCIPLES 302803 FROM GREEN MUSSEL PERNA VIRIDIS L. AND A PRODUCT INCORPORATING THESE INGREDIENTS 69/MUMNP/2014 01‐11‐2018 NON AQUEOUS ORAL CARE COMPOSITIONS 302814 3384/KOLNP/2011 01‐11‐2018 IMMUNOGENIC COMPOSITION 302822 1523/KOLNP/2013 01‐11‐2018 NOVEL ANTI‐CANCER AGENTS 302828 2079/CHE/2014 02‐11‐2018 NOVEL ANTI‐FUNGAL COMPOSITION 302838 4661/DELNP/2013 02‐11‐2018 NON AQUEOUS ORAL CARE COMPOSITION CONTAINING DENTAL 302839 OCCLUSION ACTIVES 1696/MUM/2011 02‐11‐2018 AN IMPROVED PROCESS FOR PREPARATION OF MORNIFLUMATE 302854

2158/KOLNP/2014 02‐11‐2018 NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE 302857 PREPARATION THEREOF AND THERAPEUTIC USES THEREOF 758/MUMNP/2013 02‐11‐2018 BIOERODIBLE SILICON BASED DEVICES FOR DELIVERY OF 302862 THERAPEUTIC AGENTS

Page 60 of 85 6565/DELNP/2010 02‐11‐2018 "NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF 302866 CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS" 3554/DELNP/2011 02‐11‐2018 A Polypeptide for the Suppression of Cancer 302870 13/DEL/2011 02‐11‐2018 "A PHARMACEUTICAL FORMULATION COMPRISING z‐ 302874 BUTYLIDENEPHTHALIDE" 2749/DEL/2013 02‐11‐2018 A NOVEL NANOCURCUMIN FORMULATION FOR AMELIORATING 302877 HYPOBARIC HYPOXIA INDUCED MALADIES. 5410/DELNP/2013 02‐11‐2018 A Formulation Comprising A Melt‐Processed Solid Dispersion 302878 Product’ 5283/DELNP/2012 05‐11‐2018 "METHODS OF REDUCING HAIR LOSS AND / OR FACILITATING HAIR 302908 GROWTH AND / OR REGROWTH" 1681/MUMNP/2010 05‐11‐2018 COMPOSITION OF SERINE PROTEASE INHIBITORS IN THE 302911 TREATMENT OF SKIN DISEASES 1831/CHE/2013 09‐11‐2018 NOVEL PROCESS FOR THE PREPARATION OF PURE AND 302980 CRYSTALLINE FORM OF REGADENOSON MONOHYDRATE 3119/CHE/2011 09‐11‐2018 PROCESSES FOR PREPARING EPTIFIBATIDE 302987 3906/KOLNP/2008 13/11/2018 AN ISOLATED NUCLEIC ACID MOLECULE 303055 2764/KOLNP/2010 14/11/2018 A VACCINE COMPRISING A RECOMBINANT STAPHYLOCOCCAL 303110 CLUMPING FACTOR A " 3712/DELNP/2009 14‐11‐2018 "VON WILLEBRAND FACTOR‐AND FACTOR VIII‐POLYMER 303118 CONJUGATES HAVING A RELEASABLE LINKAGE" 6772/CHENP/2014 15‐11‐2018 MIXED ESTERS AS VASELINE SUBSTITUTE 303141 2829/MUM/2015 16‐11‐2018 STABILIZED INJECTABLE EMULSION OF PROPOFOL AND KETAMINE 303184

3692/DELNP/2014 16‐11‐2018 METHOD FOR PRODUCING SUBSTITUTED 5‐FLUORO‐1H‐ 303187 PYRAZOLOPYRIDINES 4471/DELNP/2013 16‐11‐2018 A synergistic anticancer combination 303200 1394/DEL/2011 19‐11‐2018 "A NOVEL SUBMICRONIC TOPICAL FORMULATION FOR THE 303213 EFFECTIVE TREATMENT OF PSORIASIS" 8190/CHENP/2013 19‐11‐2018 PYRIMIDINE CYCLOHEXYL GLUCOCORTICOID RECEPTOR 303234 MODULATORS 4370/DELNP/2010 20/11/2018 TARGETING LIPIDS 303274 4871/DELNP/2015 20‐11‐2018 1 ‐[1‐ (BENZOYL)‐ PYRROLIDINE‐ 2‐ CARBONYL] ‐PYRROLIDINE ‐2 ‐ 303264 CARBONITRILE DERIVATIVES 8144/CHENP/2012 20‐11‐2018 FUNGAL NAIL TREATMENT COMPOSITION 303299 1974/CHE/2009 20‐11‐2018 "NOVEL SALTS OF ETHYL (3R,4S,5R)‐4,5‐IMINO‐3‐(1‐ 303314 ETHYLPROPOXY) ‐ 1‐ CYCLOHEXENE‐1‐ CARBOXYLATE" 3384/CHENP/2011 22‐11‐2018 COMPOUNDS 303329 637/KOLNP/2013 24‐11‐2018 PHARMACEUTICAL COMPOSITIONS 303371 5729/CHENP/2013 24‐11‐2018 NOVEL PREPARATION OF AN ENTERIC RELEASE SYSTEM 303373 263/KOLNP/2011 26/11/2018 PHARMACEUTICAL COMPOSITION FOR TREATMENT AND 303441 PREVENTION OF CANCER 10904/CHENP/2012 26‐11‐2018 FILLERS FOR DENTAL COMPOSITES 303397 3977/CHENP/2013 26‐11‐2018 COMPLEX FORMULATION COMPRISING LERCANIDIPINE 303402 HYDROCHLORIDE AND VALSARTAN AND METHOD FOR THE PREPARATION THEREOF 6329/DELNP/2009 26‐11‐2018 ORAL CEPHALOTAXINE DOSAGE FORMS 303405 4549/CHENP/2011 26‐11‐2018 PHARMACEUTICAL COMPOSITION COMPRISING EZETIMIBE AND 303424 SIMVASTATIN 2439/CHENP/2011 27/11/2018 CARBOHYDRATE BINDING MOLECULES 303517 8785/DELNP/2013 27‐11‐2018 COSMETIC COMPOSITION IN A CONTAINER 303458 378/DELNP/2011 27‐11‐2018 DELIVERY PARTICLE 303502 932/MUMNP/2013 27‐11‐2018 METHOD OF PREPARATION FOR STABLE MEDICINAL PREPARATION 303506 CONTAINING SELENIUM 8070/DELNP/2012 27‐11‐2018 KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH 303508 SAME 7697/DELNP/2013 27‐11‐2018 AMORPHOUS (5 FLUORO 2 METHYL 3 QUINOLIN 2 YLMETHYL 303532 INDOL 1 YL) ACETIC ACID

Page 61 of 85 376/KOL/2014 28/11/2018 IN‐SITU GENERATED MICRONIZED PARTICLES IN PERSONAL CARE 303579 RINSE‐OFF PRODUCTS FOR SUPERIOR SENSORIAL BENEFITS

4509/CHENP/2013 28‐11‐2018 AMINE‐CONTAINING TRANSFECTION REAGENTS AND METHODS 303558 FOR MAKING AND USING SAME 361/MUMNP/2014 28‐11‐2018 PHARMACEUTICAL COMPOSITION CONTAINING DIAMINE 303566 DERIVATIVE 2367/KOLNP/2010 28‐11‐2018 DRUG DELIVERY SYSTEM FOR ADMNIISTRATION OF A WATER 303598 SOLUBLE, CATIONIC AND AMPHIPHILIC PHARMACEUTICALLY ACTIVE SUBSTANCE 3095/MUM/2014 28‐11‐2018 AN ABUSE DETERRENT PHARMACEUTICAL COMPOSITION 303600 2855/CHENP/2011 28‐11‐2018 AN ANTISENSE OLIGONUCLEOTIDE FOR EFFICIENT SKIPPINGOF 303615 EXON 52 OF HUMAN DUCHENNE MUSCULAR DYSTROPHYGENE 5219/DELNP/2012 29/11/2018 “COMPOSITION FOR PREVENTING HAIR LOSS AND STIMULATING 303681 HAIR GROWTH” 1626/MUMNP/2011 29‐11‐2018 EDIBLE COMPOSITION FOR TREATING CUTANEOUS SIGNS OF 303730 AGEING 5676/DELNP/2009 29‐11‐2018 "COMPOSITIONS AND METHODS FOR DELIVERY OF ANTI‐CANCER 303734 AGENTS" 329/MUMNP/2013 29‐11‐2018 MICROPARTICLE FORMULATION FOR PULMONARY DRUG DELIVERY 303747 OF ANTI‐INFECTIVE MOLECULE FOR TREATMENT OF INFECTIOUS DISEASES 4536/DELNP/2014 30/11/2018 MULTIPHASE ORAL CARE COMPOSITIONS 303862 2349/MUMNP/2012 30‐11‐2018 ORAL CARE COMPOSITIONS COMPRISING CURCUMIN COMPOUNDS 303760 AND SOURCE OF ZINC IONS 2066/CHE/2010 30‐11‐2018 A PRODUCT CONTAINING ANTI‐INFLAMMATORY PRINCIPLES FROM 303813 GREEN MUSSEL PERNA VIRIDIS L. AND A PROCESS THEREOF

5018/CHENP/2012 30‐11‐2018 METHOD FOR PREVENTING THE CRYSTALLISATION OF 303838 PHARMACEUTICALS IN A POLYMER FILM 9323/DELNP/2012 30‐11‐2018 Method of manufacturing an oral prolonged release pharmaceutical 303849 composition 3545/KOLNP/2010 03‐12‐2018 “COMPOSITION, VACCINE AND IMMUNOTHERAPEUTIC USING IL‐ 294136 28” 2121/MUMNP/2011 03‐12‐2018 PETROLATUM BASED COMPOSITION COMPRISING GREATER THAN 294116 10% SILICONE FOR IMPROVED FEEL WHILE REMAINING STABLE

6464/DELNP/2014 03‐12‐2018 ADHESIVE PATCH WITH ANTIMICROBIAL COMPOSITION 303902 1184/KOLNP/2012 03‐12‐2018 A PHARMACEUTICAL COMPOSITION COMPRISING TRYPSINOGEN 303918 AND CHYMOTRYPSINOGEN 3064/MUM/2011 04‐12‐2018 "NANOSUSPENSION FOR OCULAR DRUG DELIVERY" 303931 749/MUM/2009 04‐12‐2018 AN IMPROVED METHOD FOR PREPARATION OF LAFUTIDINE 303932 INTERMEDIATE 2111/DELNP/2006 04‐12‐2018 ANTIBODY‐DRUG CONJUGATES AND INTERMEDIATES 303986 860/MUM/2011 04‐12‐2018 "CONTROLLED RELEASE GASTRORETENTIVE COMPOSITION" 303996 4471/KOLNP/2010 04‐12‐2018 LIPID COMPOSITION 303998 10203/CHENP/2012 05‐12‐2018 COATED PARTICLE AND METHOD FOR PRODUCING COATED 304024 PARTICLE 1814/KOLNP/2013 05‐12‐2018 USE OF TEA POLYPHENOLS AND/OR TEA PIGMENTS AS DYES AND 304041 PRODUCTS THEREOF 1055/MUMNP/2013 05‐12‐2018 NOVEL ANTIFUNGAL 5 6‐DIHYDRO‐4H‐PYRROLO[1 2 ‐A][1 4]‐ 304064 BENZODIAZEPINES AND 6H‐PYRROLO[1 2‐A][1 4]BENZODIAZEPINES SUBSTITUTED WITH BICYCLIC BENZENE DERIVATIVES

7685/DELNP/2013 06‐12‐2018 COMPOSTIONS AND METHODS FOR TREATING CHRONIC 304085 INFLAMMATION AND INFLAMMATORY DISEASES 8502/DELNP/2012 06‐12‐2018 VIRAL INHIBITOR COMPOSITIONS FOR IN VIVO THERAPEUTIC USE 304100 COMPRISING A COMBINATION OF ( ) CARVONE GERANIOL AND A FURTHER ESSENTIAL OIL COMPONENT

Page 62 of 85 269/MUMNP/2014 06‐12‐2018 BENEFIT AGENT DELIVERY PARTICLES COMPRISING NON IONIC 304101 POLYSACCHARIDES 7243/CHENP/2013 06‐12‐2018 BIS(FLUOROALKYL)‐1,4‐BENZODIAZEPINONE COMPOUNDS 304107 434/KOL/2012 06‐12‐2018 SKIN CARE COMPOSITION COMPRISING EXTRACTS OF 304117 ACHYRANTHES ASPERA 245/MUMNP/2014 06‐12‐2018 BENEFIT AGENT DELIVERY PARTICLES COMPRISING DEXTRAN 304118 1990/KOLNP/2011 06‐12‐2018 ANTITUMOR COMBINATIONS CONTAINING ANTIBODIES 304120 RECOGNIZING SPECIFICALLY CD38 AND VINCRISTINE 8089/CHENP/2013 07‐12‐2018 PROCESS FOR THE PREPARATION OF A SULFATED DERIVATIVE OF 3 304156 5 DIIODO O [3 IODOPHENYL] L TYROSINE 3349/DELNP/2011 07‐12‐2018 "POLYPEPTIDE FOR TREATING OR PREVENTING ADHESIONS" 304174 217/MUM/2011 07‐12‐2018 NOVEL COMBINATION FOR USE IN TREATING HAIR LOSS 304181 3851/DELNP/2011 07‐12‐2018 VACCINE AGAINST AFRICAN HORSE SICKNESS VIRUS 304188 49/KOL/2013 07‐12‐2018 ISOLATION OF PHYTOCONSTITUENT FROM BOMBAX CEIBA 304196 3599/DELNP/2009 07‐12‐2018 "FACTOR IX MOIETY‐POLYMER CONJUGATES HAVING A RELEASABLE 304197 LINKAGE" 3448/KOLNP/2012 07‐12‐2018 SHIP INHIBITORS AND USES THEREOF 304203 2687/CHENP/2013 07‐12‐2018 HETERO RING FUSED IMIDAZOLE DERIVATIVE HAVING AMPK 304220 ACTIVATING EFFECT 436/KOL/2012 07‐12‐2018 SKIN CARE COMPOSITION COMPRISING EXTRACTS OF FUMARIA 304222 OFFICINALIS 9455/DELNP/2014 10‐12‐2018 RADIANCE COMPOSITIONS AND METHODS OF USE 304247 3594/CHE/2012 10‐12‐2018 7‐BENZYL‐4‐HYDRAZINYL‐5,6‐DIMETHYL‐2‐PROPYL‐7H‐ PYRROLO 304256 [2,3‐D] PYRIMIDINE AS POTENT ANTIMYCOBACTERIALAGENT

2639/MUM/2015 11‐12‐2018 HYPERBARIC INJECTION SOLUTION OF ROPIVACAINE 304288 HYDROCHLORIDE AND PROCESS FOR PREPARATION THEREOF 201821010337 11‐12‐2018 DRUG COATED BALLOON 304293 9166/CHENP/2013 11‐12‐2018 SHARK LIKE CHONDROITIN SULPHATE AND PROCESS FOR THE 304313 PREPARATION THEREOF 2453/MUMNP/2015 11‐12‐2018 "NOVEL PYRIMIDINE AND PYRIDINE COMPOUNDS AND THEIR 304315 USAGE" 2203/MUM/2012 12‐12‐2018 "AN AMORPHOUS VILAZODONE HYDROCHLORIDE AND PROCESSES 304321 FOR PREPARING SAME" 5045/DELNP/2011 12‐12‐2018 "PHARMACEUTICAL COMPOSITIONS COMPRISING 2‐OXO‐1‐ 304327 PYRROLIDINE DERIVATIVES" 4558/DELNP/2011 12‐12‐2018 "ONCOLYTIC ADENOVIRAL VECTORS AND METHODS AND USES 304364 RELATED THERETO" 2911/CHENP/2011 13/12/2018 “FRUIT EXTRACTS” 304430 6896/DELNP/2012 13‐12‐2018 “LIQUID FORMULATIONS FOR LONG‐ACTING ERYTHROPOIETIN 304383 CONJUGATE” 2868/MUMNP/2012 13‐12‐2018 METHOD FOR PRODUCTION OF F‐18 LABELED AMYLOID BETA 304388 LIGANDS 2131/DEL/2010 13‐12‐2018 AQUEOUS EXTRACT OF ANIMAL SKIN FOR THERAPEUTIC BENEFITS 304390 IN EPILEPSY 2146/KOLNP/2012 13‐12‐2018 ORALLY ADMINISTRABLE PHARMACEUTICAL PELLET OF EPIDERMAL 304412 GROWTH FACTOR 3405/CHENP/2013 13‐12‐2018 SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF 304417 6867/CHENP/2012 13‐12‐2018 KIT COMPRISING REVERSE THERMOSETTINGFORMULATION FOR 304427 APPLYING MOXIFLOXACIN TO THE EAR 2830/MUM/2010 13‐12‐2018 A SUNSCREEN COMPOSITION 304431 2839/DELNP/2013 13‐12‐2018 4‐(METHYLAMINOPHENOXY) PYRDIN‐3‐YL‐ BENZAMIDE 304438 DERIVATIVES FOR TREATING CANCER 6252/CHENP/2012 14‐12‐2018 TRICYCLIC ANTIBIOTICS 304461 2116/CHE/2014 14‐12‐2018 AN IMPROVED PROCESS FOR THE PREPARATION OF LORNOXICAM 304478

9581/CHENP/2013 14‐12‐2018 HYDRAZINO 1H‐IMIDAZOQUINOLIN‐4‐AMINES AND CONJUGATES 304483 MADE THEREFROM

Page 63 of 85 9690/CHENP/2013 14‐12‐2018 HETEROBIFUNCTIONAL LINKERS WITH POLYETHYLENE GLYCOL 304485 SEGMENTS AND IMMUNE RESPONSE MODIFIER CONJUGATES MADE THEREFROM 4535/DELNP/2014 14‐12‐2018 COLOR CHANGING COMPOSITIONS 304500 2145/KOL/2008 17/12/2018 SYNERGISTIC HAIR CARE COMPOSITION 304561 2063/DELNP/2014 17‐12‐2018 HETEROCYCLIC COMPOUNDS MEDICAMENTS CONTAINING SAID 304527 COMPOUNDS USE THEREOF AND PROCESSES FOR THE PREPARATION THEREOF 1172/MUM/2011 17‐12‐2018 A PROCESS FOR PREPARING FESOTERODINE 304529 498/CHENP/2011 17‐12‐2018 A PREPARATION COMPRISING A NON‐MAMMALIAN DERIVED 304543 MIXTURE OF SERINE GLYCEROPHOSPHOLIPID CONJUGATES 7824/CHENP/2013 17‐12‐2018 GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL 304549 COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL 5888/DELNP/2013 17‐12‐2018 A SIGMA LIGAND FOR USE IN TREATMENT OF BONE CANCER PAIN 304562

10434/DELNP/2015 18‐12‐2018 “METHOD AND DEVICE FOR PRODUCING HYDROGEN CONTAINING 304570 FLUID” 255/MUM/2007 18‐12‐2018 “A COMPOSITION FOR SELECTIVE SEROTONIN REUPTAKE 304584 INHIBITION AND PROCESS THEREOF” 3276/CHE/2010 18‐12‐2018 NOVEL MICRO‐PARTICLES OF MIZOLASTINE FOR NASAL DELIVERY 304606

6156/CHENP/2012 18‐12‐2018 TOPICAL OPHTHALMIC PEPTIDE FORMULATION 304619 7171/CHENP/2010 18‐12‐2018 LONG‐CHAIN FATTY ACYL ELONGASE INHIBITOR COMPRISING 304623 ARYLSULFONYL DERIVATIVE AS ACTIVE INGREDIENT 2624/MUMNP/2012 18‐12‐2018 LEVOISOVALERYLSPIRAMYCIN I II OR III PREPARATIONS 304630 PREPARATION METHODS AND USES THEREOF 3196/KOLNP/2012 19‐12‐2018 PROCESS FOR PROVIDING PARTICLES WITH REDUCED 304644 ELECTROSTATIC CHARGES 830/MUMNP/2011 19‐12‐2018 ANTIPERSPIRANT OR DEODORANT COMPOSITIONS 304661 448/MUMNP/2014 20/12/2018 ORAL CARE COMPOSITIONS 304790 4012/KOLNP/2011 20‐12‐2018 DIMENSIONAL ANALYSIS OF SACCHARIDE CONJUGATES WITH GPC 304750 & SECMANS 1508/DELNP/2014 20‐12‐2018 3,5‐ DISUBSTITUTED ALKYNYLBENZENE COMPOUND AND SALT 304755 THEREOF 4213/CHENP/2011 20‐12‐2018 HIGH AFFINITY HUMAN ANTIBODIES TO PCSK9 304766 2280/MUMNP/2012 21‐12‐2018 EASILY DOSABLE SOLID PREPARATION 304808 3253/CHENP/2009 21‐12‐2018 MICROORGANISMS OR FRACTIONS THEREOF CAPABLE OF 304814 ACTIVATING CELLULAR IMMUNITY AGAINST CARBOHYDRATES 1556/DEL/2009 21‐12‐2018 “NOVEL ANTI‐HIV COMPOUNDS” 304819 1968/DEL/2009 21‐12‐2018 A COMPOSITION FOR EXTERNAL TROPICAL USE 304836 4537/CHENP/2011 24‐12‐2018 RECOMBINANT AVIAN INFECTIOUS CORYZA VACCINE AND PROCESS 304906 FOR PREPARING SAME 5059/KOLNP/2010 24‐12‐2018 MONOCLONAL ANTIBODY THAT BINDS FIBROBLAST GROWTH 304913 FACTOR RECEPTOR 2 3353/KOLNP/2011 26‐12‐2018 FORMULATIONS OF VIABLE CELLS FOR ORAL DELIVERY 304958 8295/DELNP/2011 26‐12‐2018 "LIQUID DEPOT FORMULATIONS" 304972 6677/CHENP/2013 27‐12‐2018 METHODS AND COMPOSITIONS FOR PREPARING NORIBOGAINE 305003 FROM VOACANGINE 1262/MUMNP/2012 27‐12‐2018 MODULATION OF HSP47 EXPRESSION 305006 5628/CHENP/2014 27‐12‐2018 Azaadmantane Compounds for treatment of disorders relating to 305017 11 beta HSD‐1activity and method of production thereof

7417/CHENP/2013 27‐12‐2018 ISOPENTYL ESTERS FOR THE USE IN COSMETIC DERMATOLOGICAL 305020 OR PHARMACEUTICAL COMPOSITIONS 7462/CHENP/2009 27‐12‐2018 METHODS AND COMPOSITIONS FOR STIMULATING NEUROGENESIS 305026 AND INHIBITING NEURONAL DEGENERATION USING ISOTHIAZOLOPYRIMIDINONES 6782/CHENP/2013 27‐12‐2018 METHOD OF PREPARATION OF METAXALONE 305029

Page 64 of 85 261/CHENP/2015 28‐12‐2018 LIQUID COMPOSITION CONTAINING TAXANE BASED ACTIVE 305055 INGREDIENT PROCESS FOR PRODUCING SAME AND LIQUID MEDICINAL PREPARATION 4123/DELNP/2011 28‐12‐2018 AN ANTIBODY FRAGMENT LINKED TO AN EPITOPE COMPLEXED 305059 WITH AN ANTIBODY THAT BINDS TO AN EPITOPE 7803/DELNP/2012 28‐12‐2018 ADDITIVE FOR ERYTHROCYTE‐RICH SOLUTION, AND CONTAINER 305065 FOR MEDICAL PURPOSES 1999/CHENP/2011 28‐12‐2018 PH‐DEPENDENT CONTROLLED RELEASE PHARMACEUTICAL OPIOID 305073 COMPOSITION WITH RESISTANCE AGAINST THE INFLUENCE OF ETHANOL 533/KOLNP/2013 28‐12‐2018 COMPOUND COMPOSITION FOR INHALATION USED FOR TREATING 305095 ASTHMA 5565/CHENP/2011 28‐12‐2018 OPTIMIZED EARLY‐LATE PROMOTER COMBINED WITH REPEATED 305110 VACCINATION FAVORS CYTOTOXIC T CELL RESPONSE AGAINST ANTIGENS IN REPLICATION DEFICIENT RECOMBINANT VIRUS VACCINES 7290/DELNP/2009 31/12/2018 "DUCK EMBRYONIC DERIVED STEM CELL LINES FOR THE 305130 PRODUCTION OF VIRAL VACCINES" 4483/DELNP/2011 31‐12‐2018 DERMATOLOGICAL OR COSMETIC COMPOSITION COMPRISING AN 305141 EXTRACT OF AERIAL PARTS OF OATS HARVESTED BEFORE EAR EMERGENCE 239/MUMNP/2015 31‐12‐2018 METHOD OF PREPARING BENZOFURAN DERIVATIVE 305149 246/DEL/2013 01‐01‐2019 PHARMACEUTICAL COMPOSITION FOR THE PROLONGED RELEASE 305171 OF TRIMETAZIDINE 7221/DELNP/2014 01‐01‐2019 COSMETIC COMPOSITION COMPRISING SILICA AEROGEL PARTICLES 305177 AND A CLAY 7515/CHENP/2012 01‐01‐2019 AN AQUEOUS COMPOSITION 305179 3552/DELNP/2013 01‐01‐2019 METHOD AND SYSTEM FOR FORMING A PHARMACEUTICAL 305182 PRODUCT DIRECTLY ONTO A PACKAGING SURFACE 117/MUMNP/2012 01‐01‐2019 "IMMUNOSTIMULATORY COMPOSITIONS COMPRISING LIPOSOME‐ 305216 ENCAPSULATED OLIGONUCLEOTIDES AND EPITPOES"

3379/KOLNP/2015 02‐01‐2019 MICROEMULSION TOPICAL DELIVERY PLATFORM 305229 2753/MUM/2010 02‐01‐2019 A SKIN LIGHTENING COMPOSITION 305261 2239/KOLNP/2013 02‐01‐2019 PYRIMIDINE GYRASE AND TOPOISOMERASE IV INHIBITORS 305263 1169/MUMNP/2012 02‐01‐2019 LIPOSOME OF IRINOTECAN OR ITS HYDROCHLORIDE AND 305281 PREPARATION METHOD THEREOF 582/KOLNP/2013 03‐01‐2019 MONOCLONAL ANTIBODY SPECIFIC TO MAJOR NEUTRALIZING 308437 EPITOPE OF INFLUENZA H5 HEMAGGLUTININ 1434/DELNP/2012 03‐01‐2019 "COMPOSITIONS COMPRISING TRAMADOL AND CELECOXIB IN THE 305298 TREATMENT OF PAIN" 2002/DEL/2011 03‐01‐2019 AN ANTIDIABETES HEALTH FOOD PRODUCT FROM SOYBEAN 305316 (GLYCINE MAX)SEEDS 4531/CHENP/2014 03‐01‐2019 2',4'‐DIFLUORO‐2'‐METHYL SUBSTITUTED NUCLEOSIDE 305321 DERIVATIVES ASINHIBITORS OF HCV RNA REPLICATION 1157/MUMNP/2013 03‐01‐2019 INDOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS 305335 2717/MUMNP/2012 03‐01‐2019 PHOSPHORIC ACID ESTER COMPOUND OF HYDROXY ACID 305349 SUBSTITUTED PHENYL ESTER, SYNTHESIS METHOD AND MEDICAL USE THEREOF 551/KOLNP/2010 04‐01‐2019 ENGINEERED ANTI‐ALPHA V‐INTEGRIN HYBRID ANTIBODIES 305395 3183/KOLNP/2011 05‐01‐2019 PURIFIED PLASMODIUM AND VACCINE COMPOSITIONS 312113 5291/DELNP/2015 07‐01‐2019 HIGH CONTENT SODIUM IBUPROFEN GRANULES, THEIR 315295 PREPARATION AND THEIR USE IN PREPARING NON EFFERVESCENT SOLID DOSAGE FORMS 2749/CHENP/2011 07‐01‐2019 PRE FILLED SYRINGE COMPRISING PERIPHERAL OPIOID RECEPTOR 305409 ANTAGONISTS 2360/DEL/2012 07‐01‐2019 A PHARMACEUTICAL FORMULATION FOR THE PREVENTION OF 305412 SEXUAL TRANSMISSION OF HIV 1505/MUMNP/2013 07‐01‐2019 HAIR TREATMENT COMPOSITIONS 305413 5193/DELNP/2010 08‐01‐2019 MODIFIED INFLUENZA VIRUS 305470

Page 65 of 85 715/CHENP/2013 09‐01‐2019 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF 305497 10507/CHENP/2012 09‐01‐2019 “AN AGENT THAT INCREASES THE NUCLEAR LOCALIZATION OF 305498 COMMD1 PROTEIN” 7909/DELNP/2013 09‐01‐2019 AZOLE DERIVATIVE 305508 1000/MUM/2011 09‐01‐2019 CONTROLLED RELEASE SOLID DOSAGE FORM OF BETAHISTINE 305513 1077/CHENP/2013 09‐01‐2019 P2X4 RECEPTOR ANTAGONIST 305515 3447/DELNP/2014 10‐01‐2019 METHOD FOR PREPARING 1 (4 (4 (3 4 DICHLORO 2 305534 FLUOROPHENYLAMINO) 7 METHOXYQUINAZOLIN 6 YLOXY)PIPERIDIN 1 YL) PROP 2 EN 1 ONE HYDROCHLORIDE AND INTERMEDIATES USED THEREIN 1171/MUMNP/2013 10‐01‐2019 A SKIN LIGHTENING COMPOSITION 305558 2645/MUMNP/2012 10‐01‐2019 “MORPHOLINO PYRIMIDINES AND THEIR USE IN THERAPY” 305564 416/KOLNP/2012 11‐01‐2019 HETEROCYLCIC DERIVATIVES AS INHIBITORS OF GLUTAMINYL 305585 CYCLASE 7836/CHENP/2014 14‐01‐2019 C 17 BICYCLIC AMINES OF TRITERPENOIDS WITH HIV MATURATION 305662 INHIBITORY ACTIVITY 73/DELNP/2013 15‐01‐2019 PHARMACEUTICAL COMPOSITION COMPRISING AMIDE DERIVATIVE 305671 OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

6546/DELNP/2014 16‐01‐2019 CONDITIONING COMPOSITION ADDITIVE FOR PROVIDING 305716 IMMEDIATE AND LONG LASTING BENEFITS TO KERATIN SUBSTRATES 8696/DELNP/2012 16‐01‐2019 NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL 305717 THROMBOCYTHEMIA 1372/MUMNP/2012 16‐01‐2019 FORMULATIONS, SALTS AND POLYMORPHS OF 305720 TRANSNORSERTRALINE AND USES THEREOF 2047/KOLNP/2013 16‐01‐2019 COMPOSITIONS AND METHODS FOR STABILIZING INGREDIENTS 305728 USING 2,4‐PENTANEDIONE COMPOUNDS 201627010917 16‐01‐2019 SUBSTITUTED PIPERIDYL‐ETHYL‐PYRIMIDINE AS GHRELIN O‐ACYL 305730 TRANSFERASE INHIBITOR 3610/CHENP/2014 16‐01‐2019 TRICYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND 305743 USES THEREOF 3184/DELNP/2013 16‐01‐2019 LIPOSOME COMPOSITION AND PROCESS FOR PRODUCTION 305744 THEREOF 201617011378 16‐01‐2019 A METHOD OF PRODUCING A PERSONAL CARE COMPOSITION 305748 2610/DELNP/2012 16‐01‐2019 "A COMPOUND" 305754 55/DELNP/2013 17‐01‐2019 PERSONAL CARE COMPOSITION ADDITIVE FOR APPLICATION ON 305781 KERATIN SUBSTRATES TO PROVIDE LONG LASTING BENEFITS 1510/MUMNP/2014 17‐01‐2019 AURORA AND FLT3 KINASES MODULATORS 305804 1211/KOLNP/2014 17‐01‐2019 PROCESS FOR RECOVERY OF NALMEFENE HYDROCHLORIDE 305808 6214/DELNP/2011 17‐01‐2019 "ABUSE RESISTANT FORMULATION" 305817 10403/DELNP/2014 17‐01‐2019 KIT AND METHOD FOR PRODUCING A RADIOPHARMACEUTICAL 305828 9083/CHENP/2012 17‐01‐2019 “CGRP ANTIBODIES” 305835 108/KOLNP/2015 18‐01‐2019 COSMETIC COMPOSITION FOR MAKING UP THE SKIN COMPRISING 305857 SEBUM PUMP FILLER AND HYDROPHOBIC FILM FORMING POLYMER

3674/KOLNP/2012 18‐01‐2019 COSMETIC COMPOSITION BASED ON A SUPRAMOLECULAR 305868 POLYMER AND AN ABSORBENT FILLER 1685/MUMNP/2013 18‐01‐2019 ORAL CARE COMPOSITIONS 305871 8962/DELNP/2010 18‐01‐2019 EMOLLIENT COMPOSITION 305878 1237/DELNP/2012 18‐01‐2019 "PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF 305913 CANCER AND OTHER DISEASES OR DISORDERS" 5320/DELNP/2012 21‐01‐2019 AMINOPYRIMIDINES AS SYK INHIBITORS 305941 2880/CHE/2012 21‐01‐2019 A NOVEL COMPOUND AND A PROCESS FOR PREPARATION THEREOF 305967

6081/CHENP/2013 21‐01‐2019 A liquid composition in the form of a physically stable O/W‐ 305981 emulsion 2098/MUM/2015 21‐01‐2019 MOLECULAR GELATORS FOR CONTAINING OIL SPILLAGE 306015

Page 66 of 85 9112/CHENP/2014 21‐01‐2019 COSMETIC COMPOSITION AND METHOD FOR USING THEREOF 306023 411/MUMNP/2014 22/01/2019 HAIR COMPOSITION 306034 9651/DELNP/2011 22‐01‐2019 "SEMI‐SOLID COMPOSITIONS AND PHARMACEUTICAL PRODUCTS" 306031

2211/DELNP/2011 22‐01‐2019 “METHOD OF TREATING DYSGLYCEMIA AND GLUCOSE 306043 EXCURSIONS” 1138/CHENP/2012 22‐01‐2019 UV FILTER COMBINATIONS COMPRISING BENZYLIDENE MALONATES 306084

8778/DELNP/2012 23‐01‐2019 SUPERCRITICAL FLUID TREATMENT OF HIGH MOLECULAR WEIGHT 306103 BIOPOLYMERS 3091/KOLNP/2011 23‐01‐2019 7‐PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES 306118 1323/MUMNP/2013 24‐01‐2019 SUBSTITUTED [(5H‐PYRROLO[2,1‐C] [1,4]BENZODIAZEPIN‐11‐ 306188 YL)PIPERAZIN‐1‐YL]‐2,2 DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5‐HT2A ANTAGONISTS

1191/MUM/2009 24‐01‐2019 MELT IN MOUTH SUSTAINED RELEASE TABLETS 306223 1596/MUMNP/2013 24‐01‐2019 IL17 AND IFN GAMMA INHIBITION FOR THE TREATMENT OF 306242 AUTOIMMUNE INFLAMMATION 746/MUMNP/2013 24‐01‐2019 A PHARMACEUTICAL COMPOSITION CONTAINING ESTERS OF 306259 ACYLOXYMETHYL)ACRYLAMIDE FOR INHIBITION OF THE THIOREDOXIN ‐ THIOREDOXIN REDUCTASE SYSTEM 2982/MUM/2012 24‐01‐2019 DRUG‐CONTAINING BIOABSORBABLE FIBERS AND IMPLANTS 306269 2199/MUM/2012 25‐01‐2019 A PROCESS FOR PREPARATION OF HERBAL GELATINE 306273 446/CHE/2012 25‐01‐2019 IMPROVED PROCESS FOR THE PREPARATION OF TRIAZOLE 306285 ANTIFUNGAL DRUG 7580/DELNP/2009 25‐01‐2019 "A PHARMACEUTICAL COMPOSITION COMPRISING TETRA‐ 306292 NITROSYL‐IRON COMPLEX WITH THIOPHENOL" 1164/MUMNP/2013 25‐01‐2019 ANALGESIC COMPOUNDS, METHODS AND FORMULATIONS 306298 144/MUMNP/2014 25‐01‐2019 (THIENO[2,3‐b][1,5]BENZOXAZEPIN‐4‐YL)PIPERAZIN‐1‐YL 306303 COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5‐HT2A ANTAGONISTS 10233/CHENP/2012 25‐01‐2019 FURANYL COMPOUNDS AND THE USE THEREOF 306307 8684/DELNP/2011 25‐01‐2019 "ORAL CARE FORMULATIONS THAT ENHANCE AMOUNT OF 306318 SOLUBLE ZINC" 2573/DELNP/2010 25‐01‐2019 "HAIR CARE COMPOSITIONS AND METHODS OF TREATING HAIR" 306323

9224/DELNP/2013 28‐01‐2019 PROCESS FOR THE PREPARATION OF 1 ‐ ( 2‐ METHYL ‐ 4 ‐ ( 2, 3, 4, 5 306340 ‐ TETRAHYDRO ‐ 1 ‐ BENZAZEPIN ‐1 ‐ YLCARBONYL) BENZYLCARBAMOYL) ‐ L ‐ PROLINE ‐ N, N‐ DIMETHYLAMIDE 4119/DELNP/2011 28‐01‐2019 "FRUIT AND VEGETABLE‐DERIVED COMPOSITIONS" 306346 1467/CHENP/2013 28‐01‐2019 PHARMACEUTICAL COMPOSITION COMPRISING AN AZIDE‐ 306347 MODIFIED FATTY ACID, CARBOHYDRATE AND LIPID 917/MUMNP/2012 28‐01‐2019 ORAL SOLID DOSAGE FORM CONTAINING NANOPARTICLES AND 306366 PROCESS OF FORMULATING THE SAME USING FISH GELATIN 185/DELNP/2014 28‐01‐2019 NOVEL COMPOUND WITH AMYLOID AFFINITY 306378 8115/CHENP/2012 28‐01‐2019 PERSONAL CARE COMPOSITIONS FOR COLORING HAIR 306394 790/MUMNP/2012 29‐01‐2019 MILD, FOAMING LIQUID CLEANSERS COMPRISING LOW LEVELS OF 306489 FATTY ISETHIONATE PRODUCT AND LOW TOTAL FATTY ACID AND/OR FATTY ACID SOAP CONTENT 945/MUM/2009 29‐01‐2019 A NOVEL CREAM AND A PROCESS TO MAKE THE SAME 306407 1230/CHE/2011 29‐01‐2019 SOLID FORMS OF ANTIRETROVIRAL COMPOUNDS, PROCESS FOR 306459 THE PREPARATION AND THEIR PHARMACEUTICAL COMPOSITION THEREOF 5367/CHENP/2012 29‐01‐2019 INDOLE COMPOUND AND PHARMACEUTICAL USE THEREOF 306479 4797/DELNP/2015 30‐01‐2019 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND 306529 BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY 7922/DELNP/2012 30‐01‐2019 PHARMACEUTICAL COMPRISING MYRAMISTIN 306539

Page 67 of 85 5046/DELNP/2013 30‐01‐2019 BROMODOMAIN INHIBITORS AND USES THEREOF 306551 9269/DELNP/2012 30‐01‐2019 HIGH PURITY SOLUBLE THROMBOMODULIN AND METHOD FOR 306554 PRODUCING SAME 4605/KOLNP/2011 30‐01‐2019 LXR MODULATORS 306583 11/CHENP/2011 31‐01‐2019 AMINO ACID SEQUENCES DIRECTED AGAINST ENVELOPE PROTEINS 306585 OF A VIRUS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF VIRAL DISEASES 3219/CHENP/2011 31‐01‐2019 MODULATION OF FACTOR 11 EXPRESSION 306586 4441/DELNP/2011 31‐01‐2019 "ANTI‐IGF ANTIBODIES" 306589 877/KOL/2012 31‐01‐2019 COMPOSITION FOR LOWERING BLOOD LIPID AND ELEVATING HIGH‐ 306593 DENSITY LIPOPROTEIN AND METHOD FOR MANUFACTURING THE SAME 2860/DELNP/2012 31‐01‐2019 "VACCINE AGAINST CHOLERA AND ENTEROTOXIGENIC E. COLI 306613 (ETEC) DIARRHEA" 7487/DELNP/2012 31‐01‐2019 LIVE VACCINE FOR AVIARY DISEASES 306614 7522/CHENP/2015 31‐01‐2019 AGENT CONTAINING LARGE QUANTITIES OF UV STABILIZERS 306619 1059/MUMNP/2013 31‐01‐2019 ANTIFUNGAL 5,6‐DIHYDRO‐4H‐PYRROLO[1,2‐A][1,4]‐ 306639 BENZODIAZEPINES AND 6H‐PYRROLO[1,2‐A][1,4]BENZODIAZEPINES SUBSTITUTED WITH PHENYL DERIVATIVES

2466/CHE/2013 31‐01‐2019 COMPOUND OF FORMULA I, PROCESS OF PREPARATION AND 306662 APPLICATION IN SYNTHESIS OF PQQ THEREOF 10558/DELNP/2013 01‐02‐2019 DIALYSIS PRECURSOR COMPOSITION 306700 668/MUMNP/2015 01‐02‐2019 COSMETIC COMPOSITION 306718 3898/DELNP/2015 01‐02‐2019 COSMETIC COMPOSITIONS AND METHODS FOR INHIBITING 306754 MELANIN SYNTHESIS 201617010759 04‐02‐2019 TOPICAL ANTI INFLAMMATORY PHARMACEUTICAL COMPOSITION 306785 WITH ZILEUTON CREAM FORMULATION 891/DEL/2008 04‐02‐2019 A RADIOACTIVE TRIMER COMPLEX FOR THE DETECTION OF 306804 TUMORS 2290/MUM/2012 05‐02‐2019 A NOVEL PHARMACEUTICAL COMPOSITION OF LINEZOLID. 312223 9905/DELNP/2011 05‐02‐2019 "DISULFIDE‐LINKED POLYETHYLENEGYLCOL/PEPTIDE CONJUGATES 306837 FOR THE TRANSFECTION OF NUCLEIC ACIDS" 2559/DEL/2011 05‐02‐2019 “STEP‐WISE FREEZE DRYING PROCESS FOR IMPROVING STABILITY 306846 OF NANO‐DRUG DELIVERY SYSTEMS” 1452/KOL/2013 05‐02‐2019 A METHOD TO MEASURE THE RINSABILITY OF CLEANSING 306850 FORMULATIONS 2003/MUMNP/2015 06‐02‐2019 ORAL CARE COMPOSITIONS 306894 201647010113 06‐02‐2019 CYCLIC PEPTIDOMIMETIC COMPOUNDS AS IMMUNOMODULATORS 306909

281/MUM/2010 06‐02‐2019 A PHOTOSTABLE SUNSCREEN COMPOSITION 306917 4677/KOLNP/2011 06‐02‐2019 CHEWING GUM AND PARTICULATE MATERIAL FOR CONTROLLED 306942 RELEASE OF ACTIVE INGREDIENTS 201747047012 07‐02‐2019 SUBSTITUTED HETEROCYCLYL DERIVATIVES AS CDK INHIBITORS 306947 1189/CHENP/2015 07‐02‐2019 COMPOUNDS OF SPERMIDINE AND COMPOSITIONCOMPRISING 306967 THE SAME FOR TREATING ALOPECIA

2652/DEL/2012 07‐02‐2019 "PROCESS FOR THE SYNTHESIS OF ANTIPILEPTIC DRUG 306977 LEVETIRACETAM" 3334/MUM/2012 07‐02‐2019 "NOVEL POLYMORPHIC FORMS OF ALCAFTADINE" 306979 254/MUMNP/2013 07‐02‐2019 WATER IN OIL TYPE EMULSION COSMETIC 306998 6382/DELNP/2008 07‐02‐2019 "An antioxidant comprising DocosaHexaenoic Acid(DHA)" 307001 553/DEL/2009 07‐02‐2019 "PROCESS FOR PRODUCING RIZATRIPTAN OR ITS 307012 PHARMACEUTICALLY ACCEPTABLE SALT" 3050/DELNP/2011 07‐02‐2019 "COMBINATION OF A PHOSPHATIDYLINOSITOL‐3‐KINASE (PI3K) 307019 INHIBITOR AND A MTOR INHIBITOR" 2323/DELNP/2013 08‐02‐2019 CONCENTRATE FOR MEDICAL SOLUTIONS PRODUCTION THEREOF 307028 AND USE THEREOF IN DIALYSIS

Page 68 of 85 267/MUMNP/2013 08‐02‐2019 Process for the preparaon 307036 of erlotinib base or a salt thereof 6907/CHENP/2012 08‐02‐2019 INHIBITORS OF CATECHOL O‐METHYL TRANSFERASE AND THEIR USE 307049 IN THE TREATMENT OF PSYCHOTIC DISORDERS 2915/MUMNP/2012 08‐02‐2019 CYTOCHROME P450 INHIBITORS AND USES THEREOF 307052 6066/DELNP/2011 08‐02‐2019 "A COMPOSITION COMPRISING SILVER NANOPARTICLES AND 307055 EXTRACTS OF POLYGONUM MULTIFLORUM THUNB AND THE USE THEREOF 8458/DELNP/2012 08‐02‐2019 “AN INTRAOCULAR IMPLANT COMPRISING A POLYMERIC LAYER 307060 COVERING A CORE CONTAINING A STEROID, THE POLYMERIC LAYER” 5667/DELNP/2012 08‐02‐2019 6 SUBSTITUTED ESTRADIOL DERIVATIVES AND COMPOSITION 307065 THEROF“ 1098/DEL/2012 08‐02‐2019 CONTROLLED RELEASE GABAPENTIN COMPOSITION AND PROCESS 307093 OF PREPARATION THEREOF 1262/MUM/2012 11‐02‐2019 "AN IMPROVED PROCESS FOR THE MANUFACTURING OF 307162 ROFLUMILAST" 3135/KOLNP/2007 12‐02‐2019 ANTIBODIES TO TGFBETA 307227 3375/DELNP/2013 12‐02‐2019 COMPOSITION FOR ENTERIC HARD CAPSULES AND ENTERIC HARD 307255 CAPSULE PREPAREDUSING THE COMPOSITION 4196/DELNP/2011 13‐02‐2019 "VESICLE PREPARATION" 307304 9723/DELNP/2012 13‐02‐2019 “NOVEL FORMULATIONS OF ACTIVE INGREDIENT(S) OF PLANT 307311 ORIGIN OR SYNTHETIC ANALOGUES THEREOF OR OF EXTRACT(S) OF PLANT ORIGIN CONTAINING SAME AND OF LECITHIN” 3795/CHENP/2013 13‐02‐2019 Pyrrolopyrimidine Fused Piperazinone Compounds as CDK 307331 Inhibitors 1856/MUMNP/2013 13‐02‐2019 PYRROLOPYRIDINEAMINO DERIVATIVES AS MPS1 INHIBITORS 307348 1897/MUM/2010 14‐02‐2019 A SUSTAINED RELEASE COMPOSITION HAVING THERAPEUTIC 307378 ACTIVITY AGAINST INTERSTITIAL CYSTITIS 583/MUMNP/2014 14‐02‐2019 COMPOSITIONS COMPRISING SALBUTAMOL SULPHATE 307393 6472/DELNP/2009 14‐02‐2019 PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS 307422 2747/CHE/2012 14‐02‐2019 "NANOPARTICLE COMPOSITIONS OF ANTIBACTERIAL COMPOUNDS 307423 AND OTHER USES THEREOF" 5980/DELNP/2013 15‐02‐2019 SOLID MOLECULAR DISPERSION 307450 6771/CHENP/2014 15‐02‐2019 GUERBET ALCOHOLS AS VASELINE SUBSTITUTE 307455 2789/KOLNP/2014 16/02/2019 PYRROLOTRIAZINONE DERIVATIVES 307495 3370/DELNP/2014 18‐02‐2019 APPARATUS AND METHOD FOR PRODUCING CONTROLLED DOSAGE 307520 OF BIOACTIVE AGENT 6441/DELNP/2013 18‐02‐2019 COSMETIC COMPOSITION COMPRISING SILICA AEROGELS 307539 PARTICLES AND HYDROCARBON BASED OILS 1504/MUMNP/2015 18‐02‐2019 PHARMACEUTICAL FORMULATION OF N‐ [5 ‐ [2‐ (3, 5 307540 DIMETHOXYPHENYL) ETHYL]‐ 2H‐ PYRAZOL‐ 3‐ YL]‐ 4‐ [(3R, 5S) 3, 5 DIMETHYLPIPERAZIN‐ 1‐ YL] BENZAMIDE 1103/MUM/2012 18‐02‐2019 ORAL PATCHES FOR APHTHOUS ULCER 307541 1483/MUMNP/2015 18‐02‐2019 (THIENO[2, 3 b][1, 5]BENZOXAZEPIN ‐4‐ YL)PIPERAZIN‐ 1‐ YL 307561 COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5 HT2A ANTAGONISTS 3246/DEL/2011 19/02/2019 “NOVEL LAYERSOME COMPOSITION FOR ORAL DELIVERY OF ANTI 307621 CANCER AGENTS” 4021/KOLNP/2012 19‐02‐2019 FUSED HETEROCYCLIC COMPOUNDS AS ION CHANNEL 307592 MODULATORS 833/DELNP/2015 19‐02‐2019 PROCESS FOR THE PREPARATION OF PEMETREXED AND LYSIN SALT 307594 THEREOF 1209/MUMNP/2012 19‐02‐2019 CARBOXYVINYL POLYMER‐CONTAINING NANOPARTICLE 307619 SUSPENSION 9291/DELNP/2012 19‐02‐2019 ORALLY DISITEGRATING TABLET CONTAINING ACARBOSE 307654 1084/CHE/2010 20‐02‐2019 NOVEL PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND ITS 307699 PHARMACEUTICALLY ACCEPTABLE SALTS 4027/KOLNP/2012 20‐02‐2019 C5AR ANTAGONISTS 307706

Page 69 of 85 6347/DELNP/2014 20‐02‐2019 COMPOSITION AND ASSOCIATION OF SUNSCREENS FOR 307723 PHOTOSTABILIZING BUTYL METHOXYDIBENZOYLMETHANE (BMDBM) 3279/MUM/2011 21/02/2019 EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS 307799 4847/DELNP/2014 21‐02‐2019 CELLULOSE ETHERS WITH IMPROVED THERMAL GEL STRENGTH 307743 2099/MUM/2012 21‐02‐2019 "A process for preparing 2‐(SUBSTITUTED‐ARYL)‐3‐(2‐OXOINDOLIN‐ 307750 3‐YLIDENE)AMINO)‐THIAZOLIDIN ‐4‐ONE COMPOUNDS

2953/MUM/2011 21‐02‐2019 AN IMPROVED PROCESS FOR THE PREPARATION OF 307758 PROMETHAZINE HYDROCHLORIDE. 2595/KOLNP/2013 21‐02‐2019 PYRIDINYL ‐ AND PYRAZINYL ‐ METHYLOXY ‐ ARYL DERIVATIVES 307781 USEFUL AS INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) 3301/CHENP/2011 21‐02‐2019 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF 307782 TRANSTHYRETIN 7839/CHENP/2012 21‐02‐2019 CGRP RECEPTOR ANTAGONIST 307814 211/KOLNP/2013 22/02/2019 CIS‐TETRAHYDRO‐SPIRO(CYCLOHEXANE‐1,1' ‐PYRIDO[3,4‐B]INDOLE)‐ 307840 4‐AMINE DERIVATIVES 2582/KOLNP/2011 22/02/2019 ANTI‐FXI ANTIBODIES AND METHODS OF USE 307903 10426/CHENP/2012 22‐02‐2019 “GLUCAGON LIKE PEPTIDE ANALOGS” 307830 10888/CHENP/2012 22‐02‐2019 STABLE ANTISEPTIC COMPOSITIONS AND METHODS 307849 876/KOL/2012 22‐02‐2019 SYNERGISTIC BLEND FOR ENHANCING ANTIFUNGAL ACTIVITY AND 307872 SOLUBILIZING ZPTO IN PERSONAL CARE FORMULATIONS 3589/DEL/2011 22‐02‐2019 "SYSTEM AND METHOD OF PROVIDING COMPLIANCE AND 307881 ALERTING OF TOXIC GAS EXPOSURE FOR HEALTH MONITORING AND PLANT MAINTENANCE" 2463/CHENP/2014 25/02/2019 PYRAZOLOQUINOLINE DERIVATIVE 307941 2153/CHE/2012 25‐02‐2019 STABILIZED PHARMACEUTICAL COMPOSITIONS OF SAXAGLIPTIN 307927

1530/MUMNP/2010 25‐02‐2019 STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE 307954

7857/CHENP/2013 25‐02‐2019 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS 307977 7331/CHENP/2012 25‐02‐2019 RECOMBINANT ATTENUATED PARVOVIRUS 307980 1424/CHENP/2011 25‐02‐2019 AGENT FOR TREATING MYELOFIBROSIS 307999 7868/CHENP/2013 25‐02‐2019 MACROCYCLIC COMPOUND AND METHODS FOR ITS PRODUCTION 308000

3358/CHENP/2011 25‐02‐2019 “RAB6KIFL/KIF20A EPITOPE PEPTIDE AND VACCINES CONTAINING 308012 THE SAME" 1065/MUMNP/2014 25‐02‐2019 SKIN ANTI AGEING COMPOSITION 308023 4169/CHENP/2012 26/02/2019 PHARMACEUTICAL COMPOSITION COMPRISING A GLP‐1 AGONIST, 308054 AN INSULIN AND METHIONINE 145/MUMNP/2014 26‐02‐2019 COMPLEX ZINC AND ALPHA CHLOROCARBOXYLIC ACID 308037 COMPOUNDS FOR TREATING SKIN LESIONS 8435/DELNP/2013 26‐02‐2019 PROCESS OF SEPARATING CHIRAL ISOMERS OF CHROMAN 308050 COMPOUNDS AND THEIR DERIVATIVES AND PRECURSORS 4920/CHE/2012 26‐02‐2019 GARLIC FORMULATION AND A PROCESS FOR PREPARING THE SAME 308057 FOR TREATMENT OF DIABETES 9063/CHENP/2013 26‐02‐2019 A TOPICAL FORMULATION FOR TREATMENT OF HYPERKERATOTIC 308061 SKIN 7955/CHENP/2013 26‐02‐2019 ALKYNE SUBSTITUTED QUINAZOLINE COMPOUND 308063 37/MUM/2010 26‐02‐2019 "A PROCESS FOR THE PREPARATION OF DIHYDROPYRIDINE 308103 COMPOUNDS" 6524/CHENP/2013 26‐02‐2019 Compositions of mTOR inhibitors and JAK inhibitors 308113 270/DEL/2011 26‐02‐2019 BENZOTHIAZOLE HYBRIDS USEFUL AS POTENTIAL ANTICANCER 308121 AGENTS AND PROCESS FOR THE PREPARATION THEREOF 8036/CHENP/2014 26‐02‐2019 FUNCTIONALIZED THIENO INDOLE DERIVATIVES FOR THE 308148 TREATMENT OF CANCER 3154/DELNP/2012 27/02/2019 "MONOCLONAL ANTIBODIES" 308160 2439/CHE/2009 27/02/2019 NOVEL MODULATORS OF CALCIUM RELEASE‐ACTIVATED CALCIUM 308182 CHANNEL

Page 70 of 85 8692/DELNP/2011 27‐02‐2019 "MODIFIED COMPSTATIN WITH PEPTIDE BACKBONE AND C‐ 308168 TERMINAL MODIFICATIONS" 711/CHENP/2014 27‐02‐2019 OXAZETIDINE BASED COMPOUNDS OF FORMULA (I) AND 308173 COMPOSITIONS THEREOF 9759/CHENP/2012 27‐02‐2019 PROCESS FOR PREPARATION OF DARUNAVIR 308174 312/MUMNP/2012 28/02/2019 METHOD FOR MAKING 3a‐HYDROXY; 3ß‐ METHYL‐5a‐PREGNAN‐2O‐ 308304 ONE (GANAXOLONE) 3182/DEL/2010 28/02/2019 A NOVEL METHOD FOR SIMULTANEOUS QUANTIFICATION OF 308356 AMLODIPINE BESYLATE AND TELMISARTAN IN TABLET 2777/KOLNP/2012 28‐02‐2019 PROCESS FOR PREPARING CARBAMOYLPYRIDONE DERIVATIVES 308276 AND INTERMEDIATES 5925/DELNP/2013 28‐02‐2019 AZOLE PHARMACEUTICAL FORMULATIONS FOR PARENTERAL 308297 ADMINISTRATION AND METHODS FOR PREPARING AND USING THE SAME AS TREATMENT OF DISEASES SENSITIVE TO AZOLE COMPOUNDS 3321/MUM/2010 28‐02‐2019 AN ANTIMICROBIAL MOUTHWASH COMPOSITION 308317 6186/CHE/2013 28‐02‐2019 N‐ METHYLPYRROLIDININE HYDROPEROXIDE AS AN EFFICIENT 308318 EPOXIDATIN REAGENT 4616/CHE/2011 28‐02‐2019 MULTIPARTICULATE PHARMACEUTICAL COMPOSITIONS 308333 COMPRISING ORLISTAT 201641042604 28‐02‐2019 IMPROVED PROCESS FOR THE PREPARATION OF ARIPIPRAZOLE 308361 LAUROXIL 1565/DELNP/2013 28‐02‐2019 ANTIBODIES TO MATRIX METALLOPROTEINASE 9 308368 548/DELNP/2015 01‐03‐2019 ATX MODULATING AGENTS 305315 8884/DELNP/2011 01‐03‐2019 "A COMPOSITION COMPRISING RADIOPHAMACEUTICAL 308393 COMPOUNDS" 10530/DELNP/2013 01‐03‐2019 DEUTERATED 1 PIPERAZINO 3 PHENYL INDANES FOR TREATMENT 308420 OF SCHIZOPHRENIA 5670/DELNP/2011 01‐03‐2019 "PRODUCT FOR PREVENTING OR TREATING HAIR GREYING" 308441 502/CHENP/2011 01‐03‐2019 SOLUBLE HYBRID FCY RECEPTORS AND RELATED METHODS 308450 264/CHENP/2014 04‐03‐2019 SELECTIVE GLYCOSIDASE INHIBITORS 310774 2861/KOLNP/2012 04‐03‐2019 SOLID COMPOSITIONS 308476 1789/KOLNP/2013 04‐03‐2019 COMPOUNDS USEFUL FOR TREATING AIDS 308479 3783/MUM/2014 05‐03‐2019 COMBINATORIAL THERAPEUTIC REGIMEN OF ANTIDIABETIC WITH 312245 ANTIHYPERTENSIVE DRUGS 10344/DELNP/2014 05‐03‐2019 FERMENTED INFANT FORMULA WITH NON DIGESTIBLE 308513 OLIGOSACCHARIDES 862/MUMNP/2014 05‐03‐2019 PURINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS 308523

2049/DEL/2013 05‐03‐2019 A TOPICAL EYE FORMULATION FOR DRY EYE DISEASE DISORDER. 308532 3655/DELNP/2014 05‐03‐2019 SKIN LIGHTENING FORMULATIONS 308545 2387/MUMNP/2013 05‐03‐2019 1,3‐DI‐OXO‐INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE 308571 SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ANTIVIRAL ACTIVE INGREDIENT 1951/DELNP/2014 05‐03‐2019 NEW DIHYDROQUINOLINE 2 ONE DERIVATIVES 308577 2515/MUMNP/2012 05‐03‐2019 METHODS AND LIPID COMPOSITIONS FOR PROMOTING 308585 DEVELOPMENT OF GUT FLORA 672/KOLNP/2014 05‐03‐2019 DERIVATIVES OF 1‐PHENYL‐2‐PYRIDINYL ALKYL ALCOHOLS AS 308589 PHOSPHODIESTERASE INHIBITORS 5277/DELNP/2014 05‐03‐2019 “PEPTIDE APTAMERS THAT BIND TO THE REP PROTEINS OF SSDNA 308597 VIRUSES” 8466/CHENP/2010 06‐03‐2019 “INORGANIC NANOPARTICLES OF HIGH DENSITY TO DESTROY CELLS 308636 IN‐VIVO” 201647004315 06‐03‐2019 QUININE COMPOUNDS AND PREPARATION METHOD THEREOF 308649 8004/DELNP/2009 06‐03‐2019 A NOVEL COMPOUND OF FORMULA 1 308650 301/KOL/2015 06‐03‐2019 A COMPOSITION COMPRISING AVOBENZONE AND LEUCAS ASPERA 308656 EXTRACT AND USES THEREOF

Page 71 of 85 3451/CHE/2010 06‐03‐2019 “PREPARATION OF FIBRIN NANOCONSTRUCTS FOR TISSUE 308660 ENGINEERING AND DRUG DELIVERY APPLICATIONS” 775/DELNP/2015 06‐03‐2019 “COMPOUNDS FOR INHIBITING NHE‐MEDIATED ANTIPORT” 308667 3947/DELNP/2015 06‐03‐2019 METHOD FOR PREPARING AN AQUEOUS STABLE PHARMACEUTICAL 308670 COMPOSITION 7867/CHENP/2014 06‐03‐2019 CAPSULE DISINTEGRABLE IN LARGE INTESTINE SPECIFIC MANNER 308674

2525/KOLNP/2014 06‐03‐2019 COMPOSITIONS AND METHODS FOR INHIBITING VIRAL 308689 POLYMERASE 4635/KOLNP/2011 07‐03‐2019 A TOPICAL COMPOSITION 315503 48/DELNP/2014 07‐03‐2019 PHOTOPROTECTIVE COMPOSITION 308815 9234/DELNP/2014 07‐03‐2019 COMPLEX COMPOUNDS OF GERMANIUM, METHODS FOR 308722 PRODUCING SAME , AND DRUGS 182/KOLNP/2014 07‐03‐2019 TAMPER‐RESISTANT TABLET PROVIDING IMMEDIATE DRUG 308730 RELEASE 3227/KOLNP/2013 07‐03‐2019 NOVEL PYRAZOLE DERIVATIVE 308761 1828/MUMNP/2011 07‐03‐2019 STABLE PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC 308764 4311/DELNP/2015 07‐03‐2019 NOVEL ROCK INHIBITORS 308778 5017/CHENP/2012 07‐03‐2019 METHOD OF PROCESSING ACTIVE INGREDIENT FOR INHALATION 308790

7963/CHENP/2011 07‐03‐2019 PROCESS TO FORM AN ORALLY DISINTEGRATING TABLET FOR 308819 HUMAN USE 6279/DELNP/2014 08‐03‐2019 ORALLY DISINTEGRATING TABLET CONTAINING BITTERNESS 308832 MASKING GRANULES 1963/CHENP/2013 08‐03‐2019 GASTRIC RESISTANT PHARMACEUTICAL OR NUTRACEUTICAL 308833 FORMULATION COMPRISING ONE OR MORE SALTS OF ALGINIC ACID 2153/DELNP/2013 08‐03‐2019 N HETEROARYL COMPOUNDS 308875 2499/KOLNP/2011 08‐03‐2019 PYRAZINE DERIVATIVES USEFUL AS INHIBITORS OF ATR KINASE 308876 2052/MUMNP/2012 08‐03‐2019 STABLE ORAL CARE COMPOSITIONS 308897 3280/KOLNP/2009 09‐‐03‐2019 “ATROPISOMER OF PYRROLE DERIVATIVE” 308904 1308/KOLNP/2013 09‐03‐2019 BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS 308903 2222/MUMNP/2012 11‐03‐2019 TUBERCULOSIS DRUG COMPOSITION BASED ON 4 ‐THIOUREIDO ‐ 309007 IMINOMETHYLPYRIDINIUM PERCHLORATE 3620/CHE/2012 11‐03‐2019 A PROCESS FOR EXTRACTION OF BIO‐ACTIVE COMPOUNDS 308951 EXHIBITING ANTICANCER PROPERTY FROM LENTINUS TUBERREGIUM 9556/DELNP/2011 11‐03‐2019 Compositions comprising essential oil of Chinese cinnamon and 308921 cinnamon bark 540/MUMNP/2014 11‐03‐2019 PYRROLOBENZODIAZEPINES 308922 8940/CHENP/2013 11‐03‐2019 COATING COMPOSITION SUITABLE FOR PHARMACEUTICAL OR 308942 NUTRACEUTICAL DOSAGE FORMS 10130/DELNP/2015 11‐03‐2019 NOVEL FLUORINATED BENZILIC ACID ESTER COMPOUND, AND SALT 308949 THEREOF 1266/MUMNP/2013 11‐03‐2019 METHOD FOR PREPARING CRYSTALLINE FORM OF ERTAPENEM 308952 SODIUM 1574/MUMNP/2013 11‐03‐2019 SUBSTITUTED MORPHOLINES AS MODULATORS FOR THE CALCIUM 308969 SENSING RECEPTOR 417/CHE/2010 12‐03‐2019 CONTROLLED RELEASE DOSAGE FORM WITH IMPROVED 309060 BIOAVAILABILITY 2157/MUM/2011 12‐03‐2019 PHARMACEUTICAL COMPOSITIONS COMPRISING BETA‐LACTAM 309017 ANTIBIOTIC, SULBACTAM AND BETA‐LACTAMASE INHIBITOR 2740/MUM/2011 12‐03‐2019 A process for preparing S‐(‐)‐9‐fluoro‐6,7‐dihydro‐8‐(4‐ 309023 hydroxypiperidin1‐yl)‐5‐methyl‐1‐oxo‐1H,‐5H‐benzo[i,j]quinolizine‐ 2‐carboxylic acid L‐arginine salt tetrahydrate

2514/MUMNP/2012 12‐03‐2019 TEMPLATED ISLET CELLS AND SMALL ISLET CELL CLUSTERS FOR 309047 DIABETES TREATMENT 201721028736 12‐03‐2019 DIRECT COMPRESSIBLE DUAL DRUG RELEASING PHARMACEUTICAL 309051 COMPOSITION

Page 72 of 85 1575/MUM/2015 12‐03‐2019 A METHOD AND A SYSTEM FOR PRODUCING THERMOLABILE 309059 NANOPARTICLES WITH CONTROLLED PROPERTIES AND NANOPARTICLES MATRICES MADE THEREBY 3942/DELNP/2015 13/03/2019 RINSE OFF SKIN CARE COMPOSITIONS CONTAINING CELLULOSIC 309095 MATERIALS 3296/MUM/2013 13‐03‐2019 A PROCESS FOR THE PREPARATION OF BENZAZEPINE DERIVATIVE 309124

6364/CHENP/2011 13‐03‐2019 A PROCESS FOR PRODUCING AN INJECTABLE COMPOSITION 309139 7094/CHENP/2013 13‐03‐2019 NITROGEN‐CONTAINING SATURATED HETEROCYCLIC COMPOUND 309148

2486/DELNP/2012 13‐03‐2019 COMPOSITION HAVING LIPOLYSIS‐PROMOTING EFFECT 309156 2393/MUMNP/2014 14‐03‐2019 NOVEL PYRIMIDINYL‐DIAZOSPIRO COMPOUNDS 309171 7153/CHENP/2011 14‐03‐2019 PHARMACEUTICAL COMPOSITION OF AN ANTIGENIC TAU PEPTIDE 309199 RECONSTITUTED IN A LIPOSOME. 3215/KOLNP/2012 14‐03‐2019 ARGININE / PHENYLALANINE PEPTIDES 309223 8862/DELNP/2014 14‐03‐2019 IMMORTALIZED STEM CELLS AND MEDICINAL COMPOSITION AND 309229 MEDICINAL PREPARATION COMPRISING PRODUCT THEREOF AS ACTIVE INGREDIENT 7190/DELNP/2012 14‐03‐2019 ANAESTHETIC FORMULATION 309244 707/MUMNP/2015 15‐03‐2019 AGGRECANASE INHIBITORS 309279 3389/KOLNP/2012 16/03/2019 IRE‐1a‐INHIBITORS 309316 2492/MUMNP/2012 16‐03‐2019 “LOW‐OIL PHARMACEUTICAL EMULSION COMPOSITIONS 309318 COMPRISING PROGESTOGEN” 1230/CHE/2013 16‐03‐2019 SITAGLIPTIN PTEROSTILBENE PHOSPHATE SALT, PROCESS FOR THE 309319 PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF

1025/MUM/2009 18‐03‐2019 A NOVEL CREAM AND A PROCESS TO MAKE THE SAME 309330 201617021294 18‐03‐2019 NOVEL TETRAHYDROPYRIDOPYRIMIDINE COMPOUND OR SALT 309366 THEREOF 511/MUMNP/2011 18‐03‐2019 “FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE 309375 TREATMENT OF BACTERIAL INFECTIONS” 409/MUMNP/2013 18‐03‐2019 PROCESS OF MANUFACTURING A STABLE SOFTGEL CAPSULE 309400 CONTAINING MICROENCAPSULATED PROBIOTIC BACTERIA 4972/CHENP/2015 19/03/2019 ANHYDROUS COSMETIC OR DERMATOLOGICAL COMPOSITION 309481 COMPRISING A MEROCYANINE AND AN OILY PHASE 2583/KOLNP/2011 19‐03‐2019 ANTIBODIES TO IL‐6 AND USE THEREOF 309445 4169/KOLNP/2009 19‐03‐2019 “BORDETELLA PARAPERTUSSIS‐CONTAINING WHOLE‐CELL VACCINE 309464 COMPOSITION” 1237/MUM/2012 19‐03‐2019 "AN IMPROVED PROCESS FOR BENDAMUSTINE HYDROCHLORIDE" 309487

3307/KOLNP/2011 19‐03‐2019 BENZOIC ACID (1‐PHENYL‐2‐PYRIDIN‐4‐YL) ETHYL ESTERS AS 309498 PHOSPHODIESTERASE INHIBITORS 6144/CHENP/2013 20/03/2019 PHARMACEUTICAL COMPOSITION COMPRISING PYRIDONE 309529 DERIVATIVES 3063/MUM/2011 20‐03‐2019 A process for preparing antifungal compound 309532 4/MUMNP/2012 20‐03‐2019 FORMULATIONS FOR THE TREATMENT OF DEEP TISSUE PAIN 309536 572/MUM/2009 20‐03‐2019 GRANULAR ASSEMBLIES OF HYDROXYL PROPYL METHYL CELLULOSE 309550 AND PROCESS OF PREPARING THE SAME 126/CHENP/2014 20‐03‐2019 METHODS FOR THE SYNTHESIS AND PURIFICATION OF 309562 DEOXYCHOLIC ACID 271/CHENP/2013 21‐03‐2019 ANTI ANGIOGENIC AGENT AND METHOD OF USING SUCH AGENT 309605 1232/DELNP/2014 21‐03‐2019 NEW BICYCLIC DIHYDROQUINOLINE 2 ONE DERIVATIVES 309623 1761/MUMNP/2015 22‐03‐2019 SKIN CARE FORMULATIONS 309629 2304/CHENP/2015 22‐03‐2019 BIODEGRADABLE DRUG DELIVERY SYSTEMS FOR THE SUSTAINED 309632 RELEASE OF PROTEINS 732/CHENP/2013 22‐03‐2019 A composition for use in the therapeutic treatment of the skin of a 309638 mammal 2911/MUM/2009 22‐03‐2019 VACCINE COMPOSITION 309639 445/MUM/2011 22‐03‐2019 "ORAL COMPOSITIONS" 309649

Page 73 of 85 5575/CHENP/2010 22‐03‐2019 METHOTREXATE ADJUVANTS TO REDUCE TOXICITY AND METHODS 309673 FOR USING THE SAME 2965/DEL/2012 22‐03‐2019 A NOVEL SYNERGISTIC HERBAL FORMULATION OF WITHANIA 309685 SOMNIFERA FOR ANTIHYPERLIPIDEMIC AND ANTIOBESITY ACTIVITY

2430/MUMNP/2012 25/03/2019 HAIR CARE COMPOSITION 309853 4721/CHENP/2013 25/03/2019 USE OF LIQUID MEDIUM EXCHANGE BY CROSS FLOW FILTRATION IN 309796 THE PREPARATION OF DRUG SUSPENSIONS 8739/DELNP/2011 25‐03‐2019 COMPOSITION FOR PREVENTING HAIR LOSS OR FOR STIMULATING 309756 HAIR GROWTH 2098/DELNP/2012 25‐03‐2019 ANIONIC‐CORE COMPOSITION FOR DELIVERY OF THERAPEUTIC 309765 AGENTS; AND METHODS OF MAKING AND USING THE SAME 3671/CHENP/2011 25‐03‐2019 MONO‐AND DI‐PEG IL‐10 PRODUCTION; AND USES 309772 9069/CHENP/2013 25‐03‐2019 SUBSTITUTED PYRIMIDINYL PYRROLES ACTIVE AS KINASE 309812 INHIBITORS 2361/CHENP/2014 25‐03‐2019 SOLID COSMETIC COMPOSITION IN COMPACT POWDER FORM 309830 1700/KOLNP/2012 25‐03‐2019 COMPOSITIONS COMPRISING ANDROGRAPHIS PANICULATA AND 309835 GINKGO BILOBA EXTRACTS COMPLEXED WITH PHOSPHOLIPIDS

2332/CHENP/2011 25‐03‐2019 TARGETING CONSTRUCT COMPRISING ANTI‐POLYMER ANTIBODY 309838 AND LIPOSOMES OR MICROVESICLES BINDING TO THE SAME

1841/MUM/2011 25‐03‐2019 FORMULATION DEVELOPMENT AND EVALUATION OF FLOATING 309848 MICROBALLOONS FOR ORAL CONTROLLED DELIVERY OF DOMPERIDONE 1214/CHENP/2015 25‐03‐2019 CHLORHEXIDINE GLUCONATE SOLUBILIZED IN A HYDROPHOBIC 309860 MONOACYLGLYCERIDE 2342/CHE/2010 25‐03‐2019 TIME AND PH DEPENDENT COLON SPECIFIC SUSTAINED RELEASE 309872 PHARMACEUTICAL COMPOSITION FOR ONCE‐A‐DAY THERAPY FOR THE TREATMENT OF RHEUMATOID ARTHRITIS 8827/CHENP/2014 25‐03‐2019 AN OIL‐IN‐WATER EMULSION‐TYPE COMPOSITION 309875 862/MUMNP/2013 25‐03‐2019 COMPOSITIONS OF ROTIGOTINE AND DERIVATIVES THEREOF 309882 1837/KOLNP/2012 25‐03‐2019 SUBSTITUTED N‐(1H‐INDAZOL‐4‐YL)IMIDAZO[1, 2‐A]PYRIDINE‐3‐ 309894 CARBOXAMIDE COMPOUNDS AS CFMS INHIBITORS 2332/CHENP/2014 26/03/2019 PHENYL DERIVATIVE 309910 577/MUMNP/2012 26/03/2019 A MONOCLONAL ANTIBODY BINDS TO PROTEIN PBP2A FROM 310007 METHICILLIN‐RESISTANT STAPHYLOCOCCUS AUREUS AND PBP5 FROM ENTEROCOCCI 1625/DEL/2013 26‐03‐2019 METHOD FOR PREPARING COMPOSITE GRANULE COMPRISING LOW‐ 309913 SUBSTITUTED HYDROXYPROPYL CELLULOSE AND RAPID RELEASE PREPARATION 4885/DELNP/2011 26‐03‐2019 PHARMACEUTICAL COMPOUNDS 309953 226/MUMNP/2009 26‐03‐2019 “COMBINATIONS FOR ORAL COMPOSITIONS, THEIR PREPARATION 309963 AND USE” 3579/KOLNP/2013 26‐03‐2019 PROCESS FOR THE PREPARATION OF A CHIRAL COMPOUND 309968 1139/CHENP/2015 26‐03‐2019 AMINE SALT AND CRYSTALS THEREOF 309971 3773/MUM/2013 26‐03‐2019 "A COMPOSITION FOR PREPARATION OF VISCOELASTIC 309981 CROSSLINKED HYALURONIC ACID, AND CROSSLINKED HYALURONIC ACID OBTAINED BY USING THE SAME" 2428/MUMNP/2013 26‐03‐2019 STABLE LIQUID FORMULATION OF ETANERCEPT 309986 3912/KOLNP/2012 26‐03‐2019 VACCINE AND METHODS TO REDUCE CAMPYLOBACTER INFECTION 309989

201617005421 26‐03‐2019 HETEROBICYCLOARYL RORC2 INHIBITORS AND METHODS OF USE 309994 THEREOF 10622/DELNP/2013 26‐03‐2019 FILM FORMING COMPOSITION AND USE THEREOF FOR TREATING 310014 HERPES 2607/CHENP/2011 27/03/2019 HUMAN ANTI‐PD‐1, PD‐L1, AND PD‐L2 ANTIBODIES AND USES 310071 THEREFOR 9836/CHENP/2012 27‐03‐2019 PROCESS FOR RALTEGRAVIR POTASSIUM FORM H1 310021

Page 74 of 85 159/MUM/2010 27‐03‐2019 METHOD FOR PREPARATION OF PITAVASTATIN AND ITS 310062 PHARMACEUTICAL ACCEPTABLE SALTS THEREOF 4199/KOLNP/2011 27‐03‐2019 ENZYME DELIVERY SYSTEMS AND METHODS OF PREPARATIONS 310064 AND USE 2392/DEL/2013 27‐03‐2019 NICOTINAMIDE‐HYDROCHLOROTHIAZIDE COCRYSTAL WITH 310067 IMPROVED HYPERTENSIVE ACTIVITY 6789/CHENP/2015 27‐03‐2019 2‐AMINOPYRIDO[4,3‐D]PYRIMIDIN‐5‐ONE DERIVATIVES AND THEIR 310088 USE AS WEE‐1 INHIBITORS 894/MUMNP/2013 27‐03‐2019 LEAVE ON NON SOLID SKIN CONDITIONING COMPOSITIONS 310121 CONTAINING 12 [(12 HYDROXYOCTADECANOYL)OXY] OCTADECANOIC ACID 1773/MUM/2011 27‐03‐2019 NOVEL PLASMODIUM PROTEIN AS MALARIAL VACCINE AND DRUG 310142 TARGET 958/CHENP/2013 27‐03‐2019 BACKING HAVING THREE‐LAYER STRUCTURE AND AQUEOUS PATCH 310146 USING THE BACKING 5019/DELNP/2015 28/03/2019 NON‐ STAINING TOOTHPASTE 310198 424/KOL/2011 28/03/2019 NOVEL TARGETS FOR ANTI‐AGEING 310176 2086/CHE/2007 28‐03‐2019 A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF 310174 PATHOLOGIES CAUSED BY THE GENERAL RESPONSE OF THE IMMUNE SYSTEM 7867/CHENP/2013 28‐03‐2019 ANTIMICROBIAL/ADJUVANT COMPOUNDS AND METHODS 310203 781/CHENP/2015 28‐03‐2019 ARYLETHYNYL PYRIMIDINES 310215 2626/KOLNP/2013 28‐03‐2019 COMPOSITIONS AND METHODS FOR SEPARATING, 310228 CHARACTERIZING AND ADMINISTERING SOLUBLE SELENOGLYCOPROTEINS 1503/DELNP/2013 28‐03‐2019 NON LIPIDATED VARIANTS OF NEISSERIA MENINGITIDIS ORF2086 310236 ANTIGENS 5084/CHENP/2015 28‐03‐2019 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A 310251 MEROCYANINE AN OILY PHASE AND A C1‐C4 MONOALKANOL 7180/DELNP/2015 28‐03‐2019 COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A 310265 MEROCYANINE AND AN INSOLUBLE ORGANIC UV‐SCREENING AGENT AND/OR AN INSOLUBLE INORGANIC UV‐SCREENING AGENT

5217/DELNP/2013 28‐03‐2019 NOVEL BACTERIUM AND EXTRACTS OF SAID BACTERIUM AND THE 310277 USE OF SAME IN DERMATOLOGY 5798/CHENP/2013 28‐03‐2019 THIAZOLYLPHENYL BENZENESULFONAMIDO DERIVATIVES AS 310287 KINASE INHIBITORS 9711/DELNP/2013 28‐03‐2019 SODIUM HYPOCHLORITE BASED BODY WASH COMPOSITIONS 310305 201621042074 28‐03‐2019 APPARATUS FOR SYNTHESIS OF NANOPARTICLE SYSTEM FOR 310318 DESALINATION AND METHOD THEREOF 37/CHENP/2010 28‐03‐2019 IN SITU, LIQUID‐ACTIVATED FILM COATED TABLETS AND A PROCESS 310329 FOR MAKING THE SAME 1855/MUMNP/2010 28‐03‐2019 A COMPOSITION FOR DECREASING THE EXTRACELLULAR MATRIX‐ 310345 PRODUCING CELLS IN THE LUNGS 7617/DELNP/2013 28‐03‐2019 CEFUROXIME SAFETY DELIVERY SYSTEM 310347 2661/MUMNP/2014 29/03/2019 THIENOPYRIDONE DERIVATIVES USEFUL AS ACTIVATORS OF AMPK 310499

5486/DELNP/2012 29/03/2019 TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING 310367 RIVASTIGMINE OR DERIVATIVES THEREOF 2760/DELNP/2015 29/03/2019 COMPOUNDS AND METHODS FOR PREVENTING , TREATING 310488 AND/OR PROTECTING AGAINST SENSORY HAIR CELL DEATH 201617011380 29‐03‐2019 PROCESS FOR MAKING PERSONAL CARE COMPOSITION USING 310356 COMPACTED RHEOLOGY MODIFIERS 7489/CHENP/2014 29‐03‐2019 GREEN CHEMISTRY SYNTHESIS OF THE MALARIA DRUG 310371 AMODIAQUINE AND ANALOGS THEREOF 2507/KOLNP/2012 29‐03‐2019 KETOPROFEN‐CONTAINING AQUEOUS ADHESIVE SKIN PATCH 310427 2560/DEL/2011 29‐03‐2019 “NANO‐DRUG DELIVERY FOR QUINAPYRAMINE SULPHATE” 310429 3677/DELNP/2013 29‐03‐2019 METHOD FOR PRODUCING AND USING A COPOLYMER OF SODIUM 310432 CARBOXYMETHYL CELLULOSE AND GOSSYPOL

Page 75 of 85 8927/DELNP/2011 29‐03‐2019 COMPOSITION CONTAINING SORBITAN MONOCAPRYLATE AND 310446 ANTIMICROBIAL ACTIVE INGREDIENTS" 2898/MUM/2009 29‐03‐2019 PEPTIDE 310477 7249/DELNP/2015 29‐03‐2019 LIPOSOME FORMULATION AND MANUFACTURE 310485 201617035178 29‐03‐2019 BISMUTH CONTAINING LIQUID PHARMACEUTICAL SUSPENSIONS 310498

6169/DELNP/2014 29‐03‐2019 FUSED TETRA OR PENTA CYCLIC 310500 DIHYDRODIAZEPINOCARBAZOLONES AS PARP INHIBITORS 5550/DELNP/2009 29‐03‐2019 "OLIGOMER‐OPIOID AGONIST CONJUGATES" 310508 1563/KOLNP/2014 29‐03‐2019 DRY POWDER FORMULATION COMPRISING A CORTICOSTERIOD 310528 AND A BETA‐ADRENERGIC FOR ADMINISTRATION BY INHALATION

698/KOLNP/2013 29‐03‐2019 SUBSTITUTED PYRAZOLO‐QUINAZOLINE DERIVATIVES KINASE 310569 INHIBITORS 4839/CHE/2012 30/03/2019 PHARMACEUTICAL COMPOSITION FOR THE PREPARATION OF 310575 INFUSION SOLUTIONS OF ANTIMICROBIAL PREPARATIONS, ITS' PRODUCTION PROCESS (VARIATIONS) 4950/KOLNP/2011 30/03/2019 COMPOUNDS USEFUL FOR TREATING PREMATURE AGING AND IN 310608 PARTICULAR PROGERIA 2598/MUMNP/2014 30‐03‐2019 INHIBITORS OF HEPATITIS C VIRUS 310576 488/MUMNP/2014 30‐03‐2019 (THIENO[2 3 B][1 5]BENZOXAZEPIN 4 YL)PIPERAZIN 1 YL 310590 COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5 HT2A ANTAGONISTS 6658/DELNP/2011 30‐03‐2019 "ALKYLAMIDO COMPOUNDS AND USES THEREOF" 310600 1415/KOL/2009 30‐03‐2019 PROCESS FOR PREPARING PHARMACEUTICAL OPHTHALMIC 310609 COMPOSITIONS 2736/KOLNP/2013 30‐03‐2019 ISOXAZOLIDINE DERIVATIVES 310617 6670/DELNP/2013 31‐03‐2019 EMULSION POLYMERISATION METHOD 310626 382/MUMNP/2013 31‐03‐2019 COMPOSITE PARTICLE ACTIVE AND METHOD FOR MAKING THE 310628 SAME 9540/DELNP/2011 01‐04‐2019 "PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF 310647 A BCL‐2 FAMILY INHIBITOR" 10374/CHENP/2013 01‐04‐2019 ACID LABILE LIPOPHILIC PRODRUGS OF CANCER 310673 CHEMOTHERAPEUTIC AGENTS 6573/DELNP/2014 03‐04‐2019 PROCESS FOR OBTAINING A MODAFINIL BASED PHARMACEUTICAL 310771 COMPOSITION RESULTING PHARMACEUTICAL COMPOSITION AND USE THEREOF 201647035515 03‐04‐2019 METHOD OF MANUFACTURING ENTERIC SOFT CAPSULE 310809 3640/DELNP/2015 04‐04‐2019 PYRIDINE DERIVATIVE 310832 10204/CHENP/2012 04‐04‐2019 PHARMACEUTICAL DOSAGE FORM COMPRISING ONE OR MORE 310844 ANTIRETROVIRAL ACTIVE INGREDIENTS 5302/DELNP/2014 04‐04‐2019 PURINONE DERIVATIVE HYDROCHLORIDE 310867 1368/DELNP/2013 04‐04‐2019 PROCESS FOR PRODUCING 1 TRIAZOLE 2 BUTANOL DERIVATIVES 310870

10408/DELNP/2013 05‐04‐2019 A SUSTAINED RELEASE COMPOSITION CONTAINING A 310923 MELANOCORTIN RECEPTOR LIGAND AS THE ACTIVE INGREDIENT 1158/MUMNP/2013 05‐04‐2019 BENZIMIDAZOLE RESPIRATORY SYNCYTIAL VIRUS INHIBITORS 310934 2366/CHENP/2013 08‐04‐2019 AMATOXIN CONJUGATES WITH IMPROVED LINKERS 310961 1988/MUM/2010 08‐04‐2019 PROCESS FOR PREPARATION OF CRYSTALLINE POLYMORPH OF 310987 BROMFENAC SODIUM 9403/DELNP/2012 09‐04‐2019 A solid support coupled to a multiplicity of substituents of the 311001 formula 2 958/MUM/2011 09‐04‐2019 A SUNCREEN COMPOSITION 311011 2008/CHENP/2012 09‐04‐2019 SUBLINGUAL AND BUCCAL FILM COMPOSITIONS 311041 10592/DELNP/2014 09‐04‐2019 NEW HYDROXYSAFFLOR YELLOW PHARMACEUTICAL SALTS 311046 204/DEL/2014 09‐04‐2019 A process for preparation medicated nano patch from nanofibre 311049 and its composition 929/MUMNP/2010 10‐04‐2019 A method of making a pharmaceutical composition 311058

Page 76 of 85 4646/CHE/2011 10‐04‐2019 " A COMPOSITION COMPRISING NANOSPHERE AND HISTONE 311070 ACETYLTRANSFERASE (HAT) ACTIVATOR, PROCESSES AND METHODS THEREOF " 2229/DELNP/2013 10‐04‐2019 A COATED STENT CONTAINING DRUG AND POLYMER COATINGS 311099 775/MUMNP/2013 12‐04‐2019 PHARMACEUTICAL COMPOSITIONS COMPRISING NANO SIZE 311181 DROPLETS OF SKIN WHITENING AGENTS 8510/DELNP/2011 12‐04‐2019 DIALYSIS SOLUTION COMPRISING CREATINE COMPOUNDS 311186 10484/CHENP/2012 12‐04‐2019 LIQUID NASAL SPRAY CONTAINING LOW DOSE NALTREXONE 311195 8894/DELNP/2012 15‐04‐2019 MICRO PARTICLES FOR ORAL DELIVERY IN ANIMALS 311208 761/CHE/2013 15‐04‐2019 COMPOSITION OF A COPPER‐QUERCETIN NANO COMPLEX FOR 311217 TREATING HUMAN PAPILLOMA VIRUS INFECTED CERVICAL CANCER

5397/CHENP/2012 15‐04‐2019 METHOD OF TREATING ATRIAL FIBRILLATION 311225 6516/CHENP/2014 15‐04‐2019 CGRP RECEPTOR ANTAGONIST COMPOUNDS AND PROCESSES 311239 FORMAKING THE SAME 4024/CHENP/2012 16‐04‐2019 PHOTOPROTECTIVE COMPOSITIONS OF A 2‐ALKOXY‐4‐ALKYL 311255 KETONE PHENOL BASED COMPOUND(S) 2682/MUMNP/2012 16‐04‐2019 A Peptide and Composition Containing The Same Peptide and 311292 TGFß1 1461/MUMNP/2014 16‐04‐2019 HAIR COMPOSITION WITH IMPROVED RHEOLOGY 311308 2062/DELNP/2013 16‐04‐2019 QUINOLINE AND QUINOXALINE DERIVATIVES AS KINASE INHIBITORS 311315

2452/DEL/2010 22‐04‐2019 A PHYTO‐PHARMACEUTICAL PREPARATION FOR THE CONTROL OF 311377 ACARICIDE RESISTANT TICK INFESTATIONS IN ANIMALS. 3885/CHENP/2013 22‐04‐2019 USE OF SILANE AND SILOXANE BIS(BIPHENYL)TRIAZINE DERIVATIVES 311378 AS UV ABSORBERS 201621042076 22‐04‐2019 ANIONIC NANOPARTICLE SYSTEM FOR DESALINATION AND 311379 METHOD THEREOF” 864/DELNP/2011 22‐04‐2019 "FILM‐FORMING LIQUID FORMULATIONS FOR DRUG RELEASE TO 311380 HAIR AND SCALP" 4945/CHENP/2014 22‐04‐2019 SITAXSENTAN DERIVATIVE 311402 940/MUM/2008 22‐04‐2019 HOMEOPATHIC COMBINATION TREATMENT TO HEAL 311417 NEUROLOGICAL DISORDERS 585/KOLNP/2014 23‐04‐2019 AN ADHESIVE PATCH CONTAINING RIVASTIGMINE AND AN ALKYL 311440 (METH) ACRYLATE ‐BASED COPOLYMER 2753/MUMNP/2012 23‐04‐2019 “OPTIMIZED IN VIVO DELIVERY SYSTEM WITH ENDOSOMOLYTIC 311443 AGENTS FOR NUCLEIC ACID CONJUGATES” 3218/MUMNP/2015 23‐04‐2019 SUBSTITUTED INDOLE COMPOUNDS 311453 3530/CHENP/2011 23‐04‐2019 “COSMETIC METHOD FOR TREATING HUMAN PERSPIRATION USING 311458 PARTICLES OF AN EXPANDED AMORPHOUS MINERAL MATERIAL; COMPOSITIONS” 4686/DELNP/2011 23‐04‐2019 A MICROENCAPSULATION PROCESS OF SERTOLI CELLS, 311475 MICROCAPSULES OBTAINED AND THEIR USE FOR PREVENTION AND CURE OF TYPE 1 DIABETES MELLITUS 2219/CHENP/2014 24‐04‐2019 ORALLY DISINTEGRATING TABLET CONTAINING HYDROXYALKYL 311512 CELLULOSE FINE PARTICLES 1792/MUM/2011 24‐04‐2019 "NOVEL SUSTAINED‐RELEASE GASTRORETENTIVE DOSAGE FORM OF 311516 ACICLOVIR" 810/MUMNP/2014 24‐04‐2019 COSMETIC COMPOSITION 311527 22/MUM/2010 24‐04‐2019 A SYNERGISTIC COMPOSITION FOR IMPROVING MALE SUB‐ 311535 FERTILITY AND INFERTILITY. 350/MUMNP/2014 24‐04‐2019 TOOTH REMINERALIZING DENTIFRICE 311536 1443/MUM/2014 24‐04‐2019 "METHOD FOR THE SIMPLIFIED PRODUCTION OF FASCIOLICIDE AND 311538 DERIVATIVE THEREOF" 1124/KOLNP/2015 24‐04‐2019 QUINAZOLINONE DERIVATIVES AS PARP INHIBITORS 311543 811/CHE/2012 24‐04‐2019 TENOFOVIR PHOSPHATE, PROCESSES FOR THE PREPARATION AND 311570 PHARMACEUTICAL COMPOSITION THEREOF 9662/CHENP/2013 24‐04‐2019 TOPICAL WASH COMPOSITION FOR USE IN ACNE PATIENTS 311577 3553/DELNP/2015 24‐04‐2019 NOVEL BENZAZEPINE DERIVATIVE AND PHARMACEUTICAL USE 311579 THEREOF

Page 77 of 85 495/DELNP/2014 24‐04‐2019 PHARMACEUTICAL COMPOSITION FOR TREATING PREMATURE 311585 EJACULATION AND METHOD FOR TREATING PREMATURE EJACULATION 2298/MUM/2010 25‐04‐2019 CONTROLLED‐RELEASE FORMULATION COMPRISING HCG 311592 201617019192 25‐04‐2019 SERINE GLYCEROPHOSPHOLIPID PREPARATION AND METHOD FOR 311605 TREATMENT OF SEIZURES 1094/MUMNP/2013 25‐04‐2019 LEAVE ON NON‐SOLID SKIN CONDITIONING COMPOSITIONS 311623 CONTAINING 12‐HYDROXYSTEARIC ACID AND ETHOXYLATED HYDROGENATED CASTOR OIL 9103/DELNP/2011 25‐04‐2019 "NITRILE DERIVATIVES AND THEIR PHARMACEUTICAL USE AND 311629 COMPOSITIONS" 962/KOLNP/2010 25‐04‐2019 ANTIDOTES FOR FACTOR XA INHIBITORS AND METHODS OF USING 311668 THE SAME 842/MUMNP/2014 26‐04‐2019 METHODS OF PREPARING ICOTINIB AND ICOTINIB HYDROCHLORIDE 311673 AND INTERMEDIATES THEREOF 41/CHENP/2013 26‐04‐2019 D2 ANTAGONISTS METHODS OF SYNTHESIS AND METHODS OF USE 311677

6436/CHENP/2013 26‐04‐2019 ORGANIC AMINE SALTS OF AZILSARTAN PREPARATION METHOD 311684 AND USE THEREOF 4379/CHENP/2012 26‐04‐2019 BIOSYNTHETIC SYSTEM THAT PRODUCES IMMUNOGENIC 311691 POLYSACCHARIDES IN PROKARYOTIC CELLS 8211/CHENP/2012 26‐04‐2019 NON‐NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS 311693 806/KOLNP/2014 26‐04‐2019 CRYSTALLINE MICROPARTICLES OF A BETA‐AGONIST COATED WITH 311733 A FATTY ACID 57/CHENP/2011 26‐04‐2019 CONDITIONED MEDIUM OF LIVER PROGENITOR CELLS 311737 1413/DELNP/2013 26‐04‐2019 HETEROCYCLIC COMPOUND AND USE THEREOF 311751 6266/DELNP/2014 29/04/2019 A DETECTING AGENT COMPOSITION AND METHOD FOR 311788 PREPARATION THEREOF 547/CHE/2012 29/04/2019 PROCESS TO PREPARE ERTAPENEM AND ITS SALTS 311872 4096/DELNP/2015 29‐04‐2019 FLOWABLE PEROXIDE CONTAINING ORAL CARE COMPOSITIONS 311768 921/DELNP/2014 29‐04‐2019 CONFORMABLE PERSONAL CARE ARTICLES 311786 7666/CHENP/2011 29‐04‐2019 COMBINATION THERAPY 311800 2738/CHENP/2013 29‐04‐2019 MELT EXTRUDED SOLID DISPERSIONS CONTAINING AN APOPTOSIS 311802 INDUCING AGENT 1860/MUM/2011 29‐04‐2019 "IMPROVED ONE POT PROCESS FOR SYNTHESIS OF BUSPIRONE 311837 BASE" 6751/CHENP/2009 29‐04‐2019 “UNACYLATED GHRELIN AS THERAPEUTIC AGENT IN THE 311846 TREATMENT OF METABOLIC DISORDERS” 1464/MUMNP/2014 29‐04‐2019 WATER IN OIL TYPE EMULSION SKIN COSMETIC 311847 10303/CHENP/2013 29‐04‐2019 PHARMACEUTICAL COMPOSITION FOR TREATING SCARS ON THE 311850 SKIN AND METHOD FOR TREATING SCARS ON THE SKIN USING SAME 3236/DELNP/2011 29‐04‐2019 "METHOD FOR PRODUCTION OF PH STABLE ENVELOPED VIRUSES" 311853

9421/DELNP/2008 29‐04‐2019 "RADIOLABELED DIHYDROTETRABENAZINE DERIVATIVES AND THEIR 311892 USE AS IMAGING AGENTS" 4774/DELNP/2013 30/04/2019 2 PIPERAZIN 1 YL 4H 1 3 BENZOTHIAZIN 4 ONE DERIVATIVES AND 311965 THEIR USE FOR THE TREATMENT OF MAMMALIAN INFECTIONS

3698/MUM/2012 30‐04‐2019 DISSOLVE 100% PURE OXYGEN GAS IN TO WATER FOR INJENCTION 311914 IP WHICH BASE OF INFUSION SALINE AND DONATED BLOOD.

751/DELNP/2014 30‐04‐2019 NOVEL BENZOIC ACID AMIDE COMPOUND 311917 5632/CHENP/2015 30‐04‐2019 SPHINGOSINE‐1‐PHOSPHATE RECEPTOR AGONISTS, METHODS OF 311950 PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT 5751/DELNP/2015 30‐04‐2019 POLYMYXINS , COMPOSITIONS AND METHODS OF USE 311955 267/MUMNP/2012 30‐04‐2019 "BISPHOSPHONATE‐PRODRUGS" 311958 6705/CHENP/2014 30‐04‐2019 MULTICOMPONENT ORAL CARE COMPOSITION 311961

Page 78 of 85 1614/KOLNP/2013 30‐04‐2019 HETEROCYCLIC DERIVATES, PREPARATION PROCESSES AND 311963 MEDICAL USES THEREOF 4450/CHENP/2011 30‐04‐2019 VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE 311964 3062/KOLNP/2013 30‐04‐2019 NOVEL GOLD‐PLATINUM BASED BI‐METALLIC NANOCRYSTAL 311966 SUSPENSIONS, ELECTROCHEMICAL MANUFACTURING PROCESSES THEREFOR AND USES FOR THE SAME 6669/CHENP/2012 30‐04‐2019 8 METHYL 1 PHENYL IMIDAZOL[1 5 A]PYRAZINE COMPOUNDS 312006 5218/CHENP/2011 30‐04‐2019 MELANOCORTIN ANALOGS WITH ANTIMICROBIAL ACTIVITY 312007 201847011475 30‐04‐2019 NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS 312021 AND USES THEREOF 7495/CHENP/2013 30‐04‐2019 PRODRUGS OF LXR MODULATING IMIDAZOLE 312025 2025/CHENP/2012 30‐04‐2019 MOLECULAR PROBE FOR IMAGING OF PANCREATIC ISLETS AND USE 312031 OF THE SAME 1168/KOLNP/2011 30‐04‐2019 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS 312047

335/DELNP/2015 30‐04‐2019 SUBSTITUTED THIOPHENE‐ AND FURAN‐FUSED AZOLOPYRIMIDINE‐ 312050 5‐(6H)‐ONE COMPOUNDS 8081/CHENP/2012 30‐04‐2019 PROCESS FOR PRODUCTION AND PURIFICATION OF RECOMBINANT 312055 LYSOSOMAL ALPHA‐MANNOSIDASE 201647042606 30‐04‐2019 SUBSTITUTED IMIDAZO[1,2‐A]PYRIDINE COMPOUNDS USEFUL FOR 312057 THE TREATMENT OF PAIN 9473/DELNP/2012 30‐04‐2019 ANTICANCER STEROIDAL LACTONES UNSATURATED IN POSITION 7 312063 (8) 10790/CHENP/2012 30‐04‐2019 CYSTEINE DERIVATIVE 312064 3436/CHENP/2013 30‐04‐2019 NOVEL ANTI DR5 ANTIBODY 312077 3060/DELNP/2013 30‐04‐2019 AGENT FOR TREATMENT OF DRY EYE CHARACTERIZED BY 312088 COMBINING P2Y2 RECEPTOR AGONIST WITH HYALURONIC ACID OR SALT THEREOF METHOD FOR TREATING DRY EYE AND USE OF THE P2Y2 RECEPTOR AGONIST AND HYALURONIC ACID OR SALT THEREOF 3338/KOLNP/2011 01‐05‐2019 BROAD SPECTRUM VACCINE AGAINST NON‐TYPHOIDAL 312110 SALMONELLA 1093/MUMNP/2013 01‐05‐2019 BOVINE VIRAL DIARRHEA VIRUS TYPE 1B VACCINE COMPOSITIONS 312123 AND METHODS 1495/MUMNP/2014 02‐05‐2019 CALMANGAFODIPIR A NEW CHEMICAL ENTITY AND OTHER MIXED 312153 METAL COMPLEXES METHODS OF PREPARATION COMPOSITIONS AND METHODS OF TREATMENT 1573/MUM/2009 02‐05‐2019 A NOVEL PROCESS FOR LARGE SCALE PRODUCTION OF VIRAL 312154 ANTIGEN 1931/MUMNP/2015 02‐05‐2019 NOVEL AMINOPYRAZINE COMPOUNDS 312181 5041/KOLNP/2011 02‐05‐2019 MATERIALS AND METHODS RELATING TO GLYCOSYLATION 312186 1891/CHENP/2013 02‐05‐2019 METHOD FOR PURIFYING PEGYLATED ERYTHROPOIETIN 312209 2009/MUMNP/2013 02‐05‐2019 a composition comprising 5‐HT2A antagonist, a norepinephrine ‐ 312213 dopamine reuptake inhibitor 241/DEL/2010 03‐05‐2019 RICE POLYNUCLEOTIDE ASSOCIATED WITH BLAST RESISTANCE AND 308533 USES THEREOF 588/CHENP/2011 03‐05‐2019 “SYNERGISTIC ANTIMICROBIAL MIXTURES” 308579 949/CHENP/2013 03‐05‐2019 COMPOSITION OF HEPATITIS C VIRUS INHIBITORS 312230 72/DELNP/2006 03‐05‐2019 "PYRIMIDINE‐2, 4‐DIONE BASED COMPOUNDS AS GONADOTROPIN‐ 312234 RELEASING HORMONE RECEPTOR ANTAGONISTS"

6157/DELNP/2011 03‐05‐2019 "A Pharmaceutical Composition Comprising 1‐chloro‐4‐(ß‐D‐ 312235 glucopyranos‐1‐yl)‐2‐[4‐((S)‐tetrahydrofuran‐3‐yloxy)‐benzyl]‐ benzene and process thereof" 9763/DELNP/2013 03‐05‐2019 PERSONAL CARE COMPOSITIONS 312237 1375/KOLNP/2012 03‐05‐2019 DERIVATIVES OF NOVEL PEROXIDES, METHOD OF PREPARATION 312244 THEREOF AND USE THEREOF IN HUMAN MEDICINE AS WELL AS IN COSMETICS FOR THE TREATMENT OR PREVENTION OF ACNE 301/CHENP/2012 03‐05‐2019 PREPARATION COMPRISING INSULIN, NICOTINAMIDE AND AN 312254 AMINO ACID

Page 79 of 85 4943/DELNP/2013 03‐05‐2019 INFUSION PREPARATION 312259 8488/CHENP/2013 03‐05‐2019 Solid oral pharmaceutical composition comprising CNS stimulant 312267

464/CHENP/2015 03‐05‐2019 Composition comprising sulfated poloxamersand methods of 312272 making same 9854/CHENP/2013 03‐05‐2019 CONSTRUCTION AND APPLICATION OF MUTANT TYPE B HUMAN 312278 ADENOVIRUS AD11 HAVING ENHANCED ONCOLYTIC POWER 2483/MUM/2011 04‐05‐2019 "COMPOSITION AND METHOD FOR AN INTRADERMAL HAIR 310925 GROWTH SOLUTION" 10626/DELNP/2013 06‐05‐2019 BIOPASSIVATING MEMBRANE STABILIZATION BY MEANS OF 312301 NITROCARBOXYLIC ACID CONTAINING PHOSPHOLIPIDS IN PREPARATIONS AND COATINGS 2443/DELNP/2013 06‐05‐2019 CYCLOSPORINE EMULSION 312315 5063/KOLNP/2011 06‐05‐2019 PYRAZINOOXAZEPINE DERIVATIVES 312319 6243/DELNP/2006 06‐05‐2019 ""AN INTRACELLULAR DELIVERY SYSTEM FOR THE DELIVERY OF AT 312340 LEAST ONE BIOACTIVE AGENT WITHIN A CELL AND A METHOD THEREOF 10454/DELNP/2012 06‐05‐2019 COMPOSITIONS FOR TREATING SKIN 312341 2993/MUMNP/2015 07‐05‐2019 COMPOSITION COMPRISING SALBUTAMOL SULPHATE 312348 4929/DELNP/2015 07‐05‐2019 1‐(substituted‐benzoyl)‐5‐fluoro‐4‐imino‐3‐methyl‐3,4‐ 312351 dihydropyrimidin‐2(1H)‐one 496/DEL/2009 07‐05‐2019 "A PROCESS AND METHOD FOR STANDARDIZED EXTRACT OF 312354 WITHANIA SOMNIFERA AND PHARMACEUTICAL USES THEREOF." 533/MUMNP/2014 07‐05‐2019 PYRROLOBENZODIAZEPINES 312392 1455/CHENP/2012 07‐05‐2019 SILVER OXIDE FORMULATIONS HAVING IMPROVED WHITENESS 312397 CHARACTERISTICS 846/KOLNP/2013 07‐05‐2019 SUBSTITUTED 2‐OXO‐ AND 2‐THIOXO‐DIHYDROQUINOLINE‐3‐ 312413 CARBOXAMIDES AS KCNQ2/3 MODULATORS 4545/CHENP/2014 08‐05‐2019 COSMETIC COMPOSITION COMPRISING OLEOGEL 312428 10677/CHENP/2012 08‐05‐2019 ANTIBODIES TO HUMAN GDF8 312458 10385/DELNP/2014 08‐05‐2019 EFFERVESCENT DOSAGE FORM 312472 516/DELNP/2012 09‐05‐2019 Topical composition containing sildenafil 312495 2539/MUM/2012 09‐05‐2019 A STABLE AQUEOUS SUSPENSION OF LOTEPREDNOL ETABONATE. 312519

6685/CHENP/2013 09‐05‐2019 METHOD FOR PREPARING MULTIPLE ANTIGEN GLYCOPEPTIDE 312498 CARBOHYDRATE CONJUGATES 1736/MUMNP/2014 09‐05‐2019 PIPERIDINO PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF 312522 VIRAL INFECTIONS 120/KOLNP/2011 09‐05‐2019 AN IMMUNOGENIC COMPOSITION 312549 463/MUMNP/2015 10‐05‐2019 HYDROMORPHONE HYDROCHLORIDE CONTAINING ORAL 312621 SUSTAINED RELEASE PHARMACEUTICAL COMPOSITION 1821/CHENP/2013 10‐05‐2019 TRIAZINE DERIVATIVE AND PHARMACEUTICAL COMPOUND THAT 312593 CONTAINS SAME AND EXHIBITS ANALGESIC ACTIVITY 2501/CHE/2009 10‐05‐2019 "A NOVEL METHOD FOR THE PREPARATION OF CHITIN/PVA/PEG 312609 CROSSLINKED HYDROGEL FOR BIOMEDICAL APPLICATION" 4997/DELNP/2011 10‐05‐2019 COVALENT DIABODIES AND USES THEREOF 312611 2511/KOLNP/2014 10‐05‐2019 METHOD FOR PREPARING LOW DOSAGE ENTECAVIR FORMULATION 312614 FOR ORAL ADMINISTRATION 2566/MUMNP/2015 10‐05‐2019 PERSONAL CARE PHOTOPROTECTIVE COMPOSITIONS WITH 312634 TRICYCLODECANE AMIDES 964/KOL/2011 10‐05‐2019 METHOD AND SYSTEM OF ENHANCED DEGRADATION OF BILIRUBIN 312640 INVOLVING ZINC OXIDE (ZnO) NANOPARTICLES 4174/CHENP/2014 10‐05‐2019 DIHYDRO BENZO OXAZINE AND DIHYDRO PYRIDO OXAZINE 312642 DERIVATIVES 10596/CHENP/2012 13‐05‐2019 BENZODIOXOLE OR BENZODIOXEPINE HETEROCYCLIC COMPOUNDS 312656 AS PHOSPHODIESTERASE INHIBITORS 8888/CHENP/2011 14‐05‐2019 ANTI‐IL17F ANTIBODIES AND METHODS OF USE THEREOF 312712 936/MUM/2012 14‐05‐2019 A PROCESS for PREPARATION of gelled ENEMA COMPOSITION 312713

Page 80 of 85 467/MUMNP/2014 14‐05‐2019 ANHYDROUS ANTIPERSPIRANT COMPOSITIONS AND METHOD FOR 312722 REDUCING PERSPIRATION 2470/MUM/2013 14‐05‐2019 “FORMULATION COMPRISING A HYPOLIPIDEMIC AGENT” 312723 2038/MUMNP/2014 15/05/2019 TOPICAL SPRAY COMPOSITION AND SYSTEM FOR DELIVERING THE 312773 SAME 1165/KOLNP/2011 15‐05‐2019 PYRAZOLO PYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS 312746

2503/DEL/2012 15‐05‐2019 PROCESS FOR THE PREPARATION OF DABIGATRAN ETEXILATE AND 312752 INTERMEDIATES THEREOF 535/KOLNP/2012 16‐05‐2019 A THERAPEUTIC COMBINATION COMPRISING A PULMONARY 312793 SURFACTANT AND ANTIOXIDANT ENZYMES 2578/DEL/2012 16‐05‐2019 FUTURE MAGIC BULLET OF "POLYHERBOCEUTICAL FORMULATION" 312803 FOR TREATMENT OF HYPERTENSION. 3093/MUMNP/2015 16‐05‐2019 A MOUTH WASH ORAL CARE COMPOSITIONS 312810 3904/CHENP/2012 17/05/2019 STABILISING EXCIPIENT FOR INACTIVATED WHOLE‐VIRUS VACCINES 312843

639/DELNP/2012 17‐05‐2019 "COMBINATION THERAPY FOR THE TREATMENT OF DIABETES" 312847 8274/CHENP/2011 17‐05‐2019 MENINGOCOCCAL AND PNEUMOCOCCAL CONJUGATE VACCINE 312855 AND METHOD OF USING SAME 4989/CHENP/2015 20/05/2019 MONOCYCLIC PYRIDINE DERIVATIVE 312904 1386/KOLNP/2011 20‐05‐2019 METHOD FOR PRODUCING A GRANULATE 312875 3029/KOLNP/2015 20‐05‐2019 SITE SPECIFIC INSULIN CONJUGATE 312893 10287/CHENP/2012 20‐05‐2019 A PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A 312913 VITAMIN D ANALOGUE AND A CORTICOSTEROID 9555/DELNP/2011 20‐05‐2019 PREVENTION AND TREATMENT OF NOSEMA DISEASE IN BEES 312922 2759/MUM/2009 21‐05‐2019 AN IMPROVED PROCESS OF PREPARING OLOPATADINE AND 312948 PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF 13/DEL/2014 21‐05‐2019 SILICON BASED FUNGICIDES 312955 10655/CHENP/2012 21‐05‐2019 PROCESS FOR PRODUCING MICROCAPSULES 312967 10088/DELNP/2014 21‐05‐2019 CAMSYLATE SALT 312976 172/MUMNP/2013 22‐05‐2019 SKIN CARE COMPOSITIONS COMPRISING SUBSTITUTED 313013 MONOAMINES 2085/MUMNP/2010 22‐05‐2019 “TETRAHYDROCYCLOPENTA[B]INDOLE ANDROGEN RECEPTOR 313020 MODULATORS” 2421/KOLNP/2013 23/05/2019 COMPOSITION FOR DYEING KERATINOUS FIBRES COMPRISING A 313105 DIRECT DYE HAVING A DISULPHIDE/THIOL FUNCTIONAL GROUP, A THICKENING POLYMER, AN ETHOXYLATED FATTY ALCOHOL AND/OR A NONIONIC SURFACTANT, AN ALKALINE AGENT AND A REDUCING AGENT 3934/DELNP/2011 23‐05‐2019 "ANTITUMOR AGENT, A METHOD FOR THE PRODUCTION OF SAID 313066 AGENT AND A METHOD FOR THE STABILISATION THEREOF" 2956/DELNP/2014 23‐05‐2019 A composition comprising Sofosbuvir and Ledipasvir 313093 2919/DELNP/2012 24‐05‐2019 "RICE WHITENING" 313134 1991/MUMNP/2014 24‐05‐2019 PRE BLENDED MIXTURES OF SPECIFIC HYDROCARBON LIQUIDS 313142 STRUCTURED WITH HIGH MELTING POINT STRUCTURING MATERIAL

1686/MUMNP/2013 24‐05‐2019 HAIR CARE COMPOSITION COMPRISING PYRITHIONE AND A PURPLE 313145 PINK OR RED COLOURING COMPONENT 5329/DELNP/2013 27/05/2019 6‐DEOXY‐6‐THIOETHER‐AMINO ACID CYCLODEXTRIN DERIVATIVES 313225 AND PREPARATION METHOD THEREOF 201617042199 27‐05‐2019 DISPERSION COMPRISING A PARTIALLY NEUTRALIZED ESTERIFIED 313198 CELLULOSE ETHER 3760/DEL/2012 27‐05‐2019 ORAL GEL FOR RELIEF OF TOOTH PAIN 313201 2463/DELNP/2013 27‐05‐2019 MEDICAL ADSORBENT AND METHOD FOR PRODUCING SAME 313219 1063/KOLNP/2011 27‐05‐2019 ATROPISOMERS OF (HYDROXYALKYL) PYRROLE DERIVATIVES 313243 5146/DELNP/2013 28/05/2019 NOVEL SUBSTITUTED ISOQUINOLINE DERIVATIVE 313264 9366/CHENP/2014 28‐05‐2019 BENZIMIDAZOLE PROLINE DERIVATIVES 313297 2428/CHENP/2013 28‐05‐2019 VESICULAR STOMATITIS VIRUSES 313304

Page 81 of 85 201617004991 29‐05‐2019 NOVEL TRIAZOLO[4,5‐D]PYRIMIDINE DERIVATIVES 313316 8840/DELNP/2011 29‐05‐2019 HPV PARTICLES AND USES THEREOF 313360 2341/MUMNP/2011 29‐05‐2019 PREBIOTIC COMPOSITION 313377 7863/DELNP/2012 29‐05‐2019 PROCESS FOR PRODUCING AN ALLERGEN EXTRACT 313394 8883/DELNP/2013 30‐05‐2019 COSMETIC COMPOSITION COMPRISING 4‐(3‐ETHOXY‐4‐ 313412 HYDROXYPHENYL)‐2‐BUTANONE AND A LIPO‐ PHILIC SOLVENT 1580/DEL/2010 30‐05‐2019 "PROCESS FOR THE PREPARATION OF ELETRIPTAN 313423 HYDROBROMIDE" 3675/DELNP/2013 30‐05‐2019 PHARMACEUTICAL FORMULATION FOR HISTONE DEACETYLASE 313431 INHIBITORS 1439/CHENP/2012 30‐05‐2019 PLASMODIUM FALCIPARUM SPOROZOITE AND LIVER STAGE 313436 ANTIGENS 2497/CHENP/2011 30‐05‐2019 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN 313452 6778/CHENP/2014 30‐05‐2019 SUBSTITUTED HETEROCYCLIC ACETAMIDES AS KAPPA OPIOID 313455 RECEPTOR (KOR) AGONISTS 5394/CHENP/2013 30‐05‐2019 NOVEL PHARMACEUTICAL FORMULATION COMPRISING NSAID AND 313476 CYCLODEXTRIN 7779/CHENP/2010 30‐05‐2019 FGF21 MUTANTS AND USES THEREOF 313496 591/KOL/2013 31/05/2019 PROCESS FOR THE PREPARATION OF PROBIOTIC FENNEL AND USES 313536 THEREOF. 1402/MUMNP/2013 31‐05‐2019 A METHOD FOR FORMATION OF HYDROXYPYRONE COMPOUNDS 313515

2912/DELNP/2015 31‐05‐2019 OXAZOLIDIN ‐2 ‐ONE ‐PYRIMIDINE DERIVATIVES 313522 5967/CHENP/2011 31‐05‐2019 POLICOSANOL NANOPARTICLES 313549 201621014443 31‐05‐2019 ROTARY ENDODONTIC FILE IN BASKET FORM. 313552 968/MUMNP/2012 31‐05‐2019 ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS 313560 2463/MUMNP/2013 31‐05‐2019 ANTIBODIES THAT BIND TO OX40 AND THEIR USES 313562 8444/CHENP/2013 31‐05‐2019 5 MEMBERED RING AROMATIC HETEROCYCLIC DERIVATIVE HAVING 313582 NPY Y5 RECEPTOR ANTAGONISTIC ACTIVITY 187/KOL/2014 31‐05‐2019 "NOVEL POLYSACCHARIDE‐BASED AMPHIPHILIC COPOLYMER AND 313586 PREPARATION OF ANTI‐RHINITIS MICELLAR SOLUTION THEREOF"

1993/DELNP/2014 31‐05‐2019 Method for synthesizing N‐[5‐(aminosulfonyl)‐4‐methyl‐1,3‐thiazol‐ 313595 2‐yl]‐Nmethyl‐2‐[4‐(2‐pyridinyl)phenyl]acetamide 1825/CHE/2012 31‐05‐2019 HYALURONIC ACID ESTERS, THEIR PREPARATIONAND USE IN 313613 DERMATOLOGY 1147/CHENP/2015 04‐06‐2019 NOVEL DEPILATORY PRODUCT 313710 5404/CHE/2015 04‐06‐2019 AN IMPROVED PROCESS FOR PREPARATION OF ATORVASTATIN OR 313751 PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF 2023/DELNP/2013 05‐06‐2019 NOVEL D3 DOPAMINE RECEPTOR AGONISTS TO TREAT DYSKINESIA 312333 IN PARKINSON'S DISEASE 379/DEL/2011 05‐06‐2019 "A NOVEL PHAR MACEUTICAL COMPOSITION COMPRISING 312307 LEVOSULPIRIDE AND HYOSCINE BUTYL BROMIDE FOR THE TREATMENT OF SPASM RELATED GERD" 2041/MUMNP/2014 06‐06‐2019 PRE BLENDED MIXTURES OF SPECIFIC NATURALLY SOURCED LIQUID 313782 MATERIALS STRUCTURED WITH NATURALLY SOURCED HIGH MELTING POINT STRUCTURING MATERIAL 1546/DELNP/2013 06‐06‐2019 QUINOLINE DERIVATIVES AND MELK INHIBITORS CONTAINING THE 313803 SAME 7885/DELNP/2014 06‐06‐2019 THIADIAZOLIDINEDIONES AS GSK 3 INHIBITORS 313804 3558/DEL/2013 06‐06‐2019 NOVEL LIQUID CRYSTALLINE NANOPARTICULATE COMPOSITION 313805 AND PROCESS OF PREPARATION THEREOF 8733/DELNP/2012 07‐06‐2019 HETEROGENEOUS IMPLANTABLE DEVICES FOR DRUG DELIVERY 313830 201617006641 07‐06‐2019 ARTICLE WITH REACTIVE METALS BOUND TO ITS SURFACE AND 313843 METHOD OF APPLICATION 2915/KOLNP/2014 07‐06‐2019 PRODRUG DERIVATIVES OF (E)‐N‐METHYL‐N‐((3‐ 313852 METHYLBENZOFURAN‐2‐YL)METHYL)‐3‐(7‐OXO‐5, 6, 7, 8‐ TETRAHYDRO‐1, 8‐ NAPHTHYRIDIN‐3‐YL)ACRYLAMIDE

Page 82 of 85 9559/DELNP/2015 07‐06‐2019 COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF 313874 PROSTAGLANDINS TO SUBCUTANEOUS FAT 29/KOL/2014 10‐06‐2019 A COSMETIC COMPOSITION FOR EXTENDED UV PROTECTION 313909 207/DEL/2011 11‐06‐2019 A SYNTHETIC PEPTIDE FORMULATION AGAINST MELANOMA AND 314002 OTHER CANCER OVER‐EXPRESSING S100B 9939/DELNP/2014 11‐06‐2019 A PROCESS FOR THE PREPARATION OF ESSENTIALLY PURE, 314005 CRYSTALLINE, N‐[({2‐[4‐(2‐ETHYL‐4,6‐DIMETHYL‐1H‐IMIDAZO[4,5‐ C]PYRIDIN‐1‐YL)PHENYL]ETHYL}AMINO)CARBONYL]‐4‐ METHYLBENZENESULFONAMIDE POLYMORPH FORM A

10686/DELNP/2012 12‐06‐2019 TETRAHYDRO PYRIDO PYRIMIDINE COMPOUNDS 314019 5790/CHENP/2014 12‐06‐2019 IMPROVED PROCESS FOR PREPARATION OF PURE LINAGLIPTIN 314036 37/DEL/2014 12‐06‐2019 COATING COMPOSITION, DRUG‐CONTAINING PARTICLE, SOLID 314058 PREPARATION AND METHOD FOR PREPARING DRUG‐CONTAINING PARTICLE 10282/CHENP/2012 12‐06‐2019 VECTORS AND SEQUENCES FOR THE TREATMENT OF DISEASES 314064 10121/CHENP/2013 12‐06‐2019 CAMPTOTHECIN DERIVATIVE METHOD FOR PREPARING SAME 314072 PHARMACEUTICAL COMPOSITION AND USE THEREOF 4057/DELNP/2015 12‐06‐2019 NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE 314085 INHIBITORS 3738/KOLNP/2011 13/06/2019 BACTERIA STRAINS HAVING A HIGH ANTI‐INFLAMMATORY ACTIVITY 314125

5957/DELNP/2012 13‐06‐2019 "A PHARMACEUTICAL COMPOSITION FOR VAGINAL APPLICATION" 314098

9281/DELNP/2012 13‐06‐2019 NOVEL HYDROXAMIC ACID DERIVATIVE 314104 158/KOL/2011 13‐06‐2019 LONG LASTING HAIR CONDITIONING FORMULATION 314112 158/CHENP/2015 13‐06‐2019 AN ANTIBODY COMPOSITION FOR PREVENTION OR TREATMENT OF 314118 MUTANT HEPATITIS B VIRUS INFECTION 3939/CHE/2013 13‐06‐2019 NOVEL ACID ADDITION SALTS OF DABIGATRAN ETEXILATE, PROCESS 314140 FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITION THEREOF 1948/KOLNP/2011 13‐06‐2019 NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF 314151 THERAPEUTICS 588/KOLNP/2013 14‐06‐2019 TAMPER RESISTANT DOSAGE FORM COMPRISING INORGANIC SALT 314203

9793/DELNP/2012 14‐06‐2019 AMINOGLYCOSIDE DERIVATIVES 314208 8189/CHENP/2013 14‐06‐2019 MESH ENCLOSED TISSUE CONSTRUCTS 314210 10747/CHENP/2012 14‐06‐2019 MACROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF HISTONE 314222 DEACETYLASES 7026/CHE/2015 17‐06‐2019 COMPOSITION FOR SUSTAINED RELEASE OF CARBONATE AND A 314266 WATER PURIFICATION DEVICE BASED ON THE SAME WITH ENHANCED BIOCIDAL ACTIVITY 1348/MUMNP/2014 19‐06‐2019 PERSONAL CARE COMPOSITIONS CONTAINING IONIC SILICONE AND 314283 FILM FORMING AGENT 9701/CHENP/2013 19‐06‐2019 METHOD FOR PRODUCING POWDER FOR INHALATION 314284 397/CHENP/2014 19‐06‐2019 CYCLIC P1 LINKERS AS FACTOR XIA INHIBITORS 314285 299/MUM/2010 19‐06‐2019 A PROCESS OF PREPARING 42‐O‐HETEROALKYL AND 42‐O‐ 314301 ALKOXYALKYL DERIVATIVES OF RAPAMYCIN. 3123/DELNP/2012 19‐06‐2019 "STABLE FAT‐SOLUBLE ACTIVE PRINCIPLES PARTICLES" 314326 4922/CHENP/2014 20/06/2019 PAROXETINE DERIVATIVE 314368 201821016579 21/06/2019 PROCESS FOR PLEATING AND FOLDING DRUG COATED BALLOON 314415 5220/DELNP/2012 21‐06‐2019 “METHOD FOR TREATING RETINAL CONDITIONS USING AN 314400 INTRAOCULAR TAMPONADE” 2361/MUM/2010 21‐06‐2019 A PERSONAL CARE COMPOSITION 314428 1036/MUMNP/2014 21‐06‐2019 MICROBICIDAL COMPOSITION 314446 3487/KOLNP/2011 21‐06‐2019 DIPEPTIDE AS FEEDSTUFF ADDITIVE 314451 5675/DELNP/2013 24/06/2019 CYCLOPROPYLAMINES AS LSD1 INHIBITORS 314483 10377/CHENP/2012 24‐06‐2019 LONG‐TERM STORAGE OF NON‐GLYCOSYLATED RECOMBINANT 314457 HUMAN G‐CSF

Page 83 of 85 7624/DELNP/2014 24‐06‐2019 “A SOLID FORMULATION COMPRISING PIMOBENDAN” 314486 1061/MUMNP/2014 24‐06‐2019 ANTIMICROBIAL COMPOSITION 314522 10384/CHENP/2012 24‐06‐2019 METHOD FOR PREPARING BROUSSONETIA KAZINOKI EXTRACT 314553 2972/CHENP/2014 24‐06‐2019 IMPROVED CROSS LINKING COMPOSITION DELIVERED BY 314564 IONTOPHORESIS USEFUL FOR THE TREATMENT OF KERATOCONUS

663/MUMNP/2014 25‐06‐2019 'Compositions comprising bacteriophage' 314580 6897/CHENP/2010 25‐06‐2019 A pharmaceutical composition for effecting weight loss and treating 314596 obesity 3180/DELNP/2014 25‐06‐2019 [1 2 3] TRIAZOLO [4 5 D] PYRIMIDINE DERIVATIVES AS AGONISTS 314598 OF THE CANNABINOID RECEPTOR 2 6270/CHENP/2013 25‐06‐2019 MUTANT INTERLEUKIN 2 POLYPEPTIDES 314600 6667/DELNP/2015 25‐06‐2019 DYNAMIC SUSPENSION DRYING (DSD) TO CONTROL OSTWALD 314650 RIPENING 3969/CHE/2011 25‐06‐2019 A PHARMACEUTICAL COMPOSITION OF FORSKOLIN WITH 314665 ENHANCED SOLUBILITY 9416/DELNP/2014 25‐06‐2019 CRYSTALLINE MICROSPHERES AND THE PROCESS FOR 314670 MANUFACTURING THE SAME 9489/DELNP/2011 25‐06‐2019 "ONE OR MORE OF VIGNA MARINA, COCOS NUCIFERA L. OR 314676 TERMINALIA CATAPPA L. EXTRACTS FOR TREATING WOUNDS, SKIN DISORDERS AND HAIR LOSS" 7035/CHENP/2013 25‐06‐2019 GUANIDINE COMPOUND 314678 83/KOLNP/2013 26‐06‐2019 NANOPARTICLE FILM DELIVERY SYSTEMS 314727 1631/CHENP/2015 26‐06‐2019 BIVALENT INHIBITORS OF IAP PROTEINS AND THERAPEUTIC 314736 METHODS USING THE SAME 201841004178 26‐06‐2019 A PROCESS FOR PREPARATION OF LULICONAZOLE 314738 8445/CHENP/2012 26‐06‐2019 HJURP PEPTIDES AND VACCINES INCLUDING THE SAME 314747 577/MUM/2014 26‐06‐2019 FUROSEMIDE NANOSUSPENSION 314760 513/MUMNP/2013 26‐06‐2019 MONOCLONAL ANTIBODY HAVING IMMUNOSUPPRESSIVE ACTIVITY 314780 OR FRAGMENT TO WHICH ANTIGEN THEREOF IS BONDED

7013/DELNP/2013 26‐06‐2019 DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE AS 314787 MEDICAMENT 1420/KOLNP/2013 26‐06‐2019 PYRROLIDINONES AS METAP‐2 INHIBITORS 314801 20/KOLNP/2013 26‐06‐2019 "PHARMACEUTICAL DOSAGE FORM COMPRISING 6'‐FLUORO‐(N‐ 314816 METHYL‐ OR N,N‐DIMETHYL‐)‐4‐PHENYL‐4',9'‐DIHYDRO‐3'H‐ SPIRO[CYCLOHEXANE‐1,1'‐PYRANO[3,4,B]INDOL]‐4‐AMINE" 48/MUMNP/2012 27/06/2019 PHARMACEUTICAL COMPOSITIONS COMPRISING 314853 COMBINATIONS OF MANGANESE COMPLEX AND NON‐MANGANESE COMPLEX COMPOUND 2357/KOLNP/2014 27/06/2019 BICYCLIC PYRAZINONE DERIVATIVES 314949 9264/CHENP/2012 27‐06‐2019 “PHARMACEUTICAL EMULSION COMPOSITIONS COMPRISING 314861 PROGESTOGEN” 7848/DELNP/2013 27‐06‐2019 A METHOD FOR PREPARING A SILDENAFIL‐FREE BASE‐CONTAINING 314868 FILM 201617041090 27‐06‐2019 COMPOSITION FOR DYEING KERATIN FIBERS 314873 4065/CHENP/2014 27‐06‐2019 PYRAZINE KINASE INHIBITORS 314887 2817/DELNP/2012 27‐06‐2019 "LOW ETHER COMPOSITION AND DELIVERY APPARATUS" 314895 3789/CHENP/2015 27‐06‐2019 HETEROBICYCLO SUBSTITUTED [1 2 4]TRIAZOLO[1 5 C]QUINAZOLIN 314911 5 AMINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES

824/MUMNP/2013 27‐06‐2019 HUMAN ANTIBODIES AND DIAGNOSTIC AND THERAPEUTIC USES 314934 THEREOF FOR THE TREATMENT OF NEUROLOGICAL DISEASE 8195/DELNP/2015 27‐06‐2019 SILK BASED CAPSULES 314975 4633/CHENP/2015 27‐06‐2019 ANTI‐APOPTOTIC BCL‐2 PROTEINS INHIBITORS 314979 5005/KOLNP/2010 27‐06‐2019 GLOBO H AND RELATED ANTI‐CANCER VACCINES WITH NOVEL 314985 GLYCOLIPID ADJUVANTS 1040/CHENP/2015 27‐06‐2019 SUBSTITUTED PYRAZOLONE COMPOUNDS AND METHODS OF USE 314996

Page 84 of 85 862/DELNP/2014 27‐06‐2019 NOVEL FXR (NR1H4) BINDING AND ACTIVITY MODULATING 315007 COMPOUNDS 2243/KOLNP/2011 28/06/2019 A METHOD OF LOWERING CIRCULATING OXIDIZED LOW DENSITY 315204 LIPOPROTEIN‐BETA‐2‐GLYCOPROTEIN 1 COMPLEX FOR TREATMENT OF ATHEROSCLEROSCLEROSIS 5660/CHENP/2015 28/06/2019 HETEROAROMATIC COMPOUNDS AS PI3 KINASE MODULATORS 315196 2446/KOLNP/2015 28‐06‐2019 INTERMEDIATES FOR USE IN THE PREPARATION OF INDAZOLE 315030 DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF 2317/MUMNP/2012 28‐06‐2019 URETHANES UREAS AMIDINES AND RELATED INHIBITORS OF 315047 FACTOR XA 7910/CHENP/2012 28‐06‐2019 THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN 315088 OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE 7495/CHENP/2011 28‐06‐2019 “NUCLEIC ACID MOLECULE” 315101 1489/KOLNP/2013 28‐06‐2019 ARYLAMIDE DERIVATIVES AS TTX‐S BLOCKERS 315110 5089/KOLNP/2011 28‐06‐2019 USE OF DERIVATIVES OF INDOLES FOR THE TREATMENT OF CANCER 315116

2993/KOLNP/2014 28‐06‐2019 INDOLECARBONITRILES AS SELECTIVE ANDROGEN RECEPTOR 315124 MODULATORS 4461/DELNP/2012 28‐06‐2019 "DUAL‐ACTION COMPOUNDS TARGETING ADENOSINE A2A 315143 RECEPTOR AND ADENOSINE TRANSPORTER FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES" 114/MUMNP/2015 28‐06‐2019 CHROMANYL DERIVATIVES FOR TREATING MITOCHONDRIAL 315199 DISEASE 201617017693 28‐06‐2019 IMIDAZOTHIAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY 315200

3226/CHE/2013 28‐06‐2019 A CHEMICAL POTENTIATING COMPOSITION 315202 2821/KOLNP/2011 28‐06‐2019 SYNERGISTIC COMBINATIONS OF CAROTENOIDS AND 315212 POLYPHENOLS 1296/MUM/2014 28‐06‐2019 METHOD FOR EFFICIENT ENZYMATIC HYDROLYSIS OF 315214 LIGNOCELLULOSIC MATERIALS. 4251/DELNP/2015 28‐06‐2019 STABLE METAL ION CONTAINING COMPOSITIONS 315235 954/MUM/2009 28‐06‐2019 A NOVEL CREAM AND A PROCESS TO MAKE THE SAME 315246 3224/KOLNP/2013 01‐07‐2019 METHOD FOR PRODUCING FINE POWDER OF LOXOPROFEN 305410 SODIUM DIHYDRATE FOR PHARMACEUTICAL PREPARATIONS 4618/DELNP/2011 02‐07‐2019 SUFENTANIL SOLID DOSAGE FORMS COMPRISING OXYGEN 315383 SCAVENGERS AND METHODS OF USING THE SAME 6609/CHENP/2013 02‐07‐2019 EMULSION W/SI FOUNDATION 315385 2194/MUMNP/2013 03‐07‐2019 COEXTRUDABLE MULTIPHASE DENTIFRICE COMPOSITIONS 308725 2880/KOLNP/2012 03‐07‐2019 PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS 308802 FOR INHALATION 4087/DELNP/2014 03‐07‐2019 LYOPHILIZED LIPOSOMES 315447 3424/DELNP/2014 03‐07‐2019 AMIDE DERIVATIVES OF N UREA SUBSTITUTED AMINO ACIDS AS 315478 FORMYL PEPTIDE RECEPTOR LIKE 1 (FPRL 1) RECEPTOR MODULATORS 201621006380 04‐07‐2019 DRUG DELIVERY SYSTEM 315542 1839/DEL/2010 04‐07‐2019 ANTI‐PRECANCER AND ANTIMICROBIAL HERBAL MOUTHWASH AND 315566 A PROCESS THEREOF. 4016/KOLNP/2012 05‐07‐2019 ANTI‐DIABETIC COMPOSITIONS AND METHODS 315589 5264/DELNP/2013 05‐07‐2019 ANTI MICROBIAL COMPOSITION 315597 637/DELNP/2015 05‐07‐2019 FORMULATIONS AND METHODS OF MANUFACTURING 315607 FORMULATIONS FOR USE IN COLONIC EVACUATION 8086/DELNP/2014 05‐07‐2019 PYRAZOLO‐TRIAZINE DERIVATIVES AS SELECTIVE CYCLIN 315609 DEPENDENT KINASE INHIBITORS 5464/CHE/2012 06‐07‐2019 PROCESS FOR PREPARING CABAZITAXEL AND ITS SOLVATE 313846

Page 85 of 85